Congress Programme 31 Final

CONGRESS PROGRAMME
3rd to 8th JULY 2023
1
2
INDEX
WELCOME TO WCD2023
6
Message from the WCD2023 President and Secretary-General
Message from the ILDS President 8
Message from the DSS President 9
Previous World Congresses 11
Officers and Committees 12
WCD Ambassadors 15
GENERAL INFORMATION 18
SCHOLARSHIPS 36
ILDS MEMBER SOCIETY & SISTER SOCIETIES MEETINGS 50
SCIENTIFIC SESSIONS
Message from the Scientific Programme Committee Chair and Vice-Chair 54
CME Accreditation 56
Plenary Speakers 57
Tuesday 4th July 60
Wednesday 5th July 92
Thursday 6th July 120
Friday 7th July 150
Saturday 8th July 182
WCD2023 POSTER ROUND SESSIONS 198
SPONSORED SESSIONS 200

Tuesday 4th July 206
Wednesday 5th July 211
Thursday 6 July
th
216
Friday 7th July 220
Sponsor Profiles 224

Exhibition Hall Floor Plan 233
Printed in June 2023
3
SUPPORTING ORGANISATIONS
4
PARTNERS
MEDIA PARTNERS
5
WELCOME TO THE 25th WORLD CONGRESS
OF DERMATOLOGY
Dear friends and colleagues,
After 4 years of preparations, we are now ready to present the 25th World Congress of Dermatology
in Singapore.
To get to this stage, we have called on the coordinated effort of numerous individuals in several organ-
isations, viz. the National Organising Committee (NOC) of the Dermatological Society of Singapore,
the Scientific Programme Committee (SPC), the Executive Committee, Board, and staff of the Interna-
tional League of Dermatological Societies (ILDS), and Triumph our professional several conference or-
ganisers. Together, we have put in thousands of hours to make the 25th WCD outstanding scientifically
and memorable socially.
The Theme of the WCD, Dermatology Beyond Borders, could not be more poignant in these times of
geopolitical tension and turmoil. It reminds us of the need for us as healthcare providers and scientists
to continue to strive for the betterment of all mankind. We can do this by keeping the platforms of dis-
cussion and channels of information exchange open, and we aim to leave a legacy to the next edition of
WCD in 4 years time. To make the WCD a truly global meeting, the NOC and the SPC have tried to be as
diverse and inclusive as possible when selecting chairs, co-chairs, speakers, session topics and moder-
ators. We are happy to report that the number and proportion of chairs and cochairs of symposia who
come from the Asia-Pacific, South Asia, the Middle East, and Africa have doubled compared to WCD2019.
The congress’s Subtheme is Science, Care and Communities. We will present a scientific programme that
is both wide as well as deep, leaving no areas uncovered. There will be 15 keynote plenaries, 60 Symposia
in 208 sessions, 8 Controversies in Dermatology debates, 24 Courses, 19 Expert Forums, 30 DSS/LADS ses-
sions, 51 Free Communications sessions, 12 Residents sessions, 5 late-breaking sessions and 3 sessions for
Hot topics. It will cover all areas of dermatology – from medical to surgical conditions, from infections to
aesthetic procedures, from skin cancers to pigmentary diseases, from paediatric dermatology to diseases
in the elderly, from basic science to quality of care, from dermatopathology to STI/HIV, from eczema to
neglected tropical diseases, from skin aging to hair and nail diseases, and everything else in between. We
will present the latest advances in diagnostics and therapeutics and take a glimpse into the future of where
dermatology is headed. We would like to thank Prof Martin Röcken and Prof Henry Lim and other members
of the Scientific Programme Committee; they have worked hard to design a truly outstanding programme.
We are incredibly grateful for the chairs, cochairs and speakers who have agreed come to Singapore and
to share their expertise. Without you there would be no WCD.
We have received a large number of abstracts and they will provide rich and informative free communi-
cations, residents, and late breaker sessions, as well as poster sessions and displays. The 25th WCD will
truly be a festival of dermatology.
To encourage the participation of patient organisations, we have planned for more sessions and pres-
entations for these groups and will have a community village. We have also lowered the registration fees
for patient support organizations, as well as for nurses and allied health personnel.
To complement the scientific content, we will present a variety of entertainment performances at our
social events. We hope to give you a taste of the colorful multicultural heritage that we have in South-
East Asia and in Singapore.
6
We are very grateful for the wonderful help from many colleagues and friends in the dermatology fra-
ternity, especially WCD Ambassadors and ILDS Board who have actively promoted the WCD2023 to all
corners of the world.
Last but certainly not least, we acknowledge and thank our industry partners. It is with their generous
sponsorship that we are able to stage the 25th WCD, and to increase the assistance for needy delegates.
We speak for all in the NOC and other presenting and supporting organisations when we say that we are
incredibly excited and very much looking forward to welcoming you to Singapore in July.
Lights, Camera, and Action!
With best wishes
Prof. Roy CHAN A/Prof. Yen Loo LIM

President Secretary-General
7
MESSAGE FROM THE ILDS PRESIDENT
Dear WCD2023 Delegates, Members of the International League of Dermatological Societies (ILDS),
Friends and Colleagues,
Welcome to Singapore and our flagship event, the World Congress of Dermatology.
Here in beautiful Singapore, surrounded by modern design, water and wonderful tropical vegetation we
will be hosted with great devotion by the Dermatological Society of Singapore for a global highlight in
dermatology.
Faithful to our mission of improving “Skin Health for the World”, the ILDS has worked hard towards mak-
ing this WCD a globally inclusive event fostering high-level dermatological education, exchange of pro-
fessional knowledge and skills, with the aim of improving our specialty and patient care.
The 25th WCD takes place every 4 years under the auspices of the ILDS and builds upon the success of
WCD 2019 Milan. I am extremely grateful to WCD2023 President Roy Chan, Secretary-General Yen Loo
Lim, and the Dermatological Society of Singapore for their tremendous devotion as hosts in challenging
post-Covid times. My thanks also to the Scientific Programme Committee, headed by Martin Röcken
(Chair) and Henry Lim (Vice-Chair) for the newly structured program with half-day/day grouped theme
tracks of great depth, quality, global representation, practical relevance, and appeal. I am confident
everyone will benefit from the exciting scientific and social program offered here in Singapore.
In tradition, WCD2023 will also be a time of suspense during which new members will be elected to the
ILDS Board of Directors and the location of the next World Congress will be decided.
It has been a true honour to serve as your ILDS President over the last four years. Representing over
190-member dermatological societies and 220,000 dermatologists worldwide, and dermatology within
the WHO as a non-state actor, is an honor! Together with dedicated dermatologists, a wonderful ILDS
office team in London, patient representatives, nurses, allied health professionals, and industry we are
delivering on our agenda (www.ilds.org) to successfully promote skin health globally. Thank you!
I truly appreciate you being with us in Singapore to share your precious time and experience with col-
leagues from different parts of the world. Please stay tuned to the latest news by following our social
media accounts @ILDSDerm on LinkedIn, Twitter, Facebook and Instagram.
I look forward to meeting you all in Singapore.
With my best personal regards,
Lars French, MD
ILDS President
8
MESSAGE FROM THE DSS PRESIDENT
A WARM WELCOME TO SINGAPORE!
It is the privilege and delight of the Dermatological Society of Singapore to be the host of the 25th World
Congress of Dermatology. This congress is the culmination of the enormous efforts and achievements put
together by the ILDS and the national organizing committee led by Prof Roy Chan and A/Prof Lim Yen Loo.
Against the backdrop of post-pandemic changes, the burden of skin disease worldwide and global events,
the theme “Dermatology Beyond Borders” resonates so much more! In the next few days of the congress,
I hope that even we are kept abreast on the latest in skin science and patient care, we will continue to
build new friendships, strengthen the existing ties, together building the global dermatology community.
Finally, in the midst of all the sessions and events, I hope that you will have the opportunities to enjoy the
food, culture and experiences that Singapore and the region has to offer.
Wishing you a fruitful time at the WCD 2023!
A/Prof. Haur Yueh Lee

President, Dermatological Society of Singapore
DERMATOLOGICAL SOCIETY OF SINGAPORE
HOST ORGANISATION
The genesis of DSS dates back to 1960 when a group of doctors founded the Sin-
gapore Dermatological Society under the umbrella of the Singapore Medical Asso-
ciation. The name of the Society was later changed to the Dermatological Society
of Singapore when it became an independent Society in 1972. DSS is an active
member of the League of ASEAN Dermatological Societies (LADS) as well as the
International League of Dermatological Societies (ILDS).
9
10
PREVIOUS WORLD CONGRESSES
The World Congress of Dermatology (WCD) is one of the largest international dermatological confer-
ences. It is organised under the auspices of the International League of Dermatological Societies (ILDS).
The first WCD was held in 1889 in Paris. It is now held every 4 years, the most recent one was the 24th
WCD, that was staged in June 2019 in Milan, Italy.
The WCD aims to promote the science and practice of dermatology, by providing a platform for spe-
cialists from around the world to showcase new knowledge, exchange clinical experiences and scien-
tific research, and to build professional and personal networks and collaborations.
Over the past 130 years, the WCD has traversed the globe. It has brought together dermatologists and
professional societies and has raised the stature and importance of skin health and diseases that affect
humankind.
11
OFFICERS AND COMMITTEES
The International League of Dermatological Societies (ILDS) promotes the improve-
ment of dermatological care, education and science across the world. We provide
leadership and support to foster initiatives, projects and policies with global impact
for those affected by skin disease. We bring together 198 Members from more than
90 countries representing over 200,000 dermatology specialists.
Our Vision: Attaining the best possible skin health for all people around the world.
Our Mission: The mission of the ILDS is to increase awareness, cooperation and com-
munication within the global dermatology community to promote high quality education, clinical care,
research and innovation that will improve skin health globally.
ILDS BOARD MEMBERS

BOARD OF DIRECTORS
Lars French, President, Germany
Hassan Galadari, Secretary-General, UAE
Brigitte Dréno, Treasurer, France
Harvey Lui, Immediate Past-President, Canada
Claire Fuller, IFD Chair, UK
María Ivonne Arellano Mendoza, Mexico

Ramesha Bhat, India
Luca Borradori, Switzerland
Roy Chan, Singapore
Jin Ho Chung, South Korea
Ncoza Dlova, South Africa
Kenji Kabashima, Japan
Margarita Larralde, Argentina
Henry W. Lim, USA
Omar Lupi, Brazil
Venkataram Mysore, India
Giovanni Pellacani, Italy
Martin Röcken,Germany
Stephen Shumack, Australia
Daniel Siegel, USA
ILDS EXECUTIVE DIRECTOR

Arpita Bhose, UK
12
COMMITTEES
ILDS/WCD2023 SCIENTIFIC PROGRAMME COMMITTE
CHAIR
Martin Röcken, Germany
VICE CHAIR
Henry Lim, USA
IADPO REPRESENTATIVE
Jennifer Austin, Canada
Ramesha Bhat, India Christopher Griffiths, UK

Roy Chan, Singapore Kenji Kabashima, Japan
Jin Ho Chung, South Korea Margarita Larralde, Argentina
Brigitte Dréno, France Yen Loo Lim, Singapore
Lars French, Germany Harvey Lui, Canada
Hassan Galadari, UAE Giovanni Pellacani, Italy
NATIONAL ORGANISING COMMITTEE

PRESIDENT
Roy Chan
SECRETARY GENERAL
Yen Loo Lim
TREASURER
Shang-Ian Tee
VICE PRESIDENTS
Haur Yueh Lee
Suat Hoon Tan
Steven Thng
HONORARY PRESIDENT
Chee Leok Goh
Chia Chun Ang, Changi General Hospital

Nisha Suyien Chandran, National University Hospital
Suzanne Cheng, National Skin Centre
Martin Chio, National Skin Centre
Sze Hon Chua, National Skin Centre
Emily Gan, KK Women’s and Children’s Hospital
Mark Koh, KK Women’s and Children’s Hospital
Hong Yi Koh, Tham Siew Nee Skin Clinic
Birgitte Lane, Skin Research Institute of Singapore
Joyce Lee, National Skin Centre
Michelle Liang, National Skin Centre
13
Joel Lim, National Skin Centre
Kar Seng Lim, The Dermatology Practice
Choon Chiat Oh, Singapore General Hospital
Hazel Oon, National Skin Centre
Jiun Yit Pan, National Skin Centre
Chris Tan, National University Hospital
Lucinda Tan, National Skin Centre
Chee Hian Tan, National Skin Centre
Mark Tang, Skin Specialists & Laser Clinic
Maurice Van Steensel, Lee Kong Chian School of Medicine
Etienne Wang, National Skin Centre
Su-Ni Wong, Dr SN Wong, Skin, Hair, Nails & Laser Specialist Clinic
Yik Weng Yew, National Skin Centre
Angeline Yong, Angeline Yong Dermatology
NOC COMMITTEES
Scientific Programme Scholarships Social Programme

Roy Chan Mark Tang & Hospitality
Yen Loo Lim Choon Chiat Oh Michelle Liang
Lucinda Tan
Abstracts Finance & Audit Angeline Yong
Suat Hoon Tan Shang Ian Tee
Yen Loo Lim Emily Gan Marketing
Sze Hon Chua & Information Technology
Joyce Lee Contracts & Agreements Martin Chio
Jiun Yit Pan Suat Hoon Tan Birgitte Lane
Maurice Van Steensel Roy Chan Chee Hian Tan
Yik Weng Yew Yen Loo Lim Shang Ian Tee
Etienne Wang
Free Communications Venue & Facilities Roy Chan
& Posters Roy Chan
Yen Loo Lim Haur Yueh Lee WCD Ambassadors
Chia Chun Ang Steven Thng Roy Chan
Mark Koh Chee Leok Goh
Haur Yueh Lee Sponsors & Exhibitors Yen Loo Lim
Joel Lim Steven Thng
Kar Seng Lim Roy Chan
Hazel Oon
Chris Tan Publications
Su Ni Wong Nisha S Chandran
Suzanne Cheng
DSS/LADS Sessions Hong Yi Koh
Haur Yueh Lee Maurice Van Steensel
Mark Koh Roy Chan
Hazel Oon
Su Ni Wong
14
WCD AMBASSADORS
AFRICA & MIDDLE EAST EUROPE
de Almeida Voumard Lidia, Angola Adaskevich Uladzimir, Belarus
Farag Assem, Egypt Skerlev Mihael, Croatia
Lartey Margaret, Ghana Vasku Vladimir, Czech Republic
Handjani Farhad, Iran Beylot-Barry Marie, France
Barzilai Aviv, Israel Caux Frédéric, France
Okudo Chita Grace, Nigeria Ionescu Marius-Anton, France
Kayitenkore Kayitesi, Rwanda Mekokishvili Lali, Georgia
Altalhab Saad, Saudi Arabia Luger Thomas, Germany
Smith Jonathan, South Africa Plewig Gerd, Germany
Mavura Daudi, Tanzania Sander Christian, Germany
Doss Nejib, Tunisia Zillikens Detlef, Germany
Mulyowa Grace Kitunzi, Uganda Zouboulis Christos C., Germany
Argenziano Giuseppe, Italy
ASIA Micali Giuseppe, Italy
Chan Vicheth, Cambodia Peris Ketty, Italy
Sithach Mey, Cambodia Rubins Andris, Latvia
Ran Yuping, China Rudnicka Lidia, Poland
Zhang Jianzhong, China Gomberg Mikhail, Russia
Chu Chia-Yu, Chinese Taipei Lvov Andrey, Russia
Huang Patrick Po-Han, Chinese Taipei Lòpez-Estebaranz Jose Luis, Spain
Wu Yu-Hung, Chinese Taipei Nuño Gonzàlez Almudena, Spain
Yang Jason Chih-Hsun, Chinese Taipei Pasquali Paola, Spain
Chan Henry Hin Lee, Hong Kong Rodríguez-Cerdeira Carmen, Spain
Godse Kiran, India Haneke Eckart, Switzerland
Lahiri Koushik, India Hsu Christophe, Switzerland
Marfatia Yogesh, India Calikoglu Emel Erdal, Turkey
Rao Narasimha P., India Sahin Mustafa Turhan, Turkey
Sarkar Rashmi, India Griffiths Christopher, UK
Listiawan M. Yulianto, Indonesia McGrath John, UK
Abe Riichiro, Japan Penzer-Hick Rebecca, UK
Amagai Masayuki, Japan
Morita Akimichi, Japan LATINA AMERICA
Sato Shinichi, Japan Cabo Horacio, Argentina
Chan Lee Chin, Malaysia Luna Paula, Argentina
Chow Steven, Malaysia Gontijo Gabriel, Brazil
Heng Agnes, Malaysia Ramos-e-Silva Marcia, Brazil
Zaw Khine Khine, Myanmar Steiner Denise, Brazil
Derla Almond, Philippines Cabrera Raúl, Chile
Handog Evangeline, Philippines Chang Patricia, Guatemala
Paz-Lao Purita (Peachy), Philippines Ocampo Candiani Jorge, Mexico
Choi Eung Ho, South Korea Poletti Eduardo David, Mexico
Chung Kee-Yang, South Korea Bravo Puccio Francisco, Peru
Kwon Ohsang, South Korea Pérez-Alfonzo Ricardo, Venezuela
Park Chun Wook, South Korea
Kahawita Indira Padmapani, Sri Lanka
Asawanonda Pravit, Thailand
Ungpakorn Rataporn, Thailand
Khang Tran Hau, Vietnam
15
NORTH AMERICA OCEANIA
Janus Christine, Canada Kumarasinghe Prasad, Australia
Shear Neil, Canada Murrell Dedee, Australia
Bergfeld Wilma, USA Rodrigues Michelle, Australia
Bhatia Neal, USA Soyer Peter, Australia
Bolognia Jean, USA Rademaker Marius, New Zealand
Eichenfield Lawrence, USA
Elston Dirk, USA
Hruza George J., USA
Kaufmann Mark, USA
Konnikov Nellie, USA
Lebwohl Mark, USA
Schmults Chrysalyne, USA
Shapiro Jerry, USA
Thiers Bruce, USA
Tomecki Kenneth, USA
Tosti Antonella, USA
Watsky Kalman, USA
Yosipovitch Gil, USA
16
GENERAL INFORMATION
3rd to 8th JULY 2023
17
17
GENERAL INFORMATION
Dates: 3rd to 8th July, 2023
City: Singapore, Singapore
CONGRESS VENUES
Suntec Singapore Convention & Exhibition Centre
1 Raffles Boulevard, Suntec City, Singapore 039593
Pan Pacific Singapore

7 Raffles Boulevard, Singapore 039595
Host: DSS - Dermatological Society of Singapore

Website: www.wcd2023singapore.org
PROFESSIONAL CONGRESS ORGANISER
TGI Singapore Pte Ltd

65 Chulia Street, #46-01, OCBC Centre, Singapore 049513
[email protected]
www.wcd2023singapore.org
REGISTRATION
DELEGATE REGISTRATION
Registration desk is located at Concourse 2-3 Level 3 of the Suntec Congress Venue.
Registration Desk Hours:

Sunday, 2nd July from 12:00 to 18:00
Monday, 3rd July from 7:00 to 19:30
Tuesday, 4th July from 6:30 to 19:00
Wednesday, 5th July from 7:00 to 19:00
Thursday, 6th July from 7:00 to 19:00
Friday, 7th July from 7:00 to 19:00
Saturday, 8th July from 7:00 to 15:00
Congress Delegate Registration Fees include:

• Access to all Congress Sessions and ePoster Area
• Access to Sponsored & Satellite Symposia and Meet the Expert Sessions
• Access to Exhibition Area (for healthcare professionals only – see below)
• Opening and Closing Ceremonies
• Delegate Bag and Congress Proceedings
• Singapore public transportation card
Registration fee does not include the printed scientific programme; you can download it through the
WCD2023 App.
Scientific Programme sessions are open to registered delegates only.
18
HEALTHCARE/NON-HEALTHCARE PROFESSIONAL
According to the HSA – HEALTH SCIENCES AUTHORITY – REGULATORY GUIDANCE the advertising of all
types of medicinal products should be directed exclusively to the following health professionals:
• Qualified Practitioners
• Registered pharmacists
• Enrolled nurses
• Registered nurses and registered midwives
• Persons undergoing training with a view to becoming qualified practitioners, registered pharmacists,
enrolled nurses, registered nurses
Companies must ensure that advertisements intended solely for these classes of persons are restricted
in circulation, and are not freely available to the general public.
As the event will take place in Singapore, and a multidisciplinary audience will be attending the 25th WCD
Congress, the Organising Secretariat will assign different badges to Healthcare Professionals (HCP) and
NON-Healthcare Professionals (NON-HCP) to ensure compliance with the above regulations.
Access to the industry Exhibition Area will be restricted to Healthcare Professionals (HCP).
Press, Patient Organisation Representatives and Accompanying Persons will not be permitted entry to
the Exhibition Area and will automatically be classified as NON-Healthcare Professionals.
Accompanying Persons Registration Fees include:

• Welcome Reception
• Two Singapore tours
• Singapore public transportation card
Accompanying Persons DO NOT have access to scientific sessions and Exhibition Area.
19
COURSES FEES
Fees below are inclusive of any applicable taxes and quoted in SGD:
COURSE DURATION DATE AM/PM RATE
Advanced Dermatological Surgery Full Day 6th July 2023 200 SGD
Advanced Dermoscopy Half Day 5th July 2023 PM 100 SGD
Basic Dermatological Surgery Full Day 4th July 2023 200 SGD
Basic Dermatopathology - Inflammatory Half Day 4th July 2023 PM 100 SGD
Basic Dermatopathology - Neoplastic Half Day 5th July 2023 AM 100 SGD
Basic Dermoscopy Half Day 5th July 2023 AM 100 SGD
Chemical Peels Half Day 4 July 2023 AM

th
100 SGD
Contact Dermatitis Half Day 7th July 2023 AM 100 SGD
Cutaneous T, B and NK cell lymphomas: classical and new treatments Half Day 5th July 2023 AM 100 SGD
Cutaneous T, B and NK cell lymphomas: diagnosis and differential
Half Day 8th July 2023 AM 100 SGD
diagnosis
Epidemiological Methods in Dermatology Research Half Day 7th July 2023 PM 100 SGD
Evaluation of and testing for drug allergy/hypersensitivity Half Day 6 July 2023 PM
th
100 SGD
Hair transplantation: from principles to post-operative care Half Day 4th July 2023 AM 100 SGD
Laser I: Pigment and Assisted Hair Removal Lasers Half Day 7th July 2023 AM 100 SGD
Laser II: Skin Rejuvenation and Scars Half Day 7th July 2023 PM 100 SGD
Laser III: Vascular Lesions Half Day 8th July 2023 AM 100 SGD
Motivational Interviewing in Supportive Patient Care Half Day 8 July 2023 AM

th
100 SGD
Nail surgery Half Day 5th July 2023 PM 100 SGD
Paediatric Dermatology: Genodermatoses Half Day 7th July 2023 AM 100 SGD
Paediatric Dermatology: Vascular anomalies and practical therapies Half Day 7th July 2023 PM 100 SGD
Paediatric Immunodermatology Half Day 5th July 2023 PM 100 SGD
Phototherapy & Photoprotection Half Day 4 July 2023 PM

th
100 SGD
Trichoscopy Half Day 6th July 2023 AM 100 SGD
Update in Dermatopathology Full Day 6th July 2023 200 SGD
NAME BADGES
For security reasons delegates, accompanying persons, and exhibitors must wear their name badges at
all times to access Suntec and Pan Pacific Hotel congress venues, scientific sessions and social activities.
Name badges will be scanned for admission to Courses.
Replacement conference badges will be charged SGD 80 a card.
NAME CHANGES
Name changes are possible during the pre-registration period only. Thereafter no name change requests
will be accepted.
Name changes will be allowed between delegates belonging to the same registration category.
Participants belonging to different registration categories will not be entitled to reimbursement if
the fee paid by the old delegate is higher than the new participant fee (e.g. ILDS Members replacing
Non-Members. This will apply to any registration category).
20
Participant replacing a delegate registered with a lower registration fee is requested to pay the difference
between his registration fee and the old delegate one (e.g. Non-Members replacing ILDS Members).
Each name change will cost SGD 80,00.
DELEGATE BAGS
Delegate bags can be collected at the Congress Bag Desk in Registration Area (Level 3) by scanning the
name badge.
EXHIBITOR REGISTRATION
Hours of Operation:
EXHIBITOR BADGES
Exhibitor badges allow access to the Exhibition Area, Opening and Closing Ceremony. Exhibitor badges do
not allow access to Scientific Sessions. Exhibitors can access to their own company sponsored sessions.
Exhibitors who rent an exhibition booth are entitled to a specific number of free Exhibitor badges.
Badges purchased on site have a cost of SGD 300,00 + 8% GST.
EXHIBITION AREA
One of the highlights of the 25th World Congress of Dermatology is the Exhibition Area. Located at Level
4, this is your chance to visit over 100 exhibitors.
Hours of operation:
Exhibitors are allowed to access the Exhibition Area from 8:00 in the morning.
Congress participants are allowed to access the Exhibition Area the from 9:00 in the morning.
Important note: please do not arrange meetings with clients within the exhibition booth outside the
exhibition opening hours as delegates with a full congress registration badge are not allowed to enter
the exhibition before the official opening hours.
Consult the Exhibition & Sponsored Symposia section for all the details you need, including Floor Plans
and Exhibitor Profiles. This information is also available on the WCD2023 App.
PATIENT ORGANISATIONS & DERMATOLOGY COMMUNITY VILLAGE

Located at Hall 602, Level 6. In this area you can find Patients Organisations, Scientific Associations and
WCD2027 Bid stands.
21
Hours of Operation:
MEDIA REGISTRATION
Registration Desk Hours:

MEDIA CENTRE
Located at Level 3 – Room 304
WCD2023 Media Centre opening hours are:

• 3rd July 2023 from 10:00 to 17.30
• From 4th to 7th July 2023 from 08:00 to 18.00
• 8th July 2023 from 08:00 to 14.00
PRESS CREDENTIAL ACCESS

Registered media will have access to:
• Access to all Congress Sessions and ePoster Area
• Access to Sponsored & Satellite Symposia and Meet the Expert Sessions
• Delegate Bag and Congress Proceedings
There is an SGD 80.00 fee to issue a replacement for a lost badge.
Members of the press who have questions for presenters should arrange interviews with them rather
than ask questions during the session.
Members of the media are observers of and not participants in educational sessions.
Registered Media are prohibited from developing CME content, or its international equivalent, based
on information presented at the WCD2023.
Press is prohibited from attending:

• Business/operational meetings of the International League of Dermatologic Societies’ National and
Affiliate Member Societies, including but not limited to: annual general meetings, board of directors’
meetings, advisory boards, councils, committees, task forces and any special meetings/forums re-
quiring specific membership, ILDS general assembly
22
• Courses
• Welcome Reception, Social Events, President’s Dinner, Society and/or Sponsor Receptions.
PHOTOGRAPHY, VIDEO AND AUDIO RECORDING

Registered media is allowed to:
• Conduct video-recorded interviews only in the designated Interview Room or, in exceptional circum-
stances, with the accompaniment of a WCD2023 media department officer.
• Audio record interviews only with the written consent of the interviewee, in order to gather informa-
tion for accuracy and not for retransmission or reproduction.
Registered media are prohibited from:

• Photographing or videotaping in any scientific session, in the Exhibition Area or in the ePoster Area
• Photographing scientific material in the Exhibition Area, Poster Area, and Scientific Sessions, including
the use of digital cameras and mobile phones.
The WCD2023 Media Department will provide the media with official pictures every day.
Any violations of these rules will result in expulsion from the session, and from the 25th World Congress
of Dermatology.
Sessions will be closely monitored for such occurrences.
WCD2023 MEDIA CENTRE USE

Only those who have registered as Media are permitted to use the Media Centre as a working space and
to use all facilities (equipped with table, chairs, and electrical outlets). Doctors and other participants
who are not registered as Media are not permitted access to the Media Centre, unless they are partici-
pating in an interview with a registered Media; in that case, interviewees must always be accompanied
by a registered Media and may not remain in the room for more than one hour.
Please note that the Media Centre may not be used for equipment storage.
The Interview Room is located in Room 305 Suntec Congress Venue.
Opening hours:
From 4th to 7th July 2023: 9:00 to 17.00
This space must be booked ahead of time at the Media desk and is available on a first come, first served
basis. It can be reserved for free for a maximum of one hour.
The equipment must be assembled and disassembled within the time frame specified.
Unless otherwise announced, all interviews will take place in the Interview Room.
After reviewing the programme, journalists must send their interview requests to
[email protected].
The Photocall Area is located at Level 3, in the foyer in front of Room 303.
Opening hours:
• 3rd July 2023: 10:00 to 17:30
• 4-5-6-7 July 2023: 8:00 to 18:00
• 8th July 2023: 8:00 to 14:00
The Opening Press Conference will take place in Room 303, Level 3, on 3rd July at 12:30.
COPYRIGHT INFORMATION
The 25th World Congress of Dermatology is wholly owned by the ILDS and is not a public event. Any un-
authorised use of program content, which includes, but is not limited to, oral presentations, audio-visual
23
materials used by speakers, poster abstracts, and programme papers, outlines and handouts, without
the written consent of the WCD2023 is prohibited and will be grounds for termination of press creden-
tials, a ban from future meetings and prosecution for infringement of applicable copyright law.
Handout materials are prepared and submitted for distribution by the presenters, who are solely respon-
sible for their content.
Under no circumstances may the information presented at the WCD2023, with the exception of news
releases, be republished in its original format in print, broadcast or electronic media.
The views expressed and the techniques presented by the speakers at WCD2023 sponsored education-
al meetings are not necessarily shared or endorsed by the WCD2023.
INTERPRETATION & APPLICATION OF MEDIA & PRESS GUIDELINES

All issues and questions not specifically covered by these Media guidelines are subject to the decisions
of the WCD2023. WCD2023 reserves the right to amend or supplement these guidelines as necessary
and to notify of such changes to registered press.
WCD2023 APP
The official WCD2023 App will offer delegates a convenient way to stay up-to-date
with the scientific programme via their phones or tablets. View the programme, speak-
ers, maps and sponsors; save your favourite sessions in your agenda and exchange
contacts with other delegates!
You can access the App using your registration credentials or by scanning your badge.
Download it on iOS and Android!
SOCIAL MEDIA CHANNELS FOR WCD2023

Share your experience and images from WCD2023 with colleagues and friends via Twitter, Instagram,
Facebook and LinkedIn.
Follow us on:
Instagram: @wcd2023singapore
Twitter: @wcd2023sg
Facebook: @WCD2023-Singapore
LinkedIn: 25th World Congress of Dermatology
and use the official Congress hashtag & tag: #WCD2023Singapore
WCD2023 ePOSTER AREA

Located at Level 6 – Hall 602
POSTER ROUND SESSION

Platinum Featured Posters and Featured Posters have been selected by the Free Communications Commit-
tee among over 4,300 poster submissions, based on their scientific, clinical, and educational merit.
Posters will be displayed on high-resolution LCD monitors within the ePoster Area, Level 6, Hall 602.
A dedicated Poster Round Session is daily scheduled in the ePoster Area, from the 4th to the 7th July,
from 14:30 to 15:30. The Presenters will be available to introduce and discuss about their Platinum Fea-
tured Posters.
SPEAKERS’ PREVIEW ROOMS

Located in Room 333, Level 3 – Suntec Convention & Exhibition Centre
Located in Ocean 8, Level 2 – Pan Pacific Hotel Singapore
24
The Speakers’ Preview Rooms are open to assist presenters of Congress Scientific Programme, Free
Communications sessions, ILDS Member Societies & ancillary Group Meetings.
Please, ensure you provide the final version of your presentation a minimum four (4) hours prior to your
scheduled presentation times.
Hours of Operation:
ILDS OFFICE
It is located at Level 3 – Summit Suite.
QUIET ROOM
There is a Quiet Room, located at Level 3, Foyer 3 in a corner where the massage chairs are, available for
delegate use. This is designated as quiet space for contemplation, meditation and prayer.
COMMON AREA
Located at Level 6 in Hall 602 and Hall 605.
Hall 602 will be open as follows:

• from 4th to 6th July from 8:00 to 18:30, and on the 7th July from 8:00 to 17:00
Hall 605 will be open as follows:

• 4th July from 14:00 to 18:30
• 5th and 6th July from 8:00h to 18:30
• 7th July from 8:00 to 17:00
INFO DESK
Located in the Registration Area, Concourse 2-3, Level 3
Exhibition Area, Level 4
Common Area, Hall 602, Level 6
Common Area, Hall 605, Level 6
WI-FI
Free Wi-Fi service available. Select SSID - WCD_FREE_WiFi@SuntecSingapore to get connected in:
• Exhibition Area
• Registration Area
• Common Areas
LANGUAGE
The official language of the Congress is English. No simultaneous translation is available.
LOST AND FOUND

Information on lost and found will be available at the Info Desk at Level 3 – Concourse 2-3 – Registration Area.
25
LUGGAGE DEPOSIT AVAILABLE
A limited capacity luggage deposit will be available on 7th and 8th July at the Registration Area, Level 3.
ATM
ATMs are conveniently located at Suntec City Mall.
MEETING ROOM CAPACITIES

We want your WCD2023 experience to be a safe one. Every session room has a room capacity that has been
approved by Firefighters. Rooms are set to the maximum approved capacity, and no extra chairs can be added.
Seating space is limited and cannot be guaranteed. Session seating is available on a first come, first served basis.
For safety reasons, the Organising Secretariat will not allow delegates to stand in the back of the room,
in the aisles or lean against the walls. People standing will be asked to find a seat in the room and dele-
gates will be stopped from entering the session during this time.
OVERFLOW
In the event of an overflow, attendees will be able to follow the live sessions via the official WCD2023
App by clicking on the Streaming overflow icon available on Homepage 2.
Please check the room number of the desired session and connect by clicking on the matching button.
Streaming sessions can be followed in the common areas Hall 602, Hall 605 Level 6 and the plenary room
Hall 603-604.
Remember to bring your own earphones!
ATTIRE
Business casual attire is appropriate. Conference venue room temperature will be around 22°C/71,6°F
according to Singapore regulations. We suggest to dress in layers for personal comfort.
BABY CARE ROOM

Baby Care Room is available at Level 3 for breastfeeding and nappy changing.
CHILD POLICY
The Congress does not provide childcare. Children under the age of 18 are not allowed to access in the
whole Congress Venue, Welcome Cocktail, and Social Evening.
CERTIFICATE OF ATTENDANCE
Congress attendance certificates can be downloaded online, by accessing your User Area, 10 days after
the end of the event.
An email will be sent to inform all participants of the correct procedure.
CONCESSIONS/FOOD SERVICES
Breakfasts, lunches and coffee breaks are NOT included in the registration fee. Sandwiches, snacks and
beverages can be purchased at Suntec City Shopping Mall, Marina Square.
CAFETERIA
A cafeteria will be located in the Common Areas, Hall 602 and Hall 605 and will open on 4th July from
14.00 to 18.00, and from 5th to 7th July from 7.00 to 17.00.
CONGRESS DAILY NEWSPAPER

Daily online newspaper will be available by scanning the Qr code, and by downloading
the WCD2023 App.
26
WHEELCHAIR AND DISABLED ACCESS
All floors of the Congress Venues can be reached by elevators.
SUSTAINABILITY AT WCD2023
As the leading global dermatology congress, taking place in the city-state of Singapore, the go-to
destination for global business event, we felt the need to keep our environmental, social and econom-
ic impact in check and lead the way for more sustainable actions.
We drafted a document that became the Congress Manifesto: the WCD2023 Green Policy, taking into
account the United Nations Sustainable Development Goals (UN SDGs) and the Singapore Green Plan
2030.
The policy is complemented by the WCD2023 Green Nudges, a list of 25 actions aimed at instilling a
sense of responsibility to all stakeholders involved.
This will hopefully mitigate negative impact inherent in the realisation of this major event.
Furthermore, sponsors and exhibitors are more involved in this process, with the Congress launching
a Green Challenge to demonstrate how waste and pollution caused by product packaging can be
reduced, as well as sharing their sustainable production and disposal practices.
WCD2023 has also joined the OneMillionTrees movement, a project that aims to protect nature in Sin-
gapore by planting one million trees over the next 10 years.
The initiative is part of Singapore’s transformation into a City in Nature, a key component of the Sin-
gapore Green Plan 2030, to which WCD2023 has made a concrete contribution through a fundraising
campaign to support the local charity Garden City Fund, in order to offset the Congress’ effects.
GREEN CHALLENGE
Categories involved:
- Pharmaceutical and dermocosmetic companies submitted a maximum of 4 videos each, featuring in-
novative projects related to product packaging that have been on the market since June 2019 (date of
the latest WCD edition);
- Medical equipment companies shared a maximum of 4 videos each, featuring good sustainable practic-
es in manufacturing processes and equipment disposal that have been on the market since June 2019.
How the Challenge works:

- Voting is available exclusively through the WCD2023 App: Homepage 2 > Green Challenge
- Each registrant (attendee, exhibitor, sponsor, etc.) with a unique registration number can only vote once
- Each registrant can vote for 1 project and 1 best practice
INSURANCE
The Congress fee does not include individual insurance coverage. All participants are advised to arrange
their own travel and health insurance, which must be purchased in your country of origin. The organizers
will also not be responsible for loss of or damage to a person or personal belongings.
MOBILE PHONES & PERSONAL DEVICES

Please be considerate by silencing all notifications on your mobile phone, laptop and personal mobile
devices prior to entering any session room.
PHOTOGRAPHY
Recording or taking photos of any Scientific Sessions is NOT permitted, and this policy will be strictly enforced.
SMOKING POLICY
It is strictly forbidden to smoke inside the Congress Venue at any time. The restriction applies to all types
of electronic cigarettes.
27
CONGRESS VENUES MASTER PLAN
SUNTEC FLOOR PLANS
28
PAN PACIFIC - PACIFIC BALLROOMS - LEVEL 1
PAN PACIFIC - OCEAN ROOMS - LEVEL 2
29
OFFICIAL WCD SOCIAL EVENTS
Please ensure you wear your Congress delegate badge to all Networking and Social Activities.
Your badge will be scanned at the entrance to gain access.
OPENING CEREMONY
Suntec Convention & Exhibition Centre - Level 6, Hall 603-604
Be sure to attend the WCD2023 Opening Ceremony on the evening of 3rd July. Addressed by the ILDS,
WCD2023 Organising Committee will welcome you to the host city of Singapore and officially commence
the 25th World Congress of Dermatology. Following the Opening Ceremony, a dance performance enti-
tled The MUSIC of “Fire & Light” is a fusion of Western, Malay, Chinese & Indian beats & rhythms.
The Opening ceremony is open to all registered delegates, accompanying persons, sponsors, exhibitors,
and patient organisations.
WELCOME RECEPTION
Suntec Convention & Exhibition Centre - Level 6, Hall 605
Dress code: Business attire
We invite you to join us the 25th World Congress of Dermatology with an exhilarating experience as you
mingle with colleagues, old & new ones. Enjoy culinary delights highlighting Singapore’s rich culture and
savour the festive atmosphere as you are entertained by extraordinary performers.
Admission by pre-purchased ticket only. The Welcome Reception is included in the Accompanying Per-
son registration fee.
Attendees must wear their Congress badge and it must be scanned to gain access to the event.
Attendees must be at least 18 years of age.
WCD SOCIAL EVENING

Gardens by the Bay – Waterview Room & Flower Field Hall
Dress code: Informal
Theme: Floral Fantasy e.g. flower motifs, Hawaiian shirts, batik or orchid shirts
The Social Dinner for the 25th World Congress of Dermatology will take place at the Gardens by the Bay
on Friday, 7th July 2023.
Guests will be invited to a buffet dinner showcasing famous local street food in the Flower Field Hall and
Waterview Room. The evening will be hosted by 2 Singaporean Dermatologists.
They will then have the chance to visit the beautiful Flower Dome and admire performances by groups
of South-East Asian Dermatologists.
The event will end at the Supertree Grove, with a light show which mixes international and local sounds
and themes.
The event will be a true showcase of Asian flavours and beauty, with a modern and international approach.
Admission by pre-purchased ticket only

Attendees must wear their Congress badge and it must be scanned to gain access to the event.
Transfers to the event are via coach, please see details in the Registration Area.
Tickets: SGD 220,00 GST included.
Tickets are subject to availability and can be purchased at the Congress Registration Desk.
Ticket purchase is not available at the event location.
30
CLOSING CEREMONY
Saturday, 8th July from 12:45 - 13:45
Suntec Convention & Exhibition Centre – Summit 1, Level 3
The Closing Ceremony will conclude a memorable and rewarding week of academic, social and business
exchanges. The Closing Ceremony is open to all registered delegates, accompanying persons, sponsors
exhibitors, and patient organisations.
ABOUT SINGAPORE
Singapore is an island nation with a population of 5.7 million people, comprising of mostly Chinese,
Malay and Indian ethnicities. It offers visitors a fascinating fusion of many cultures from East and West,
and has an outstanding record of racial and religious harmony. English is the main language of commu-
nication, everyone is multi-lingual, and it is likely to be the only country in the world where the majority
of the population speaks both English and their mother tongue language of Mandarin, Malay or Tamil.
Singapore is an open, modern and secular democracy.
EFFECTIVE COVID-19 PANDEMIC CONTROL

Singapore has been relatively successful in managing Covid-19, there is a very high vaccination coverage
and very low mortality rate. Safety measures are continuously updated to control the epidemic and to
make your visit smoother and safer.
Covid-19 related travel health and border regulations will be updated on the congress website, so check
it periodically.
CLEAN, GREEN AND SUSTAINABLE

Singapore is also known as the Garden City, with over 50% of its area covered in greenery. With hun-
dreds of parks, nature reserves, mangroves, tidal flats and coral reefs, it is no concrete jungle. The Botan-
ic Gardens, a UNESCO Heritage site, and the award-winning Gardens by the Bay are especially popular.
Singapore is an eminently liveable and sustainable city, with clean air, healthy living environment, and a
robust and diversified supply of water. It has strived to maintain a balance between development and
conserving the environment.
EFFICIENT & AFFORDABLE TRANSPORTATION

Travel within the city-state is convenient and hassle-free, and traffic jams are rare. Visitors have options
to several inexpensive, safe and reliable transportation choices, including the MRT metro system, buses
and taxis. This means that hotels, restaurants, cultural venues and other places of interest are all easily
accessible.
SAFETY & SECURITY

You can visit Singapore with the confidence that your personal safety is in good hands. Singapore is
widely regarded as one of the safest countries in the world, with consistently low crime rates, a trans-
parent legal system, and a reliable police force.
LOCAL CULTURE & CUISINE

The melding of our rich tapestry of cultures into a harmonious collective is arguably the country’s biggest
attraction. There is also an impressive range of more than 40 different museums, there will be something
to discover for every interest.
Singapore is home to more dishes than you can eat in a lifetime - from Michelin-starred restaurants to
affordable yet scrumptious meals, this is where you can taste it all. Nothing reflects the patchwork of
cultures more than the food here.
31
WEATHER & CLOTHING
The weather is tropical, which means it is hot and humid through most of the year. It is advisable to wear
light, cotton clothing. Jackets are not needed unless indicated. Fortunately, all hotels, offices, shopping
malls and the public transport are air-conditioned, so you would hardly feel uncomfortable.
CURRENCY
The Singapore dollar is the official currency. It is made up of 100 cents and is abbreviated with the dollar
sign S$, or SGD to distinguish it from other dollar-denominated currencies.
TIME ZONE
Singapore Time is consistent with UTC +8. The Singapore Time does not have an associated daylight-sav-
ing time. The Singapore Time applies only to Singapore.
LANGUAGE
There are 4 official languages: Malay, English, Mandarin, and Tamil.
English is the primary spoken language of the country.
ELECTRICITY
In Singapore the electrical current is 230V supply voltage and 50Hz.
GETTING AROUND SINGAPORE

Singapore’s public transport system is fast and efficient, and will whizz you to memorable attractions
without fuss:
• Metro – Singapore’s MRT (Mass Rapid Transit) and bus systems have an extensive network of routes
that will help you zip around the city.
• Bus - bus routes are also some of the most scenic, allowing you to indulge in the lush greenery and
beautiful architecture of our ‘City in a Garden’. All public buses are wheelchair accessible and open
strollers are allowed.
• Taxi - Taxis are comfortable and especially handy if you want to go to places not accessible by the
bus or MRT. Cabs here are metered, but there may be surcharges depending on when, where and
which company’s taxi you board.
• Ride-hailing APPS - you may use one of the ride-hailing applications available in Singapore to book
a ride from your preferred pick-up point to your desired destination. Some options available include
Grab, Gojek, Ryde and TADA.
HOW TO REACH THE CONGRESS VENUE

BY METRO/MRT
Alight at Esplanade or Promenade* via the Circle Line, and City Hall** via the East West Line.
Follow these directions to get to Suntec Singapore:
• From CC3 Esplanade MRT Station (3 min): Take Exit A and follow the signage to our Centre.
• From CC4 Promenade MRT Station (5 min): Take Exit C, walk through Suntec City Mall and follow the
signage to our Centre.
• From EW13 City Hall MRT Station (8 min): Walk through City Link Mall and then Esplanade Exchange to
get here.
* Promenade is also on the Downtown Line.

** City Hall is on the East West Line and North South Line.
32
BY BUS
Depending on which bus service you are taking, you may choose to alight at the following stops:
•
Suntec Singapore: 36, 70M, 111, 133, 133A, 162M, 518, 518A, 700A, 857, NRI, 97, 97A, 70A, 106, 502, 502A,
502B, 518, 551, 578, 581, 577, 580, 575, 576, 579
•
Opposite Suntec Singapore: 36, 36A
•
Suntec Tower Two: 107M, 551, 578, 581, 577
•
Suntec Tower Three: 36, 36A, 531
•
Suntec City/Opposite Suntec City: 10, 14, 16, 70, 70M, 196, 608, 541, 547, 70A, 196°
BY CAR/TAXI
Alight at our driveway along Temasek Boulevard, where The Big Picture is located.
For those driving, you may access our basement carpark via the following routes:
• Nicoll Highway
• Raffles Boulevard (from Bras Basah Road)
• Temasek Avenue (from Raffles Boulevard)
• Rochor Road exit from East Coast Expressway (ECP)
Park at West Wing (Green Zone) and use lift lobbies A or B for quick access to Suntec Singapore (L3, L4 or L6).
ENTRANCES
Ledwall entrance: 7 Raffles Boulevard
Marina Link Bridge: connection from Pan Pacific Hotel
SINGAPORE TELEPHONE COUNTRY CODE

Country code for Singapore: +65
International outgoing code: 00
EMERGENCY NUMBERS IN SINGAPORE

Police: 999
Fire Engine/Ambulance: 995
33
34
SCHOLARSHIPS
35
SCHOLARSHIPS RECIPIENTS
Congratulations to our scholarship recipients and many thanks to the sponsoring organisations.
SCHOLARSHIPS FROM WCD 2023 & ILDS

A S Savitha India Al-Kutubi Huda UK
Abalos-Babaran Shahara Philippines Almanzar de la Torre Elaine Charina Dominican Republic
Abdelkareem Ibrahim Egypt Almonte Karla Venezuela
Abdelmouttalib Asmae Morocco Alonzo Christine Azalea Philippines
Abdelshafy Ahmed Said Egypt AltamIrano Jara Jenny Belén Brazil
Abdollahimajd Fahimeh Iran Altangerel Baigalmaa Mongolia
Abella Aira Monica Philippines Alur Dr Sainath kumar India
Abiodun Annalise USA Alvares Penha Mariana Brazil
Abrar Ayesha Pakistan AlZahrani Fatmah USA
Abudagga Ziyad Palestine Amalia Novia Rizki Indonesia
Abuelkhair Islam Egypt Amato Simone Italy
Acatitla Acevedo Graciela Astrid Mexico Amatya Bibush Nepal
Achdiat Pati Aji Indonesia Amin Nurul Bangladesh
Acos Roy Luister Philippines Anaba Ehiaghe Nigeria
Adisasmito Ayutika Saraswati Indonesia Anaje Chetanna Nigeria
Adrian Rivera Cristina Beatriz Dominican Republic Anandita Rafithia Indonesia
Agbon R-Jay Philippines Ananthan Lokapriya UK
Aggarwal Bharti India Andiani S Indonesia
Agrawal Rashi India Andrada Mary Viadelle Philippines
Agrawal Akriti India Andrianarison Malalaniaina Madagascar
Agrawal Sonia India Anggawirya Bonnie Yudistha Indonesia
Aguilar Gonzalez Alejandra Mexico Anggraeni Sylvia Indonesia
Agusni Regitta Indira Indonesia Angoori Gnaneshwar India
Agustina Fitria Indonesia Anisah Ghea Indonesia
Ahmed Sk Shahriar India Anissa Lidwina Indonesia
Ahuja R India Anjaneyan Gopikrishnan India
Akingbola Christiana UK Annadya S Indonesia
Akinkugbe Ayesha Nigeria Antonius Cayadi Sidarta Indonesia
Al Bahri M Oman Anuntrangsee Tanaporn Thailand
Al Ghazawi Feras Canada Anyanechi Chinechelum Nigeria
Al Haddabi Atheer UK Aquino Jay Mohamad Ryan Philippines
Ala NMI Indonesia Arachman Mochammad Ayyub Indonesia
Alam Mohd Nurul Alam Bangladesh Araghi Farnaz Iran
Alarcón Pérez Camilo E. Spain Araiza Atanacio María Isabel Mexico
Alarilla Frances Beatrice Philippines Arar Yazan Palestine
Albela Henrietta Malaysia Archika Alvares Deasy Indonesia
Aldona Wenty Septa Indonesia Argentina Fifa Indonesia
Alexandra Denisa Oprea France Arianto TR Indonesia
Al-Faris Hadi Kuwait Arias-Rodriguez Camilo Colombia
Alfieri Alessandro Indonesia Arif Abdul Indonesia
Alfyanita Affifah Indonesia Arif Sitti Musafirah Indonesia
Ali Nadia Pakistan Arora Aakanksha India
Alifiar No Indonesia Arora Astha India
Alinda Medhi Denisa Indonesia Arora Dr. Damini India
Alitin Hans Elmund Philippines Arora Pooja India
Aliwardani Ambar Indonesia Arora Mohak India
36
Arriel Kaique Brazil Bhardwaj Kolin India
Arthur Anita USA Bhargava Shashank India
Arvianty Intan Indonesia Bhatta Anil Kumar Nepal
Asial Santiago Argentina Bhattacharjee Rohan India
Asifa Nadia Nur Indonesia Bilgic Asli Turkey
Asmaa El Kissouni Morocco Binova Mariya Bulgaria
Asmare Selamawit worku Ethiopia Birame Seck Senegal
Astari Linda Indonesia Bissoli Tolomelli Jessica Brazil
Atika K Indonesia Bm Shashikumar India
Atiyah D Indonesia Bn Namratha India
Austria Karmina Jaymee Heredia Philippines Bochnia Cerci Felipe Brazil
Avriyanti Erda Indonesia Bodkhe Prachi India
Awad Andrew Australia Boland Rodríguez E Mexico
Awal Guneet India Bolanos Marco Mexico
Awatef Kelati Morocco Bonny Agnes Tanzania
Ayanlowo Olusola Nigeria Bossardi Priscila Brazil
B Spoorthy India Bouattour Emna Tunisia
Babu Aneeha India Bouazzi Dorra Denmark
Bacalla Ana Gabrielle Philippines Boudaya Sonia Tunisia
Badad Ambresh India Boukherroubi Hamza Algeria
Baeza-Hernández Gloria Spain Boumaiza Sirine Tunisia
Bagci Isin Sinem USA Bravo Erick Peru
Bal Avcı Elif Turkey Buana Khumayroh Rachmawati Buana Indonesia
Balaban Mihaela Romania Bucoy Sy Ma. Carmela Philippines
Balaceanu Beatrice Romania Budiarsa Marshel Indonesia
Balbinot Lucca Marcelo Brazil Buenaflor Maria Carla Philippines
Balendran Thanushah Sri Lanka Cabugao Daniel Brian Philippines
Balgomera Marie Nikki Philippines Cahyono Aris Indonesia
Banciu Mădălina Laura Romania Calderón Cisneros Massiel Alejandra El Salvador
Bano Rubeena India Calitoiu Andra Romania
Banodkar Kruti India Camacho Michelle Brazil
Banodkar Pravin India Camayo-Vásquez Tatiana Colombia
Bansal Akshi India Camela Elisa Italy
Barahona Maureen Guatemala Camiletti Virginia Leylen Argentina
Baral Rashmi Nepal Campos Rojas Kendry Arleth Bolivia
Baral Suwash Nepal Cañadas Nadia Argentina
Barlow Richard UK Carbonell-Garcia Dayana Colombia
Barquero-Orias Daniel Costa Rica Carelle Lois See Philippines
Baskota Rabindra Nepal Caro-Chang Leah Antoinette Philippines
Bassey Thelma Nigeria Caroline Devy Indonesia
Bathula Savitha India Carpio Camila Dominican Republic
Balendran Thanushah Sri Lanka Carrascoza G. G. Brazil
Belhadj Oumaima Tunisia Castellammare Halfeld Paola Brazil
Bellan Srinivasan Subhasree India Castillo Greta Mexico
Ben Kahla Marouane Tunisia Castillo J Ecuador
Ben Rejeb Mohamed Tunisia Castro Ludwin F. El Salvador
Bendary walaa Elhady Egypt Cele Nkosiyenzile South Africa
Benhayoun Fatimazahrae Morocco Ceryn Justyna Poland
Bernstorff Franciozi Amithis Brazil Chaabouni Rim Tunisia
Bertholdi Luiza Brazil Chabbouh Amel Tunisia
Bertolucci Stéfani Brazil Chabchoub Ines Tunisia
Bhalla Mala India Chagraoui Hind Morocco
37
Chakiri Radia Morocco Cucu Corina Ioana Romania
Chakraborty Sayantani India Cvenkel Klara Slovenia
Chalik Cherry Chalik Indonesia D Senkadhir Vendhan India
Chamli Amal Tunisia Dadkhahfar Sahar Iran
Chan Kam Veng Malaysia Dal Magro Ana Claudia Brazil
Chan Koreen Blossom Philippines Dalilah Nur Indonesia
Chan Yip Keyla Brazil Damayanti Damayanti Indonesia
Chanana Charvi India Damevska Stefana Bulgaria
Chandna Rohatgi Dr Pallavi India Darmasatria Rendra Indonesia
Chandra Rudi Indonesia Das Anupam India
Chang Wei Hsi Malaysia Das Nilay India
Chang Janis Canada Davalos Tanaka Monica Mexico
Chaparro Reyes Laura Daniela Colombia Davanco Rodrigo Brazil
Chathra Namitha India David Criselda Philippines
Chauhan Ankita India David Denise Marie Philippines
Chaves Bruna Cabral Meira Brazil Dayanan Jasper Nuel Philippines
Chavez Czarina Philippines De Abhishek India
Chehad Ahmed Samaouel Algeria De Ávila Coelho Rachel Brazil
Chen Xue-Yan China De Boni Gauer Taísa Brazil
Chen Steven Usa De La Torre Maria Mexico
Cherif Meriem Tunisia De La Torre García Monica Elizabeth Mexico
Chhabra Geetika India De Las Alas Alexis Philippines
Chhangte Mary India De Los Angeles Blanco Maria Venezuela
Chia Cara Lynn Marie Philippines De Melo Carvalho Raquel Brazil
Chia Jian Qin Malaysia Deb Samujjala India
Chiong Mary Joyce Philippines Debinta Arlha Aporia Indonesia
Cho Mi Yeon South Korea Dennis Magdalena Tanzania
Choi Ellie Singapore Desacada Dianne Philippines
Chokshi Hiloni India Desai Kavya USA
Choudhary Aastha India Desai Saloni India
Choudhary Ankita India Dewan Krati India
Choudhary Nishant India Dewi IP Indonesia
Choudhary Nishant India Dewi Shinta Trilaksmi Indonesia
Christian Muteba Baseke Congo Dhariwal Sukhjit Kaur UK
Chua Angelie Therese Philippines Dharmasamitha Indira Indonesia
Chugh Vishal India Dhurat Rachita India
Chung Amanda Philippines Diah Ngesti Kumalasari DN Kumalasari Indonesia
Ciprian Shantal Dominican Republic Diallo Moussa Senegal
Citrashanty Irmadita Indonesia Diaz Rosa Beatriz Philippines
Claudia Hodas Romania Diaz Jianella Catrisse Philippines
Conde Vásquez Laura G. Dominican Republic Díaz-Mestre María Paula Colombia
Contreras Andrea Isabel Philippines Didona Dario Italy
Costa Luciana Soledad Argentina Diong Sophie Ireland
Costa Buzatto Brenda Brazil Dİşlİ Furkan Alperen Turkey
Costina-Cristiana Mutu Romania Doda Dimple India
Couppoussamy Kanmani Indra India Donoseputro Intan Wasaputri Indonesia
Covian Esteban Argentina Doss Reham William Egypt
Cox Victoria Australia Douhi Zakia Morocco
Crisan Diana Germany Douja Hamdi Tunisia
Csiki Kersztin Lorett Romania Drullis Cruz Carolina Brazil
Cua Val Constantine Philippines Dsouza Deepti India
Cuatriz Tanya Rae Philippines Dsouza Dr Myfanwy India
38
Dudani Pankhuri India Fonna Nellia Indonesia
Dultra Mariana Brazil Foo Hui Ling Singapore
Dumlao Jolene Kristine Philippines Freites-Martinez Azael Venezuela
Dungarwal Yashashree India Frewen John UK
Duran Celine Mae Philippines Fujishige Clarisse Brazil
Duran Schmalbach Gustavo Andres Brazil Gahalaut P India
Dwigunasari Pr Indonesia Galan Flores Juan Luis El Salvador
Dyavannavar Veeresh India Galicia Maldonado Mariela Mexico
Dybala Agnieszka Ewa Italy Galvan Maria Agustina Argentina
Dzuali Fiatsogbe USA Gan Alex UK
E E Chia Qi Malaysia Gan Patricia Rochelle Philippines
Ednalino Kimberly Anne Philippines Gan Weh Kiat UK
Ekinde Sean Italy Ganbat Zolzaya Mongolia
Ekpudu Violet Nigeria Ganguly Satyaki India
El Hadadi Farah Morocco Ganjuur Nomun Germany
Elinkichari Dorsaf Tunisia Gankhulug Zolzaya Mongolia
Elkalioby Mona Egypt Gara Soumaya Tunisia
Ellistasari Ey Indonesia Garcia Ma. Desiree Hannah Philippines
Elmasry Maha Fathy Egypt Gatmaitan Julius Philippines
Eltaweel Abdelaziz Egypt Gebeyehu Netsanet Ethiopia
Emeka Chika Mary Nigeria Gedeon Inna Ukraine
Emna Mnif Tunisia Georgakopoulos Jorge Canada
Enbiale Wendemagegn Ethiopia George Anju India
Enechukwu Nkechi Anne Nigeria George Neethu Mary India
Enigbokan Omololu Nigeria Ghannem Azza Tunisia
Er Lestari Indonesia Gharib Jamila Tanzania
Ervianti Evy Indonesia Gharib Khaled Egypt
Escandor Soraya Elisse Philippines Gil-Pallares Pedro Spain
Escobar-Ramírez Karina Mexico Gincheva Veronika Bulgaria
Evyana Dina Indonesia Go Janelle Philippines
Faisal Ummu Aiman Malaysia Gochoco John Benjamin Philippines
Fajardo Maria Kristina Philippines Gokyayla Ece Turkey
Fakhmiyogi Fakhmiyogi Indonesia Gomez-Bernal Nilda Mexico
Faldian Y Indonesia Gonzalez M C C Philippines
Farabi Banu USA Gopalakrishnan Vinitha India
Farabi Atak Seher Banu USA Gorislavskaia Tatiana Russia
Farah Marraha Morocco Goyal Dikshita India
Farrell Joshua Australia Goyal Shivam India
Faruk Smrasel Bangladesh Gracia Christa Desire Indonesia
Fasano Gaia Italy Grimaldi Gianluca Italy
Fatma Jendoubi France Guerrero Granados Angelica Careli Brazil
Febrieza A Indonesia Guerrero Granados Sindy Karolina Brazil
Felmingham Claire Australia Guerrero Hernandez Diana Valeria Mexico
Fernandez Jobelline Mae Philippines Guerrero Putz Maria Dolores Mexico
Fernandez-Parrado Miriam Spain Guevara Bryan Philippines
Fernandez-Vergara Ma. Denisse Philippines Guevara Suazo Iris Sarai Honduras
Filofteia-Adelina Ghilencea Romania Guida Stefania Italy
Filoni Angela Italy Guimarães Ribeiro Natália Brazil
Fiocco Zeno Germany Gulati Dr. Amit India
Firdaus Chaerani Pratiwi Indonesia Gulati Nicholas USA
Flora Akshay Australia Gund Gayatri India
Fong Kenneth Singapore Gündüz Müge Turkey
39
Gungaanyam Tsogzol Mongolia Ikebudu Adaeze Viola Nigeria
Gupta Dr. Pratibha India Ikuno Yasuaki Japan
Gupta Sachin India Ilhan Erdil Dilara Turkey
Gupta Sanjeev India Illango Abitha UK
Gupta Somesh India İlter Tuğba Turkey
Gwillim Eran USA Indramaya Diah Mira Indonesia
Hadiwidjaja Farsha Naufal Indonesia Ines Lahouel Tunisia
Hadzhiyska Mariya Bulgaria Ion Gabriela Romania
Hailu Selamawit Girma Ethiopia Iqbal Amina Asfiya M India
Halim Melissa Indonesia Isamukhamedova Saida Uzbekistan
Hamada N Indonesia Ishak Lelania Indonesia
Han Ju Hee South Korea Ismiranty D Indonesia
Hanifati Sonia Indonesia Isupova Alena Kirghizistan
Hapsari Annisa Prasetyati Indonesia Iyengar Laxmi Australia
Hardjodipuro Andira Indonesia İzci Nil Efsun Turkey
Harini Rona Lintang Indonesia Jacem Rouatbi Tunisia
Harningtyas Citra Dwi Indonesia Jagun Oluwadamilola UK
Hartanto Felix Indonesia Jahaj Edison Greece
Haryo Jatmiko Pandu Indonesia Jahan Sharmin Bangladesh
Hasibuan Putri Mulia Bela Grania Indonesia Jagadeesh Soundarya India
Hasniah Minna Indonesia Jangid Kirti India
Hassan Fouz Siria Jangid Dr. Neha India
Hassan Hafidh Tanzania Janušonytė Eglė Switzerland
Hawash Ahmed USA Jargalsaikhan Bulgan Mongolia
Hayder Faten Tunisia Jassi Rubina India
Heah Mm Malaysia Jastrząb Beata Poland
Heddle Georgina Australia Jawaid Kalsoom Pakistan
Hegde Shibhani Sudheer India Jaworecka Kamila Poland
Heh Ding Yang Malaysia Jeftic Jelena Serbia
Heirich Manalili Philippines Jesmin Afroza Bangladesh
Hemdani Ruchi India Jha Abhijeet India
Hemrajani Priyanka India Jia Jocelyn Canada
Henry Kathrin Kezia Indonesia Jihane Belcadi Morocco
Herlina Lengga Indonesia Jin Shanglin China
Hermosa Duenas Maria Martha Mexico Jocic Ivana Serbia
Herwanto Nanny Indonesia Johan Reyshiani Indonesia
Hewitt Rachael UK Jouini Wafa Tunisia
Hibler Brian USA Juhasz Margit USA
Hidayati Afif Nurul Indonesia K C Shekhar Nepal
Ho Wen Chung Malaysia Kaaz-Florjańska Karolina Poland
Holgersen Nikolaj Denmark Kaderbhai Dr Hashim Shaukatali Kenya
Hongal Amrita India Kakkar Sahil India
Hsieh Tyng-Shiuan Chinese Taipei Kalisa Raja Eka Citra Indonesia
Husadani Desidera Indonesia Kanak Kusumika India
Hussain Aamir USA Kanathur Shilpa India
Noer Resya Indonesia Kang Mina Australia
Ibanez Alexis Paula Philippines Kanumuru Dr.pooja India
Ibarra Morals Dalia Mexico Kapetanovic Igor Serbia
Ibarra Puentes Anna Luisa Mexico Kapil Kanupriya India
Ibekwe Perpetua Nigeria Kapoor Dipali India
Ibrahima Traore Guinea Kapoor Priya India
Iglesia Bernadette Philippines Kapoor Shrea India
40
Karagaiah Priyanka India Lage Bruna Brazil
Kassang Panawé Togo Lagman Ana Veronica Philippines
Katayama Sho Japan Laguna Meraz Jose Pablo Mexico
Katibi Oludolapo Nigeria Lahouel Maha Tunisia
Kaur Amrit India Lai Belinda Australia
Kaur Jaskanwal India Lai Shiau Wei Malaysia
Kawamura Takuya Japan Lake Susanna Australia
Kenani Mohamed Zied Tunisia Lam Mun Wai UK
Kerure Amit India Lamissa Cisse Mali
Keyal Uma Nepal Landini Enríquez Venecia Mexico
Khadga Shreyesha Nepal Lansangan Patrick Philippines
Khairani Fatima Aulia Indonesia Larasaty Nanda Shaskia Indonesia
Khan Farhat India Lazo-García Estela Cristina Mexico
Khan Mohammad Uzire Azam Bangladesh Le Michelle Canada
Khandelwal Ayushi India Lee Sumin South Korea
Khemani Usha India Lelonek Edyta Poland
Khonkhodjaev Sherzod Uzbekistan León Pacari Mónica Jaqueline Bolivia
Khoo Voon Ling Malaysia Li Heidi Canada
Khouw Deddy Indonesia Lim Agnes Singapore
Kılıç Sayar Sıla Turkey Lim Shi Yu Derek Singapore
Kim Jinkyeong South Korea Lim Ai Y’ng Malaysia
Kindi Maria Konana Tanzania Lim Joanne Malaysia
Kiratiwongwan Rungsima Thailand Lim Shelly Indonesia
Kishore Karthi India Lim Ai Wei Malaysia
Klosowicz Agata Poland Limchoc Ma. Milagros Socorro Philippines
Knight Lauren South Africa Lindsø Andersen Pernille Denmark
Kocic Hristina Serbia Line Mezni Tunisia
Koh Xuan Qi Singapore Linhares Maia Santana Victoria Brazil
Kolerova Anastasiia Russia Lissir Arij Tunisia
Kollabathula Siri Sri India Litaiem Noureddine Tunisia
Kołt-Kamińska Marta Poland Lituma Maria Brazil
Konathan Rajyalaxmi India Liu Chaocheng Canada
Konda Deepthi India Liu Ziqi China
Korany Mona Mostafa Egypt Lo Hiu Lai Hong Kong
Korbi Mouna Tunisia Lodaya Bhavini India
Kormos Nicholas Romania Loh Chee Hoou Singapore
Kosnin Jassriwati Malaysia Loo Yin Pin Malaysia
Kothari Rohit India Lovino-Ty Janine Michele Philippines
Kovitwanichkanont Tom Australia Lubuva Maria Felix Tanzania
Krajewski Piotr Poland Lugasan Maynie Bambi Philippines
Kranz Stefanie Germany Luna Garza Debanhi Kassandra Mexico
Kravvas G UK Luspo Maria Ana Patricia Philippines
Krishnegowda Ranjitha India Lwin Su M UK
Krzysiek Joanna Poland Lynda Noufack Senegal
Kua-Uy Katrina Kashmyr Borjal Philippines M Upadya Gatha India
Kumar Pradeep India Madhumita Monisha India
Kumavat Shrikant India Madziyire Clarice Zimbabwe
Kuntoji Vidya India Mahabal Gauri India
Kuraitis Drew USA Mahadevia Bansri India
Kurniawati Yuli Indonesia Mahamadou Garba Togo
Kuthial Madhu Bahrain Maharani Retno Hesty Indonesia
Kwapisz Justyna Poland Mahariski Pande Agung Indonesia
41
Mahmoudi Hamidreza Iran Meriem Younsi Algeria
Maia Palhano Ana Clara Brazil Merilleno Arbie Sofia Philippines
Mak Anthony Canada Mesi Lami Matthew Nigeria
Malekar Pooja India Metwally Wessam Egypt
Mallawaarachchi Kanchana Sri Lanka Mhatre Madhulika India
Mamoudou Diakite Mali Mhlanga Tinyiko Sthembiso South Africa
Manalo Doha Mae Laurisse Philippines Miccio L Italy
Mancuso Fabrizio Rocco Italy Michelini Simone Italy
Manea Lorena Romania Michelucci Alessandra Italy
Mani Oumayma Tunisia Mimanda Suci Leni Indonesia
Manohar Prasad Anupama India Minja John Tanzania
Mansh Matthew USA Mirza Fatima N. USA
Manuputty Amanda Gracia Indonesia Mitra Debdeep India
Manurung Teguh Hopkop Putera Indonesia Mitsunaga Keila Spain
Manzo Margiotta Flavia Italy Mittal Govind Suresh India
Mapunda Doreen Tanzania Mittal Rashmi India
Marahatta Suchana Nepal Miulescu Raluca Romania
Marcelo-De Jesus Jean Anne Camille Macam Philippines Miyashiro Denis Brazil
Mardani Ghazal Iran Moata Hajar Morocco
Mareta S Indonesia Modha Jay India
Mariem Amouri Tunisia Moftah Nayera Egypt
Martínez Gayosso Adrián Mexico Mohamed Denguezli Tunisia
Martinez-Rosales Ki Mexico Mohamed N G Egypt
Martin-Zamora Ana Camila Costa Rica Mohamed Rodaina Egypt
Masanje Caroline Francis Tanzania Mohamed Twaseem India
Masenga Gloria Tanzania Mohamed Kassim Bushra Muna India
Mashuhuri Aidan Tanzania Mohta Alpana India
Mastoraki Evanthia UK Mokni Sana Tunisia
Mastorino Luca Italy Molochkova Yulia Russia
Masuka Josiah Tatenda South Africa Monica Pristia Widya Indonesia
Matcha Archana India Monteiro Rochelle India
Mateo De Oleo Claudia Carolina Venezuela Montenegro Matilde Krisha Philippines
Mathachan Sinu India Montero Stefania Mexico
Maulia Firyal Indonesia Moquete Taveras Michelle Dominican Republic
Mavura Daudi Tanzania Moreno Ruiz José El Salvador
Mbali Hawah Tanzania Mosor Adriana - Mihaela Romania
Mchenga M Tanzania Mosquera Lisseth Brazil
Mckesey Jacqueline USA Mowla Mohammad Rafiqul Mowla Bangladesh
Megna Matteo Italy Moyano Vega Cecilia Venezuela
Mehnaaz Mehnaaz India Mozafari Nikoo Iran
Mehta Arnav India Mrigpuri Sahil India
Mehta Hitaishi India Mseddi Madiha Tunisia
Mehta Nikhil India Mudia Kam Indonesia
Meilinda Puti Rineska Indonesia Mughni Fadhli Aulia Indonesia
Meiviana Gisca Indonesia Mukhtar Sadaf UK
Mejía Mariana Venezuela Muliro Cyndy Tanzania
Mejia Mesa Susana Colombia Muminova Sevara Uzbekistan
Melendez Henriquez Katherine El Salvador Mun Andrey Uzbekistan
Mella Corazon Almira Philippines Mundin Camille Clarisse Philippines
Mendoza Maria Brazil Munjal Ananya USA
Merenzon Sabrina Argentina Murasmita Alamanda Indonesia
Meribout Marwa Algeria Mustari Akash India
42
Mutmainnah Euis Indonesia Orduz Robledo Mariana Colombia
Nafaisa He Yeon Asva Indonesia Orellana Daniel Brazil
Nagara Adianto Jaya Nagara Indonesia Orlic Tijana Serbia
Nagendran Adithya India Ornek Sinem Turkey
Nagia Sonal India Ortega Springall Maria Fernanda Mexico
Nagodavithana Nisansala Mahenthi Sri Lanka Ortiz Ysabel Regina H. Philippines
Nahata Vaishali India Osi Raiza Mae Philippines
Nambudiri Vinod Usanamutebi Fiona Uganda Ossanai Schoenardie Bruna Brazil
Narayan Vanya India Otike-Odibi Bolaji Nigeria
Nareswari Adniana Indonesia Otrofanowei Erere Nigeria
Nastiti Ha Indonesia Öztürk Gizem Özge Turkey
Nasution Khalishaturrahmi Indonesia P Dev Prabin India
Navarro Amelia Dominican Republic Pai Anusha .H India
Navarro-Bielsa Alba Spain Palabyab - Imperial Isabel Philippines
Nayak Vijayalakshmi India Palacios Narvaez Diana Carolina Mexico
Nayak Chitra India Palakornkitti Pasita Thailand
Nazzaro Gianluca Italy Pamela Ruri Diah Indonesia
Neema Shekhar India Pamin Joanne Philippines
Negasheva Ekaterina Russia Pan Yi Austria
Nerva Kyla Janika Philippines Pandit Vishalakshi India
Nery Dana Andrea Philippines Pandita-Reyes Bai Shariffah Philippines
Neves Barros De Almada Justino Georgia Brazil Pandya Ipsa India
Ng Chau Yee Chinese Taipei Pangilinan Angeli Elaine Philippines
Ngo Jennifer Lavina Philippines Parajuli Niraj Nepal
Nguyen Uyen UK Parajuli Sudip Nepal
Nicas Salva-Angelina Tanzania Paramita Deryne Anggia Indonesia
Niknezhad Nasim Iran Paramita Listya Indonesia
Nishnianidze Nino Georgia Pararajasingam Abirami UK
Nogueira Marcelle Brazil Paredes Ma Bernadette Beatrize Philippines
Nono Seudjip Congo Parygina Olga Russia
Noor Towhida Bangladesh Pasaribu Uly Aanda Maria Nugraheni Indonesia
Nouh Ahmed Egypt Passarela Karoline Brazil
Nováková Michaela Czech Republic Patel Fenil India
Nugraha Rizki Hapsari Indonesia Patel Kajal Australia
Nugraha T Indonesia Patel Mitesh UK
Nuñez Nicolette Philippines Pathania Yashdeep India
Nurani Nb Indonesia Patil Aishwarya India
Nurhadi Stefani Indonesia Paudel Upama Nepal
Nuzuliyah G Indonesia Paudel Vikash Nepal
Nwigwe Chinwendu Nigeria Pawitri Anandika Indonesia
Obregon Rixiel Venezuela Pazzini Bomfim Diogo Brazil
Octavia Nadia Indonesia Pejcic Irena Serbia
Octyvani Tiar Marina Indonesia Pelangi Aurora Indonesia
Oh Dawn Singapore Penaloza Denys Argentina
Okafor Love Nigeria Persa Oana-Diana Germany
Ollero Ma. Patricia Gertrude Camille R. Philippines Pethe Sumeet India
Ollero Florteresa Philippines Petrova Vita Ukraine
Olvera Alejandra Mexico Petruzzellis Alessandra Italy
Omangayon Ma Fatima Lourdes Philippines Giang Pham Vietnam
Omatighene Enovwo Obaro Nigeria Phan D.b. UK
Ong Kimber Allison Philippines Phuan Crystal Zhen Yu Singapore
Orabi Sarah Egypt Phusuphitchayanan Phanitchanat Thailand
43
Pichardo Lina Dominican Republic Raju Sahana P India
Pillai Rahul India Ramadan Ah Egypt
Pillai Dr Jisha India Ramadhan R Indonesia
Pinto-Pulido Elena Lucía Spain Ramatou Dembele Mali
Poddar Shreya India Rambhia Sweta India
Podder Indrashis India Ramesh Dr. Heera India
Poh Alicia Wan Yan Brunei Ramírez Gina Dominican Republic
Poojary Shital India Ramos Michelle Ann Philippines
Pospos Ag Indonesia Ramos Veronica Marie Philippines
Potestio Luca Italy Rangaswamy Mahesh Ashwini Brunei
Potula A India Ranka Nishita India
Pozzobon Torres Flavia Carolina Colombia Rao Sophia India
Pradhan Swetalina India Rapelanoro Rabenja Fahafahantsoa Madagascar
Pradhan Namrata Nepal Rathod Dipali India
Pradhan Sushmita Nepal Ravindran Niwasini Malaysia
Pradipta Nabila Kirtti Indonesia Rayos-Lopez Eunice Kaye Philippines
Pradita Riva Ambardina Indonesia Rech Vieira Alexandra Brazil
Prakasita Karine Annisa Indonesia Regalado Ana Lourdes Philippines
Prakoeswa Cita Rosita Sigit Indonesia Reginata G Indonesia
Pranata Radema Indonesia Regmi Bidhi Nepal
Preclaro Ivan Arni Philippines Rekik Mariem Tunisia
Preisler Luisa Brazil Relova-Haresco Ma. Bianca Therese Philippines
Prezotto Giordani Lucas Brazil Resuello Tina Elaine Philippines
Primisawitri Pratiwi Prasetya Indonesia Reti H Indonesia
Priyadarshni Smita India Reyes Haider Philippines
Proskurina Maria Russia Rhee Schuldt Ana Luiza Brazil
Pudasaini Prajwal Nepal Rheza Agung Mohamad Indonesia
Pudukadan David India Rianty Fathia Indonesia
Puravoor Jayasree India Ribeiro Froes Junior Luis Alberto Brazil
Purnamasari Indah Purnamasari Indonesia Ribeiro Porfírio Ludmila Nathaly Brazil
Purnawan Shafira Anindya Indonesia Rifko Ani Indonesia
Purushothaman Suruthi India Rivanzah Y Indonesia
Purwoko M. Izazi Hari Indonesia Rivera Nicole Philippines
Puspitosari D Indonesia Rivero Patricia Daniela Bolivia
Putra Nanda Daiva Indonesia Rizqandaru T Indonesia
Putri Ad Indonesia Roa Eduardo Colombia
Putri Anna Kautsaria Indonesia Roccuzzo Gabriele Italy
Putri Dewi Utami Indonesia Rocha Araujo Adriana Aila Brazil
Putri Dixy Febrianita Titi Pratama Indonesia Rodriguez Vazquez Marla USA
Putri Fitria Indonesia Rodríguez-Cuadrado Francisco José Spain
Quijote Kirk Llew V. Philippines Rosario Solis Aniberka Dominican Republic
Quinio Maria Franchesca Sotto Philippines Rosete Raisa Celine Philippines
R Divya India Rossi Anthony Usa
Rada Nuñez Julieth Paola Brazil Rosso Maria Victoria Spain
Radwan Nashwa Egypt Rout Arpita Nibedita India
Rahmadewi Rahmadewi Indonesia Ruchiatan Kartika Indonesia
Rahmadini Meirina Indonesia Ruggiero Angelo Italy
Rahmanda M. Rezi Indonesia Rusmawardiana Rusmawardiana Indonesia
Rahmatika Amira Suryani Indonesia Russo Roberto Italy
Rahmi Alfina Multaza Indonesia Ryan Elisabeth Indonesia
Raissa Raissa Indonesia Rym Zmiti Tunisia
Rajan Aswath India Ryoto Viensa Indonesia
44
S Dr Parag India Senador Danielle Marlo Philippines
S Rahim Jemshi India Sendrasoa Fandresena Arilala Madagascar
Saba Mussali Alberto Jacobo Mexico Septharina R Indonesia
Sabushimike Doriane Tanzania Septiafni Kiki Indonesia
Sachan Suvigya India Serquiña Brice Philippines
Sachdev Mukta India Serrano Christine Marie Philippines
Saddi Menezes Costa Marcela Brazil Seshadri Divya India
Saeed Haroon South Africa Sethi Sheenam India
Safa Djebbbas Algeria Sethia Khushboo India
Safari Giv Toktam Iran Setyono Alfred Indonesia
Saikaly Sami USA Shaafie Harris Ishtiyaq India
Saikia Uma Nahar India Shafiq Arifa Billah Bangladesh
Sainzaya Undram Mongolia Shah Anchal India
Salas-Walinsundin Wilsie Philippines Shah Prof Dr Bhuvnesh India
Salazar Roxanne Louise Philippines Shah Nidhi Nepal
Salazar-Paras Dianne Katherine Philippines Shahid Rashid India
Saldana Carlos Nicaragua Shahid M. Bulgaria
Salunke Dr Tejaswini India Sharma Ananya India
Sana Bouzid Tunisia Sharma Apoorva India
Sanchez Maria Juliana Colombia Sharma Aseem India
Sánchez Meza Emmanuel Mexico Sharma Ashimav Deb India
Sanchez Stieb Ana Paula Argentina Sharma Meghna India
Sanciangco Cagulada Ivy Philippines Sharma Nidhi India
Sanke Sarita India Sharma Ramesh Nepal
Sansan Maria Vianney Indonesia Sharma Richa India
Santiago Rosalie Deeneye Philippines Sharma Surabhi Australia
Santos Danelle Anne Philippines Shetty Vinma. H India
Santos Fernanda Brazil Shiiya Chihiro Japan
Santos Kelsie Kirsty Philippines Shim Joonho South Korea
Santos Maria Lourdes Philippines Shiri Mehdi Iran
Santosa Adinia Singapore Shishak Mansak India
Saputra Muhammad Akip Riyan Indonesia Shou Yanhong China
Sara Oulad Ali Morocco Shrestha D P Nepal
Sarawgi Harsha India Shrestha Rushma Nepal
Sarbu Maria Isabela Romania Shucheng Huidi China
Sarenas Donna May Philippines Siddiqui Faryal USA
Sari Mutia Indonesia Sidhu Ishvant Malaysia
Sari Arista Putri Rakhmana Indonesia Siekierko Aleksandra Poland
Sari Agnes Rosarina Prita Indonesia Sigid Novita Permatasari Indonesia
Sari Maylita Indonesia Sikora Mariusz Poland
Sarra Saad Tunisia Sil Abheek India
Satjamanggala Pr Indonesia Silva Betina Brazil
Satria Sunrise Dewantara Indonesia Silva Dimitri Luz Felipe Brazil
Savu Alexandra-Petruta Romania Simbillo Jenika Gracia Philippines
Sawatkar Gitesh India Singdia Heena India
Sawitri Sawitri Indonesia Singh Sushil Kumar India
Sayo Marianne Isabel A. Philippines Singh Saurabh India
Sayson Christine Lyka Philippines Sinha Surabhi India
Sboui Karama Tunisia Sinkos Fernanda Brazil
Schuh Sandra Germany Sitaula Seema Nepal
Sechi Andrea Italy Slape Dana Australia
Selvakumar Swetha Shri India So Neda Australia
45
Sobolewska-Sztychny Dorota Poland Tania Anesia Indonesia
Sodré De Souza Eller Lílith Argentina Tankeh Anna Philippines
Solal Nouboadinan Bienvenue Chad Tariq Asma Pakistan
Solon Patricia Philippines Tay Mei Ee Malaysia
Somashekhar Dr Sachin India Tay Woo Chiao Singapore
Sørensen Jennifer Astrup Denmark Tazakka Achmad Aidil Indonesia
Soriano Agustin Miguel Philippines Teo Hock Gin Malaysia
Soto Ricart Maria Carlota Dominican Republic Teo Ying Xin UK
Souissi Ismahene Tunisia Thamm Janis Raphael Germany
Soares Dos Santos Marcel Alex Brazil Thammannagowda Prarthana India
Spina Papaleo Bianca Brazil Thandi Charankumal Singh UK
Sridhar Dr. Swetha India Thekke Pulukkul Afra India
Srinivas Sahana India Thekkinadeth David Polly India
Srinivasa Dr Manoj India Thendria Tessa Indonesia
Sriram Rashmi India Thurkintavide Muhammed Razmi India
Srivastava Prakhar India Tika Dwi Sabtika Julia Indonesia
Stancic Hrvatin Bor Slovenia Ting Ingrid Pao Lin Malaysia
Stefaniak Aleksandra Poland Ting Sarajane Australia
Subramanian Dr Kumudhini India Tirelli Luciana Argentina
Sudarsono Sudarsono Indonesia Tolone Martina Italy
Sugiatno Belladikna Brillianty Indonesia Tolosa Maria Teresa Philippines
Suhada Ku Indonesia Tomás-Velázquez Alejandra Spain
Suhendra Riski Bagus Indonesia Tomaszewska Katarzyna Poland
Sulaikha Khalida Rieka Indonesia Torrejon Silva Edith Bolivia
Sun Yonghu China Torres Patricia Monique Philippines
Sunarto Olivia Awwalin Indonesia Touati Hanane Algeria
Sundani A Indonesia Trejo Chavira Nohemi Mexico
Sunki Karthik India Trevisan Thais Brazil
Suphatsathienkul Panittra Thailand Triani Aisha Indonesia
Supradnyan I Komang Harry Indonesia Trimeche Khaoula Tunisia
Suprapto Novita Indonesia Trisadi Sefrina Indonesia
Suseno Sutarjo Agassi Indonesia Trisna Leonardo Indonesia
Sutantoyo Catherina Jessica Indonesia Trisnariski Leonardo Indonesia
Sutisna Fd Indonesia Truong Kelvin Australia
Suvirya Dr Swastika India Tsai Tsung-Fu Chinese Taipei
Suwarsa Oki Indonesia Tsaqilah L Indonesia
Świerczyńska-Mróz Karolina Poland Tsekova Traykovich Natasha Bulgaria
Syarif Merlinda Nur Annissa Indonesia Tseng Han Chi Chinese Taipei
Syiemlieh Abigail India Tuknayat Ankita India
Tache N Indonesia Ty Charlotte Giselle Philippines
Taguibao Jerson Jerick Ngo Philippines Uddin Mohammad Jamal Bangladesh
Tahiri Hajar Morocco Ujile Ichechiek Nigeria
Takharya Rajkiran India Umali Iris Charmaine Philippines
Talaee Rezvan Iran Umborowati Menul Ayu Indonesia
Talukdar Krishna India Unni Mahesh India
Tambe Swagata India Upendra Yasha India
Tan Nicole Marella Philippines Utama Redha Cipta Indonesia
Tan Anna Patricia Baesa Philippines Utomo Thomas Indonesia
Tan Yi Jun Malaysia Valecha Pravesh India
Tan See Ling Malaysia Valenzuela Rios Luis Ernesto Mexico
Tan Wen Hao Singapore Valero Erick Mexico
Tana Mobbydick Philippines Valeva Elia Bulgaria
46
Van Straalen Kelsey Netherlands Yamoussa Karabinta Mali
Varshney Ajitesh Prakash India Yaseen Atiya India
Vasilev Preslav Bulgaria Ye Weiyu UK
Vasudevan Biju India Ye Li-Ran China
Vázquez Medrano Diana Alejandra Mexico Yendo Tatiana Mina Brazil
Vega Nadia Chile Yeom Kyujin South Korea
Velásquez Bámaca Jimmy Steven Guatemala Yip Alphonsus Yun-Xin UK
Venegas Andrade Andrea Mexico Yiu Zenas UK
Venturi Federico Italy Yousfi Yosr Tunisia
Verdelli Alice Italy Yuniasih Dwi Intan Indonesia
Vergel De Dios Yzabel Philippines Yunitasari Y Indonesia
Verma Kaushal India Yustiana E Indonesia
Veronica Veronica Indonesia Yusuf Hasbiallah Indonesia
Vetsiou Evangelia UK Zaghloul Adel Egypt
Villamin Mary Rae Kate Philippines Zengarini Corrado Italy
Villaverde Marian Rosel Philippines Zhang Ditte Georgina Denmark
Villegas Blanco Yollany Alicia Venezuela Zhang Meijie China
Villena Juan Paolo David Philippines Zhou Yuan China
Voicu Elena Alexandra Romania Zokhidova Makhliyokhon Uzbekistan
Vojvodic Aleksandra Serbia Zulfan Z Indonesia
Vradeli Georgia Germany Zulkarnain Sarah Diba Indonesia
Wahab Farhana Bangladesh Żychowska Magdalena Poland
Waheed Sohail Pakistan
Waly Ahmed Egypt
Wang Zhaoyuan China
Wang Ping China
Wardhani Putri Hendria Indonesia
Wardiana Maya Indonesia
Waskiel-Burnat Anna Poland
Watanabe Yoshinori Japan
Waworuntu Grace Indonesia
Wei Yiran Italy
Werner Markus Germany
Whaley Kristen Therese Philippines
Widhiati Suci Indonesia
Widia Yuri Indonesia
Widiatma Ridha Ramadina Indonesia
Widjaja S Indonesia
Widjaya Mrh Indonesia
Wilches Diana Ecuador
Wilson Anna Australia
Wirya Andrew Yoshihiro Indonesia
Wirya Stephen Akihiro Indonesia
Wong Mary Darice Philippines
Woo Taylor Canada
Wu Xiaotian Singapore
Wungu Kartika Dewi Arifiana Indonesia
Xu Zhongyi China
Xu Jingyuan UK
Xue Xiaotong China
Yadav Neha India
Yahya Aishatu Nigeria
47
WCD2023 Scholarships sponsored in part by PIERRE FABRE and RELIFE
ILDS MEDAL OF ACHIEVEMENTS IN GLOBAL DERMATOLOGY

Jean Bolognia
Presented during the Opening Ceremony of the 25th World Congress of Dermatology, 3rd July 2023,
Plenary Room Hall 603-604.
ILDS YOUNG DERMATOLOGIST INTERNATIONAL ACHIEVEMENT AWARD

Bilcha Kassahun, USA
Devaraj Dinesh Kumar, India
Melo Fernandes Daniel, Brazil
Nakamizo Satoshi, Japan
Recalcati Sebastiano, Italy
AMERICAN ACADEMY OF DERMATOLOGY

Ahad Tashmeeta, Canada Montgomery Simone, USA
Balu Bharath, USA Motosko Catherine, USA
Chapman Sara, USA Muntyanu Anastasiya, Canada
Choi Franchesca, USA Park Seiwon, Canada
Cronin Megan, USA Rankin Brian, Canada
Dany Mohammed, USA Rodriguez Olaf, USA
Durkin John, USA Rusu Corina, USA
Ezekwe Nneamaka, USA Sathe Nishad, USA
Goddard Lindsey, USA Snyder Alan, USA
Huang Christina, Canada Subhadarshani Sweta, USA
Issa Naiem, USA Tan Marcus, USA
Khosravi-Hafshejani Touraj, Canada Thakur Juthika, Canada
Kwa Michael, USA Thomas Mary, Canada
Kwan Kevin, USA Thompson Alina, USA
Liu Harry Chaocheng, Canada Watchmaker Jacqueline, USA
Liu Annie, Canada Zhong Connie, USA
Mansour Danny, Canada Zhou Linda, Canada
48
ILDS MEMBER SOCIETY
& SISTER SOCIETIES
MEETINGS
49
ILDS MEMBER SOCIETY MEETINGS
& ANCILLARY GROUP MEETINGS
MONDAY 3rd JULY, 2023
The following satellite sessions have been organised by national and international societies (i.e. ILDS
member societies and affiliate groups) for the benefit of WCD2023 delegates. They represent and ad-
junct to the main World Congress scientific programme and are meant to showcase activities and ex-
pertise in dermatology from around the world. Attendance at these sessions is generally open to all
WCD2023 registrants but for some sessions, advance preregistration through the individual societies
may have been required.
SISTER NAME VENUE ROOM TIME SESSION TITLE
Advanced Systemic
American Academy of Dermatology - AAD Suntec 328+329 08:30-12:30
Therapeutics
American Hair Research Society - AHRS Suntec 320 13:30-17:30 AHRS Session
Best of British Session:

British Association of Dermatologists - BAD Suntec 310+311 13:30-17:10 Leading in Education &
Research
British Dermatological Nursing Group - BDNG Pan Pacific Pacific 2 09:25–17:00 BDNG Session
8th Global Chinese

Dermatological Summit
Chinese Society of Dermatology - CSD Suntec 323 08:30-12:30 (GCDS) & Chinese Society
of Dermatology (CSD) Joint
Symposium
Dermatologic Aesthetic Surgery International
Suntec 308+309 13:30-17:30 DASIL Session
League - DASIL
Egyptian Society of Dermatology & Venereology Pan Pacific Pacific 3 08:30-12:30 ESDV Session
Egyptian Women’s Dermatologic Society -

Suntec 308+309 08:30-12:30 EWDS Session
EWDS
European Hidradenitis Suppurativa Foundation e.V. Pan Pacific Pacific 1 13:30-17:30 EHSF e.V. Session
European Society for Cosmetic and Aesthetic

Joint Meeting of ESCAD &
Dermatology -ESCAD & European Society for Suntec 310+311 08:30-12:30
ESLD
Lasers and Energy Based Devices - ESLD
European Society for Dermatology and Psychiatry
- ESDaP & Association for Psychoneurocutaneous Joint Meeting of ESDaP &
Pan Pacific Pacific 3 13:30-17:30
Medicine of North America - APMNA & Japanese APMNA & JPSD
Society of Psychosomatic Dermatology - JPSD
European Society for Photodermatology - World Photodermatology
Suntec Nicoll 3 08:30-17:30
ESPD & Photodermatology Society Day
European Women Dermatological and

Suntec 331 08:30-12:30 EWDVS Session
Venerological Society - EWDVS
Gloderm Suntec 334+335+336 08:30-12:30 Gloderm Session
Ibero Latin American College of Dermatology

Pan Pacific Pacific 1 08:30-12:30 CILAD Session
- CILAD
Indian Association of Dermatologists,

Suntec 332 09:00–16:30 IADVL Session
Venereologists & Leprologists - IADVL
50
SISTER NAME VENUE ROOM TIME SESSION TITLE
Pearls form Archipelago:

Indonesian Society of Dermatology and
Suntec 320 08:30-12:30 Interesting Cases and Studies
Venereology - INSDV
from Indonesia
The War of the World - Round
International Academy of Cosmetic Dermatology
Suntec 324+325+326 08:30-12:30 3 - The Good VS. The Bad, And
- IACD
The Ugly
Global Perspectives in AD:
International Eczema Council - IEC Suntec Summit 2 08:30-12:30 Non-Atopic Challenges in AD
Patients
International Peeling Society - IPS Suntec 324+325+326 13:30-17:30 IPS Session
Psoriasis Management and

International Psoriasis Council - IPC Suntec Nicoll 1 14:30–17:30 Treatment – An International
Perspective
Standardization of Clinical
International Society for Cutaneous and Pathologic Reports in
Suntec Summit 1 09:00–15:30
Lymphomas - ISCL Mycosis Fungoides/Sézary
Syndrome
International Society of Atopic Dermatitis - Global aspects of Atopic
Pan Pacific Ocean 1-3 08:30–12:00
ISAD Dermatitis
International Society of Dermatology - ISD Suntec 323 13:30–16:00 ISD Session
Dermatopathology
Worldwide: The Importance
International Society of Dermatopathology - ISDP
Pan Pacific Ocean 4-5 13:30-17:30 of Dermatopathology in
& American Society of Dermatopathology - ASDP
Dermatology for Better
Clinical Care Worldwide
Paediatric Dermatology -
International Society of Paediatric
Suntec 328+329 13:30-16:30 Lessons Learned from Life
Dermatology - ISPD
and Literature
Pigmentary Disorders Society - PDS Suntec Summit 2 13:30-17:30 PDS Session
Saudi Society of Dermatology and

Suntec 334+335+336 13:30-17:30 SSDDS Session
Dermatologic Surgery
SIDeMaST Suntec 331 13:30-17:30 Italy and Friends
Where Science, Innovation &

Skin of Color Society Suntec 330 13:30-17:30 Inclusion Meet on the
Global Stage
La Journée de la
Société Française de Dermatologie Pan Pacific Ocean 4-5 09:00–12:30
Dermatologie Francophone
Society of Dermatologists, Venereologists and

Pan Pacific Ocean 1-3 13:30–16:00 SODVELON Session
Leprologists of Nepal - SODVELON
Tropical pearls – Dimensions

Sri Lanka College of Dermatologists - SLCD Suntec 330 08:30-12:30
of Diversity and Relevance
Tunisian Society of Dermatology and Venereology Suntec 327 08:30-17:30 STDV/ISTD/MEIDAM Session
Women’s Dermatologic Society Suntec Nicoll 2 08:30-12:30 International WDS Forum
51
52
SCIENTIFIC SESSIONS
4th - 8th JULY 2023
53
MESSAGE FROM THE SCIENTIFIC PROGRAMME
COMMITTEE CHAIR AND VICE-CHAIR
Dear colleagues,
Warm welcome to the World Congress of Dermatology 2023 in Singapore! To make a difference, the
scientific programming committee (SPC) developed an entirely new format for this event. Despite the
global threats, the world is moving closer together and the interdependencies are increasing. In this
challenging context, the World Congress of Dermatology 2023 provides the highest quality of global
dermatology continuing education as specialists from all over the world, including areas previously un-
derrepresented, will enrich us from different angles.
Major inclusive effort has been taken to identify and invite leading dermatologists from Africa, Asia, Mid-
dle-East and South-America to enrich the scientific program. To make the Congress a true World Con-
gress, the SPC and local organizer have:
• invited distinguished speakers on topics of global responsibility

• provided an unprecedented number of scholarships to support attendees especially from low
and lower-middle-income countries
• completely restructured the congress format, moving towards a structured format promoting
exchange on topics most relevant to dermatology in 2023 and beyond.
How does the new format look like?
Distinguished Lectures which go beyond clinical medicine. Prominent scientists will address topics
of world-wide impact such as the distribution of resources or the human impact on climate change.
In subsequent Plenary Lectures, internationally-recognized experts summarize newest insights into 15
disease entities.
Instead of the classical formats, 60 full- or half-day Symposia focus on individual disease entities, from
epidemiology and pathophysiology through clinical and histological diagnosis to treatment – address-
ing both classical and most recent approaches. This allows to get profound insights into many important
skin diseases and their treatments from different parts of the world.
Furthermore, two Hot Topics sessions will address entities of immediate relevance to our specialty.
The third new format, the Expert Forum, will be truly interactive. Short statements by widely known
experts introduce debated topics to be subsequently discussed between experts and delegates. To
ensure lively discussions, Expert Forums have a maximum of 100 participants. The discussions will be
summarized by the chair.
Because of their success during previous congresses, we will keep the Controversy Sessions, the Cours-
es and Free Communications.
Organizing such a program with a world-wide scope is the work of many. First of all, I want to thank the
chairs and speakers. They are the ones who prepared their presentations and will enrich us with their
knowledge. We are especially grateful to all those from low- and middle-income countries, for whom
joining this congress is also a major financial effort.
We all are grateful to the hundreds of experts and the ILDS member societies who helped to form the pro-
gram, to formulate the most appropriate and most pressing questions, and to find the best speakers from
54
all over the world. You might miss the participation of some prominent experts – we hope that these ex-
perts and also you forgive us for that, as we took a major effort to involve young stars, early in their career.
We would like to thank the strong support provided by members of the Scientific Program Committee,
Professor Roy Chan, the local organizing committee, and the ILDS member societies from all over the
world for helping to shape a world-wide and balanced program.
I’m especially grateful to Professor Henry Lim, co-chair of the SPC and ILDS president-elect. He provid-
ed tremendous help and guided the SPC for some months during difficult periods. Without his support
realizing this program would have been impossible.
This said, we sincerely hope that you will enjoy the program and that this World Congress will deeply
enrich us and make all of us better dermatologists for our patients.
Yours
PROF. DR. MARTIN RÖCKEN PROF. HENRY W. LIM

Chair, Scientific Programme Committee Vice Chair, Scientific Programme Committee
55
SESSION CODES
CN CONTROVERSIES IN DERMATOLOGY LS LUNCHTIME SPONSORED SYNÌMPOSIA
CO COURSES ME MEET THE EXPERTS
DL DSS/LADS SESSIONS PL PLENARY SESSIONS
EF EXPERT FORUMS RS RESIDENTS SESSIONS
FC FREE COMMUNICATIONS SS SATELLITE SYMPOSIA
HT HOT TOPIC AND ILDS SESSIONS SY SYMPOSIA
LB LATE-BREAKER SESSIONS
CME ACCREDITATION
Participants must ensure that their badges are scanned both at the entrance and at the exit of each
session to be acknowledged for UEMS-EACCME and Singapore CME accreditation.
The 25th World Congress has been granted 32 European CME credits (ECMEC®s) by the European Ac-
creditation Council for Continuing Medical Education (EACCME®).
Each participant can only receive the number of credits he/she is entitled to according to his/her actual
participation at the event once he/she has completed the feedback form.
Please find below the breakdown of ECMEC®s per day:

03.07.2023 – 0.00
04.07.2023 – 7.00
05.07.2023 – 7.00
06.07.2023 – 7.00
07.07.2023 – 7.00
08.07.2023 – 4.00
The EACCME® awards ECMEC®s on the basis of 1 ECMEC® for one hour of CME with a maximum of 8
ECMEC®s per day.
SINGAPORE CME ACCREDITATION

Continuing Medical Education (CME) points for the local medical practitioners are being applied with the
Singapore Medical Council. Once approved, information on the number of points for the main meeting of
the World Congress in Dermatology (WCD) will be made known. CME points for attendance at sessions
at the WCD will be uploaded to the SMC website within 2-4 weeks after the event.
FACULTY CONFLICT OF INTEREST DISCLOSURES

According to the UEMS-EACCME® WCD2023 requires that all individuals who make any presentation at
the Congress declare their conflicts of interest in relation to their presentation(s). If there are no relevant
conflicts this must also be specifically declared. The list of conflict of interest declarations is available
for review on the Congress website www.wcd2023singapore.org/cme. All presenters must provide a
declaration of COI at the time of presentation. More detailed information on individual disclosures by any
specific author, listed by specific type of conflict and commercial relation(s), are available for review by
direct request to the Organising Secretariat.
56
PLENARY SPEAKERS
WCD2023 DISTINGUISHED SPEAKERS
Global experts discuss important medical and scientific issues relevant to dermatology.
JABBAR R. BENNETT CHORH CHUAN TAN ADEEBA KAMARULZAMAN

(USA) (SINGAPORE) (MALAYSIA)
DAVID LANE HARALD LESCH

(UK) (GERMANY)
WCD2023 KEYNOTE SPEAKERS

Keynote talks by 15 leading clinicians and scientists on significant advances, from basic science to
global dermatology.
WEN-HUNG CHUNG ESTHER FREEMAN KAMRAN GHORESCHI

(CHINESE TAIPEI) (USA) (GERMANY)
57
CHANDER GROVER EMMA GUTTMAN-YASSKY MUZLIFAH HANIFFA
(INDIA) (USA) (UK)
DORIS M. HEXSEL KIARASH KHOSROTEHRANI BRIAN S. KIM

(BRAZIL) (AUSTRALIA) (USA)
GEORGINA LONG CHRYSALYNE D. SCHMULTS ELI SPRECHER

(AUSTRALIA) (USA) (ISRAEL)
SUSAN TAYLOR YANG WANG MARC YALE

(USA) (CHINA) (USA)
58
SCIENTIFIC SESSIONS
TUESDAY 4th JULY 2023
59
DAY AT A GLANCE | TUESDAY 4th JULY 2023
TIME SESSION CODE SESSION TITLE SESSION ROOM
7:00-7:45 DL01D PAEDIATRIC DERMATOLOGY IN SOUTH-EAST ASIA SUNTEC - 320
7:00-7:45 DL02E PIGMENTARY DISORDERS IN SOUTH-EAST ASIA SUNTEC - 323
7:00-7:45 DL03C HAIR DISORDERS SUNTEC - 327
7:00-7:45 DL04B HIGHLIGHTS OF MALAYSIAN DERMATOLOGY (PDM) SUNTEC - 330
PATIENT SUPPORT GROUPS/ADVOCACY - PSORIASIS ASSOCIATION OF

7:00-7:45 DL05D SUNTEC - 331
SINGAPORE
7:00-7:45 DL06E VALUE DRIVEN CARE IN DERMATOLOGY SUNTEC - 332
ATOPIC DERMATITIS: NEW DEVELOPMENTS - DISEASE PHENOTYPES AND

8:00-9:20 SY01A SUNTEC - HALL 606
COMORBIDITIES
DIGITAL DERMATOLOGY AND ARTIFICIAL INTELLIGENCE - ARTIFICIAL

8:00-9:20 SY09A SUNTEC - SUMMIT 1
INTELLIGENCE
8:00-9:20 SY24A DERMOSCOPY I - DERMOSCOPY: OVERVIEW SUNTEC - SUMMIT 2
8:00-9:20 SY40A MEDICAL AESTHETICS I - CHEMICAL PEELS, PRP AND MESOTHERAPY SUNTEC - NICOLL 1
8:00-9:20 SY35A BENIGN NEOPLASMS - BENIGN NEOPLASMS I SUNTEC - NICOLL 2
8:00-9:20 SY12A KERATINOCYTE CARCINOMAS - BASAL CELL CARCINOMAS SUNTEC - NICOLL 3
GRANULOMATOUS DISEASES (NON-INFECTIOUS) - GRANULOMATOUS

8:00-9:20 SY30A SUNTEC - 308+309
DISEASES I
SKIN BLEACHING - SKIN LIGHTENING WITH GLUTATHIONE IS EFFECTIVE

8:00-9:20 CN07 SUNTEC - 310+311
AND HARMLESS FOR COSMETIC SKIN LIGHTENING
8:00-9:20 RS01 AUTOIMMUNE BLISTERING DISEASES SUNTEC - 320
MEDICAL DERMATOLOGY (GRANULOMATOUS DISEASES/AUTOINFLAMMATION,

8:00-9:20 FC05 SAPHO, PAPA AND NEUTROPHILIC DERMATOSES/EOSINOPHILIC SUNTEC - 323
DERMATOSES)
8:00-9:20 SY29A NAILS AND NAIL SURGERY - MALIGNANT TUMOURS OF THE NAILS SUNTEC - 324+325+326
ETHICS, QUALITY OF CARE, QUALITY OF LIFE AND COSTS - ACCESS TO

8:00-9:20 SY55A SUNTEC - 327
CARE AND TREATMENTS
8:00-9:20 SY05A BACTERIAL INFECTIONS - BACTERIAL INFECTIONS I PART I SUNTEC - 328+329
8:00-9:20 FC09 CONTACT DERMATITIS SUNTEC - 330
8:00-9:20 FC11 DERMATOLOGICAL SURGERY SUNTEC - 331
8:00-9:20 EF01 DERMATOLOGY & SEXUAL HEALTH IN LGBTQ+ PATIENTS SUNTEC - 332
8:00-9:20 FC12 ACNE, HIDRADENITIS SUPPURATIVA, ROSACEA 1 SUNTEC - 334+335+336
60
8:00-9:20 COFD03 BASIC DERMATOLOGICAL SURGERY PAN PACIFIC - PACIFIC 1
8:00-9:20 COHD13 HAIR TRANSPLANTATION: FROM PRINCIPLES TO POST-OPERATIVE CARE PAN PACIFIC - PACIFIC 2
8:00-9:20 COHD07 CHEMICAL PEELS PAN PACIFIC - PACIFIC 3
ATOPIC DERMATITIS: NEW DEVELOPMENTS - GENOTYPES AND

9:30-10:50 SY01B SUNTEC - HALL 606
PATHOGENESIS
DIGITAL DERMATOLOGY AND ARTIFICIAL INTELLIGENCE - SMARTPHONE

9:30-10:50 SY09B SUNTEC - SUMMIT 1
APPS AND SOCIAL MEDIA
9:30-10:50 SY24B DERMOSCOPY I - DERMOSCOPY: PIGMENTED LESIONS I SUNTEC - SUMMIT 2
9:30-10:50 SY40B MEDICAL AESTHETICS I - COMPLICATIONS SUNTEC - NICOLL 1
9:30-10:50 SY35B BENIGN NEOPLASMS - BENIGN NEOPLASMS II SUNTEC - NICOLL 2
9:30-10:50 SY12B KERATINOCYTE CARCINOMAS - EPIDEMIOLOGY AND PRECURSORS SUNTEC - NICOLL 3
GRANULOMATOUS DISEASES (NON-INFECTIOUS) - GRANULOMATOUS

9:30-10:50 SY30B SUNTEC - 308+309
DISEASES II
SKIN CANCER - NON-INVASIVE IMAGING WILL REPLACE SKIN BIOPSY AS

9:30-10:50 CN08 SUNTEC - 310+311
THE STANDARD FOR ROUTINE DIAGNOSIS OF KERATINOCYTE CARCINOMA
9:30-10:50 FC02 SKIN IMAGING OTHER THAN DERMOSCOPY SUNTEC - 320
9:30-10:50 FC06 URTICARIA AND ANGIOEDEMA SUNTEC - 323
9:30-10:50 SY29B NAILS AND NAIL SURGERY - NAIL DISEASES I SUNTEC - 324+325+326
ETHICS, QUALITY OF CARE, QUALITY OF LIFE AND COSTS - CHALLENGING

9:30-10:50 SY55B SUNTEC - 327
DECISION MAKING I
9:30-10:50 SY05B BACTERIAL INFECTIONS - BACTERIAL INFECTIONS I PART II SUNTEC - 328+329
9:30-10:50 FC10 TELEDERMATOLOGY SUNTEC - 330
9:30-10:50 RS02 HIDRADENITIS SUPPURATIVA/CONTACT DERMATITIS SUNTEC - 331
9:30-10:50 EF02A ADVANCED HISTOPATHOLOGY (INFLAMMATORY SKIN DIESEASE) SUNTEC - 332
9:30-10:50 FC13 ACNE, HIDRADENITIS SUPPURATIVA, ROSACEA 2 SUNTEC - 334+335+336
9:30-10:50 COHD13 HAIR TRANSPLANTATION: FROM PRINCIPLES TO POST-OPERATIVE CARE PAN PACIFIC - PACIFIC 2
9:30-10:50 COHD07 CHEMICAL PEELS PAN PACIFIC - PACIFIC 3
61
11:00-12:30 PL01 PLENARY SESSION SUNTEC - HALL 603+604
ATOPIC DERMATITIS: NEW DEVELOPMENTS - SYSTEMIC AND NEW

14:30-15:50 SY01C SUNTEC - HALL 606
TREATMENTS
DIGITAL DERMATOLOGY AND ARTIFICIAL INTELLIGENCE -

14:30-15:50 SY09C SUNTEC - SUMMIT 1
TELEDERMATOLOGY
14:30-15:50 SY24C DERMOSCOPY I - DERMOSCOPY: PIGMENTED LESIONS II SUNTEC - SUMMIT 2
14:30-15:50 SY40C MEDICAL AESTHETICS I - FILLERS AND THREADS SUNTEC - NICOLL 1
14:30-15:50 SY35C BENIGN NEOPLASMS - DISORDERS OF DERMIS AND SUBCUTANEOUS FAT SUNTEC - NICOLL 2
14:30-15:50 SY12C KERATINOCYTE CARCINOMAS - SQUAMOUS CELL CARCINOMAS SUNTEC - NICOLL 3
14:30-15:50 HT03 ILDS PROMOTING SKIN HEALTH FOR THE WORLD: INSIGHT SUNTEC - 308+309
IMMUNOSUPPRESSIVE AGENTS - TRADITIONAL IMMUNOSUPPRESSIVE

14:30-15:50 SY50A SUNTEC - 310+311
AGENTS I
14:30-15:50 FC03 SKIN AGING: EXTRINSIC AND INTRINSIC FACTORS SUNTEC - 320
14:30-15:50 FC07 WOUND HEALING & KELOIDS SUNTEC - 323
14:30-15:50 SY29C NAILS AND NAIL SURGERY - NAIL DISEASES II SUNTEC - 324+325+326
ETHICS, QUALITY OF CARE, QUALITY OF LIFE AND COSTS - CHALLENGING

14:30-15:50 SY55C SUNTEC - 327
DECISION MAKING II
14:30-15:50 SY05C BACTERIAL INFECTIONS - BACTERIAL INFECTIONS II PART I SUNTEC - 328+329
14:30-15:50 LB01 LATE-BREAKER SESSIONS SUNTEC - 330
14:30-15:50 SY53A URTICARIA AND ANGIOEDEMA - URTICARIA AND ANGIOEDEMA I SUNTEC - 331
14:30-15:50 EF02B ADVANCED HISTOPATHOLOGY (TUMOURS OF THE SKIN) SUNTEC - 332
UNIQUE DERMATOLOGY ISSUES SEEN IN MIGRANTS AND REFUGEES - SKIN

14:30-15:50 SY51A SUNTEC - 334+335+336
ISSUES IN NEWLY ARRIVING MIGRANTS AND REFUGEES I
14:30-15:50 COHD04 BASIC DERMATOPATHOLOGY - INFLAMMATORY PAN PACIFIC - PACIFIC 2
14:30-15:50 COHD22 PHOTOTHERAPY & PHOTOPROTECTION PAN PACIFIC - PACIFIC 3
ATOPIC DERMATITIS: NEW DEVELOPMENTS - THE BARRIER AND CLASSICAL

16:00-17:20 SY01D SUNTEC - HALL 606
THERAPIES
16:00-17:20 SY09D DIGITAL DERMATOLOGY AND ARTIFICIAL INTELLIGENCE - WEARABLES SUNTEC - SUMMIT 1
62
16:00-17:20 SY24D DERMOSCOPY I - DERMOSCOPY: SPECIAL INDICATIONS SUNTEC - SUMMIT 2
MEDICAL AESTHETICS I - REJUVENATION AND SKIN TIGHTENING WITH

16:00-17:20 SY40D SUNTEC - NICOLL 1
LASERS AND EBDs
16:00-17:20 SY35D BENIGN NEOPLASMS - DISORDERS OF SWEAT GLANDS SUNTEC - NICOLL 2
KERATINOCYTE CARCINOMAS - THERAPY OF ADVANCED SQUAMOUS CELL

CARCINOMAS
16:00-17:20 FC01 SKIN CANCER EXCLUDING MELANOMA SUNTEC - 308+309
IMMUNOSUPPRESSIVE AGENTS - TRADITIONAL IMMUNOSUPPRESSIVE

16:00-17:20 SY50B SUNTEC - 310+311
AGENTS II
16:00-17:20 FC04 ARTIFICIAL INTELLIGENCE SUNTEC - 320
16:00-17:20 FC08 SOCIAL MEDIA, PATIENT SUPPORT GROUPS AND ENGAGEMENT SUNTEC - 323
16:00-17:20 SY29D NAILS AND NAIL SURGERY - SURGERY AND HISTOPATHOLOGY OF THE NAILS SUNTEC - 324+325+326
ETHICS, QUALITY OF CARE, QUALITY OF LIFE AND COSTS - ETHICS IN

16:00-17:20 SY55D SUNTEC - 327
DERMATOLOGY
16:00-17:20 SY05D BACTERIAL INFECTIONS - BACTERIAL INFECTIONS II PART II SUNTEC - 328+329
16:00-17:20 RS03 PSYCHODERMATOLOGY/TELEDERMATOLOGY SUNTEC - 330
16:00-17:20 SY53B URTICARIA AND ANGIOEDEMA - URTICARIA AND ANGIOEDEMA II SUNTEC - 331
PATIENTS AS PARTNERS IN ADVANCING DERMATOLOGY THROUGH

16:00-17:20 EF13 SUNTEC - 332
RESEARCH AND ADVOCACY
UNIQUE DERMATOLOGY ISSUES SEEN IN MIGRANTS AND REFUGEES - SKIN

16:00-17:20 SY51B SUNTEC - 334+335+336
ISSUES IN NEWLY ARRIVING MIGRANTS AND REFUGEES II
16:00-17:20 COHD04 BASIC DERMATOPATHOLOGY - INFLAMMATORY PAN PACIFIC - PACIFIC 2
16:00-17:20 COHD22 PHOTOTHERAPY & PHOTOPROTECTION PAN PACIFIC - PACIFIC 3
63
SCIENTIFIC PROGRAMME | TUESDAY 4th JULY 2023 | SUNTEC
SUNTEC | LEVEL 3 | ROOM 320 | 07:00-07:45 SUNTEC | LEVEL 3 | ROOM 327 | 07:00-07:45
DL (DL01D) PAEDIATRIC DERMATOLOGY IN
DL (DL03C) HAIR DISORDERS
SOUTH-EAST ASIA
CHAIRS: CHAIRS:
Maria Victoria Dizon (Philippines) Aishwarya Sridharan (Singapore)
Mark Koh (Singapore) Etienne Wang (Singapore)
07:00 Introduction 07:00 Scarring alopecia: Clinical and pathological

Mark Koh (Singapore) perspectives
Joyce Lee (Singapore)
07:03 Cases from India
Surabhi Sinha (India) 07:15 Novel insights linking menopause and hair loss
Aishwarya Sridharan (Singapore)
07:10 Cases from Indonesia
Margaretha Indah Maharani (Indonesia) 07:30 Trichoscopy in Asians
Etienne Wang (Singapore)
07:17 Cases from Malaysia
Henrietta Albela (Malaysia)
SUNTEC | LEVEL 3 | ROOM 330 | 07:00-07:45
07:24 Cases from Philippines DL (DL04B) HIGHLIGHTS OF MALAYSIAN

Carmela Augusta F. Dayrit-Castro (Philippines) DERMATOLOGY (PDM)
07:31 Cases from Singapore CHAIRS:

Lynette Wee (Singapore) Noor Zalmy Azizan (Malaysia)
Sabeera Begum (Malaysia)
07:38 Cases from Thailand
Sanchawan Wittayakornrerk (Thailand) 07:00 20 years of genes hunting in Malaysia
Kin Fon Leong (Malaysia)
07:15 Atopic Dermatitis in the sunny sunshine

SUNTEC | LEVEL 3 | ROOM 323 | 07:00-07:45 Adawiyah Jamil (Malaysia)
DL (DL02E) PIGMENTARY DISORDERS IN SOUTH-

EAST ASIA 07:30 M
alaysian Psoriasis Registry: The Journey so far
Suganthy Robinson (Malaysia)
CHAIRS:
Almond Derla (Philippines)
Steven Thng (Singapore)
07:00 Innovations in the treatment of pigmentary DL (DL05D) PATIENT SUPPORT GROUPS/

disorders ADVOCACY - PSORIASIS ASSOCIATION OF
Leihong Flora Xiang (China) SINGAPORE
07:10 Lichen Planus pigmentosus - Diagnosis and CHAIRS:

management Benjamin Goh (Singapore)
Davinder Parsad (India) Colin Theng (Singapore)
07:20 Vitiligo research in Taiwan 07:00 Treatment goals for psoriasis - is Clear or
Cheng-Che Eric Lan (Chinese Taipei) Almost clear a realistic target?
Pravit Asawanonda (Thailand)
07:30 Management of Melasma in Skin of Colour
Rashmi Sarkar (India) 07:20 Cumulative life course impairment in Psoriasis
Colin Theng (Singapore)
07:40 Q&A
07:35 Psoriasis - Insights into the Patient Journey
Benjamin Goh (Singapore)
64
SUNTEC | LEVEL 3 | ROOM 332 | 07:00-07:45 SUNTEC | LEVEL 3 | NICOLL 1 | 08:00-09:20
DL
(DL06E) VALUE DRIVEN CARE IN SY ( SY40A) MEDICAL AESTHETICS I - CHEMICAL
DERMATOLOGY PEELS, PRP AND MESOTHERAPY
CHAIRS: CHAIR:
Yung Hian Leow (Singapore) Claudia Borelli (Germany)
Ki Wei Tan (Singapore) CO-CHAIRS:
07:00 Introduction Maya Vedamurthy (India)
08:00 Epidermal barrier repair

07:04 Right-siting patients with stable chronic skin TBA
conditions to primary care
Hazel Oon (Singapore) 08:15 Q&A
TBA
07:13 Empowering nursing and allied health
professionals care in team based care 08:20 How to choose the best peel
Yu Yan Wang (Singapore) Claudia Borelli (Germany)
07:18 Empowering nursing and allied health 08:35 Q&A

professionals care in team based care Claudia Borelli (Germany)
Prabha Rukmalee Wijesinghe (Singapore)
08:40 A critical appraisal of PRP
07:22 Reduced patient visits - use of skin imaging in Almond Derla (Philippines)
skin cancer management
Sai Yee Chuah (Singapore) 08:55 Q&A
07:31
Reducing hospital readmissions for
09:00 New insights into mesotherapy
dermatological care - use of ambulatory Maya Vedamurthy (India)
topical therapy
Hua Liang Joel Lim (Singapore) 09:15 Q&A
Maya Vedamurthy (India)
07:40 Q&A
SUNTEC | LEVEL 3 | NICOLL 2 | 08:00-09:20

SUNTEC | LEVEL 6 | HALL 606 | 08:00- 09:20 SY (SY35A) BENIGN NEOPLASMS - BENIGN

SY ( SY01A) ATOPIC DERMATITIS: NEW NEOPLASMS I
DEVELOPMENTS - DISEASE PHENOTYPES
AND COMORBIDITIES CHAIR:
Jacqueline Junkins-Hopkins (USA)
CHAIR: CO-CHAIRS:
Tilo Biedermann (Germany) TBA
CO-CHAIRS: Shigeto Matsushita (Japan)
Norito Katoh (Japan)
08:00 Dermoscopy and pathological diagnosis of
Amy Paller (USA) benign epithelial tumours
Jun Asai (Japan)
08:00 Stratifying AD endotypes and phenotypes for
clinical management: Promises and limitations 08:15 Dermal cyst: clinical case and differential
Kenji Kabashima (Japan) diagnosis
TBA
08:20 AD children are also not just small adults:
Insights in diagnostics, monitoring, and 08:20 Dermal Hypertrophies and Benign
management Fibroblastic/Myofibroblastic Tumours
Amy Paller (USA) Gauri Panse (USA)
08:40
Co-morbidities in AD - Are there global 08:35 Histiocytoses
differences based on location and Melissa Pulitzer (USA)
environment?
Christian Vestergaard (Denmark) 08:50 Xanthomas: Old and New treatment options
Elena Rossi (Italy)
09:00 How do comorbidities associated with AD 09:05 Dermal hypertrophy: Case presentations
Jacqueline Junkins-Hopkins (USA)
affect diagnosis and management?
Tilo Biedermann (Germany) 09:10 Q&A
65
SUNTEC | LEVEL 3 | NICOLL 3 | 08:00-09:20 SUNTEC - LEVEL 3 - SUMMIT 2 - 08:00-09:20
SY ( SY12A) KERATINOCYTE CARCINOMAS - SY (SY24A) DERMOSCOPY I - DERMOSCOPY:

BASAL CELL CARCINOMAS OVERVIEW
CHAIR: CHAIR:
Christopher Bichakjian (USA) Luc Thomas (France)
CO-CHAIRS: CO-CHAIRS:
Nicole Kelleners-Smeets (Netherlands) Raimonds Karls (Latvia)
Melissa Wee Ping Tan (Singapore) Susana Puig (Spain)
08:00 Pathophysiology and hedgehog inhibitors 08:00 D

ermoscopy of skin inflammatory diseases
Brian Berman (USA) Aimilios Lallas (Greece)
08:20 Surgical therapies 08:20 Dermoscopy in skin oncology

Melissa Wee Ping Tan (Singapore) Giuseppe Argenziano (Italy)
08:40 Topical therapies 08:40 Dermoscopy and genetics

Nicole Kelleners- Smeets (Netherlands) Susana Puig (Spain)
09:00 De-intensification of treatment 09:00 Dermoscopy on special sites

Christopher Bichakjian (USA) Luc Thomas (France)
SUNTEC | LEVEL 3 | SUMMIT 1 | 08:00-09:20 SUNTEC | LEVEL 3 | ROOM 308+309 | 08:00-09:20

SY ( SY09A) DIGITAL DERMATOLOGY AND SY ( SY30A) GRANULOMATOUS DISEASES (NON-
ARTIFICIAL INTELLIGENCE - ARTIFICIAL INFECTIOUS) - GRANULOMATOUS DISEASES I
INTELLIGENCE
CHAIR:
CHAIR: Werner Kempf (Switzerland)
Soo Ick Cho (Republic of Korea) CO-CHAIRS:
CO-CHAIRS: Riad Mashal (UAE)
Kaliyadan Feroze (Saudi Arabia) Ramon Pujol (Spain)
Peggy Bui (USA)
08:00 Classification of granulomatous disorders
08:00 Developing AI for Health: Opportunities & Werner Kempf (Switzerland)
Challenges
Peggy Bui (USA) 08:20 Granuloma annulare, actinic granuloma and
elastolytic giant cell granuloma
08:20 AI beyond skin cancer - How will AI fit into Christina Mitteldorf (Germany)
the clinical field of dermatology
Alexander A. Navarini (Switzerland) 08:40 Interstitial granulomatous disease
Ramon Pujol (Spain)
08:40 Looking for the diagnosis online - The good,
the bad, the ugly 09:00 Sarcoidosis
Seung Seog Han (Republic of Korea) Riad Mashal (UAE)
09:00 S
kin diversity - Underrepresentation of
skin types, gender, and age in current
dermatology AI models
Vinod Nambudiri (USA)
66
SUNTEC | LEVEL 3 | ROOM 310+311 | 08:00-09:20 SUNTEC | LEVEL 3 | ROOM 320 | 08:00-09:20
CN ( CN07) SKIN BLEACHING - SKIN LIGHTENING RS (RS01) AUTOIMMUNE BLISTERING DISEASES
WITH GLUTATHIONE IS EFFECTIVE
AND HARMLESS FOR COSMETIC SKIN CO-CHAIRS:
LIGHTENING Valeria Aoki (Brazil)
Jasmin Jamora (Philippines)
CHAIR:
Daniel M. Siegel (USA) 08:00 M
anagement of pemphigus with Rituximab
DISCUSSANTS AGAINST: versus Dexamethasone Pulse therapy: a
Seemal Desai (USA) comparative study with special reference
DISCUSSANT FOR: to changes in histopathology and direct
Evangeline Handog (Philippines) immunofluorescence
Alpana Mohta (India)
08:00 Introduction
Daniel Siegel (USA) 08:15
Prevalence of depression in bullous diseases
seen at Inkosi Albert Luthuli Central Hospital
08:10 Motion “For” (IALCH) and King Edward VIII Hospital, Durban
Evangeline Handog (Philippines) South Africa: Preliminary results
Nkosiyenzile Cele (South Africa)
08:20 Motion “Against”
Seemal Desai (USA) 08:30 E
xpression of JAK/STAT signalling in bullous
pemphigoid
08:30 Intra-Panel Discussion Laxmi Iyengar (Australia)
08:50 Q&A 08:45 C
linical effect of concomitant treatment of
rituximab and oMalizumab in patients with
09:00 Closing Remarks “For” refractory bullous pemphigoid
Evangeline Handog (Philippines) Il Joo Kwon (Republic of Korea)
09:05 Closing Remarks “Against” 09:00 A
dverse Cutaneous Events of Low-Dose
Seemal Desai (USA) Methotrexate: A Systematic Review
Touraj Khosravi-Hafshejani (Canada)
09:10 Results
09:15 Discussion
67
SUNTEC | LEVEL 3 | ROOM 323 | 08:00-09:20 SUNTEC | LEVEL 3 | ROOM 324+325+326 | 08:00-09:20
FC (FC05) MEDICAL DERMATOLOGY
SY (SY29A) NAILS AND NAIL SURGERY -

(GRANULOMATOUS DISEASES/ MALIGNANT TUMOURS OF THE NAILS
AUTOINFLAMMATION, SAPHO, PAPA
AND NEUTROPHILIC DERMATOSES/ CHAIR:
EOSINOPHILIC DERMATOSES) Bertrand Richert (Belgium)
CO-CHAIRS:
CO-CHAIRS: Andre Lencastre (Portugal)
Almudena Nuño Gonzalez (Spain) Sana Mokni (Tunisia)
Yayoi Tada (Japan)
08:00 Diagnosis of periungual squamous cell
08:00
A vexing case of VEXAS syndrome carcinoma
Al-Kutubi Huda (UK) Bertrand Richert (Belgium)
08:10
Bone marrow tryptase a new diagnostic 08:20 How to deal with longitudinal melanonychia?
criterion for systemic mastocytosis: Sana Mokni (Tunisia)
prospective multicenter study
Cristina Bulai Livideanu (France) 08:40 Diagnosis and therapy of nail unit melanoma
Andre Lencastre (Portugal)
08:20
The changing face of Blashkitist
Sayantani Chakraborty (India) 09:00 Mohs micrographic surgery for nail unit
Michela Starace (Italy)
08:30 W
idespread Necrotizing Purpura and
Lucio Phenomenon as the First Diagnostic
Presentation of Diffuse Nonnodular
Lepromatous Leprosy SUNTEC | LEVEL 3 | ROOM 327 | 08:00-09:20
Maha Fathy Elmasry (Egypt) SY (SY55A) ETHICS, QUALITY OF CARE, QUALITY

OF LIFE AND COSTS - ACCESS TO CARE AND
08:40 U
tility of Laboratory Monitoring in Patients TREATMENTS
Using Hydroxychloroquine: a Retrospective
Cohort Study CHAIR:
Drew Kuraitis (USA) Aldo Morrone (Italy)
CO-CHAIRS:
08:50
Dermatological Manifestations of Extreme Matthias Augustin (Germany)
Weather Events: an Examination of Cutaneous Hosea Wilfred Waweru (Kenya)
Disease and Associated Vulnerability
Eva Rawling Parker (USA) 08:00 Quality of care among fragile patients. The
experience of San Gallicano Institute (IRCCS)
09:00
Cutaneous clinical and laboratory findings in Aldo Morrone (Italy)
patients with adult-onset immunodeficiency
due to anti-interferon gamma autoantibodies 08:20 V
alues are key in practice: A holistic health
Chudapa Sereeaphinan (Thailand) economic view for global dermatology
Matthias Augustin (Germany)
09:10 A
necrobiotic disorder with limited response
to numerous systemic therapies 08:40 A
re we equal when it comes to Medical Care?
Charankumal Sigh Thandi (UK) Nejib Doss (Tunisia)
09:00 A
ccess to care and treatments in resource
challenged areas
Hosea Wilfred Waweru (Kenya)
68
SUNTEC | LEVEL 3 | ROOM 328+329 | 08:00-09:20 09:00
Induction of Th2 inflammation in 3D skin
CN ( SY05A) BACTERIAL INFECTIONS - explant culture model
BACTERIAL INFECTIONS I PART I Jang Sunhyae (Republic of Korea)
CHAIR: 09:10 Inflammatory cytokines as biomarkers of

Scott Worswick (USA) disease activity in patients of allergic contact
CO-CHAIRS: dermatitis due to weed parthenium
Lally Mekokishvili (Georgia) Kaushal Verma (India)
Jiun Yit Pan (Singapore)
08:00 Prevention and therapy of staph aureus

infections SUNTEC | LEVEL 3 | ROOM 331 | 08:00-09:20
Lally Mekokishvili (Georgia) FC (FC11) DERMATOLOGICAL SURGERY
08:20 Staphylococcal infections and toxins CO-CHAIRS:

Scott Worswick (USA) Tri Nguyen (USA)
Reinaldo Tovo (Brazil)
08:40 Bacterial and Mycobacterial Infections In the Tropics
Pan Jiun Yit (Singapore) 08:00
Surgical Site Infections in Dermatological
Surgery: A Diagnostic Challenge
09:00 M
anagement of Recurrent Cellulitis - Richard Barlow (UK)
Challenges and Updates
Piotr Maciej Chlebicki (Singapore) 08:10
Extramammary Paget Disease: A Case
Series of Multiflap Repairs Following Mohs
Micrographic Surgery to Decrease Morbidity
Iren Kossintseva (Canada)
SUNTEC | LEVEL 3 | ROOM 330 | 08:00-09:20 08:20
Bleeding risk following mohs micrographic
FC (FC09) CONTACT DERMATITIS surgery in patients using novel oral anti-
coagulants
CO-CHAIRS: Margit Juhasz (USA)
Rosemary Nixon (Australia)
Kalman Watsky (USA) 08:30
National Trends in the Epidemiology
and Treatment with Surgical Excision or
08:00
Comparison of patch test positivity after Mohs Micrographic Surgery of Merkel Cell
24 and 48 hours of occlusion time in adult Carcinoma: A United States Population-Based
patients of allergic contact dermatitis: a Cohort Analysis
prospective study Fatima N. Mirza (USA)
Rhea Ahuja (India)
08:40
Mohs Micrographic Surgery (MMS) in Younger
08:10
Allergic Contact Dermatitis to Toilet Seat in Adults
Children and Patch testing - A clinical study Yee Wei Phoon (Singapore)
Vinitha Gopalakrishnan (India)
08:50
Modified horizontal V-Y advancement flap
08:20
Allergic Contact Dermatitis Associated with lower eyelid defects: Series of 300 cases
Religious Practices: Review of the Literature Mehdi Shiri (Iran)
and Culturally-Sensitive Suggestions for
Management 09:00
A new rung in the reconstructive ladder:
Aamir Hussain (USA) the porcine small intestinal submucosal
extracellular matrix offers a viable repair
08:30
The safety and usefulness of newly developed option for post-mohs surgical defects
hair dyes for patients with a history of hair Ally-Khan SOmani (USA)
dye allergy evaluated by a 6-month usage test
Kayoko Matsunaga (Japan) 09:10
Direct Oral Anticoagulants in Skin Surgery: A
Systematic Review
08:40 H
yperkeratotic flexural erythema with use of Patrick Ireland (Australia)
laundry sanitizers containing benzalkonium
chloride
Claire Ronaldson (Australia)
08:50
Systemic Nickel Contact Dermatitis and its
clinical management
Ashimav Deb Sharma (India)
69
EF ( EF01) DERMATOLOGY & SEXUAL HEALTH IN FC (FC12) ACNE, HIDRADENITIS SUPPURATIVA,

LGBTQ+ PATIENTS ROSACEA 1
CHAIR: CO-CHAIRS:
Klint Peebles (USA) Giuseppe Micali (Italy)
CO-CHAIRS: Haley Naik (USA)
Martin Chio (Singapore)
Winlove Mojica (Philippines) 08:00
Diagnostic and Management challenge;
perianal HS and fistulizing perianal IBD
08:00 Overview of the Geopolitical Landscape of Afsaneh Alavi (USA)
Sexual & Gender Diverse Healthcare
Klint Peebles (USA) 08:10
Spesolimab for hidradenitis suppurativa: A
proof-of-concept study
08:12 Establishing the Safe Space and Promoting Afsaneh Alavi (USA)
Cultural Humility: A Regional Perspective
Martin Chio (Singapore) 08:20 T
he human skin commensal, Cutibacterium
acnes, induces epidermal lipid synthesis
08:24 Clinical Care Perspectives and Challenges: David Boudier (France)
Regional Lessons
Winlove Mojica (Philippines) 08:30
Unique molecular features of the Cutibacterium
acnes 70S ribosome and its implications for
08:36
HPV Infection: Unique Considerations in antibiotic therapy in acne vulgaris
Global Sexual Health - The Challenge of Organ Christopher Bunick (USA)
Transplant Recipients Living with HIV
Muhammad (Monty) Junejo (UK) 08:40
No association of isotretinoin exposure
with risk of inflammatory bowel disease: a
08:48 N
ovel Approaches to Unmet Needs: systematic review with meta-analysis and trial
Experiences in South America sequential analysis
Juan Marcelo Lefimil (Chile) Ching-Chi Chi (Chinese Taipei)
09:00 P
earls in Gender - Affirming Dermatology and 08:50
Creation of Three-Dimensional Models of
Building Professional Allyship Complex Pelvic Hidradenitis Suppurativa
Ahmed Kazmi (UK) Tracts using MRI to Assist in Multidisciplinary
Team Care and Surgical Planning
09:12 Discussion Aashay Nobre (Australia)
09:00
Successful modulation of the PPARγ-receptor
in the treatment of Acne Vulgaris: Results of
an international phase 2b study with NAC-
GED-0507 gel. The GEDACNE Study
Mauro Picardo (Italy)
09:10
Paroxetine is an effective treatment for
refractory erythema of rosacea: primary
results from PRRERCT (Prospective Rosacea
Refractory Erythema Randomized Clinical Trial)
Ben Wang (China)
70
SUNTEC | LEVEL 6 | HALL 606 | 09:30-10:50 SUNTEC | LEVEL 3 | NICOLL 2 | 09:30-10:50
SY (SY01B) ATOPIC DERMATITIS: NEW
SY ( SY35B) BENIGN NEOPLASMS - BENIGN
DEVELOPMENTS - GENOTYPES AND NEOPLASMS II
PATHOGENESIS
CHAIR:
CHAIR: Pierre Wolkenstein (France)
Stephan Weidinger (Germany) CO-CHAIRS:
CO-CHAIRS: Yasuhiro Fujisawa (Japan)
Yifeng Guo (China) Melissa Piliang (USA)
Emma Guttman-Yassky (USA)
09:30 Adnexal neoplasms
09:30 The role of genetics in the pathogenesis, Melissa Piliang (USA)
phenotype, ethnic differences, and outcomes
of AD 09:50 Benign melanocytic neoplasms
Akiharu Kubo (Japan) Yasuhiro Fujisawa (Japan)
09:50 Immunology of AD 10:10 Neural and neuroendocrine neoplasms

Stephan Weidinger (Germany) Melissa Pulitzer (USA)
10:10 The microbiome in AD 10:30 Neurofibromatosis type I

Yifeng Guo (China) Pierre Wolkenstein (France)
10:30 Biomarkers of AD based on disease endotypes

and personalized medicine
Emma Guttman-Yassky (USA) SUNTEC | LEVEL 3 | NICOLL 3 | 09:30-10:50
SY ( SY12B) KERATINOCYTE CARCINOMAS -
EPIDEMIOLOGY AND PRECURSORS
CHAIR:
SUNTEC | LEVEL 3 | NICOLL 1 | 09:30-10:50 David Whiteman (Australia)
SY (SY40B) MEDICAL AESTHETICS I -
CO-CHAIRS:
COMPLICATIONS Peter Foley (Australia)
Günther Hofbauer (Switzerland)
CHAIR:
Murad Alam (USA) 09:30 Epidemiology and risk groups
CO-CHAIRS: David Whiteman (Australia)
Laurence Imhof (Switzerland)
Leihong Flora Xiang (China) 09:50 Skin cancers in skin of colour
Michelle Rodrigues (Australia)
09:30 IPL and Laser Complications: How to Avoid Them?
Keyvan Nouri (USA) 10:10 Actinic keratosis: Treatment options and how
to choose the best one
09:50 Complications of Energy Based Devices (EBD) Peter Foley (Australia)
Arisa Ortiz (USA)
10:30 F
ield cancerization in the immune suppressed
10:10 Complications with both Toxins and Fillers - Günther Hofbauer (Switzerland)
Upper Face
Omar Ibrahimi (USA)
10:30 Understanding and Treating Filler Necrosis

Wilson Ho (Hong Kong)
71
SY (SY09B) DIGITAL DERMATOLOGY AND
SY ( SY30B) GRANULOMATOUS DISEASES (NON-
ARTIFICIAL INTELLIGENCE - SMARTPHONE INFECTIOUS) - GRANULOMATOUS DISEASES II
APPS AND SOCIAL MEDIA
CHAIR:
CHAIR: Daniel D. Bennett (USA)
Kavita Mariwalla (USA) CO-CHAIRS:
CO-CHAIRS: Antonios Kolios (Switzerland)
Maurice Mars (South Africa) Bea Puno (Philippines)
Grace Okudo Chita (Nigeria)
09:30 Rheumatoid granulomatous disorders
09:30 A
lgorithm based smartphone apps to assess Daniel D. Bennett (USA)
risk of skin cancer and skin lesions
Kavita Mariwalla (USA) 09:50 Granulomas in the setting of primary
immunodeficiency
09:50 B
asic skin diagnosis and apps supporting Yvonne Chiu (USA)
community healthcare
Maurice Mars (South Africa) 10:10 Necrobiosis lipoidica
Afsaneh Alavi (Canada)
10:10 Social media and modern dermatology
Sandra Lee (USA) 10:30 Granulomatous filler reactions
Viktoryia Kazlouskaya (USA)
10:30 Lessons learned educating the public and
other physicians on social media
Muneeb Shah (USA)
SUNTEC | LEVEL 3 | ROOM 310+311 | 09:30-10:50
CN ( CN08) SKIN CANCER - NON-INVASIVE
IMAGING WILL REPLACE SKIN BIOPSY AS THE
SUNTEC | LEVEL 3 | SUMMIT 2 | 09:30-10:50 STANDARD FOR ROUTINE DIAGNOSIS OF
SY ( SY24B) DERMOSCOPY I - DERMOSCOPY: KERATINOCYTE CARCINOMA
PIGMENTED LESIONS I
CHAIR:
CHAIR: Venkataram Mysore (India)
Harald Kittler (Austria) DISCUSSANT AGAINST:
CO-CHAIRS: Gilberto Moreno (Australia)
Raul Cabrera (Chile) DISCUSSANT FOR:
Peter Soyer (Australia) Steven Thng (Singapore)
09:30 How early can we diagnose melanoma today? 09:30 Introduction

Harald Kittler (Austria) Venkataram Mysore (India)
09:46 How to diagnose Lentigo Maligna with 09:40 Motion “For”

confidence Steven Thng (Singapore)
Cristian Navarrete-Dechent (Chile)
10:02 Infrequent forms of presentation of melanoma Gilberto Moreno (Australia)
that are easy to misdiagnose
Raul Cabrera (Chile) 10:00 Intra-Panel Discussion
10:18 Dermoscopy of congenital naevi: How to 10:20 Q&A

monitor and when to worry
Christoph Mueller (Austria) 10:30 Closing Remarks “For”
Steven Thng (Singapore)
10:34 Precision Prevention for Melanoma
Peter Soyer (Australia) 10:35 Closing Remarks “Against”
Gilberto Moreno (Australia)
10:40 Results
72
Lanadelumab treatment in a case of
FC (FC02) SKIN IMAGING OTHER THAN
hereditary angioedema
DERMOSCOPY Duarte Flor (Portugal)
CO-CHAIRS: 09:50
Remibrutinib inhibits effector cell activation
Sai Yee Chuah (Singapore) triggered by serum from chronic urticaria
Giovanni Pellacani (Italy) patients
Ana M Giménez-Arnau (Spain)
09:30 D
istinguishing Malignant from benign skin
lesions using desorption electrospray 10:00
Comparing azathioprine with cyclosporine in the
ionization mass spectrometry imaging treatment of antihistamine refractory chronic
Sumaira Aasi (USA) spontaneous urticaria: A randomized prospective
active-controlled non-inferiority study
09:40 Preoperative identification of cartilage/ Yashdeep Pathania (India)
bone infiltration in non-melanoma skin cancer
(NMSC) by means of ultrasound enhances and 10:10 Is Omalizumab the panacea for delayed pressure
refines the therapeutic guidance urticaria? Therapeutic response and Clinical
Diana Crisan (Germany) predictors - An open-label, prospective study
Indrashis Podder (India)
09:50 L
entigo Maligna and lentigo Maligna
melanoma differentiation with dermoscopy 10:20 H
ot bath therapy for Cholinergic Urticaria
and reflectance confocal microscopy with Hypohidrosis or Anhidrosis
Stefania Guida (Italy) Satoshi Yoshida (Japan)
10:00
Ultra high frequency ultrasound mapping of 10:30
Prevalence and predictors of hypothyroidism
recurrent basal cell carcinoma in patients with chronic spontaneous urticaria
Agata Janowska (Italy) Ditte Georgina Zhang (Denmark)
10:10 Ultra high frequency ultrasound monitoring of 10:40
The effect of oral PREDNISONE therapy on
melanomas arising in congenital melanocytic immunoglobulin E in health people and
nevi: a case series urticaria patients
Agata Janowska (Italy) Renshan Sun (China)
10:20 V
isualization of In Vivo Tattoo Particles
After Laser Treatment Using Multiphoton
Tomography and Fluorescence Lifetime
SUNTEC | LEVEL 3 | ROOM 324+325+326 | 09:30-10:50
Imaging
Lynhda Nguyen (Germany)
SY (SY29B) NAILS AND NAIL SURGERY - NAIL

DISEASES I
10:30
Total-absorption photoacoustic remote
CHAIR:
sensing (TA-PARS) microscopy provides high
resolution label-free skin images Adam Rubin (USA)
Ally-Khan Somani (USA) CO-CHAIRS:
Soumiya Chiheb (Morocco)
10:40
Visualising cancer in 3D: 3-Dimensional Tissue Rosamary Soto Paredes (Chile)
Imaging for management of cutaneous basal
cell carcinoma 09:30 Dermoscopy of the nail unit
Yingrou Tan (Singapore) Matilde Iorizzo (Switzerland)
09:50 L
ichen planus of the nail unit: Current
management consensus and future
SUNTEC | LEVEL 3 | ROOM 323 | 09:30-10:50 development
FC (FC06) URTICARIA AND ANGIOEDEMA Maria José Aldunce Soto (Chile)
CO-CHAIRS: 10:10 Nail unit psoriasis: Clinicopathologic

Ana Giménez-Arnau (Spain) correlations and therapy
Kiran Godse (India) Adam Rubin (USA)
09:30
A cross-sectional, institution-based study 10:30 B
enign nail tumours: Diagnosis and surgical tips
to identify the endotypes of chronic Eckart Haneke (Germany)
spontaneous urticaria and find their
demographic and clinical relevance
Abhishek De (India)
73
SY ( SY55B) ETHICS, QUALITY OF CARE, QUALITY FC (FC10) TELEDERMATOLOGY
OF LIFE AND COSTS - CHALLENGING
DECISION MAKING I CO-CHAIRS:
Ousmane Faye (Mali)
CHAIR: Toby Maurer (USA)
Saroj Suvanasuthi (Thailand)
CO-CHAIRS: 09:30
A Comparative Study of Common Dermatoses
Pablo Fernandez-Penas (Australia) seen at the Out-Patient Department
Mey Sithach (Cambodia) During the Pre-Pandemic Period and via
Teledermatology During the COVID-19
09:30 Suspecting child abuse, when to report? Pandemic in a Tertiary Government Hospital
Li-Chuen Wong (Australia) Ana Gabrielle Bacalla (Philippines)
09:46
Side effects, when not to change medications?
09:40 Improving access to skin care through
Pablo Fernandez-Penas (Australia)
teledermatology in a remote island in Eastern
10:02 Limited skin disease, when to use systemic Indonesia
therapy? Marlous Grijsen (Indonesia)
Azura Mohd Affandi (Malaysia)
09:50
Digital documentation with clinical and
10:18 Telemedicine, when is not better? patient-reported outcomes in dermatology –
Saroj Suvanasuthi (Thailand) a Monitoring tool for clinical practice
Marina Otten (Germany)
10:34 S
CC in transplant patients, when to stop
immunosuppression? 10:00
Patient’s and physician’s perspectives
Emily Smith (USA) on an implemented store-and-forward
teledermatological application in Germany
Marina Otten (Germany)

PASSION project: AI driven teledermatology
SY ( SY05B) BACTERIAL INFECTIONS - for common skin conditions in Africa
BACTERIAL INFECTIONS I PART II Philippe Gottfrois (Switzerland)
CHAIR: 10:20
Place of Atopic Dermatitis (AD) in Data
Koji Sayama (Japan) collection of five paediatric dermatology in
CO-CHAIRS: Madagascar: PASSION project
Maia Datuashvili (Georgia) Rabenja Fahafahantsoa Rapelanoro (Madagascar)
Tenganawo Esther Mzumara (Malawi)
10:30
Determination of usability of validated scoring
09:30 The skin microbiome and its effect on skin criteria for assessment of disease severity of
infections pemphigus by telecommunication
Yumi Matsuoka-Nakamura (Japan) Prarthana Thammannagowda (India)
09:50 Superficial streptococcal infections 10:40

Clinical profile and diagnostic accuracy
Tenganawo Esther Mzumara (Malawi) of patient-submitted photographs in
teledermatology
10:10 Deep streptococcal infections Ankita Tuknayat (India)
Asha Bowen (Australia)
10:30 S
taphylococcal infection: clinical
manifestations and treatments
Maia Datuashvili (Georgia)
74
SUNTEC | LEVEL 3 | ROOM 331 | 09:30-10:50 UNTEC | LEVEL 3 | ROOM 334+335+336 | 09:30-10:50
S
RS (RS02) HIDRADENITIS SUPPURATIVA/
FC (FC13) ACNE, HIDRADENITIS SUPPURATIVA,

CONTACT DERMATITIS ROSACEA 2
Rosemary Nixon (Australia) Marius Rademaker (New Zealand)
John Ingram (UK) Christos Zouboulis (Germany)
09:30 H
idradenitis Suppurativa and Major Adverse 09:30
Combination Treatment with Adipose Stem
Cardiac Events: A Systematic Review and Cell Exosomes (ASCE) and Fractional CO2
Meta-Analysis Laser for Acne Scars: A 12-week Prospective,
Heidi Li (Canada) Double-blind, Randomized, Split-face Study
Byong Seung Cho (Republic of Korea)
09:45
Overexpression of Hypoxia-Inducible Factor-
1α in Hidradenitis Suppurativa: The Link 09:40
The Reliability of Tape Stripping in Acne
between Deviated Immunity and Metabolism Research: Does the Depth matter?
Naglaa Agamia (Egypt) Kang Nien How (Malaysia)
10:30
Textile Dermatitis in Healthcare Workers at a 09:50 P
yoderma gangrenosum-like hidradenitis
COVID-19 care centre in India suppurativa phenotype
Ananya Sharma (India) Evgeniya Hristakieva (Bulgaria)
10:15
Inhibition of tissue resident memory T-cells as
10:00
Daylight photodynamic therapy (DL-PDT) as a
a therapy for contact hypersensitivity
new treatment for papulopustular rosacea: a
Touraj Khosravi-Hafshejani (Canada)
prospective randomized controlled trial
10:30 Discussion Jian Li (China)
10:10
Role of pre-surgical mapping with ultra-
high frequency ultrasound of Hidradenitis
SUNTEC | LEVEL 3 | ROOM 332 | 09:30-10:50 Suppurativa lesions treated with wide local
EF (EF02A) ADVANCED HISTOPATHOLOGY excision and second intention healing
(INFLAMMATORY SKIN DISEASE) Flavia Manzo Margiotta (Italy)
CHAIR: 10:20
Cross-sectional survey-based study reveals
Catherine Stefanato (UK) self-diagnosis of Hidradenitis Suppurativa
CO-CHAIRS: via internet search in over 10% of patients
Martin Sangueza (Bolivia) and severe impact to QOL, worse than
Ben Tallon (New Zealand) inflammatory bowel disease
Alexandra Mortimore (Australia)
09:30 Inflammatory Dermatoses with a twist
Jaime Eduardo Calonje (UK) 10:30
Switching from adalimumab originator
to biosimilar in patients with hidradenitis
09:40 Hiv-Associated Lichenoid Photoeruptions suppurativa results in losses of response –
Wayne Grayson (South Africa) data from the German HS registry HSBest
Frenz Ohm (Germany)
09:50 Unusual Patterns in Infectious Diseases
Werner Kempf (Switzerland) 10:40
Biofilm Forming Cutibacterium acnes and
Staphylococcus epidermidis: A Clinico-
10:00 Facial Lichen Planus: “The Indian Experience” epidemiology Perspective in Indonesian Acne
Asha Kubba (USA) Patients
Kartika Ruchiatan (Indonesia)
10:10 Detangling a Mystery - Acquired Diffuse
Trichomalacia
Joyce Lee (Singapore)
10:20 The 5 Dermatopathologic Dimensions of

Inflammatory Diseases
Dieter Metze (Germany)
10:30 Cases with a message

Omar Sangueza (USA)
10:40 Panel Discussion
75
SUNTEC | LEVEL 6 | HALL 603+604 | 11:00-12:30 SUNTEC | LEVEL 3 | NICOLL 1 | 14:30-15:50
PL (PL01) PLENARY SESSION 1 SY (SY40C) MEDICAL AESTHETICS I - FILLERS

AND THREADS
CHAIRS:
Terrence Cronin (USA) CHAIR:
Claire Fuller (UK) Andre Braz (Brazil)
Haur Yueh Lee (Singapore) CO-CHAIRS:
Jose Luis Lopez-Estebaranz (Spain) Vince Bertucci (Canada)
Kyle Kooil Seo (Republic of Korea)
11:00 Lessons learnt from the two pandemics
Adeeba Kamarulzaman (Malaysia) 14:30 Anatomy applied for injectable fillers
Andre Braz (Brazil)
11:30 Recent advances and challenges in severe
cutaneous adverse reactions 14:46 Injectable fillers - Upper face
Wen-Hung Chung (Chinese Taipei) Vince Bertucci (Canada)
11:50 Aesthetic Dermatology: A Legacy of Pioneers 14:58 Injectable fillers - Midface

Doris Hexsel (Brasil) Hassan Galadari (UAE)
12:10 Psoriasis salve and solved 15:10 Injectable fillers - Lower face
Kamran Ghoreschi (Germany) Ada Trindade de Almeida (Brazil)
15:22 Injectable fillers - body

Sabrina Fabi (USA)
SUNTEC | LEVEL 6 | HALL 606 | 14:30-15:50
SY (SY01C) ATOPIC DERMATITIS: NEW
15:34 Q&A
DEVELOPMENTS - SYSTEMIC AND NEW
TREATMENTS
CHAIR: SUNTEC | LEVEL 3 | NICOLL 2 | 14:30-15:50

Carle Paul (France) SY (SY35C) BENIGN NEOPLASMS - DISORDERS

CO-CHAIRS: OF DERMIS AND SUBCUTANEOUS FAT
Saeko Nakajima (Japan)
Ruby Umesh Pawankar (Japan) CHAIR:
Luca Stingeni (Italy) Joyce Lee (Singapore)
CO-CHAIRS:
14:30 Systemic therapy: Classical immune Valeria Mateeva (Bulgaria)
suppression Esperanza Welsh (Mexico)
Mette Deleuran (Denmark)
14:30 Fibrous and fibrohistiocytic proliferations
14:46 Biomarkers for systemic inflammation in Jaime Eduardo Calonje (UK)
atopic dermatitis
Andreas Wollenberg (Germany) 14:45 Q&A
Jaime Eduardo Calonje (UK)
15:02 Systemic therapy with antibodies what and when
Luca Stingeni (Italy) 14:50 A potpourri of selected smooth muscle,
adipose and osteo-cartilaginous neoplasms
15:18 New therapeutic approach: Jak inhibitors, Victor Lee (Singapore)
PDE4 inhibitors and others
Carle Paul (France) 15:05 Q&A
Victor Lee (Singapore)
15:34 Biologics in the management of Atopic
Dermatitis in children 15:10 Update on lipodystrophies
Ruby Umesh Pawankar (Japan) Hua Liang Joel Lim (Singapore)
15:25 Q&A
Hua Liang Joel Lim (Singapore)
15:30 Update on mastocytosis

Valeria Mateeva (Bulgaria)
15:45 Q&A
Valeria Mateeva (Bulgaria)
76
SUNTEC | LEVEL 3 | NICOLL 3 | 14:30-15:50 SUNTEC | LEVEL 3 | SUMMIT 2 | 14:30-15:50
SY (SY12C) KERATINOCYTE CARCINOMAS -
SY (SY24C) DERMOSCOPY I - DERMOSCOPY:

SQUAMOUS CELL CARCINOMAS PIGMENTED LESIONS II
CHAIR: CHAIR:
Christopher Baker (Australia) Ketty Peris (Italy)
Konstantinos Liopyris (Greece) Ahmed Abdel Fattah (Egypt)
Ricardo Vieira (Portugal) Monika Arenbergerova (Czech Republic)
14:30 Squamous cell carcinomas: Epidemiology, 14:30 Extrafacial lentigo Maligna

genetics and risk factors for advanced disease Ketty Peris (Italy)
Kiarash Khosrotehrani (Australia)
14:50 Dermoscopy on mucosa: Pigmented lesions
14:50 Squamous cell carcinomas: Surgical therapies Monika Arenbergerova (Czech Republic)
Miguel Sánchez Viera (Spain)
15:10 Dermoscopy for diagnosis and treatment
15:10 Squamous cell carcinomas: When and how to monitoring in melasma
use x-ray therapy Ahmed Abdel Fattah (Egypt)
Stephen Shumack (Australia)
15:30 Evaluation of pigmented nail bands
15:30 Squamous cell carcinomas: Advances in Petr Arenberger (Czech Republic)
systemic therapy
Chrysalyne D. Schmults (USA)

HT (HT03) ILDS PROMOTING SKIN HEALTH FOR
SUNTEC | LEVEL 3 | SUMMIT 1 | 14:30-15:50 THE WORLD: INSIGHT
SY (SY09C) DIGITAL DERMATOLOGY

AND ARTIFICIAL INTELLIGENCE - CHAIRS:
TELEDERMATOLOGY Lars French (Germany)
Henry Lim (USA)
CHAIR: Claire Fuller (UK)
Alexander Zink (Germany)
CO-CHAIRS: 14:30 T
he International League of Dermatological
Ousmane Faye (Mali) Societies: What, How & Who
Toby Maurer (USA) Lars French (Germany)
14:30 Practical Guidelines for teledermatology 14:45

Neglected Tropical Diseases – opportunities for
Alexander Zink (Germany) dermatology influence - the bigger picture
Claire Fuller (UK)
14:50 Issues, controversies and innovations in
teledermatology 15:00 Grand Challenges in Global Skin Health -
Toby Maurer (USA) Lesson learned from the Global Psoriasis Atlas
Cristopher Griffiths (UK)
15:10 Teledermatology in resource-limited countries
Rabenja Fahafahantsoa Rapelanoro (Madagascar) 15:15 ICD-11: Why the 11th Revision of the International
Classification of Diseases is good news for
15:30
Teledermatology to triage access to inpatient dermatologists
dermatology Jonathan White (Belgium)
Carrie Kovarik (USA)
15:30
The World Skin Summit – Addressing Global
Challenges to our Specialty
Henry Lim (USA)
15:40 Q&A
77
A study of skin photoaging by age groups in
SY (SY50A) IMMUNOSUPPRESSIVE AGENTS an ex vivo human skin model
- TRADITIONAL IMMUNOSUPPRESSIVE Da Yeong Nam (Republic of Korea)
AGENTS I
15:40
New Anti-Pollution Benefits of a Serum with
CHAIR: Ascorbic Acid, Ferulic Acid, and Tocopherol in
Hideo Hashizume (Japan) a Human Clinical Trial
CO-CHAIRS: Giuseppe Valacchi (Italy)
Chia-Yu Chu (Chinese Taipei)
Nejib Doss (Tunisia)
14:30 Azathioprine and mycophenolate Mofetil SUNTEC | LEVEL 3 | ROOM 323 | 14:30-15:50
Po-Wei Huang (Chinese Taipei) FC (FC07) WOUND HEALING & KELOIDS
14:50 Calcineurin Inhibitors CO-CHAIRS:

Ruaa Al Harithy (Saudi Arabia) Michel Gilliet (Switzerland)
Khine Khine Zaw (Myanmar)
15:10 Methothrexate
Noureddine Litaiem (Tunisia) 14:30
Novel anti-microbial peptides derived from
differentiating adipose-derived stem cells
15:30 Dapsone against chronic wound infections
Taisuke Ito (Japan) Smarajit Chakraborty (Singapore)
14:40
Combination approach using laser assisted
drug delivery (LADD) and topical treatment
SUNTEC | LEVEL 3 | ROOM 320 | 14:30-15:50 for the treatment of keloid and hypertrophic
FC (FC03) SKIN AGING: EXTRINSIC AND
scar: case series
INTRINSIC FACTORS Irmadita Citrashanty (Indonesia)
CO-CHAIRS: 14:50 A
nti-IL17A, Ixekizumab, for treatment-
Sewon Kang (USA) resistant chronic venous leg ulcers: a phase II
Rachel Watson (UK) randomized, double-blind, placebo-controlled
pilot trial
14:30
The mechanism of immunoevasive Charlotte Cox (Australia)
senescence, an insidious strategy involved in
skin aging 15:00
A comparative study of efficacy of intradermal
David Boudier (France) injection of hyaluronidase in combination with
triamcinolone acetonide and 5-fluorouracil in
14:40
Efficacy of combined treatment with adipose keloids and hypertrophic scars
tissue stem cell exosomes (ASCE) and Rachita Dhurat (India)
microneedling for facial skin aging: a 12-week
prospective, randomized, split-face study 15:10 TBA
15:20
Accelerating of healing time of bed sores
14:50
Clinical and microscopic patterns of by Irradiated amniotic membrane dressing
photoaging: reflectance confocal microscopy compared to traditional wound care
and optical coherence tomography evaluation procedures
Agnieszka Ewa Dybala (Italy) Nashwa Radwan (Egypt)
15:00
Objective and subjective evaluation of a daily 15:30
MicroRNA-based topical formulation to treat
self-massage on skin aging signs diabetic foot ulcers
Frederic Flament (France) Prabha Sampath (Singapore)
15:10
Sun exposure is associated with sex-specific 15:40
Addressing the peri-wound skin of diabetic
patterns of epigenetic aging in dermal and foot ulcers with biologics: Application of
topical red deer conditioned media (PTT-6) to
epidermal skin
hard-to-heal DFUs
Richie Jeremian (Canada)
Keng Lin Francis Wong (Singapore)
15:20
An all-in-one dynamic line evaluation system
and its application
LI Jing (China)
78
SUNTEC | LEVEL 3 | ROOM 324+325+326 | 14:30-15:50 SUNTEC | LEVEL 3 | ROOM 328+329 | 14:30-15:50
SY (SY29C) NAILS AND NAIL SURGERY - NAIL
SY ( SY05C) BACTERIAL INFECTIONS -
DISEASES II BACTERIAL INFECTIONS II PART I
CHAIR: CHAIR:
Molly Hinshaw (USA) Marcia Ramos e Silva (Brazil)
Bertrand Richert (Belgium) Carmen-Maria Salavastru (Romania)
Archana Singal (India) Sandra Widaty (Indonesia)
14:30 Paediatric nail disorders 14:30 Staphylococcal infections and resistance

Archana Singal (India) Carmen-Maria Salavastru (Romania)
14:50 Parasitic infection of the nails 14:50 The spectrum of gram-negative infections
Bertrand Richert (Belgium) Elisa Miranda (Indonesia)
15:10 Diagnosis of onychomycosis in the 21st century 15:10 Gram-negative folliculitis

Nilton Gioia Di Chiacchio (Brazil) Mark Davis (USA)
15:30 Nail disorders in people of colour 15:30 Clostridiae and coryne bacteria
Molly Hinshaw (USA) Valeria Aoki (Brazil)

SY (SY55C) ETHICS, QUALITY OF CARE, QUALITY

OF LIFE AND COSTS - CHALLENGING
DECISION MAKING II
CHAIR:
Benjamin K. Stoff (USA)
CO-CHAIRS:
Catherine Harwood (UK)
Anthony Rossi (USA)
14:30 Mass drug administration for scabies

Andrew Steer (Australia)
14:50 Skin cancer near the end of life: To treat or

not to treat
Anthony Rossi (USA)
15:10 Advanced skin cancer and organ

transplantation: Who should be excluded from
receiving or donating organs?
Catherine Harwood (UK)
15:30 Dermatology and palliative care: When should

we collaborate?
Benjamin K. Stoff (USA)
79
LB (LB01) LATE-BREAKER SESSION SY ( SY53A) URTICARIA AND ANGIOEDEMA -
URTICARIA AND ANGIOEDEMA I
CHAIRS:
Richard Langley (Canada) CHAIR:
Todd Schlesinger (USA) Michihiro Hide (Japan)
CO-CHAIRS:
14:30 Efficacy of intralesional botulinum toxin, Ana Giménez-Arnau (Spain)
intralesional corticosteroids and topical Clive Grattan (UK)
vitamin D/steroid in nail psoriasis: a
comparative randomized intra- individual 14:30 Understanding mediators, mechanisms
controlled study and inflammation pathways in chronic
Premjit Juntongjin (Thailand) spontaneous urticaria helps us to treat our
patients
14:40 Efficacy, safety, and mechanism of action Michihiro Hide (Japan)
of abrocitinib in the treatment of prurigo
nodularis (PN) and chronic pruritus of 14:50 Causes, co-morbidities and differential
unknown origin (CPUO) diagnosis of chronic spontaneous urticaria
Shawn Kwatra (USA) from infancy to old age
Clive Grattan (UK)
14:50 A
Phase 2, Randomized, Placebo-controlled,
Dose-ranging Study of Oral JNJ-77242113 for 15:10 The spectrum of inducible urticarias: how do
the Treatment of Moderate-to-Severe Plaque we recognize, diagnose and manage them?
Psoriasis: FRONTIER 1 Ana Giménez-Arnau (Spain)
Robert Bissonnette (Canada)
15:30 Is angioedema more than one illness?
15:00 Spesolimab for the prevention of generalized Jason Fok (Australia)
pustular psoriasis (GPP) flares: Results from
the randomized, placebo-controlled trial
Effisayil 2
Mark Lebwohl (USA) SUNTEC | LEVEL 3 | ROOM 332 | 14:30-15:50
EF ( EF02B) ADVANCED HISTOPATHOLOGY
15:10 New pharmaceutical technology from (TUMORS OF THE SKIN)
Germany: The Hidradenitis Suppurativa
3D-SeboSkin model CHAIR:
Christos C. Zouboulis (Germany) Victor Prieto (USA)
CO-CHAIRS:
15:20 The application of topical gentamicin Wayne Grayson (South Africa)
ointment in treatment of Nagashima-type Werner Kempf (Switzerland)
palmoplantar keratosis in children with
nonsense mutation 14:30 Soft tissue: Pseudosarcomatous lesions
Wang Shan (China) Kong Bing Tan (Singapore)
15:30 Patients with prurigo nodularis treated with 14:43 Hematolymphoid: Lymphoma
nemolizumab achieved itch-free state: Results Werner Kempf (Switzerland)
from a phase 3 trial (OLYMPIA 2)
Sonja Ständer (Germany) 14:56 Infectious: Tumours associated with viral
infections
15:40 Microencapsulated Benzoyl Peroxide Cream, Wayne Grayson (South Africa)
5% Effects on the Microbiome of the Skin in
Subjects With Moderate to Severe Rosacea 15:09 Epithelial Carcinoma: Merkel
Raja Sivamani (USA) Phyu P Aung (USA)
15:22 Melanocytic: Update in Spitzoid lesions

update
Victor Prieto (USA)
15:35 Adnexal tumours

Omar Sangueza (USA)
80
SUNTEC | LEVEL 3 | ROOM 334+335+336 | 14:30-15:50 SUNTEC | LEVEL 3 | NICOLL 1 | 16:00-17:20
SY ( SY51A) UNIQUE DERMATOLOGY ISSUES SY (SY40D) MEDICAL AESTHETICS I -

SEEN IN MIGRANTS AND REFUGEES - SKIN REJUVENATION AND SKIN TIGHTENING WITH
ISSUES IN NEWLY ARRIVING MIGRANTS AND LASERS AND EBDS
REFUGEES I
CHAIR:
CHAIR: Henry Hin Lee Chan (China)
Valeska Padovese (Malta) CO-CHAIRS:
CO-CHAIRS: Chrang-Shi Lin (Chinese Taipei)
Ilia Meskhi (Georgia)
Alexia Knapp (USA)
Aisha Sethi (USA) 16:00 Aging of extracellular matrix: main target for
rejuvenation by chemical compounds
14:30 Skin lesions in migrating populations Ilia Meskhi (Georgia)
Valeska Padovese (Malta)
16:20 Recent advance in laser and energy based
14:50 Initiatives to manage migrating populations devices for skin rejuvenation among skin of
Aisha Sethi (USA) colour
Henry Hin Lee Chan (China)
15:10 Physical exhaustion
Apostolos Veizis (Greece) 16:40 T
he feasibility of applying optical coherence
tomography (OCT) as a visual tool on skin
15:30 Malnutrition and hypovitaminoses rejuvenation procedures
Alexia Knapp (USA) Chrang-Shi Lin (Chinese Taipei)
17:00 Microcoring device for skin rejuvenation

Fernanda Sakamoto (USA)
SY ( SY01D) ATOPIC DERMATITIS: NEW
DEVELOPMENTS - THE BARRIER AND SUNTEC | LEVEL 3 | NICOLL 2 | 16:00-17:20
CLASSICAL THERAPIES SY (SY35D) BENIGN NEOPLASMS - DISORDERS

OF SWEAT GLANDS
CHAIR:
Michael Cork (UK) CHAIR:
CO-CHAIRS: Dee Anna Glaser (USA)
Patrick Brunner (USA) CO-CHAIRS:
Kilian Eyerich (Germany) Josette Andre (Belgium)
Jaishree Sharad (India)
16:00 Repairing the defective skin barrier in atopic
dermatitis 16:00 Hypo- and hyperhidrosis: clinical problems,
Michael Cork (UK) and their diagnosis, and impact
Dee Anna Glaser (USA)
16:20 The role of antiseptics and antibiotics in AD
management 16:15 Q&A
Patrick Brunner (USA)
16:18 Hyperhidrosis: Using Botulinum toxins
16:40 The role of phototherapy in AD management Jaishree Sharad (India)
Kilian Eyerich (Germany)
16:33 Q&A
17:00 Topical therapy for atopic dermatitis Jaishree Sharad (India)
Linda Stein Gold (USA)
16:36 Hypo- and Hyperhidrosis: medical therapeutic
17:04
Prevention of AD by skin emollients: pro and contra options
TBA David Pariser (USA)
16:51 Q&A
David Pariser (USA)
16:54 Hyperhidrosis: Surgical options

17:09 Q&A
17:12 Q&A
81
SY (SY12D) KERATINOCYTE CARCINOMAS -
SY (SY24D) DERMOSCOPY I - DERMOSCOPY:

THERAPY OF ADVANCED SQUAMOUS CELL SPECIAL INDICATIONS
CARCINOMAS
CHAIR:
CHAIR: Caterina Longo (Italy)
Ketty Peris (Italy) CO-CHAIRS:
CO-CHAIRS: Zoe Apalla (Greece)
Daudi Mavura (Tanzania) Nkechi Anne Enechukwu (Nigeria)
Michael R. Migden (USA)
16:00 Dermoscopy in paediatrics
Giovanni Pellacani (Italy)
16:00 What is new in the squamous cell carcinoma
guidelines 16:20 Dermoscopy in surgery
Ketty Peris (Italy) Cristian Navarrete-Dechent (Chile)
16:15 Discussion 16:40 Dermoscopy in cosmetics

Ketty Peris (Italy) Stefania Guida (Italy)
16:20 The role of surgical treatment in high-risk 17:00 Dermoscopy in skin of colour
squamous cell carcinoma Nkechi Anne Enechukwu (Nigeria)
Roland Kaufmann (Germany)
16:35 Discussion
Roland Kaufmann (Germany) SUNTEC | LEVEL 3 | ROOM 308+309 | 16:00-17:20
FC ( FC01) SKIN CANCER EXCLUDING
16:40 Neoadjuvant, Intralesional and Combination MELANOMA
Immunotherapy of Cutaneous Squamous Cell
Carcinoma CO-CHAIRS:
Michael R. Migden (USA) Jonathan Smith (South Africa)
Chrysalyne D. Schmults (USA)
16:55 Discussion
Michael R. Migden (USA) 16:00
Sebaceous Carcinoma: Diagnostic and
Management Pearls
17:00 SCC in people with albinism (PWA) in Bharath Balu (USA)
Kilimanjaro, Tanzania
Daudi Mavura (Tanzania) 16:10 fficacy and safety of nicotinamide in skin
E
cancer chemoprophylaxis: an interventional,
17:15 Discussion phase IV single-arm study on metabolic
Daudi Mavura (Tanzania) profiles
Elena Campione (Italy)
16:20 Immunological deficiency in cutaneous

SUNTEC | LEVEL 3 | SUMMIT 1 | 16:00 - 17:20 squamous cell carcinoma of patients with
SY (SY09D) DIGITAL DERMATOLOGY AND
recessive dystrophic epidermolysis bullosa
ARTIFICIAL INTELLIGENCE - WEARABLES Angela Filoni (Italy)
CHAIR: 16:30
Non-ablative fractional laser treatment
Chang Hun Huh (Republic of Korea) is associated with a decreased risk of
CO-CHAIRS: subsequent facial keratinocyte carcinoma
Yong Cui (China) development
Christophe Hsu (Switzerland) Brian Hibler (USA)
16:00 New generations of smart skin 16:40
Presurgical margins assessment of basal cell
Chengxu Li (China) carcinoma by combined imaging techniques:
rcm/oct/fcm ex-vivo
16:20 Elastic second skin
Simone Michelini (Italy)
Alexander Zink (Germany)
16:40 Digital Health Sensing for Personalized 16:50

Tumor proliferation of androgen receptor-
Dermatology positive extramammary Paget’s disease is
Wilson Ho (Hong Kong) regulated by androgen signalling pathway;
establishment of organoids and those
17:00 Wearables as a use case in atopic dermatitis biological analysis
and contraception Yoshio Nakamura (Japan)
Sarah Preis (Germany)
82
17:00
HSP27 promotes cutaneous squamous SUNTEC | LEVEL 3 | ROOM 320 | 16:00-17:20
cell carcinoma progression by inhibiting FC (FC04) ARTIFICIAL INTELLIGENCE
ferroptosis
Ping Wang (China) CO-CHAIRS:
Kaliyadan Feroze (Saudi Arabia)
17:10
Clinical, dermoscopic, ultrasonographic, Trilokraj Tejasvi (USA)
and histopathologic correlations in Kaposi’s
sarcoma lesions and their differential 16:00
AIPDerm: A Perpetually Improving AI Engine
diagnoses: a single-center prospective Loop Deployed in Europe
observational study Latif Abid (Hungary)
Yiran Wei (Italy)
16:10 evelopment of a deep-learning model for
D
image-based prediction of Monkeypox
Pankhuri Dudani (India)
SY (SY50B) IMMUNOSUPPRESSIVE AGENTS
16:20
Performance of Artificial Intelligence-driven
- TRADITIONAL IMMUNOSUPPRESSIVE mobile application in image diagnosis of
AGENTS II venereal and non-venereal genital and peri
genital diseases
CHAIR: Somesh Gupta (India)
Jan Gutermuth (Belgium)
CO-CHAIRS: 16:30
Evaluation of accuracy of artificial intelligence
Paulo Machado (Brazil) application in the diagnosis of dermatological
Jan Christoph Simon (Germany) conditions: man versus machine
Arun Inamadar (India)
16:00 Phosphodiesterase inhibitors
Ulrich Mrowietz (Germany) 16:40
An artificial intelligence based mobile
application for quantitative trichoscopic
16:15 Q&A analysis: a derivation and validation study
Ulrich Mrowietz (Germany) Debdeep Mitra (India)
16:20 Dimethylfumarate 16:50 C

linical Utility of an Elastic-Scattering
Jan Christoph Simon (Germany) Spectroscopy Device in Assisting Primary Care
Physician’s Detection of Skin Cancers
16:35 Q&A Daniel M. Siegel (USA)
Jan Christoph Simon (Germany)
17:00
Machine Learning in the Genomic-Clinical
16:40 Glucocorticosteroids Classification of Cutaneous T-Cell Lymphoma
Jan Gutermuth (Belgium) Celine Schreidah (USA)
16:55 Q&A 17:10 ulti-Channel Content-Based Image Retrieval

M
Jan Gutermuth (Belgium) System For Skin Diseases
Yuheng Wang (Canada)
17:00 Thalidomide
Paulo Machado (Brazil)
17:15 Q&A
Paulo Machado (Brazil)
83
FC ( FC08) SOCIAL MEDIA, PATIENT SUPPORT SY ( SY29D) NAILS AND NAIL SURGERY -
GROUPS AND ENGAGEMENT SURGERY AND HISTOPATHOLOGY OF THE
NAILS
CO-CHAIRS:
Almudena Nuño Gonzalez (Spain) CHAIR:
Sandra Lee (USA) Je-Ho Mun (Republic of Korea)
CO-CHAIRS:
16:00 “ Skin to Skin” a comprehensive program of Neal Bhatia (USA)
prevention, assistance, and help for people Siliang Xue (China)
from urban marginal communities in Cuenca,
16:00 Nail Anatomy and anesthesia
Ecuador, South America, 2022 Eckart Haneke (Germany)
Juan Ambrosi (Ecuador)
16:10 Q&A
16:10
Evaluation of the Content of YouTube Videos Eckart Haneke (Germany)
About Skin Cancer for English and Portuguese
Speaking Population 16:12 Nail biopsy techniques and handling of nail
Paola Castellammare Halfeld (Brazil) specimens (from operating theater to the lab)
Adam Rubin (USA)
16:20
Youtube as a Source of Patient Information for
Dermal Filler 16:22 Q&A
Christina Huang (Canada) Adam Rubin (USA)
16:30
Social media as a tool for psoriasis disease 16:24 Surgery for ingrowing nails and benign nail
awareness in Malaysia tumours
Azura Mohd Affandi (Malaysia) Siliang Xue (China)
16:40
Dermatology Patients’ Internet Use Patterns 16:34 Q&A
to Access Dermatology Health Information Siliang Xue (China)
Simone Montgomery (USA)
16:36 Surgery for Malignant nail tumours
Nathaniel Jellinek (USA)
16:50
Can social media prevent sunbeds from going viral?
Sarah O’Mahony (Ireland) 16:46 Q&A
Nathaniel Jellinek (USA)
17:00
Pattern of social media and internet use
among dermatology patients: a cross 16:48 Basics of nail histopathology
sectional survey Dong Youn Lee (Republic of Korea)
Jayasree Puravoor (India)
16:58 Q&A
17:10
Hidradenitis suppurativa and social media; Dong Youn Lee (Republic of Korea)
thematic and content analyses of patient
source of information 17:00 Pits and splits: update on nail signs and
Sarah O’Mahony (Ireland) histopathology in systemic diseases
Natasha Atanaskova Mesinkovska (USA)
17:10 Q&A
17:12 Tips in nail surgery

Je-Ho Mun (Republic of Korea)
17:17 Q&A
Je-Ho Mun (Republic of Korea)
84
SUNTEC | LEVEL 3 | ROOM 327 | 16:00-17:20 SUNTEC | LEVEL 3 | ROOM 330 | 16:00 - 17:20
SY (SY55D) ETHICS, QUALITY OF CARE,
RS (RS03) PSYCHODERMATOLOGY/

QUALITY OF LIFE AND COSTS - ETHICS IN TELEDERMATOLOGY
DERMATOLOGY
CO-CHAIRS:
CHAIR: Khaled Ezzedine (France)
Isabel Casas (Argentina) Ousmane Faye (Mali)
CO-CHAIRS:
Marlies Wakkee (Netherlands) 16:00
Pharmacological Interventions for Primary
Noor Zalmy Azizan (Malaysia) Psychodermatologic Disorders: An Evidence
Mapping and Appraisal of Randomized
16:00 Skin Cancer Screening: is it necessary? Controlled Trials
Marlies Wakkee (Netherlands) Chaocheng Liu (Canada)
16:20 Partnerships with Industry 16:15

Cervical Trophic Syndrome: A Case Series
Fernando Stengel (Argentina) Richard Barlow (UK)
16:40 Ethics in aesthetic dermatology 16:30

Change in Quality of Life Among Patients with
Noor Zalmy Azizan (Malaysia) Acne Vulgaris Managed via Teledermatology in
Rizal Medical Center: A Prospective Cohort Study
17:00 Ethical dilemmas of corporization of Florteresa Ollero (Philippines)
dermatology practices
Isabel Casas (Argentina) 16:45
High Diagnostic Accuracy and Low Face-to-
Face Follow-up Rates of a Store-and-Forward
Teledermatology Platform in Maccabi
healthcare services: An 18-month Cohort Study
SUNTEC | LEVEL 3 | ROOM 328+329 | 16:00-17:20 Jonathan Shapiro (Israel)
SY (SY05D) BACTERIAL INFECTIONS -

BACTERIAL INFECTIONS II PART II 17:00 D
iagnostic concordance and interobserver
variability between teledermatology (store-
CHAIR: and-forward) and in-person evaluation for
Robert Mullegger (Austria) in-patient dermatology consultations
CO-CHAIRS: Pratibha Gupta (India)
Carrie Kovarik (USA)
Ricardo Perez-Alfonzo (Venezuela)
16:00 Bartonella
Carrie Kovarik (USA) SUNTEC | LEVEL 3 | ROOM 331 | 16:00-17:20
SY (SY53B) URTICARIA AND ANGIOEDEMA -

16:20 Borrelia burgdorferi URTICARIA AND ANGIOEDEMA II
Robert Mullegger (Austria)
CHAIR:
16:40 M
ycobacteriosis associated to cosmetic Marcus Maurer (Germany)
procedures CO-CHAIRS:
Ricardo Perez-Alfonzo (Venezuela) Jinhua Xu (China)
Karen Choo (Singapore)
17:00 Actinomycosis and Nocardiosis
Roberto Arenas (Mexico) 16:00 Type I allergy and urticaria
Karen Choo (Singapore)
16:20 C
hronic urticaria: Disease activity, monitoring
and classical therapy
Hui Tang (China)
16:40 U
rticaria and angioedema in pregnant and
breast-feeding women
Emek Kocatürk Goncu (Turkey)
17:00 N
ovel and future urticaria therapies
Marcus Maurer (Germany)
85
EF ( EF13) PATIENTS AS PARTNERS IN SY (SY51B) UNIQUE DERMATOLOGY ISSUES

ADVANCING DERMATOLOGY THROUGH SEEN IN MIGRANTS AND REFUGEES - SKIN
RESEARCH AND ADVOCACY ISSUES IN NEWLY ARRIVING MIGRANTS AND
REFUGEES II
CHAIR:
Jennifer Austin (Canada) CHAIR:
CO-CHAIRS: Romain Blaizot (Guyana)
Susan Thornton (USA) CO-CHAIRS:
Gaylord Inena Wa Inena Dulini Liyanagama (Sri Lanka)
(Democratic Republic of Congo) Amra Osmancevic (Sweden)
16:00 Introduction 16:00 Leprosy in refugees

Jennifer Austin (Canada) Dulini Liyanagama (Sri Lanka)
16:10 Benefits of engaging patient organizations in 16:16 Signs of torture in migrants

research (Why) Patricia Duarte Deps (Brazil)
Carsten Flohr (UK)
16:32 Dermatophytes epidemiology in immigrants
16:15 Best practices in partnering with patient living in Scandinavia
advocates for research projects (How) Ditte Marie Saunte (Denmark)
Susan Thornton (USA)
16:48 Vitamin D deficiency in a group of Somali
16:20 What does good research collaboration look like? women living in Sweden
Matthias Augustin (Germany) Amra Osmancevic (Sweden)
16:25 Discussion & Audience Questions 17:04 Tropical diseases in migrants: example of
endemic mycoses imported to French Guiana
16:40 Making lives better through patient-led Geoffrey Grotta (Guadeloupe)
evidence-based advocacy
Silvia Fernandez Barrio (Argentina)
16:45 Case study 1: PC Project

Eli Sprecher (Israel)
16:50 Case study 2: Albinism in DRC

Gaylord Inena Wa Inena
(Democratic Republic of Congo)
16:55 Case study 3: HOME Initiative

Christian Apfelbacher (Germany)
17:00 Discussion & audience Questions
17:15 Closing remarks
86
SCIENTIFIC PROGRAMME | TUESDAY 4th JULY 2023 | PAN PACIFIC
PAN PACIFIC | PACIFIC 1 | 8:00-17:20 15:15 Q&A
CO (CO FD03) BASIC DERMATOLOGICAL
George Hruza (USA)
SURGERY
15:20 E
lectrocautery, snip excision, shave excision,
CHAIR: cryosurgery (skin tags, dermatosis papulosa
George Hruza (USA) nigra, seborrheic keratosis)
CO-CHAIRS: Chih-Hsun Jason Yang (Chinese Taipei)
Sze Hon Chua (Singapore)
Kishwer Nehal (USA) 15:35 Q&A
Chih-Hsun Jason Yang (Chinese Taipei)
08:00 Pre and post-operative assessment
Dana Sachs (USA) 15:40 Break
08:20 Q&A 15:50 Incision & drainage (abscess, infected

Dana Sachs (USA) epidermal cyst)
Shueh Wei Lim (Malaysia)
08:25 Anesthesia (including nerve blocks)
Teresita Ferrariz (Philippines) 16:05 Q&A
08:45 Q&A
Teresita Ferrariz (Philippines) 16:10 Minimal excision technique, elliptical
technique (epidermal cyst, Pilar cyst,
08:50 Surgical anatomy (including danger zones) Pilomatricoma, lipoma)
Patrick K. Lee (USA) Sze Hon Chua (Singapore)
09:10 Q&A 16:25 Q&A

Patrick K. Lee (USA) Sze Hon Chua (Singapore)
09:15 Smart suturing techniques & instruments 16:40 Surgical Pearls from around the world
Michael Muehlstaedt (Switzerland) George Hruza (USA)
09:35 Q&A 16:43 Surgical Pearls from around the world

Michael Muehlstaedt (Switzerland) Kishwer Nehal (USA)
09:40 Biopsy techniques (including special sites) 16:46 Surgical Pearls from around the world
David Zloty (Canada) Sze Hon Chua (Singapore)

David Zloty (Canada) Dana Sachs (USA)
10:05 Basic excision and repairs (undermining, 16:53 Surgical Pearls from around the world
hemostasis, elliptical, purse string and Teresita Ferrariz (Philippines)
M-plasty closures)
Terrence Cronin (USA) 16:56 Surgical Pearls from around the world
Michael Muehlstaedt (Switzerland)
10:25 Q&A
Terrence Cronin (USA) 17:00 Surgical Pearls from around the world
David Zloty (Canada)
10:30 W
ound healing, dressings including biologic
dressings 17:03 Surgical Pearls from around the world
Murad Alam (USA) Terrence Cronin (USA)

Murad Alam (USA) Murad Alam (USA)
10:55 Break 17:11 Surgical Pearls from around the world

Chih-Hsun Jason Yang (Chinese Taipei)
14:30 Managing complications
Kishwer Nehal (USA) 17:14 Surgical Pearls from around the world
14:50 Q&A
Kishwer Nehal (USA) 17:17 Surgical Pearls from around the world
Patrick K. Lee (USA)
14:55 Optimizing Surgical Outcomes
George Hruza (USA)
87
PAN PACIFIC | PACIFIC 2 | 08:0 -10:50 PAN PACIFIC | PACIFIC 3 | 08:00-10:50
CO ( CO HD13) HAIR TRANSPLANTATION: FROM CO (CO HD07) CHEMICAL PEELS
PRINCIPLES TO POST-OPERATIVE CARE
CHAIR:
CHAIR: Seaver L. Soon (USA)
Moonkyu Kim (Republic of Korea) CO-CHAIRS:
CO-CHAIRS: Suzanne Cheng (Singapore)
Damkerng Pathomvanich (Thailand) Sahar Ghannam (Kuwait)
Chris Tan (Singapore)
08:00
An introduction to chemical peeling: chemical
08:00 Principles of Hair Transplantation peel types, skin preparation and aftercare to
Robin Unger (USA) optimize outcome
Sahar Ghannam (Kuwait)
08:16 FUE vs. FUT Selection 08:14 Histologic effects of superficial, medium and
Damkerng Pathomvanich (Thailand) deep chemical peels
Suzanne Cheng (Singapore)
08:32 Preoperative Stage: Hairline design, Scalp
Anesthesia 08:28 Superficial chemical peels: my 2 favourite
Nicole Rogers (USA) superficial peels and how I do it
Kachiu Lee (USA)
08:48 Donor Harvesting: Principles & Techniques
Damkerng Pathomvanich (Thailand) 08:42 Medium depth chemical peels: my 2 favourite
medium depth peels and how I do it
09:04 Recipient-Site Planning & Distribution Seaver L. Soon (USA)
Jae Hyun Park (Republic of Korea)
08:56 Deep chemical peels: my 2 favourite deep
09:20 Break peels and how I do it
Carlos Gustavo Wambier (USA)
09:30 Graft Preparation
Corazon Almira Mella (Philippines) 09:10 Chemical peeling for medical indications
Marina Landau (Israel)
09:46 Graft Placement
Moonkyu Kim (Republic of Korea) 09:24 Break
10:02 Post-operative Care 09:30 Special considerations in melasma and in skin

Nicole Rogers (USA) of colour
Sahar Ghannam (Kuwait)
10:18 Challenges, Complications, and Difficult
Situations 09:44 Special considerations in body peeling
Jae Hyun Park (Republic of Korea) Doris Hexsel (Brazil)
10:34 F
uture of Hair transplantation/Technological 09:58 Complications and management
advances Fotini Bageorgou (Greece)
Robin Unger (USA)
10:12 Combination chemical peeling therapy for
acne scars, a common, distressing problem
Peter Rullan (USA)
10:26
Histology and treatment outcomes of
melasma with Hetter 1.2% croton oil
formulation
Denise Steiner (Brazil)
10:40 Q&A
88
PAN PACIFIC | PACIFIC 2 | 14:30-17:20 PAN PACIFIC | PACIFIC 3 | 14:30-17:20
CO ( CO HD04) BASIC DERMATOPATHOLOGY - CO (CO HD22) PHOTOTHERAPY &

INFLAMMATORY PHOTOPROTECTION
CHAIR: CHAIR:
Maria Yadira Hurley (USA) Tania Cestari (Brazil)
Maxwell Fung (USA) Eugene Tan (Singapore)
Michelle Liang (Singapore) Chanisada Wongpraparut (Thailand)
14:30 Introduction 14:30 Introduction

Maria Yadira Hurley (USA)
14:35 Choosing the right light for the right dermatosis
Wei Sheng Chong (Singapore)
14:40 Spongiotic
Maxwell Fung (USA) 14:55 Photoprotection: visible light, infrared
radiation and light emitting devices
15:00 Psoriasiform Tania Cestari (Brazil)
Maxwell Fung (USA)
15:15 Physical and oral methods of photoprotection
15:20 Vesiculobullous Chanisada Wongpraparut (Thailand)
Michelle Liang (Singapore)
15:35 Q&A
15:40 Vasculopathic
Maria Yadira Hurley (USA) 15:45 Break
15:55 Break 16:00 Essentials and updated indications of

Photodynamic Therapy
16:00 Panniculitis Eugene Tan (Singapore)
Michelle Liang (Singapore)
16:20 Phototesting and Photodesensibilization
16:20 Alopecia Peter Wolf (Austria)
Maria Yadira Hurley (USA)
16:40 Phototherapy beyond Dermatology – infiltrative
16:35 Lichenoid disorders, scleroderma, lymphoid neoplasias
Paula Andrea Enz (Argentina)
Hua Liang Joel Lim (Singapore)
17:00 Q&A
16:55 Granulomatous
Hua Liang Joel Lim (Singapore) 17:10 Closing remarks
17:15 Q&A
89
90
SCIENTIFIC SESSIONS
WEDNESDAY 5th JULY 2023
91
DAY AT A GLANCE | WEDNESDAY 5th JULY 2023
7:00-7:45 DL01B DERMATOLOGICAL SURGERY AND LASERS IN ASIA SUNTEC - 320
7:00-7:45 DL02D SKIN CANCERS IN SOUTH-EAST ASIA SUNTEC - 323
7:00-7:45 DL03A ADVERSE REACTIONS TO VACCINES AND BIOLOGICS SUNTEC - 327
7:00-7:45 DL04D HIGHLIGHTS OF THAI DERMATOLOGY (DST) SUNTEC - 330
7:00-7:45 DL05B PATIENT SUPPORT GROUPS/ADVOCACY - DEBRA SINGAPORE SUNTEC - 331
7:00-7:45 DL06C MIGRANT CARE DERMATOLOGY SUNTEC - 332
VITILIGO, MELASMA AND HYPERPIGMENTATION - SPECIAL ASPECTS AND

8:00-9:20 SY39A SUNTEC - HALL 606
TREATMENT OF HYPERPIGMENTATION
8:00-9:20 SY06A MYCOBACTERIA - ATYPICAL MYCOBACTERIA AND LEPROSY I SUNTEC - SUMMIT 1
AUTOIMMUNE AND INFECTIOUS BLISTERING DISEASES - AUTOIMMUNE

BULLOUS DISEASES I
8:00-9:20 SY36A SKIN OF COLOUR - SKIN OF COLOUR I: INFLAMMATORY DISEASES SUNTEC - NICOLL 1
8:00-9:20 FC14 AESTHETIC AND COSMETIC DERMATOLOGY, AND LASERS 1 SUNTEC - NICOLL 2
8:00-9:20 SY60A LASERS AND LASER MEDICINE - BASICS AND CLASSICAL INDICATIONS SUNTEC - NICOLL 3
SEXUALLY TRANSMITTED DISEASES (STD) - WHAT IS RELEVANT IN 2023 -

8:00-9:20 SY03A SUNTEC - 308+309
EPIDEMIOLOGY OF STD IN AFRICA, AND SYPHILIS
HIDRADENITIS SUPPURATIVA - BIOLOGICS SHOULD BE USED AS A FIRST

8:00-9:20 CN04 SUNTEC - 310+311
LINE OF TREATMENT FOR HIDRADENITIS SUPPURATIVA
8:00-9:20 SY16A GENETICS - GENETICS: ADNEXAL AND COMPLEX DISEASES SUNTEC - 320
8:00-9:20 SY42A SKIN AGING: EXTRINSIC AND INTRINSIC FACTORS - DERMAL SKIN AGEING SUNTEC - 323
8:00-9:20 SY13A MELANOMAS - EARLY MELANOMAS SUNTEC - 324+325+326
8:00-9:20 FC20 EPIDEMIOLOGY SUNTEC - 327
8:00-9:20 SY02A ECZEMAS: THE WORLDWIDE RELEVANCE - CONTACT ALLERGENS SUNTEC - 328+329
8:00-9:20 SY57A PSYCHODERMATOLOGY - BURDEN OF DISEASE I SUNTEC - 330
8:00-9:20 RS04 ATOPIC DERMATITIS SUNTEC - 331
8:00-9:20 EF03 PATHOGENESIS AND MANAGEMENT OF SEVERE DRUG REACTIONS SUNTEC - 332
SURGICAL THERAPY I - BASIC PRINCIPLES FOR SUCCESSFUL

8:00-9:20 SY33A SUNTEC - 334+335+336
DERMATOLOGICAL SURGERY I
92
CUTANEOUS T, B AND NK CELL LYMPHOMAS: CLASSICAL AND NEW

8:00-9:20 COHD09 PAN PACIFIC - PACIFIC 1
TREATMENTS
8:00-9:20 COHD06 BASIC DERMOSCOPY PAN PACIFIC - PACIFIC 2
8:00-9:20 COHD05 BASIC DERMATOPATHOLOGY - NEOPLASTIC PAN PACIFIC - PACIFIC 3
9:00-10:45 HT01 HOT TOPIC AND ILDS SESSIONS SUNTEC - HALL 603+604
VITILIGO, MELASMA AND HYPERPIGMENTATION - SPECIAL ASPECTS OF

9:30-10:50 SY39B SUNTEC - HALL 606
HYPO AND DEPIGMENTATION
9:30-10:50 SY06B MYCOBACTERIA - LEPROSY II SUNTEC - SUMMIT 1

BULLOUS DISEASES II
SKIN OF COLOUR - SKIN OF COLOUR II: ADNEXAL GLANDS AND SCAR

9:30-10:50 SY36B SUNTEC - NICOLL 1
FORMATION
9:30-10:50 FC15 AESTHETIC AND COSMETIC DERMATOLOGY, AND LASERS 2 SUNTEC - NICOLL 2
9:30-10:50 SY60B LASERS AND LASER MEDICINE - LASERS: NEW DEVELOPMENTS SUNTEC - NICOLL 3

9:30-10:50 SY03B SUNTEC - 308+309
GLOBAL STD EPIDEMIOLOGY (EXCEPT FOR AFRICA)
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS)/

9:30-10:50 CN03 DRUG-INDUCED HYPERSENSITIVITY SYNDROME (DIHS) - SYSTEMIC SUNTEC - 310+311
CORTICOSTEROIDS ARE THE FIRST LINE TREATMENT FOR DRESS
GENETICS - GENETICS: ALOPECIA, TUMOUR SUPPRESSOR GENES AND

9:30-10:50 SY16B SUNTEC - 320
CANCER
SKIN AGEING: EXTRINSIC AND INTRINSIC FACTORS - MECHANISM AND

9:30-10:50 SY42B SUNTEC - 323
FACTORS OF SKIN AGEING
9:30-10:50 SY13B MELANOMAS - EPIDEMIOLOGY AND GENETIC CHANGES SUNTEC - 324+325+326
9:30-10:50 FC21 TRANSLATIONAL SCIENCE SUNTEC - 327
9:30-10:50 SY02B ECZEMAS: THE WORLDWIDE RELEVANCE - CONTACT HYPERSENSITIVITY SUNTEC - 328+329
9:30-10:50 SY57B PSYCHODERMATOLOGY - BURDEN OF DISEASE II SUNTEC - 330
9:30-10:50 RS05 DERMOSCOPY SUNTEC - 331
JAK INHIBITORS AND SMALL MOLECULES: MOA, DEVELOPMENTS AND RISK

9:30-10:50 EF05 SUNTEC - 332
BENEFIT EVALUATION
SURGICAL THERAPY I - BASIC PRINCIPLES FOR SUCCESSFUL

9:30-10:50 SY33B SUNTEC - 334+335+336
DERMATOLOGICAL SURGERY II
CUTANEOUS T, B AND NK CELL LYMPHOMAS: CLASSICAL AND NEW

TREATMENTS
9:30-10:50 COHD06 BASIC DERMOSCOPY PAN PACIFIC - PACIFIC 2
93
9:30-10:50 COHD05 BASIC DERMATOPATHOLOGY - NEOPLASTIC PAN PACIFIC - PACIFIC 3
VITILIGO, MELASMA AND HYPERPIGMENTATION - VITILIGO: INTRODUCTION

14:30-15:50 SY39C SUNTEC - HALL 606
AND OVERVIEW
14:30-15:50 SY06C MYCOBACTERIA - LEPROSY III: PREVENTION AND THERAPY SUNTEC - SUMMIT 1

BULLOUS DISEASES III
SKIN OF COLOUR - SKIN OF COLOUR III: PIGMENTARY DISORDERS AND

14:30-15:50 SY36C SUNTEC - NICOLL 1
AESTHETICS
14:30-15:50 FC16 PSORIASIS 1 SUNTEC - NICOLL 2
14:30-15:50 SY60C LASERS AND LASER MEDICINE - LASERS: SPECIAL ASPECTS SUNTEC - NICOLL 3

14:30-15:50 SY03C SUNTEC - 308+309
GONORRHEA AND CHLAMYDIA
14:30-15:50 FC18 ATOPIC DERMATITIS 1 SUNTEC - 310+311
14:30-15:50 SY16C GENETICS - GENETICS: EPIDERMAL AND DERMAL DISEASES SUNTEC - 320
SKIN AGEING: EXTRINSIC AND INTRINSIC FACTORS - MOLECULAR

14:30-15:50 SY42C SUNTEC - 323
MECHANISMS OF AGEING
14:30-15:50 SY13C MELANOMAS - SYSTEMIC THERAPIES AND STAGE IV MELANOMA SUNTEC - 324+325+326
14:30-15:50 RS06 MEDICAL DERMATOLOGY SUNTEC - 327
14:30-15:50 SY02C ECZEMAS: THE WORLDWIDE RELEVANCE - PRURIGO AND ECZEMA THERAPY SUNTEC - 328+329
14:30-15:50 SY57C PSYCHODERMATOLOGY - PSYCHODERMATOLOGY I SUNTEC - 330
14:30-15:50 FC23 DERMOSCOPY & TRICHOSCOPY 1 SUNTEC - 331
14:30-15:50 EF04 EARLY MYCOSIS FUNGOIDES AND ERYTHRODERMA - HOW TO BEST SUNTEC - 332
IDENTIFY CUTANEOUS LYMPHOMA: CASE-BASED DISCUSSION
SURGICAL THERAPY I - BASIC TO INTERMEDIATE LEVEL RECONSTRUCTIONS SUNTEC - 334+335+336

14:30-15:50 SY33C AND SURGICAL TECHNIQUES I
14:30-15:50 COHD21 PAEDIATRIC IMMUNODERMATOLOGY PAN PACIFIC - PACIFIC 1
14:30-15:50 COHD02 ADVANCED DERMOSCOPY PAN PACIFIC - PACIFIC 2
14:30-15:50 COHD18 NAIL SURGERY PAN PACIFIC - PACIFIC 3
VITILIGO, MELASMA AND HYPERPIGMENTATION - VITILIGO: PROCEDURAL

16:00-17:20 SY39D SUNTEC - HALL 606
THERAPY AND SPECIAL ASPECTS
94
16:00-17:20 SY06D MYCOBACTERIA - TUBERCULOSIS SUNTEC - SUMMIT 1

16:00-17:20 SY18D SUNTEC - SUMMIT 2
BULLOUS DISEASES IV
16:00-17:20 SY36D SKIN OF COLOUR - SKIN OF COLOUR IV: SPECIAL TOPICS SUNTEC - NICOLL 1
16:00-17:20 FC17 PSORIASIS 2 SUNTEC - NICOLL 2
16:00-17:20 SY60D LASERS AND LASER MEDICINE - LASERS: SPECIAL INDICATIONS SUNTEC - NICOLL 3

16:00-17:20 SY03D SUNTEC - 308+309
OTHER FORMS OF URETHRITIS AND HPV
16:00-17:20 FC19 ATOPIC DERMATITIS 2 SUNTEC - 310+311
GENETICS - THE GENETIC FOUNDATIONS OF CUTANEOUS INFLAMMATORY SUNTEC - 320

16:00-17:20 SY16D DISEASES
16:00-17:20 SY42D SKIN AGEING: EXTRINSIC AND INTRINSIC FACTORS - SPECIAL ASPECTS SUNTEC - 323
16:00-17:20 SY13D MELANOMAS - TREATMENT SIDE EFFECTS AND NEW DEVELOPMENTS SUNTEC - 324+325+326
16:00-17:20 FC22 PHYSICAL THERAPIES (PDT, CRYOTHERAPY, IONTOPHORESIS, DCP) SUNTEC - 327
16:00-17:20 SY02D ECZEMAS: THE WORLDWIDE RELEVANCE - SKIN BARRIER IN ECZEMA SUNTEC - 328+329
16:00-17:20 SY57D PSYCHODERMATOLOGY - PSYCHODERMATOLOGY II SUNTEC - 330
16:00-17:20 FC24 DERMOSCOPY & TRICHOSCOPY 2 SUNTEC - 331
16:00-17:20 EF08 HOW TO SUCCESSFULLY PUBLISH YOUR RESEARCH SUNTEC - 332
SURGICAL THERAPY I - BASIC TO INTERMEDIATE LEVEL RECONSTRUCTIONS SUNTEC - 334+335+336

16:00-17:20 SY33D AND SURGICAL TECHNIQUES II
16:00-17:20 COHD21 PAEDIATRIC IMMUNODERMATOLOGY PAN PACIFIC - PACIFIC 1
16:00-17:20 COHD02 ADVANCED DERMOSCOPY PAN PACIFIC - PACIFIC 2
16:00-17:20 COHD18 NAIL SURGERY PAN PACIFIC - PACIFIC 3
95
SCIENTIFIC PROGRAMME | WEDNESDAY 5th JULY 2023 | SUNTEC
SUNTEC | LEVEL 3 | ROOM 320 | 07:00-07:45 SUNTEC | LEVEL 3 | ROOM 327 | 07:00- 07:45
DL (DL01B) DERMATOLOGICAL SURGERY AND
DL (DL03A) ADVERSE REACTIONS TO VACCINES

LASERS IN ASIA AND BIOLOGICS
CHAIRS: CHAIRS:
Nancy Garcia-Tan (Philippines) Jiun Yit Pan (Singapore)
Su-Ni Wong (Singapore) Ee Chee Ren (Singapore)
07:00 Vascular Lesions 07:00 Paradoxical Reactions to Biologics

Chee Leok Goh (Singapore) Ding Yuan Wang (Singapore)
07:05 Fat reduction/contouring 07:15 Mechanism of anaphylaxis in COVID vaccine

Henry Hin Lee Chan (China) Ee Chee Ren (Singapore)
07:10 Pigmentation 07:30 Cutaneous reactions to COVID Vaccine

Nancy Garcia-Tan (Philippines) Karen Choo (Singapore)
07:15 Tightening
Yulianto Listiawan (Indonesia)
07:20 Keloid/Hypertrophic scars DL (DL04D) HIGHLIGHTS OF THAI

Woraphong Manuskiatti (Thailand) DERMATOLOGY (DST)
07:25 Post-inflammatory Hyperpigmentation CHAIR:

Henry Foong Boon Bee (Malaysia) Pravit Asawanonda (Thailand)
07:30 Acne/Acne scars 07:00 Hot Stuff from Thailand: Live, On-Stage
Irma Bernadette S. Sitohang (Indonesia) Podcast
Rungsima Wanitphakdeedecha (Thailand)
07:35 Melasma
Niwat Polnikorn (Thailand) 07:23 Hot Stuff from Thailand: Live, On-Stage
Podcast
07:40 Q&A Pamela Chayavichitsilp Davis (Thailand)
DL (DL02D) SKIN CANCERS IN SOUTH-EAST ASIA DL (DL05B) PATIENT SUPPORT GROUPS/

ADVOCACY - DEBRA SINGAPORE
CHAIRS:
Choon Chiat Oh (Singapore) CHAIRS:
Larisa Paramitha Wibawa (Indonesia) Ritu Jain (Singapore)
Birgitte Lane (Singapore)
07:00 Trends of skin cancer in Malaysia
Zhenli Kwan (Malaysia) 07:00 DEBRA: what and why
Birgitte Lane (Singapore)
07:15 Trends of skin cancer in Indonesia
Larisa Paramitha Wibawa (Indonesia) 07:10 Living with EB – Patient perspectives
Ira Jain (Singapore)
07:30 Trends of skin cancer in Singapore
Choon Chiat Oh (Singapore) 07:18 Living with EB – Patient perspectives
Lena Riedl (Austria)
07:27 Living with EB – Patient perspectives

Nick Turnbull (Singapore)
07:35 Balancing Priorities

Ritu Jain (Canada)
96
DL (DL06C) MIGRANT CARE DERMATOLOGY SY (SY36A) SKIN OF COLOUR - SKIN OF

COLOUR I: INFLAMMATORY DISEASES
CHAIRS:
Benjamin Kuan (Singapore) CHAIR:
Kian Teo Tan (Singapore) Daudi Mavura (Tanzania)
CO-CHAIRS:
07:00 Healthserve - Meeting the needs of migrant Mahira El Sayed (Egypt)
workers in Singapore Sujay Khandpur (India)
Benjamin Kuan (Singapore)
08:00 Psoriasis in skin of colour
Mahira El Sayed (Egypt)
07:20 Volunteer dermatology clinics in Healthserve
- Common cases 08:20 Targeted phototherapy in vitiligo in skin of
Hong Yi Koh (Singapore) colour patients in a resource limited setting
Sujay Khandpur (India)
07:30 Challenges
Kian Teo Tan (Singapore) 08:40 Repigmentation of a stubborn vitiligo
Doriane Sabushimike (Tanzania)
07:40 Q&A
09:00 Does diagnosing atopic dermatitis in skin of
colour needs a different criteria?
Daudi Mavura (Tanzania)
SY (SY39A) VITILIGO, MELASMA AND

HYPERPIGMENTATION - SPECIAL ASPECTS
AND TREATMENT OF HYPERPIGMENTATION SUNTEC | LEVEL 3 | NICOLL 2 | 08:00-09:20
FC ( FC14) AESTHETIC AND COSMETIC
CHAIR: DERMATOLOGY, AND LASERS 1
Julien Seneschal (France)
Ibrahim Galadari (UAE) Purita (Peachy) Paz-Lao (Philippines)
Klauz Fritz (Germany)
Tasneem Mohammad (USA)
08:00
Anatomical proposal for hyaluronic acid filler
08:00 Introduction injection in subzygomatic arch depression: A
dual-plane injection technique
08:03 Adverse events associated with depigmented Kyu-Ho Yi (Republic of Korea)
agents
Tasneem Mohammad (USA) 08:10 A split-face comparison of novel microneedle
patch versus botulinum toxin-a and
08:21 Melasma: Clinical presentation and microneedle patch for improvement in
management undereye skin texture
Pearl Grimes (USA) Te Polen (Thailand)
08:39 Erythema dyschromicum perstans, lichen 08:20

Lichen sclerosis treatment with Erbium Yag
planus pigmentosus, ashy dermatosis: laser: our experience
Pathophysiology, clinical presentation, Natasa Teovska Mitrevska (Macedonia)
diagnosis and management
Amit G. Pandya (USA) 08:30
IPL delivered with mechanical pressure
following a period of red light activation
08:57 Acquired disorders with hyperpigmentation enhances efficacy of photodynamic treatment
Julien Seneschal (France) of BCCs
Robert Stephens (Australia)
09:15 Conclusion
08:40
An Assessment and Comparison of Adverse
Effect Rates in Differing Absorbable Threadlift
Suture Materials
Sami Saikaly (USA)
08:50
Effectiveness of combined microfocused
ultrasound with visualization and subdermal
calcium hydroxyapatite injections for the
management of brachial skin laxity
Sylvia Ramirez (Singapore)
97
09:00
A new, multi-sensor open chamber water SUNTEC | LEVEL 3 | SUMMIT 1 | 08:00-09:20
evaporation device to assess transepidermal SY
(SY06A) MYCOBACTERIA - ATYPICAL
water loss in humans: A validation study MYCOBACTERIA AND LEPROSY I
Joachim Fluhr (Germany)
CHAIR:
09:10
Laser-assisted delivery of vitamin C, vitamin Viviek Vaseudev Pai (India)
E, and ferulic acid formula serum for skin CO-CHAIRS:
rejuvenation: a prospective split-face double- Hendra Gunawan (Indonesia)
blind randomized placebo-controlled trial Yogesh Marfatia (India)
Valeria Campos (Brazil) Vijay Zawar (India)
08:00 Are all Mycobacterium leprae similar? Lessons

from field cases and laboratory studies in Amazon
SUNTEC | LEVEL 3 | NICOLL 3 | 08:00-09:20 Marco Andrey Cipriani Frade (Brazil)
SY (SY60A) LASERS AND LASER MEDICINE -

BASICS AND CLASSICAL INDICATIONS 08:13 Clinical problems, Disability and Disease
Burden in leprosy - Challenges in
CHAIR: management
Viviek Vaseudev Pai (India)
Steven Nisticò (Italy)
CO-CHAIRS: 08:26 Epidemiology of Leprosy - changing scenario
Emel Erdal Calikoglu (Turkey) Yogesh Marfatia (India)
Woraphong Manuskiatti (Thailand)
08:39 Leprosy reaction: Immunity, atypical
08:00 Laser and tissue interaction: Basic Principles presentation, and its management
of ablative and non-ablative lasers Hendra Gunawan (Indonesia)
Shady Mohmoud Attia Ibrahim (Egypt)
08:52 The challenges of cutaneous infection by non-
08:15 How to choose the best laser device for dark- tuberculous mycobacteria
skinned individuals Steve Walker (UK)
08:30 The use of appropriate lasers for ageing skin

Steven Nisticò (Italy) 09:05 Atypical presentation of Leprosy: lessons from
resource restricted clinical settings
08:45 Lasers in Ota Nevus and other benign Vijay Zawar (India)
pigmented disorders
Ester Del Duca (Italy) 09:18 Q&A
09:00 Laser for the treatment of Tattoos

Keyvan Nouri (USA)
SUNTEC | LEVEL 3 | SUMMIT 2 | 08:00-09:20
09:15 Final Discussion
SY (SY18A) AUTOIMMUNE AND INFECTIOUS

BLISTERING DISEASES - AUTOIMMUNE
BULLOUS DISEASES I
CHAIR:
Masayuki Amagai (Japan)
CO-CHAIRS:
Valeria Aoki (Brazil)
Michael Hertl (Germany)
08:00
Pathophysiology of pemphigus, lessons from
endemic form of pemphigus, fogo selvagem
Valeria Aoki (Brazil)
08:20 Novel therapeutic approach

Frédéric Caux (France)
08:40 Immunological network in pemphigus as

therapeutic targets
Michael Hertl (Germany)
09:00 Functionally stabilized antigen-specific iTreg

therapy for pemphigus
Hayato Takahashi (Japan)
98
SY (SY03A) SEXUALLY TRANSMITTED DISEASES
SY (SY16A) GENETICS - GENETICS: ADNEXAL

(STD) - WHAT IS RELEVANT IN 2023 - AND COMPLEX DISEASES
EPIDEMIOLOGY OF STD IN AFRICA, AND
SYPHILIS CHAIR:
John McGrath (UK)
CHAIR: CO-CHAIRS:
Valeska Padovese (Malta) Bruno Reversade (Singapore)
CO-CHAIRS: Marimar Saez de Ocariz (Mexico)
Sasha Fahme (USA)
Enbiale Yeshanehe Wendemagegn (Ethiopia) 08:00 Inflammasome genetic disorders
Bruno Reversade (Singapore)
08:00 STDs in Africa
Enbiale Yeshanehe Wendemagegn (Ethiopia) 08:20 Frontal fibrosing Alopecia
Tuntas Rayinda (Indonesia)
08:20 STIs among migrant and displaced populations
Sasha Fahme (USA) 08:40 New Mendelian genodermatoses affecting
skin and hair
08:40 Syphilis: epidemiology, differential diagnosis John McGrath (UK)
and therapy
Valeska Padovese (Malta) 09:00 CYLD cutaneous syndrome
Neil Rajan (UK)
09:00 Insight on neurosyphilis diagnostic and
therapeutic challenges
Nicolas Dupin (France)
SY (SY42A) SKIN AGING: EXTRINSIC AND

INTRINSIC FACTORS - DERMAL SKIN AGEING
CN (CN04) HIDRADENITIS SUPPURATIVA -
CHAIR:
BIOLOGICS SHOULD BE USED AS A FIRST Anna Chien (USA)
LINE OF TREATMENT FOR HIDRADENITIS CO-CHAIRS:
SUPPURATIVA Oliver Dreesen (Singapore)
CHAIR:
Harvey Lui (Canada) 08:00 Pollution and smoking
DISCUSSANT AGAINST: Oliver Dreesen (Singapore)
Klemens Rappersberger (Austria)
DISCUSSANT FOR: 08:20 Extracellular matrix
Haley Naik (USA) Abigail Langton (UK)
08:00 Introduction 08:40 Hypertrophic and Atrophic Photoaging

Harvey Lui (Canada) Anna Chien (USA)
08:10 Motion “For” 09:00 Preventing skin ageing

Haley Naik (USA) Mauro Picardo (Italy)

08:30 Intra-Panel Discussion
08:50 Q&A
09:00 Closing Remarks “For”

Haley Naik (USA)
09:05 Closing Remarks “Against”

09:10 Results
99
SY (SY13A) MELANOMAS - EARLY MELANOMAS SY (SY02A) ECZEMAS: THE WORLDWIDE

RELEVANCE - CONTACT ALLERGENS
CHAIR:
Darrell Rigel (USA) CHAIR:
CO-CHAIRS: Peter Schmid-Grendelmeier (Switzerland)
Aaron Farberg (USA) CO-CHAIRS:
Willie Visser (South Africa) Swet Malte John (Germany)
Anna Josefson (Sweden)
08:00 Melanomas on skin of colour Akiko Yagami (Japan)
Willie Visser (South Africa)
08:00 Contact allergens: allergens in daily life
08:20 Staging and prognosis of melanomas including new allergens
Aaron Farberg (USA) Anna Josefson (Sweden)
08:40 Management of stage I and stage II melanomas 08:20 Occupational contact allergy in Europe and
Johann de Wet (South Africa) the Americas
Swen Malte John (Germany)
09:00 Technologies enhancing melanoma diagnosis
Darrell Rigel (USA) 08:40 Metal allergy in Asia
Anthony Goon (Singapore)
09:00 Occupational contact allergy in Africa

FC Erere Otrofanowei (Nigeria)
(FC20) EPIDEMIOLOGY
CO-CHAIRS:
Joel Gelfand (USA)
Yik Weng Yew (Singapore) SUNTEC | LEVEL 3 | ROOM 330 | 08:00-09:20
SY (SY57A) PSYCHODERMATOLOGY - BURDEN

08:00
Generalized pustular psoriasis (GPP): OF DISEASE I
Epidemiology and Care - Results from a
Health Insurance Claims Data Base Analysis CHAIR:
Nesrine Ben-Anaya (Germany) Khaled Ezzedine (France)
CO-CHAIRS:
08:10 L
eishmaniasis in Libya Jung Min Bae (Republic of Korea)
Fathi Elkasah (Libya) Se Mang (Simon) Wong (Canada)
08:20
Sleep Disorders in Patients with Prurigo 08:00 Burden of vitiligo in Asia
Nodularis: a Population-level, Matched-cohort Hyun Jeong Ju (Republic of Korea)
study using The Health Improvement Network
Shawn Kwatra (USA) 08:20 Burden of vitiligo in dark skinned patients
Khaled Ezzedine (France)
08:30 Impact of Race/Ethnicity on the Association
between Sexual Orientation and Lifetime 08:40 Burden of vitiligo in fair skinned patients
Prevalence of Skin Cancer Among US Adults Sunil Kalia (Canada)
Matthew Mansh (USA)
09:00 Burden of Atopic Dermatitis
08:40
A Decline in Invasive Melanoma Incidence in Se Mang (Simon) Wong (Canada)
New Zealand: Trends of Cutaneous Melanoma
2010-2020
Richard Martin (New Zealand)
08:50
Initial Presentation of Monkeypox: A First Look
at the American Academy of Dermatology
and International League of Dermatologic
Societies Monkeypox Registry
Janet Lobov (USA)
09:00
Topical Lindane Treatment of Scabies
Infestation and the Risk of Parkinson’s Disease
Kao-Sung Tsai (Chinese Taipei)
09:10 Q&A
100
SUNTEC | LEVEL 3 | ROOM 331 | 08:00-09:20 08:40 What are the most suitable hopes to reduce
RS (RS04) ATOPIC DERMATITIS the mortality of SJS/TEN?
Elizabeth Phillips (USA)
CO-CHAIRS:
Kenji Kabashima (Japan) 08:45 Q&A
Charles W. Lynde (Canada) Elizabeth Phillips (USA)
08:00
Contact Sensitization to Methylisothiazolinone 08:50 How to better manage SJS/TEN sequelae?
and Methylchloroisothiazolinone in atopic Saskia Oro (France)
dermatitis: results of a prospective study
Khaoula Trimeche (Tunisia) 08:55 Q&A
Saskia Oro (France)
08:15
Video-based education as an adjunct
treatment for paediatric atopic dermatitis: a
09:00 How to classify the severe drug reactions
randomized, assessor-blind, controlled trial
induced by checkpoint inhibitors?
Arbie Sofia Merilleno (Philippines)
Lars French (Germany)
08:30
Corticophobia among atopic dermatitis
patients: a Southern Brazilian sample 09:05 Q&A
Bruna Ossanai Schoenardie (Brazil) Lars French (Germany)
08:45
Using upadacitinib to treat and maintain 09:10 How herpes reactivation is involved in the
remission of alopecia areata with concurrent pathogenesis of DIHS/DRESS
atopic dermatitis: a case series Satoru Shinkuma (Japan)
Ivana Chim (Australia)
09:15 Q&A
09:00 Discussion Satoru Shinkuma (Japan)
EF (EF03) PATHOGENESIS AND MANAGEMENT
SY ( SY33A) SURGICAL THERAPY I -
OF SEVERE DRUG REACTIONS BASIC PRINCIPLES FOR SUCCESSFUL
DERMATOLOGICAL SURGERY I
CHAIR:
Saskia Oro (France) CHAIR:
CO-CHAIRS: Aleksandar Krunic (USA)
Riichiro Abe (Japan) CO-CHAIRS:
Rannakoe Joseph Lehloenya (South Africa) Leandra d’Orsi Metsavaht (Brazil)
Pieter Jacobus du Plessis (South Africa)
08:00 Should we predict and prevent DRESS/DIHS
using genetic analysis?
08:00 The past, the present and the future of
dermatological surgery
08:05 Q&A Sean Ekinde (Italy)
08:20 Danger zones
08:10 How to score the severity of DRESS? Pieter Jacobus du Plessis (South Africa)
Sarah Walsh (UK)
08:40 Preventing complications: pre-op planning
08:15 Q&A Aleksandar Krunic (USA)
Sarah Walsh (UK)
09:00 Undermining and hemostasis
08:20 Are case definitions in SJS/TEN inadequate? Leandra d’Orsi Metsavaht (Brazil)
Rannakoe Joseph Lehloenya (South Africa)
08:25 Q&A
08:30 Is it possible to diagnosis SJS/TEN before

bulla/erosion appear?
Natsumi Hama (Japan)
08:35 Q&A
Natsumi Hama (Japan)
101
SUNTEC | LEVEL 6 | HALL 603+604 | 09:00-10:45 SUNTEC | LEVEL 3 | NICOLL 1 | 09:30-10:50
HT (HT01) HOT TOPIC AND ILDS SESSIONS SY ( SY36B) SKIN OF COLOUR - SKIN OF COLOUR
II: ADNEXAL GLANDS AND SCAR FORMATION
CHAIR:
Brigitte Dreno (France) CHAIR:
CO-CHAIRS: Byalakere Shivanna Chandrashekar (India)
Ncoza Dlova (South Africa) CO-CHAIRS:
Omar Lupi Da Rosa Santos (Brazil) Andrew Alexis (USA)
Fatimata Ly (Senegal)
09:00 Introduction
09:30 Acne and rosacea in dark skin: Pecularities
and challenges
09:05 Can we cure psoriasis?
Andrew Alexis (USA)
09:50 Acne keloidalis and psychosis barbae: Natural
09:25 R
isk of cancer and opportunistic infections: course and treatment options
JAK inhibitors versus biologics Fatimata Ly (Senegal)
Martin Roecken (Germany)
10:10 Prevention and latest treatment of PIH
09:45 Can skin bleaching cause skin cancer? Byalakere Shivanna Chandrashekar (India)
Ousmane Faye (Mali)
10:30 Keloids prevention and management: What is
10:05 Dermatological effects of global warming new and practical
Eva Rawling Parker (USA) C. Madura (USA)
10:25 Epidermolysis bullosa: new and emerging

trends with topical gene therapy
Matt Peter Marinkovich (USA) SUNTEC | LEVEL 3 | NICOLL 2 | 09:30-10:50
FC (FC15) AESTHETIC AND COSMETIC

DERMATOLOGY, AND LASERS 2
CO-CHAIRS:
SY Koushik Lahiri (India)
( SY39B) VITILIGO, MELASMA AND
Po-Han Patrick Huang (Chinese Tapei)
HYPERPIGMENTATION - SPECIAL ASPECTS
OF HYPO AND DEPIGMENTATION 09:30
Decoding skin tightness, from clinical
parameters to biomarkers: ceramides as the
CHAIR: new target
Thierry Passeron (France) Anne Potter (France)
CO-CHAIRS:
Valerie Callender (USA) 09:40 D
ifferent injection techniques of hyaluronic
Suresh Joshipura (India) acid filler for lip augmentation: A randomized
left-right comparative study
09:30 New treatments arising including JAK-inhibitors Tanaporn Anuntrangsee (Thailand)
Thierry Passeron (France)
09:50
Defining the Concepts of Beauty, Skin Aging
09:50 Albinisms and Facial Aesthetics in Women of Color
Tamio Suzuki (Japan) Valerie Callender (USA)
10:10 Post-inflammatory and infection-associated 10:00

595nm Pulsed Dye Laser For Hypetrophic
hypomelanosis And Keloid Scars Treatment. A Randomized-
Suresh Joshipura (India) Controlled Study
Angela Filoni (Italy)
10:30 Hereditary hypomelanosis
Valerie Callender (USA) 10:10
Comparative Study of Fractional Erbium
(2940 nm) Laser and Fractional CO2 Laser on
Mucosal Lichen Planus
Rokon Uddin (Bangladesh)
10:20
Skin care promotes cutaneous microbiome
recovery and protection in an acute stratum
corneum stress model in healthy volunteers
and patients with inflammatory bowel diseases
102
10:30
Differences in antibody responses of SUNTEC | LEVEL 3 | SUMMIT 2 | 09:30-10:50
intradermal and intramuscular injections of SY ( SY18B) AUTOIMMUNE AND INFECTIOUS
botulinum toxin type A BLISTERING DISEASES - AUTOIMMUNE
Surachet Sirisuthivoranunt (Thailand) BULLOUS DISEASES II
10:30 Improvement in Skin Elasticity Using Red Deer CHAIR:

Umbilical Cord Lining Mesenchymal Stem Cell Hideyuki Ujiie (Japan)
Conditioned Media CO-CHAIRS:
Mitchel P. Goldman (USA) Dipankar De (India)
Clarisse G. Mendoza (Philippines)
09:30 Costs and long-term safety of new and

SUNTEC | LEVEL 3 | NICOLL 3 | 09:30-10:50 classical therapies
SY ( SY60B) LASERS AND LASER MEDICINE - Jong Hoon Kim (Republic of Korea)
LASERS: NEW DEVELOPMENTS
09:50 Autoimmune bullous diseases in infants and
CHAIR: children
Omar Ibrahimi (USA) Dipankar De (India)
CO-CHAIRS:
Lisa Alenmyr (Sweden) 10:10 Bullous pemphigoid (BP) and premonitoric BP
Jong Hee Lee (Republic of Korea) Hideyuki Ujiie (Japan)
09:30 Nonablative Fractional Laser 10:30 Atypical cases of Bullous Pemphigoid

Jong Hee Lee (Republic of Korea) Clarisse G. Mendoza (Philippines)
09:46 Ablative Lasers

Arisa Ortiz (USA)
10:02 Medical applications of Laser technology SY ( SY03B) SEXUALLY TRANSMITTED DISEASES
Lisa Alenmyr (Sweden) (STD) - WHAT IS RELEVANT IN 2023 - GLOBAL
STD EPIDEMIOLOGY (EXCEPT FOR AFRICA)
10:18 What is new with lasers
Omar Ibrahimi (USA) CHAIR:
Theodora Elvira Wi (Switzerland)
10:34 C
omplications and Legal Considerations of CO-CHAIRS:
Laser, Light, and Energy-Based Treatments David Lewis (Australia)
Mathew Avram (USA) Angelika Stary (Austria)
09:30 Global epidemiology of STIs: Challenges and

opportunities to control STIs
SUNTEC | LEVEL 3 | SUMMIT 1 | 09:30-10:50 Theodora Elvira Wi (Switzerland)
SY (SY06B) MYCOBACTERIA - LEPROSY II
09:45 STIs in Europe: what is new and what has
CHAIR: changed
P. Narasimha Rao (India) Angelika Stary (Austria)
CO-CHAIRS:
Cita Rosita Sigit Prakoeswa (Indonesia) 10:00 Emerging and re-emerging STIs in the Asia
Archana Singal (India) Pacific region
Khine Khine Zaw (Myanmar) David Lewis (Australia)
09:30 Pitfalls of leprosy diagnosis 10:15 TIs increase in the Regions of North America:
S
P. Narasimha Rao (India) a neglected problem?
Bradley Stoner (Canada)
09:50 L
eprosy in the Indian subcontinent:
epidemiology, management and challenges 10:30 Situation of STIs in Latin America
Archana Singal (India) Carolina Talhari (Brazil)
10:10 Issues in management of Lepra reactions 10:45 Q&A
Cita Rosita Sigit Prakoeswa (Indonesia)
10:30 Leprosy workup: tests and procedures

Sujai Suneetha (India)
103
CN ( CN03) DRUG REACTION WITH SY (SY42B) SKIN AGING: EXTRINSIC AND

EOSINOPHILIA AND SYSTEMIC SYMPTOMS INTRINSIC FACTORS - MECHANISM AND
(DRESS)/DRUG-INDUCED HYPERSENSITIVITY FACTORS OF SKIN AGEING
SYNDROME (DIHS) - SYSTEMIC
CORTICOSTEROIDS ARE THE FIRST LINE CHAIR:
TREATMENT FOR DRESS Ervin Tschachler (Austria)
CO-CHAIRS:
CHAIR: Abdul Hameed (Pakistan)
Luca Borradori (Switzerland) Rachel Watson (UK)
DISCUSSANT AGAINST:
Sarah Walsh (UK) 09:30 The clock of ageing
DISCUSSANT FOR: Abdul Hameed (Pakistan)
Saskia Oro (France)
09:46 Exposomics of extrinsic skin ageing
09:30 Introduction Jean Krutmann (Germany)
Luca Borradori (Switzerland)
10:02 UV, visible light and infra-red and the skin
09:40 Motion “For” Florian Gruber (Austria)
Saskia Oro (France)
10:18 Inflammation/inflammageing
09:50 Motion “Against” Rachel Watson (UK)
Sarah Walsh (UK)
10:34
Transcriptomic differences of epidermal cells
10:00 Intra-Panel Discussion in young and older skin
Ervin Tschachler (Austria)
10:20 Q&A

Saskia Oro (France) SUNTEC | LEVEL 3 | ROOM 324+325+326 | 09:30-10:50
SY ( SY13B) MELANOMAS - EPIDEMIOLOGY AND
10:35 Closing Remarks “Against” GENETIC CHANGES
Sarah Walsh (UK)
CHAIR:
10:40 Results Aideen McInerney-Leo (Australia)
CO-CHAIRS:
Allan Halpern (USA)
Hunter Shain (USA)
SY ( SY16B) GENETICS - GENETICS: ALOPECIA,
TUMOUR SUPPRESSOR GENES AND CANCER 09:30 Mainstreaming genetic testing for melanoma
Aideen McInerney-Leo (Australia)
CHAIR:
Neil Rajan (UK) 09:50 Histology and sub types of melanoma and
CO-CHAIRS: rational genetic analysis
Yutaka Shimomura (Japan) Victor Prieto (USA)
Ingrid Winship (Australia)
10:10 Genetic changes associated with disease
09:30 Genetic causes of alopecia progression
Yutaka Shimomura (Japan) Hunter Shain (USA)
09:50 Rare skin cancers and linked genetic conditions 10:30 C

hanging melanoma epidemiology: Impact of
Neil Rajan (UK) effective therapies and overdiagnosis
Allan Halpern (USA)
10:10 Melanoma genetics: an update
10:30 Genetic mismatch repair deficiency in

cutaneous carcinoma
104
SUNTEC | LEVEL 3 | ROOM 327 | 09:30-10:50 SUNTEC - LEVEL 3 - ROOM 330 - 09:30 - 10:50
FC (FC21) TRANSLATIONAL SCIENCE SY (SY57B) PSYCHODERMATOLOGY - BURDEN

OF DISEASE II
CO-CHAIRS:
Birgitte Lane (Singapore) CHAIR:
Manabu Fujimoto (Japan) Marie-Aleth Richard (France)
CO-CHAIRS:
09:30
All-Trans Retinoic Acid Effect on Candida Ibrahima Traoré (Guinea)
albicans Growth and Biofilm Formation Hardyanto Soebono (Indonesia)
Terenzio Cosio (Italy)
09:40 Identifying Targetable Disease Drivers in 09:30 Burden of Hidradenitis suppurativa

Necrobiosis Lipoidica Marie-Aleth Richard (France)
Alysia Hughes (USA)
09:46 GUINEA: Burden of HIV infections in Africa
09:50
Vitamin D3 and deconvoluting a skin rash Ibrahima Traoré (Guinea)
Kurt Lu (USA)
10:02 Burden of Leprosy
10:00
Overexpression and Potential Roles of Midkine Niraj Parajuli (Nepal)
via Regulation of Vascular Endothelial Growth
Factor A in Psoriasis 10:18 Indonesia: Burden of leprosy
Huidi Shucheng (China) Renni Yuniati (Indonesia)
10:10 IRAK4 inhibition impacts pathogenic 10:34 France: burden of psoriasis
processes driving inflammatory skin diseases Laurent Misery (France)
Frenz Ohm (Germany)
10:20
Gut-skin axis in psoriasis – focusing on gut
barrier integrity and bacterial metabolites
Mariusz Sikora (Poland)
RS (RS05) DERMOSCOPY
10:30
REVskin, a skin-on-chip equivalent (SoCE) with
advanced blood-flow mimicry, represents a CO-CHAIRS:
significant improvement in 3D culture models Raul Cabrera (Chile)
for wound-healing and skin-ageing studies Alex Chamberlain (Australia)
Sebastien Teissier (Singapore)
09:30
Role of mucoscopy in non infective dermatoses
10:40 Infinite and finite dose permeation of small Arnav Mehta (India)
molecules through biological and synthetic skin
simulants using an organ-on-chip platform 09:45
Basal cell carcinoma in an Asian population:
Sebastien Teissier (Singapore) Dermoscopic and histological correlation
Dawn Oh (Singapore)
10:00 D
ermoscopic evaluation of breast cancer
SUNTEC | LEVEL 3 | ROOM 328+329 | 09:30-10:50 patients under radiotherapy and determining
SY ( SY02B) ECZEMAS: THE WORLDWIDE its predictive role in radiation dermatitis: A
RELEVANCE - CONTACT HYPERSENSITIVITY
Prospective Study
CHAIR: Twaseem Mohamed (UK)
Margarida Goncalo (Portugal)
CO-CHAIRS: 10:15
Nail involvement in connective tissue
David Cohen (USA) diseases: Usefulness of dermoscopy
Alireza Firooz (Iran) Azza Ghannem (Tunisia)
09:30 Contact hypersensitivity: When and how to test 10:30

To evaluate and compare nail changes in
Alireza Firooz (Iran) leprosy and diabetic neuropathy on clinical
examination, onychoscopy and nail fold
09:50 Unusual presentations of contact dermatitis capillaroscopy
Margarida Goncalo (Portugal) Bharti Aggarwal (India)
10:10 When to suspect allergic contact dermatitis 10:45 Discussion
in atopic dermatitis patients
David Cohen (USA)
10:30 Airborne contact dermatitis and photocontact

dermatitis
Kaushal Verma (India)
105
SUNTEC | LEVEL 3 | ROOM 332 | 09:30-10:50 SUNTEC | LEVEL 6 | HALL 603+604 | 11:00-12:30
EF ( EF05) JAK INHIBITORS AND SMALL PL (PL02) PLENARY SESSION 2
MOLECULES: MOA, DEVELOPMENTS AND
RISK BENEFIT EVALUATION CHAIRS:
Hassan Galadari (UAE)
CHAIR: Nellie Konnikov (USA)
Luis Puig (Spain) Steven Thng (Singapore)
CO-CHAIRS: Vijay Zawar (India)
Mark G. Lebwohl (USA)
Atsushi Otsuka (Japan) 11:00 ingapore’s Healthcare System and possible
S
lessons for health reform efforts elsewhere
09:30 JAK/STAT as druggable pathways Chorh Chuan Tan (Singapore)
Luis Puig (Spain)
11:30 The precision medicine path in Atopic Dermatitis
09:38 Differences in JAK Inhibitors Emma Guttman-Yassky (USA)
Atsushi Otsuka (Japan)
11:50 eyond Borders: Providing dermatological care
B
09:50 Topical JAK Inhibitors for Atopic Dermatitis in under-resourced settings around the world
Chisa Nakashima (Japan) Esther E. Freeman (USA)
10:02 Systemic JAK Inhibitors for Atopic Dermatitis 12:10 he importance of total margin control
T
Jose Manuel Carrascosa (Spain) (PDEMA) for DFSP and high risk SCC: Current
NCCN guidelines and rationale
10:14 J AK Inhibitors for Psoriatic Disease, Alopecia Chrysalyne D. Schmults (USA)
Areata, and Vitiligo
Bruce Strober (USA)
10:26 hy We Should Use JAK Inhibitors: Risk

W SUNTEC | LEVEL 6 | HALL 606 | 14:30-15:50
Benefit Ratios SY ( SY39C) VITILIGO, MELASMA AND
Mark G. Lebwohl (USA) HYPERPIGMENTATION - VITILIGO:
INTRODUCTION AND OVERVIEW
10:42 Discussion
CHAIR:
Nanja Van Geel (Belgium)
CO-CHAIRS:
SUNTEC | LEVEL 3 | ROOM 334+335+336 | 09:30-10:50 Samia Esmat (Egypt)
SY ( SY33B) SURGICAL THERAPY I - Davinder Parsad (India)
BASIC PRINCIPLES FOR SUCCESSFUL
DERMATOLOGICAL SURGERY II 14:30 Melanocyte biology
CHAIR:
Kee Yang Chung (Republic of Korea) 14:50 itiligo: Pathofisiology of segmental and
V
CO-CHAIRS: acquired vitiligo
Falk Bechara (Germany) Samia Esmat (Egypt)
Cesar Villarreal (Mexico)
15:10 Vitiligo: Clinical classification, associated
09:30 Surgical pearls disorders and clinical assessment
Falk Bechara (Germany) Nanja Van Geel (Belgium)
09:50 Smart suture techniques? 15:30 itiligo: Phototerapies and topical therapies
V
Cesar Villarreal (Mexico) (corticosteroids, topical calcineurin inhibitors
and JAK inhibitors)
10:10 How to minimize scars from surgery Davinder Parsad (India)
Kee Yang Chung (Republic of Korea)
10:30 Managing post-surgical complications

Tri Nguyen (USA)
106
SUNTEC | LEVEL 3 | NICOLL 1 | 14:30-15:50 15:20
Indirect Comparison of Deucravacitinib and
SY ( SY36C) SKIN OF COLOUR - SKIN OF Other Systemic Treatments for Moderate to
COLOUR III: PIGMENTARY DISORDERS AND Severe Plaque Psoriasis in Asian Populations:
AESTHETICS A Systematic Literature Review and Network
Meta-Analysis
CHAIR: Tsen-Fang Tsai (Chinese Taipei)
Ganesh S. Pai (India)
CO-CHAIRS: 15:30
Discovery of serum proteomic signature
Ayesha Omolara Akinkugbe (Nigeria) in different sub-types of psoriasis patients
Deepani Munidasa (Sri Lanka) based on data-independent acquisition mass
spectrometry
14:30 ssessing facial hyperpigmentation in skin
A Ping Wang (China)
type V & VI
Madhuri Agarwal (India)
15:40
Deucravacitinib, an Oral, Selective, Allosteric
14:37 Lasers in skin type V and VI: What works and Tyrosine Kinase 2 (TYK2) Inhibitor, in Asian
what doesn’t Patients With Moderate to Severe Psoriasis:
Ganesh S. Pai (India) Maintenance of Improvements in Patient-
Reported Outcomes
14:55 Bleaching and its consequences Jianzhong Zhang (China)
Ayesha Omolara Akinkugbe (Nigeria)
15:13 acial hyperpigmentation and melasma in

F
dark skinned persons SUNTEC | LEVEL 3 | NICOLL 3 | 14:30-15:50
Anil Ganjoo (India) SY ( SY60C) LASERS AND LASER MEDICINE -
LASERS: SPECIAL ASPECTS
15:31 Cosmetic issues and its nuances in dark skin
Anusha H. Pai (India) CHAIR:
Purita (Peachy) Paz-Lao (Philippines)
CO-CHAIRS:
Chee Leok Goh (Singapore)
SUNTEC | LEVEL 3 | NICOLL 2 | 14:30-15:50 Zeina Tannous (Lebanon)
FC (FC16) PSORIASIS 1
14:30 Lasers for Skin of Colour
CO-CHAIRS: Henry Hin Lee Chan (China)
Antonio Costanzo (Italy)
Colin Theng (Singapore) 14:50 Lasers for Tattoo Removal
Mathew Avram (USA)
14:30
An update on the status of the German
Psoriasis Registry PsoBest
Nomun Ganjuur (Germany) 15:10 Lasers for Hair Removal
Christine Dierickx (Luxembourg)
14:40
Deucravacitinib Long-term Efficacy With
Continuous Treatment in Plaque Psoriasis: 15:30 Lasers for Pigmentary Disorders
2-Year Results From the Phase 3 POETYK PSO- Purita (Peachy) Paz-Lao (Philippines)
1 and PSO-2 Trials
Mark G. Lebwhol (USA)
14:50 Identification of HLA-C*06:02 and BTN3A3

as novel molecules implicated in generalized
pustular psoriasis in a Chinese population
Hong Liu (China)
15:00
New-Onset Psoriatic Arthritis under Biologics
in Psoriasis Patients
Matteo Megna (Italy)
15:10
Deucravacitinib, an Oral, Selective, Allosteric
Tyrosine Kinase 2 Inhibitor, Improves
Outcomes in Plaque, Generalized Pustular, or
Erythrodermic Psoriasis in Japan: Results From
the POETYK PSO-4 Study
Yayoi Tada (Japan)
107
SUNTEC | LEVEL 3 | SUMMIT 1 | 14:30 -15:50 SUNTEC | LEVEL 3 | ROOM 308+309 |14:30-15:50
SY ( SY06C) MYCOBACTERIA - LEPROSY III: SY ( SY03C) SEXUALLY TRANSMITTED DISEASES
PREVENTION AND THERAPY (STD) - WHAT IS RELEVANT IN 2023 -
GONORRHEA AND CHLAMYDIA
CHAIR:
Dhelya Widasmara (Indonesia) CHAIR:
CO-CHAIRS: Nina Madnani (India)
Indira Padmapani Kahawita (Sri Lanka) CO-CHAIRS:
Furen Zhang (China) Olusola Ayanlowo (Nigeria)
Somesh Gupta (India)
14:30 Leprosy Susceptibility: Genetic Variations
Regulate Innate and Adaptive Immunity, and 14:30 Gonorrhoea in East Asia
Pingyu Zhou (China)
Disease Outcome
Yonghu Sun (China) 14:50 Gonorrhea Epidemiology and Therapy
Niti Khunger (India)
14:50 Leprosy in Asia
Furen Zhang (China) 15:10 Updates of the Comprehensive Responses to
Chlamydia Infections in China (CRECIC)
15:10 Leprosy Prevention: Medical and Social Xiang-Sheng Chen (China)
Strategies
Dhelya Widasmara (Indonesia) 15:30
Chlamydia in the Genitourinary Medicine and
APIN clinics of Lagos University Teaching
15:30 Multi Drug Therapy for Leprosy, challenges Hospital, Lagos Nigeria
and new developments Olusola Ayanlowo (Nigeria)
Indira Padmapani Kahawita (Sri Lanka)

SUNTEC | LEVEL 3 | SUMMIT 2 | 14:30-15:50 FC (FC18) ATOPIC DERMATITIS 1
SY ( SY18C) AUTOIMMUNE AND INFECTIOUS
BLISTERING DISEASES - AUTOIMMUNE CO-CHAIRS:
BULLOUS DISEASES III Uladzimir Adaskevich (Belarus)
Patrick Brunner (Austria)
CHAIR:
Miloš Nikolic (Serbia) 14:30 M
inimal-to-no itch with baricitinib in patients
CO-CHAIRS: with moderate-to-severe atopic dermatitis:
results from three randomized, phase 3
Frédéric Caux (France)
clinical trials
Hayato Takahashi (Japan) Sonja Ständer (Germany)
14:30 Diagnosis and treatment of bullous 14:40 L
ong-range Nanopore sequencing enables
pemphigoid allele classification and mutation phasing in
Miloš Nikolic (Serbia) the FLG gene to study phenotypic variability
and gene evolution
14:50 D
iagnosis and treatment of linear IgA John Common (Singapore)
dermatosis
Frédéric Caux (France) 14:50
Time Spent in Efficacy Response With
Abrocitinib or Dupilumab in Adults With
15:10 Dermatitis herpetiformis Moderate-to-Severe Atopic Dermatitis: A Post
John Zone (USA) Hoc Analysis of JADE COMPARE and JADE
DARE
15:30 Drug-induced bullous diseases Claire Clibborn (UK)
Jun Yamagami (Japan)
15:00
Abrocitinib Long-Term Efficacy by Race in
Patients With Moderate-to-Severe Atopic
Dermatitis: Interim Analysis of JADE EXTEND
Andrew Alexis (USA)
15:10
Evaluation of crisaborole in reducing topical
steroid use and improving quality of life in
paediatric patients with atopic dermatitis
Ananya Munjal (USA)
108
15:20 E
valuating the Flexibility of Abrocitinib: Treating SUNTEC | LEVEL 3 | ROOM 324+325+326 | 14:30-15:50
Flares with Step-up and Step-down Therapy SY ( SY13C) MELANOMAS - SYSTEMIC THERAPIES
Erman Güler (Turkey) AND STAGE IV MELANOMA
15:30
Development and Validation of an Investigator CHAIR:
Global Assessment Score for Keratosis Pilaris Hensin Tsao (USA)
Madeline Wang (Australia) CO-CHAIRS:
Lukas Flatz (Germany)
15:40
Eblasakimab improves multiple disease measures Alexander Roesch (Germany)
in adult patients with moderate-to-severe atopic
dermatitis in a randomized, double-blinded, 14:30 Adjuvant therapy
placebo-controlled, Phase 1 study Christian Posch (Austria)
Eric Simpson (USA)
14:50 Rational therapy of metastatic melanomas
including surgery and neoadjuvant
approaches
SUNTEC | LEVEL 3 | ROOM 320 | 14:30-15:50 Richard Quek (Singapore)
SY ( SY16C) GENETICS - GENETICS: EPIDERMAL
AND DERMAL DISEASES 15:10 argeted therapies of stage IV melanomas:
T
When, how and what
CHAIR: Lucie Heinzerling (Germany)
Johann Bauer (Austria)
CO-CHAIRS:
15:30 S
ystemic therapy for advanced acral and
Oliver Dreesen (Singapore)
mucosal melanoma
Dan Vodovich (Israel)
TBA
14:30 Ichthyoses
Dan Vodovich (Israel)
14:50 Keratodermas SUNTEC | LEVEL 3 | ROOM 327 | 14:30 - 15:50

Matthias Schmuth (Austria) RS (RS06) MEDICAL DERMATOLOGY
15:10 Skin fragility CO-CHAIRS:

Katsuto Tamai (Japan) Benjamin Oh (Singapore)
Mey Sithach (Cambodia)
15:30 Dermal diseases
Dimitra Kiritsi (Germany) 14:30 “ All that is red is not cellulitis”, retrospective
application of the ALT 70 scoring system in patients
diagnosed as lower extremity cellulitis in the
emergency department by non-dermatologists.
SUNTEC | LEVEL 3 | ROOM 323 | 14:30-15:50 Sweta Subhadarshani (USA)
SY ( SY42C) SKIN AGING: EXTRINSIC AND
INTRINSIC FACTORS - MOLECULAR 14:45
Hematological Inflammatory Markers: Do They
MECHANISMS OF AGEING Matter in Stevens-Johnson Syndrome?
Andrew Yoshihiro Wirya (Indonesia)
CHAIR:
Karin Scharffetter-Kochanek (Germany) 15:00
Pattern of nailfold capillaroscopy in patients
CO-CHAIRS: with Behçet’s disease
Sewon Kang (USA) Dilara Ilhan Erdil (Turkey)
Matias Maskin (Argentina)
15:15 alignancy in Dermatomyositis: A Mono-
M
14:30 F
ibroblast senescence in tissue decline and centric Retrospective Study of 134 Patients in
skin ageing – Future therapies Eastern China
Karin Scharffetter-Kochanek (Germany) Zl Tang (China)
14:50 Impact of ageing and senescent fibroblasts on 15:30 Anti IL- 23 monoclonal antibodies: a new
skin pigmentation therapeutic approach for the treatment of
Sang Ho Oh (Republic of Korea) recalcitrant Pyoderma gangrenosum
Alessandra Michelucci (Italy)
15:10 The sunlight spectrum in ageing
Matias Maskin (Argentina)
15:30 Solar lentigines and NRF-2

Sewon Kang (USA)
109
SY ( SY02C) ECZEMAS: THE WORLDWIDE FC (FC23) DERMOSCOPY & TRICHOSCOPY 1
RELEVANCE - PRURIGO AND ECZEMA
THERAPY CO-CHAIRS:
Enzo Errichetti (Italy)
CHAIR: Babar Rao (USA)
Sandipan Dhar (India)
CO-CHAIRS: 14:30
Dermoscopic pattern of topical steroid
Laurent Misery (France) damaged/dependent face in skin of colour
Asit Mittal (India) Vishal Chugh (India)
14:30 Prurigo: Clinical features and conventional therapy 14:40

Cutaneous squamous cell carcinoma: clinico-
Asit Mittal (India) dermoscopic and histological correlation:
about 72 cases
14:45 Q&A Sara Elloudi (Morocco)
Asit Mittal (India)
14:50
A study on trichoscopic analysis of healthy
14:50 N
ew and future treatments of prurigo males for standardization of the measurable
(including anti-Il31 and other biotherapies) parameters among the Indian population
Laurent Misery (France) Amina Asfiya M Iqbal (India)
15:05 Q&A 15:00
Total body mapping and digital dermatoscopy
Laurent Misery (France) as a response evaluation tool for metastatic
melanoma patient treated with targeted therapy
15:10 topic Dermatitis in skin of colour - clinical
A Sandra Peternel (Croatia)
presentations & challanges in therapy
Sandipan Dhar (India) 15:10
Trichoscopic features of scalp discoid lupus
erythematosus: a cross sectional study
15:25 Q&A Asmahane Souissi (Tunisia)
Sandipan Dhar (India)
15:20
Assessment of microvascular complications
15:30 Guiding the way to unmet needs in atopic
in diabetes mellitus using Nailfold
dermatitis: focus on systemic therapies
Carsten Flohr (UK) Capillaroscopy
Prakhar Srivastava (India)
15:45 Q&A
Carsten Flohr (UK) 15:30 V
alidating a novel technique of dermatoscopic
imaging for sequential comparison of target
lesions in vitiligo
V. Keshavamurthy (India)
SY (SY57C) PSYCHODERMATOLOGY -
15:40 D
iagnostic accuracy of spitzoid dermoscopic
PSYCHODERMATOLOGY I patterns in clinical practice
Nadia Vega (Spain)
CHAIR:
Carmen Rodriguez Cerdeira (Spain)
CO-CHAIRS:
Andrey Lvov (Russia)
Antonio Sison (Philippines)
14:30 Body dysmorphic disorders

Antonio Sison (Philippines)
14:46 Recognizing and managing “TrichotillOmania”

Carmen Rodriguez Cerdeira (Spain)
15:02 A
n implicated concept of Delusional
Parasitosis: a dermatological and psychiatric
overview
Dmitry Romanov (Russia)
15:18 Clinical spectrum of self-affiliated diseases

Jacek Szepietowski (Poland)
15:34 Sexually transmitted infections, HIV and psyche

Monika Fida (Albania)
110
EF ( EF04) EARLY MYCOSIS FUNGOIDES AND SY ( SY33C) SURGICAL THERAPY I - BASIC TO
ERYTHRODERMA- HOW TO BEST IDENTIFY INTERMEDIATE LEVEL RECONSTRUCTIONS
CUTANEOUS LYMPHOMA: CASE-BASED AND SURGICAL TECHNIQUES I
DISCUSSION
CHAIR:
CHAIR: John Paoli (Sweden)
Emmilia Hodak (Israel) CO-CHAIRS:
CO-CHAIRS: Iren Kossintseva (Canada)
Paula Andrea Enz (Argentina) Osvaldo Vazquez (Mexico)
Yang Wang (China)
14:30 Fine-tuning the elliptical excision/closure
14:30 Introduction Anna Bar (USA)
14:35 Case presentation 14:50 Principles for skin grafting
Werner Kempf (Switzerland)
Osvaldo Vazquez (Mexico)
14:40 Interactive Discussion
Werner Kempf (Switzerland) 15:10 Principles for flap reconstructions
Laurin Council (USA)
14:44 Case presentation
Pietro Quaglino (Italy) 15:30 3 workhorse flaps for the lower face
Iren Kossintseva (Canada)
Pietro Quaglino (Italy)
14:53 Case presentation SUNTEC | LEVEL 6 | HALL 606 | 16:00-17:20

Larisa Geskin (USA) SY (SY39D) VITILIGO, MELASMA AND

HYPERPIGMENTATION - VITILIGO:
14:58 Interactive Discussion PROCEDURAL THERAPY AND SPECIAL
Larisa Geskin (USA) ASPECTS
15:02 Case presentation CHAIR:

Joan Guitart (USA) Davinder Parsad (India)
CO-CHAIRS:
15:07 Interactive Discussion Ahmed Mohammed Al Issa (Saudi Arabia)
Joan Guitart (USA) Sang Ho Oh (Republic of Korea)
15:11 Case presentation 16:00 Vitiligo: Lasers and surgical therapies
Jose Antonio Sanches Jr (Brazil) Jung Min Bae (Republic of Korea)
16:20 Vitiligo: Depigmentation
Jose Antonio Sanches Jr (Brazil)
Ahmed Mohammed Al Issa (Saudi Arabia)
Emmilia Hodak (Israel) 16:40 Special aspects of vitiligo in the Far East
Tamio Suzuki (Japan)
Emmilia Hodak (Israel) 17:00 Special aspects of vitiligo in Africa
Noufal Raboobee (South Africa)


Yang Wang (China)

Yang Wang (China)
111
SUNTEC | LEVEL 3 | NICOLL 1 | 16:00-17:20 17:00 U
ptake of biosimilars for psoriasis: A study
SY ( SY36D) SKIN OF COLOUR - SKIN OF from the British Association of Dermatologists
COLOUR IV: SPECIAL TOPICS Biologics and Immunomodulators Register
(BADBIR)
CHAIR: D.B. Phan (UK)
Rebecca Vasquez (USA)
CO-CHAIRS: 17:10 rade-offs and Decision Making in Moderate
T
Ellen E. Pritchett (USA) to Severe Psoriasis for Oral vs. Injectable
Grace Okudo Chita (Nigeria) Treatment: Data from Australian Patients and
Dermatologists
16:00 What is new in afrotextured hair Saxon D. Smith (Australia)
Amy McMichael (USA)
16:20 Tinea incognita and its causes in dark skinned SUNTEC | LEVEL 3 | NICOLL 3 | 16:00-17:20
populations SY ( SY60D) LASERS AND LASER MEDICINE -
Jyothi Jayaraman (India) LASERS: SPECIAL INDICATIONS
16:40 S
pecial manifestations of HIV in people of colour CHAIR:
Chika Mary Emeka (Nigeria) Ines Verner (Israel)
CO-CHAIRS:
17:00
Deep fungal infections: What is new on the horizon Christine Dierickx (Luxembourg)
Francisco G. Bravo Puccio (Peru) Nicola Zerbinati (Italy)
16:00 L
aser and other Technology for Scars and
Keloids
SUNTEC | LEVEL 3 | NICOLL 2 | 16:00-17:20 Ines Verner (Israel)
FC (FC17) PSORIASIS 2
16:16 Laser Assisted Drug Delivery
CO-CHAIRS: Christine Dierickx (Luxembourg)
Wei Li (China)
Julia-Tatjana Maul (Switzerland) 16:32 Laser Treatment of Skin Cancer
Zeina Tannous (Lebanon)
16:00 E
nhancing precision medicine: the structure
of IL-23 inhibitor epitopes correlates with 16:48 Treatment of Skin with the Picosecond Laser
short-term clinical efficacy in plaque psoriasis Nicola Zerbinati (Italy)
Christopher Bunick (USA)
17:04 Treatment of Skin with Intense Pulsed Light
16:10
Paternal safety of psoriasis treatments Sources
Xiaoling Huang (Singapore) Michael Gold (USA)
16:20 S
ystematic targeted review of study design
and analytic methods in long-term biologic
studies for moderate to severe psoriasis
Richard G. Langley (Canada)
16:30
Symptom and Impact Experience of Adults
with Generalized Pustular Psoriasis (GPP)
or Palmoplantar Pustulosis (PPP) from an
International Web Survey and Qualitative
Interview Study
Mark G. Lebwohl (USA)
16:40
Validation and field testing of a 6-items-
screening tool to assess the need for
treatment optimization in psoriasis
Christine Lee Seifert (Germany)
16:50
Association of IL36RN and CARD14 mutations with
clinical manifestations and laboratory findings in
patients with generalized pustular psoriasis
Trai Nguyen Ngoc (Vietnam)
112
SY (SY06D) MYCOBACTERIA - TUBERCULOSIS SY ( SY03D) SEXUALLY TRANSMITTED DISEASES
(STD) - WHAT IS RELEVANT IN 2023 - OTHER
CHAIR: FORMS OF URETHRITIS AND HPV
Rie Yotsu (Japan)
CO-CHAIRS: CHAIR:
Federica Dassoni (Italy) Xinghua Gao (China)
Vinod K. Sharma (India) CO-CHAIRS:
Stefan Lautenschlager (Switzerland)
16:00 Tuberculosis: infection immunity Michael Waugh (UK)
Francisco G. Bravo Puccio (Peru)
16:00 Mycoplasma infections
16:18 Q&A Liu Quanzhong (China)
16:20 Atypical forms of urethritis
16:20 Epidemiology Stefan Lautenschlager (Switzerland)
Rie Yotsu (Japan)
16:40 HPV infections and associated HPV-genotypes
16:38 Q&A Xinghua Gao (China)
Rie Yotsu (Japan)
17:00
STDs - What is relevant in 2023 with an
16:40 Tuberculosis of the skin including atypical Update on HPV Vaccine
manifestations Michael Waugh (UK)
Federica Dassoni (Italy)
16:58 Q&A
Federica Dassoni (Italy) SUNTEC | LEVEL 3 | ROOM 310+311 | 16:00-17:20
FC (FC19) ATOPIC DERMATITIS 2
17:00 Tuberculosis therapy
Vinod K. Sharma (India) CO-CHAIRS:
Luca Stingeni (Italy)
17:18 Q&A Alain Taieb (France)
Vinod K. Sharma (India)
16:00
Combination of low dose oral alitretinoin
with narrow-band UVB versus high dose
oral alitretinoin monotherapy and narrow-
SUNTEC | LEVEL 3 | SUMMIT 2 | 16:00 - 17:20 band UVB monotherapy for chronic hand
SY (SY18D) AUTOIMMUNE AND INFECTIOUS
dermatitis: a retrospective study
BLISTERING DISEASES - AUTOIMMUNE Mohannad Abu-Hilal (Canada)
BULLOUS DISEASES IV
16:10 Itch and Sleep Improvements in a Pooled
CHAIR: Analysis of Neurokinin-1 Receptor Antagonist
Enno Schmidt (Germany) Tradipitant in Atopic Dermatitis
CO-CHAIRS: Jesse Carlin (USA)
Emanuele Cozzani (Italy)
Norito Ishii (Japan) 16:20
Three-year drug survival of dupilumab for
atopic dermatitis: a real-world Canadian
16:00 R
ational serological and immunopathological multi-center retrospective study
diagnosis and pitfalls Jorge Georgakopoulos (Canada)
Enno Schmidt (Germany)
16:30 E
valuation of a paraffin-based moisturizer as
16:20 R
elevant associations and co-morbidities in compared to a ceramide-based moisturizer
pemphigoid diseases in children with atopic dermatitis: a double-
Barbara Horvath (Netherlands) blinded two group equivalence randomized
controlled trial
16:40 Cicatrizing forms of pemphigoid disorders Sachin Gupta (India)
Norito Ishii (Japan)
16:40 L
ong-term drug survival of dupilumab and
17:00 T
reatment development for autoimmune associated predictors in moderate to severe
bullous diseases atopic dermatitis: a real-world prospective
Emanuele Cozzani (Italy) cohort study
Elena Pezzolo (Italy)
113
16:50 IL-13Rα1 Signaling in Atopic Dermatitis SUNTEC | LEVEL 3 | ROOM 323 | 16:00-17:20
Ferda Cevikbas (USA) SY ( SY42D) SKIN AGEING: EXTRINSIC AND
INTRINSIC FACTORS - SPECIAL ASPECTS
17:00
Dupilumab efficacy and safety: a real-world
experience in the long term treatment CHAIR:
Silvia Ferrucci (Italy) Jean Krutmann (Germany)
CO-CHAIRS:
17:10
Analysis of serum lipidomics in children with Sergio Schalka (Brazil)
atopic dermatitis based on high performance Yan Wu (China)
liquid chromatography-mass spectrometry
Fengli Xiao (China) 16:00 Skin of colour
Sergio Schalka (Brazil)
16:20 Prevention of skin ageing: do sunscreens help?

SUNTEC | LEVEL 3 | ROOM 320 | 16:00-17:20 Jean Krutmann (Germany)
SY ( SY16D) GENETICS - THE GENETIC
FOUNDATIONS OF CUTANEOUS 16:40 The effect of caloric restriction/diet on skin ageing
INFLAMMATORY DISEASES Craig A. Elmets (USA)
CHAIR: 17:00 Why does the sun make us feel happy?

Eli Sprecher (Israel) Thierry Passeron (France)
CO-CHAIRS:
James Tilford Elder (USA)
Akiharu Kubo (Japan)
16:00 The genetic basis of psoriasis SY ( SY13D) MELANOMAS - TREATMENT SIDE
James Tilford Elder (USA) EFFECTS AND NEW DEVELOPMENTS
16:15 Q&A CHAIR:

James Tilford Elder (USA) Dagmar Whitaker (South Africa)
CO-CHAIRS:
16:20 The genetic basis of atopic dermatitis Lucie Heinzerling (Germany)
Akiharu Kubo (Japan) Christian Posch (Austria)
16:35 Q&A 16:00 Update on Melanoma Trials

Akiharu Kubo (Japan) Hensin Tsao (USA)
16:40 The genetic basis of pemphigus 16:14 Q&A

Eli Sprecher (Israel) Hensin Tsao (USA)
16:55 Q&A 16:20 Tumour evolution and mechanisms of

Eli Sprecher (Israel) resistance to MAPK inhibitors
Alexander Roesch (Germany)
17:00 The genetics of morphea
Hirotsugu Oda (Germany) 16:34 Q&A
Alexander Roesch (Germany)
17:15 Q&A
Hirotsugu Oda (Germany) 16:40 New combinations (LAG3, TLR)
16:54 Q&A
17:00 New therapy approaches (mRNA, CART, TIL,

bispecifics)
Christian Posch (Austria)
17:14 Q&A
114
SUNTEC | LEVEL 3 | ROOM 327 | 16:00-17:20 SUNTEC | LEVEL 3 | ROOM 328+329 | 16:00-17:20
FC (FC22) PHYSICAL THERAPIES (PDT, SY ( SY02D) ECZEMAS: THE WORLDWIDE
CRYOTHERAPY, IONTOPHORESIS, DCP) RELEVANCE - SKIN BARRIER IN ECZEMA
CO-CHAIRS: CHAIR:
Saad Altalhab (Saudi Arabia) JiaDe (Jeff) Yu (USA)
Paola Pasquali (Spain) CO-CHAIRS:
Eung Ho Choi (Republic of Korea)
16:00
Study of platelet rich plasma in the David Cohen (USA)
management of chronic non-healing ulcers
Gnaneshwar Angoori (India) 16:00 The skin barrier
Eung Ho Choi (Republic of Korea)
16:10
PDT Light: minimal pain, maximal effect. An
enhanced method of a laser-assisted very-low- 16:20 Cumulative toxic eczema
irradiance-PDT, combined with a shortened David Cohen (USA)
daylight illumination
Martin Braun (Germany) 16:40 C
umulative toxic eczema: Prevention and
therapies
16:20 A simplified photodynamic therapy regime Kalman Watsky (USA)
against the standard regime in low-risk basal
cell carcinoma: a single-blind, non-inferiority, 17:00 C
ontact hypersensitivity: manifestations,
randomized controlled multicenter study differential diagnosis
Eidi Christensen (Norway) JiaDe (Jeff) Yu (USA)
16:30 L
arge adenoid seborrheic keratosis of the
vulva treated with photodynamic therapy
Sirui Hua (China) SUNTEC | LEVEL 3 | ROOM 330 | 16:00-17:20
SY (SY57D) PSYCHODERMATOLOGY -
16:40 A
bility to transform white adipose tissue into PSYCHODERMATOLOGY II
and brown tissue using cryolipolysis: pilot study
Patricia Meyer (Brazil) CHAIR:
Uwe Gieler (Germany)
16:50
A study on efficacy and safety of CO-CHAIRS:
iontophoretic delivery of methotrexate John Koo (USA)
versus oral methotrexate in treatment of Antonio Sison (Philippines)
palmoplantar hyperkeratotic eczema
Suvigya Sachan (India) 16:00 Glossodynia
Uwe Gieler (Germany)
17:00
Photodynamic treatment of BCCs using a
biphasic activation protocol consisting of 16:20 Skin Picking Management
red light followed by intense pulsed light Antonio Sison (Philippines)
delivered with mechanical pressure
Robert Stephens (Australia) 16:40 Pruritus - Psychoimmunology
Martin Steinhoff (Qatar)
17:00 Discussion
17:00 T
herapeutics and therapeutic approaches in
psychodermatology
John Koo (USA)
115
SUNTEC | LEVEL 3 | ROOM 331 | 16:0 -17:20
FC (FC24) DERMOSCOPY & TRICHOSCOPY 2 16:26 rief communications vs full length articles:
B
when and why?
CO-CHAIRS: Lidia Rudnicka (Poland)
Mustafa Turhan Sahin (Turkey)
Zoe Apalla (Greece) 16:35 final checklist before submitting your
A
manuscript
16:00
Dermoscopy use by Moroccan dermatologists Bruce H. Thiers (USA)
and its impact on the confidence level: a
cross-sectional survey 16:44 R
eviewers: the unsung heroes of the scientific
Kelati Awatef (Morocco) publishing exercise
Yolanda Gilaberte (Spain)
16:10
Dermoscopic findings during Sporotrichosis
treatment 16:53 How to reply to reviewers’ comments
Regina Casz Schechtm (Brazil) Cristian Navarrete-Dechent (Chile)
16:20
Dermatoscopic features of primary cutaneous 17:02 The top 10 reasons manuscripts are accepted
anaplastic CD30 (+) ALK (-) large cell Johannes Ring (Germany)
lymphoma: a case series
Banu Farabi (USA) 17:11 The top 10 reasons manuscripts are rejected
Dirk Elston (USA)
16:30
Dermoscopic Features of Actinic Cheilitis
and Other Common Inflammatory Cheilitis: a
Retrospective Observational Study
Abhijeet Jha (India) SUNTEC | LEVEL 3 | ROOM 334+335+336 | 16:00-17:20
SY ( SY33D) SURGICAL THERAPY I - BASIC TO
16:40
Mucoscopy of lip squamous cell carcinoma INTERMEDIATE LEVEL RECONSTRUCTIONS
and correlation with skin phototype and AND SURGICAL TECHNIQUES II
histological differentiation: a multicentric
retrospective observational study CHAIR:
Abhijeet Jha (India) Severin Laeuchli (Switzerland)
CO-CHAIRS:
16:50 D
ermoscopy of follicular papules: a series of Ki Hoon Song (Republic of Korea)
28 Indian patients Luiz Roberto Terzian (Brazil)
Rubina Jassi (India)
16:00 3 workhorse flaps for the nose
17:00 S
calp involvement in sarcoidosis : a report of Luiz Roberto Terzian (Brazil)
three cases
Boumaiza Sirine (Tunisia) 16:13 Discussion
Luiz Roberto Terzian (Brazil)
17:10 Discussion
16:16 3 workhorse flaps for the ear
Michael Muehlstaedt (Switzerland)
SUNTEC | LEVEL 3 | ROOM 332 | 16:00-17:20 16:29 Discussion

EF ( EF08) HOW TO SUCCESSFULLY PUBLISH Michael Muehlstaedt (Switzerland)
YOUR RESEARCH
16:32 3 workhorse flaps for the upper face
CHAIR: Severin Laeuchli (Switzerland)
Bruce H. Thiers (USA)
CO-CHAIRS: 16:45 Discussion
Karalikkattil T Ashique (India) Severin Laeuchli (Switzerland)
16:48 3 workhorse flaps for the scalp and dealing
16:00 Getting it right from the start: publishing with exposed bone
resources to use at the study planning stage Ki Hoon Song (Republic of Korea)
John Ingram (UK)
17:01 Discussion
16:08 Publishing papers: a private practitioner’s Ki Hoon Song (Republic of Korea)
perspective
Karalikkattil T Ashique (India) 17:04 Surgical procedures for Vitiligo
16:17 Open access vs subscription publications:
which is best for your research? 17:17 Discussion
Dedee Murrell (Australia) Somesh Gupta (India)
116
SCIENTIFIC PROGRAMME | WEDNESDAY 5th JULY 2023 | PAN PACIFIC
PAN PACIFIC | PACIFIC 1 | 08:00-10:50 08:53 Inflammatory Lesions
CO (CO HD09) CUTANEOUS T, B AND NK
Babar Rao (USA)
CELL LYMPHOMAS: CLASSICAL AND NEW
TREATMENTS 09:20 Break
CHAIR: 09:30 Special Sites - mucosa and scalp

John Zic (USA) Teresa Kraenke (Austria)
CO-CHAIRS:
Takatoshi Shimauchi (Japan) 09:56 Nail disease
Maarten Vermeer (Netherlands) Je-Ho Mun (Republic of Korea)
08:00 Clinicopathologic features of MF 10:22 Paediatric Lesions

Maarten Vermeer (Netherlands) Oriol Yelamos (Spain)
08:16 MF variants
Emmilia Hodak (Israel)
PAN PACIFIC | PACIFIC 3 | 08:00-10:50
08:32 Staging and Prognosis MF/SS CO ( CO HD05) BASIC DERMATOPATHOLOGY -
Evangelia Papadavid (Greece) NEOPLASTIC
08:48 Treatment of early stages of MF CHAIR:

John Zic (USA) Melissa Piliang (USA)
CO-CHAIRS:
09:04 Treatment of advanced stages of MF/SS Aleodor Andea (USA)
Youn Kim (USA) Hui Yi Chia (Singapore)
09:20 Break 08:00 Introduction
09:30 Classical and new treatment options 08:05 Nevi

for primary cutaneous CD30-positive Ahmed K. Alomari (USA)
lymphoproliferative disorders
08:25 Q&A
Tomomitsu Miyagaki (Japan)
Ahmed K. Alomari (USA)
09:46 Immunobiology of MF/SS 08:30 Melanoma
Alejandro Gru (USA) Aleodor Andea (USA)
10:02 Genomic landscape of MF/SS 08:50 Q&A
Larisa Geskin (USA) Aleodor Andea (USA)
10:18 Diagnosis and management of adult T-cell 08:55 Adnexal
leukemia lymphoma Melissa Piliang (USA)
Takatoshi Shimauchi (Japan)
09:15 Q&A
10:34 EBV-associated T/NK cell neoplasms in Asia Melissa Piliang (USA)
(extranodal NK/T cell lymphoma, nasal type,
hydroa vacciniforme-like lymphoproliferative 09:20 Break
disorder and severe mosquito bite allergy)
Kasuyasu Fujii (Japan) 09:30 Epidermal
Hui Yi Chia (Singapore)
09:50 Q&A
PAN PACIFIC | PACIFIC 2 | 08:00-10:50 Hui Yi Chia (Singapore)
CO (CO HD06) BASIC DERMOSCOPY
09:55 Soft Tissue
CHAIR: Thomas Brenn (Canada)
Rainer Hofmann-Wellenhof (Austria)
CO-CHAIRS: 10:15 Q&A
Babar Rao (USA) Thomas Brenn (Canada)
Choon Chiat Oh (Singapore)
10:20 Lymphoma
08:00 Melanocytic Lesions – Benign/Malignant Michi M. Shinohara (USA)
Rainer Hofmann-Wellenhof (Austria)
10:40 Q&A
08:27 Non Melanocytic Lesions – Benign/Malignant Michi M. Shinohara (USA)
Choon Chiat Oh (Singapore)
10:45 Wrap up
117
SCIENTIFIC PROGRAMME | WEDNESDAY 5th JULY 2023 | PAN PACIFIC
PAN PACIFIC | PACIFIC 1 | 14:30-17:20 16:00 Update on Trichoscopy
CO (CO HD21) PAEDIATRIC IMMUNODERMATOLOGY
Samipa Mukherjee (India)
CHAIR: 16:35 Discussion

Arti Nanda (Kuwait) Samipa Mukherjee (India)
CO-CHAIRS:
Jihee Kim (Republic of Korea) 16:40 Dermoscopy in General Dermatology
Elena Pope (Canada) Enzo Errichetti (Italy)
14:30 Autoimmune Blistering Disorders in Children 17:15 Discussion

Dedee Murrell (Australia) Enzo Errichetti (Italy)
14:50 Skin Manifestations of Primary Immunodeficiency

(Inborn Errors of Immunity) Disorders
Arti Nanda (Kuwait) PAN PACIFIC - PACIFIC 3 - 14:30 - 17:20
CO (CO HD18) NAIL SURGERY
15:10 Skin Manifestations of Graft Versus Host Disease
Jennifer Huang (USA) CHAIR:
Eckart Haneke (Germany)
15:30 Q&A CO-CHAIRS:
Chia Chun Ang (Singapore)
15:45 Break Nilton Gioia Di Chiacchio (Brazil)
15:55 Morphea (An Update) 14:30

Local anesthesia, hemostasis, and pain
Elena Pope (Canada) management, post op dressings
Eckart Haneke (Germany)
16:15 Dermatomyositis (An Update)
Jihee Kim (Republic of Korea) 14:50 Nail bed diagnostic procedure: punch or
excision biopsy
16:35 Neonatal Lupus Severin Laeuchli (Switzerland)
Rebecca Levy (Canada)
15:10 Nail bed therapeutic procedure: Glomus
16:45 Autoinflammatory Syndromes: Management tumour, onychopapilloma and longitudinal
Approach erythronychia
Kin Fon Leong (Malaysia) Bertrand Richert (Belgium)
17:05 Q&A 15:30 Nail matrix diagnostic procedure: diagnostic

excision of longitudinal melanonychia
Chander Grover (India)
PAN PACIFIC - PACIFIC 2 - 14:30 - 17:20 15:50 Q&A

CO (CO HD02) ADVANCED DERMOSCOPY Chia Chun Ang (Singapore)
CHAIR: 16:00 Break

Peter Soyer (Australia)
CO-CHAIRS: 16:10 ail matrix therapeutic procedure:
N
Samipa Mukherjee (India) onychomatricoma and digital fibrokeratoma
Steven Thng (Singapore) Nilton Gioia Di Chiacchio (Brazil)
14:30 Dermoscopy in Asian Skin 16:30 N

ail fold therapeutic procedure: Ingrown nail
Steven Thng (Singapore) phenol matricectomy and other techniques
Fatih Goktay (Turkey)
15:05 Discussion
Steven Thng (Singapore) 16:50 Nail unit therapeutic surgery: surgery for
Bowens disease of the nail
15:10 Dermoscopy of Naevi and Melanomas Olivier Cogrel (France)
17:10 Q&A
15:45 Discussion Chia Chun Ang (Singapore)
15:50 Break
118
SCIENTIFIC SESSIONS
THURSDAY 6th JULY 2023
119
DAY AT A GLANCE | THURSDAY 6th JULY 2023
7:00-7:45 DL01C DRUG REACTIONS IN SOUTH-EAST ASIA SUNTEC - 320
7:00-7:45 DL02B DERMATOPATHOLOGY IN SOUTH-EAST ASIA SUNTEC - 323
7:00-7:45 DL03E INSTRUCTIVE CASES FROM SINGAPORE SUNTEC - 327
7:00-7:45 DL04C HIGHLIGHTS OF PHILIPPINES DERMATOLOGY (PDS) SUNTEC - 330
7:00-7:45 DL05A PATIENT SUPPORT GROUPS/ADVOCACY - ACTION FOR AIDS SUNTEC - 331
7:00-7:45 DL06D TELEDERMATOLOGY IN SOUTH-EAST ASIA SUNTEC - 332
8:00-9:20 SY23A PSORIASIS - PSORIASIS I SUNTEC - HALL 606
DERMATOPATHOLOGY FOR THE CLINICIAN - ADVANCED DIAGNOSTIC

TOOLS IN DERMATOPATHOLOGY
8:00-9:20 SY10A HAIR DISEASES - ALOPECIA AREATA AND GENETIC DISORDERS I SUNTEC - SUMMIT 2
8:00-9:20 SY52A SKIN ULCERS AND KELOIDS - BIOLOGY OF WOUND HEALING SUNTEC - NICOLL 1
8:00-9:20 LB03 LATE-BREAKER SESSIONS SUNTEC - NICOLL 2
PAEDIATRIC DERMATOLOGY - HEREDITARY AND INFLAMMATORY DISEASES

OF CHILDHOOD
8:00-9:20 SY47A TOPICAL THERAPIES - TOPICAL THERAPIES I SUNTEC - 308+309
ARTIFICIAL INTELLIGENCE - ARTIFICIAL INTELLIGENCE WILL REPLACE

8:00-9:20 CN01 SUNTEC - 310+311
DERMATOLOGISTS IN THE FUTURE
8:00-9:20 SY14A DERMATO-ONCOLOGY - BASIC DERMATO-ONCOLOGY SUNTEC - 320
8:00-9:20 SY07A PARASITIC INFECTIONS - DEEP PARASITIC INFECTIONS SUNTEC - 323
8:00-9:20 SY41A MEDICAL AESTHETICS II - BOTULINUMTOXIN SUNTEC - 324+325+326
8:00-9:20 SY21A PHOTODERMATOLOGY - INTRODUCTION SUNTEC - 327
MIXED CONNECTIVE TISSUE DISEASES - MIXED CONNECTIVE TISSUE

8:00-9:20 SY19A SUNTEC - 328+329
DISEASES I
8:00-9:20 SY04A HIV AND AIDS: UPDATE - HIV AND AIDS PART I SUNTEC - 330
MELANOMA AND NAEVI/ONCOLOGY AND TRANSPLANT DERMATOLOGY

8:00-9:20 RS07 SUNTEC - 331
(INCLUDING CADR TO NOVEL CHEMO AND IMMUNE-THERAPIES)
8:00-9:20 EF07 DERMATOLOGY EDUCATION WORLD CAFÉ SUNTEC - 332
FUNGAL DISEASES: CUTANEOUS AND SUBCUTANEOUS - DIFFERENTIAL

8:00-9:20 SY44A SUNTEC - 334+335+336
DIAGNOSIS AND DIAGNOSTIC PROCEDURES
120
8:00-9:20 COFD01 ADVANCED DERMATOLOGICAL SURGERY PAN PACIFIC - PACIFIC 1
8:00-9:20 COFD24 UPDATE IN DERMATOPATHOLOGY PAN PACIFIC - PACIFIC 2
8:00-9:20 COHD23 TRICHOSCOPY PAN PACIFIC - PACIFIC 3
9:30-10:50 HT02 HOT TOPIC AND ILDS SESSIONS SUNTEC HALL 603+604
9:30-10:50 SY23B PSORIASIS - PSORIASIS II SUNTEC - HALL 606
DERMATOPATHOLOGY FOR THE CLINICIAN - CLINICAL PATHOLOGICAL

CORRELATIONS
9:30-10:50 SY10B HAIR DISEASES - ANDROGENETIC AND CICATRICIAL ALOPECIA SUNTEC - SUMMIT 2
9:30-10:50 SY52B SKIN ULCERS AND KELOIDS - CHRONIC LEG ULCERS SUNTEC - NICOLL 1
9:30-10:50 LB02 LATE-BREAKER SESSIONS SUNTEC - NICOLL 2
9:30-10:50 SY37A PAEDIATRIC DERMATOLOGY - EMERGING TREATMENTS IN SPECIAL TOPICS SUNTEC - NICOLL 3
9:30-10:50 SY47B TOPICAL THERAPIES - TOPICAL THERAPIES II SUNTEC - 308+309
ATOPIC DERMATITIS - EARLY SYSTEMIC TREATMENT CHANGES THE

9:30-10:50 CN02 SUNTEC - 310+311
NATURAL HISTORY OF ATOPIC DERMATITIS
9:30-10:50 SY14B DERMATO-ONCOLOGY - MERKEL CELL CARCINOMAS SUNTEC - 320
9:30-10:50 SY07B PARASITIC INFECTIONS - CUTANEOUS LEISHMANIASIS SUNTEC - 323
MEDICAL AESTHETICS II - PRACTICE MANAGEMENT INCLUDING PSYCHOLOGY, SUNTEC - 324+325+326

9:30-10:50 SY41B LEGAL ISSUES, QUALIFICATIONS, COMPLIANCES
9:30-10:50 SY21B PHOTODERMATOLOGY - PHOTODERMATOSES SUNTEC - 327

9:30-10:50 SY19B SUNTEC - 328+329
DISEASES II
9:30-10:50 SY04B HIV AND AIDS: UPDATE - HIV AND AIDS PART II SUNTEC - 330
9:30-10:50 RS08 SKIN INFECTIONS/PSORIASIS SUNTEC - 331
9:30-10:50 EF06 HISTORY OF DERMATOLOGY SUNTEC - 332
FUNGAL DISEASES: CUTANEOUS AND SUBCUTANEOUS - INFLAMMATORY

9:30-10:50 SY44B MYCOSES - THE GROWING IMPORTANCE OF NEGLECTED FUNGAL TROPICAL SUNTEC - 334+335+336
DISEASE (NTDs) OF THE SKIN
121
9:30-10:50 COHD23 TRICHOSCOPY PAN PACIFIC - PACIFIC 3
14:30-15:50 SY23C PSORIASIS - PSORIASIS III SUNTEC - HALL 606
DERMATOPATHOLOGY FOR THE CLINICIAN - COMMUNICATION BETWEEN

CLINICIANS AND DERMATOPATHOLOGISTS
14:30-15:50 SY10C HAIR DISEASES - BASIC APPROACHES TO HAIR DISEASES SUNTEC - SUMMIT 2
SKIN ULCERS AND KELOIDS - PATHOLOGICAL WOUND HEALING AND

KELOIDS
SKIN INFECTIONS, TROPICAL DERMATOLOGY, SKIN DISEASES AFFECTING

14:30-15:50 FC25 SUNTEC - NICOLL 2
MIGRANTS AND REFUGEES 1
14:30-15:50 SY37C PAEDIATRIC DERMATOLOGY - INFECTIOUS DISEASES OF CHILDHOOD SUNTEC - NICOLL 3
14:30-15:50 SY47C TOPICAL THERAPIES - TOPICAL THERAPIES III SUNTEC - 308+309
14:30-15:50 FC27 HAIR DISORDERS 2 SUNTEC - 310+311
14:30-15:50 SY14C DERMATO-ONCOLOGY - SARCOMAS SUNTEC - 320
14:30-15:50 SY07C PARASITIC INFECTIONS - SCABIES SUNTEC - 323
MEDICAL AESTHETICS II - TREATING CLASSIC MEDICAL DERMATOLOGY

14:30-15:50 SY41C SUNTEC - 324+325+326
INDICATIONS EXCLUDING SCARS WITH LASERS
14:30-15:50 SY21C PHOTODERMATOLOGY - PHOTOTHERAPIES SUNTEC - 327

14:30-15:50 SY19C SUNTEC - 328+329
DISEASES III
14:30-15:50 SY04C HIV AND AIDS: UPDATE - HIV AND AIDS PART III SUNTEC - 330
14:30-15:50 FC29 PAEDIATRIC DERMATOLOGY, GENETICS AND GENODERMATOSES 1 SUNTEC - 331
14:30-15:50 EF09 COVID-19, POST COVID-19 SYNDROMES AND VACCINE REACTIONS SUNTEC - 332
FUNGAL DISEASES: CUTANEOUS AND SUBCUTANEOUS - SUPERFICIAL

14:30-15:50 SY44C SUNTEC - 334+335+336
FUNGAL INFECTIONS: WHEN TREATMENT RESPONSE IS CHALLENGING
14:30-15:50 COHD12 EVALUATION OF AND TESTING FOR DRUG ALLERGY/HYPERSENSITIVITY PAN PACIFIC - PACIFIC 3
16:00-17:20 SY23D PSORIASIS - PSORIASIS IV SUNTEC - HALL 606
122
DERMATOPATHOLOGY FOR THE CLINICIAN - INTRODUCTION TO

16:00-17:20 SY48D SUNTEC - SUMMIT 1
DERMATOPATHOLOGY
16:00-17:20 SY10D HAIR DISEASES - GENETIC DISORDERS II AND SPECIAL ASPECTS SUNTEC - SUMMIT 2
SKIN ULCERS AND KELOIDS - TREATMENT OPTIONS FOR KELOIDS AND

HYPERTROPHIC SCARS
SKIN INFECTIONS, TROPICAL DERMATOLOGY, SKIN DISEASES AFFECTING

16:00-17:20 FC26 SUNTEC - NICOLL 2
16:00-17:20 SY37D PAEDIATRIC DERMATOLOGY - INFLAMMATORY DISEASES OF CHILDHOOD SUNTEC - NICOLL 3
16:00-17:20 SY47D TOPICAL THERAPIES - TOPICAL THERAPIES IV SUNTEC - 308+309
16:00-17:20 FC28 HAIR DISORDERS 2 SUNTEC - 310+311
16:00-17:20 SY14D DERMATO-ONCOLOGY - VASCULAR SARCOMAS SUNTEC - 320
16:00-17:20 SY07D PARASITIC INFECTIONS - SUPERFICIAL INFECTIONS AND INJURIES SUNTEC - 323
MEDICAL AESTHETICS II - WHAT'S NEW IN TREATMENTS FOR

16:00-17:20 SY41D SUNTEC - 324+325+326
REJUVENATION AND SIGNS OF AGEING
16:00-17:20 SY21D PHOTODERMATOLOGY - UV IN HEALTH AND DISEASE SUNTEC - 327

16:00-17:20 SY19D SUNTEC - 328+329
DISEASES IV
16:00-17:20 SY04D HIV AND AIDS: UPDATE - HIV AND AIDS PART IV SUNTEC - 330
16:00-17:20 FC30 PAEDIATRIC DERMATOLOGY, GENETICS AND GENODERMATOSES 2 SUNTEC - 331
16:00-17:20 EF10 PYODERMA GANGRENOSUM SUNTEC - 332
16:00-17:20 SY44D FUNGAL DISEASES: CUTANEOUS AND SUBCUTANEOUS - TREATMENT OPTIONS SUNTEC - 334+335+336
16:00-17:20 COHD12 EVALUATION OF AND TESTING FOR DRUG ALLERGY/HYPERSENSITIVITY PAN PACIFIC - PACIFIC 3
123
SCIENTIFIC PROGRAMME | THURSDAY 6th JULY 2023 | SUNTEC
DL (DL01C) DRUG REACTIONS IN SOUTH-EAST
DL ( DL04C) HIGHLIGHTS OF PHILIPPINES
ASIA DERMATOLOGY (PDS)
CHAIRS: CHAIRS:
Haur Yueh Lee (Singapore) Krisinda Dim-Jamora (Philippines)
Pawinee Rerknimitr (Thailand) Patricia Tinio (Philippines)
07:00 Severe Cutaneous Adverse Reactions in 07:00 D

etermination of minimal erythema dose in
Malaysia Filipino adults towards standardization of
Siew Eng Choon (Malaysia) initial Narrowband UB dosing
Patricia Tinio (Philippines)
07:15 In-vitro testing in severe cutaneous adverse
reactions: a Thai perspective 07:10 Development of Dermoscopic training and
Pawinee Rerknimitr (Thailand) clinical use in the Philippines - case showcase of
brown skin tumours and inflammatory lesions
07:30 Emerging triggers of SCARs in Asia Jasmin Jamora (Philippines)
Haur Yueh Lee (Singapore)
07:20 Brown Skin: Published Papers on Procedural
Dermatology in the Philippines
Krisinda Dim-Jamora (Philippines)
DL (DL02B) DERMATOPATHOLOGY IN SOUTH-
07:30 Q&A
EAST ASIA
CHAIRS:
Nopadon Noppakun (Thailand) SUNTEC | LEVEL 3 | ROOM 331 | 07:00-07:45
Arnelfa Paliza (Philippines) DL ( DL05A) PATIENT SUPPORT GROUPS/
ADVOCACY - ACTION FOR AIDS
07:00 Introduction
CHAIRS:
07:06 Cutaneous Infections in SE Asia Sumita Banerjee (Singapore)
Nopadon Noppakun (Thailand) Benson Yeo (Singapore)
07:16 Inpatient Dermatology in SE Asia 07:00 Introduction

Eileen Cubillan (Philippines) Benson Yeo (Singapore)
07:26 Cutaneous Neoplasia in SE Asia 07:05 Navigating awareness on HIV prevention &
Hui Yi Chia (Singapore) testing in the era of global pandemics for Men
who have sex with Men
07:36 Q&A/Audience participation Chronos Kwok (Singapore)
07:13 taying Relevant: HIV Prevention & Testing for

S
High-Risk Heterosexual Males
SUNTEC | LEVEL 3 | ROOM 327 | 07:00-07:45 Terry Lim (Singapore)
DL (DL03E) INSTRUCTIVE CASES FROM

SINGAPORE 07:21 Role of a specialist STI clinic in supporting
outreach programmes
CHAIRS: Benson Yeo (Singapore)
Lucinda Tan (Singapore)
Shang Ian Tee (Singapore) 07:29 B
reaking the Barriers to HIV Testing:
Perspectives from a PLHIV
07:00 Challenging cases from a tertiary academic Calvin Tan (Singapore)
hospital
Kirsten Yeo (Singapore) 07:37 Q&A
07:15 A case from the paediatric dermatology clinic

Emily Gan Yiping (Singapore)
07:30 Diagnostic Challenges with Blisters

Lucinda Tan (Singapore)
124
DL (DL06D) TELEDERMATOLOGY IN SOUTH-
LB (LB03) LATE-BREAKER SESSION
EAST ASIA
CO-CHAIRS:
CHAIRS: Mitchel P. Goldman (USA)
Nisha Suyien Chandran (Singapore)
Eugene Tan (Singapore) Rodney Sinclair (Australia)
07:00 Introduction 08:00 Long-term safety and efficacy analysis of

picosecond alexandrite laser for benign
07:03 Outpatient Teledermatology pigmentary disorders
Ellie Choi (Singapore) Kentaro Oku (Japan)
07:16 Telecollaboration in Dermatology 08:10 Synchronous ultrasound parallel beam
Yee Kiat Heng (Singapore) technology for lifting lax submental and neck
07:29 Teledermatology: the experience in the skin and lifting eyebrow skin
Philippines Ruthie Amir (Israel)
Jacqueline Melendres (Philippines)
08:20 The effect of botulinum toxin type A on
07:42 Q&A normal human dermal fibroblasts in an in vitro
wound healing assay
Yanisa Ratanapokasatit (Thailand)
SUNTEC | LEVEL 6 | HALL 606 | 08:00-09:20 08:30 L
ong-term efficacy of ritlecitinib up to Month
SY (SY23A) PSORIASIS - PSORIASIS I
24: integrated analysis of the ALLEGRO phase
CHAIR: 2b/3 and long-term phase 3 clinical studies in
Xuejun Zhang (China) alopecia areata (AA)
CO-CHAIRS: Melissa Piliang (USA)
Darren Ashcroft (UK)
Antonio Costanzo (Italy) 08:40 E
ffectiveness of autologous platelet rich
fibrin membrane versus autologous platelet
08:00 Epidemiology and the global psoriasis atlas rich plasma therapy in trophic ulcer due to
Darren Ashcroft (UK) leprosy: An observer-blind, randomized, non-
08:20 Genetics and clinical subtypes in Europe and inferiority trial
the United States Amrita Sil (India)
Antonio Costanzo (Italy)
08:50 Role of platelet rich fibrin matrix in the
08:40 Genetics and clinical subtypes in Asia management of non-healing ulcers
Liangdan Sun (China) Monica Das (India)
09:00 New developments in biomarkers in psoriasis 09:00 Optimizing Image Capture in Skin of Color for
Qing-Sheng Mi (USA) Dermatology
Kuda Maloney (USA)
SUNTEC | LEVEL 3 | NICOLL 1 | 08:00-09:20 09:10 Early Use Experience with Dermal Micro-
SY ( SY52A) SKIN ULCERS AND KELOIDS - coring in Treating Asian Patients
BIOLOGY OF WOUND HEALING Jenny Kim Bedingfield (USA)
CHAIR:
Michel Gilliet (Switzerland)
CO-CHAIRS:
Ardeshir Bayat (South Africa)
David Margolis (USA)
08:00 Immunology of wound healing
08:20 Biomarkers for wound debridement
Robert Kirsner (USA)
08:40 Wound healing gone awry: The epidemiology
of chronic wounds
David Margolis (USA)
09:00 Pathophysiology of poor scar outcomes
Ardeshir Bayat (South Africa)
125
SY ( SY37B) PAEDIATRIC DERMATOLOGY - SY ( SY10A) HAIR DISEASES - ALOPECIA AREATA
HEREDITARY AND INFLAMMATORY DISEASES AND GENETIC DISORDERS I
OF CHILDHOOD
CHAIR:
CHAIR: Alessandra Anzai (Brazil)
Srie Prihianti Gondokaryono (Indonesia) CO-CHAIRS:
CO-CHAIRS: Ruban Nathan (Malaysia)
Mark Koh (Singapore) Julio Salas (Mexico)
Pierre Vabres (France)
08:00 Alopecia areata: novel therapeutic
08:00 Dermatoses in neonates: Hereditary diseases approaches
of the epidermis and dermis Sergio Vano Galvan (Spain)
08:20 Pathobiology of alopecia areata: recent
08:20 Dermatoses in neonates: Hereditary immune progress and major open questions
deficiencies Alessandra Anzai (Brazil)
Arti Nanda (Kuwait)
08:40 Research frontiers in genetic hair disorders
08:40
Inflammatory diseases: Atopic dermatitis John McGrath (UK)
(diagnosis and treatment in early childhood)
Mark Koh (Singapore) 09:00 Pathogenesis and management of frontal
fibrosing alopecia
09:00 Inflammatory diseases: Psoriasis (diagnosis Matthew Harries (UK)
and treatment in early childhood)
Lawrence Eichenfield (USA)
UNTEC | LEVEL 3 | ROOM 308+309 | 08:00-09:20

S
SY (SY47A) TOPICAL THERAPIES - TOPICAL

SUNTEC | LEVEL 3 | SUMMIT 1 | 08:00-09:20 THERAPIES I
SY ( SY48A) DERMATOPATHOLOGY FOR THE
CLINICIAN - ADVANCED DIAGNOSTIC TOOLS CHAIR:
IN DERMATOPATHOLOGY Norbert Ferenc Kiss (Hungary)
CO-CHAIRS:
CHAIR: Kiran Godse (India)
Jeffrey North (USA) Nayera Hassan Moftah (Egypt)
CO-CHAIRS:
Wayne Grayson (South Africa) 08:00 Choosing the right vehicle
Dong Youn Lee (Republic of Korea) Gabor Dobos (Germany)
08:00 Immunohistochemistry and molecular testing 08:20 The correct therapeutic approach with
for melanocytic tumours glucocorticosteroids
Jeffrey North (USA) Kiran Godse (India)
08:20 N
ail pathology based on new molecular 08:40 Calcineurin inhibitors: fears, facts, possibilities
techniques and off-label
Dong Youn Lee (Republic of Korea) Norbert Ferenc Kiss (Hungary)
08:40 Molecular testing: non-neoplastic conditions 09:00 New topical anti-inflammatory drugs
Wayne Grayson (South Africa) Nayera Hassan Moftah (Egypt)
09:00 Immunohistochemistry and molecular testing

for inflammatory skin disease
Raymond Cho (USA)
126
CN (CN01) ARTIFICIAL INTELLIGENCE - SY ( SY07A) PARASITIC INFECTIONS - DEEP
ARTIFICIAL INTELLIGENCE WILL REPLACE PARASITIC INFECTIONS
DERMATOLOGISTS IN THE FUTURE
CHAIR:
CHAIR: Soner Uzun (Turkey)
Jin Ho Chung (Republic of Korea) CO-CHAIRS:
DISCUSSANT AGAINST: Saravu R Narahari (India)
Maria Wei (USA) Rabenja Fahafahantsoa Rapelanoro
DISCUSSANT FOR: (Madagascar)
Alexander A. Navarini (Switzerland)
08:00 Post-kala-azar dermal leishmaniasis and
08:00 Introduction therapy
Jin Ho Chung (Republic of Korea) Mourad Mokni (Tunisia)
08:10 Motion “For” 08:20 Filariasis

Alexander A. Navarini (Switzerland) Saravu R Narahari (India)
08:20 Motion “Against” 08:40 Chromoblastomycosis and sporotrichosis

Maria Wei (USA) Rabenja Fahafahantsoa Rapelanoro
(Madagascar)
09:00 Atypical manifestations of cutaneous
08:50 Q&A leishmaniasis
Soner Uzun (Turkey)
09:05 Closing Remarks “Against” SUNTEC | LEVEL 3 | ROOM 324+325+326 | 08:00-09:20

Maria Wei (USA) SY (SY41A) MEDICAL AESTHETICS II -

BOTULINUMTOXIN
09:10 Results
CHAIR:
Denise Steiner (Brazil)
CO-CHAIRS:
SUNTEC | LEVEL 3 | ROOM 320 | 08:00-09:20 Marina Landau (Israel)
SY ( SY14A) DERMATO-ONCOLOGY - BASIC Doris Hexsel (Brazil)
DERMATO-ONCOLOGY
08:00 Neuromodulator for upper and mid face
CHAIR: Doris Hexsel (Brazil)
Allison Hanlon (USA)
CO-CHAIRS: 08:15 Q&A
Stephan Grabbe (Germany) Doris Hexsel (Brazil)
Atsushi Otsuka (Japan)
08:20 Neuromodulator for lower face and neck
08:00 Cancer syndromes Denise Steiner (Brazil)
Stephan Grabbe (Germany)
08:35 Q&A
08:20 A
typical Fibroxanthoma: diagnosis and Denise Steiner (Brazil)
treatment
Allison Hanlon (USA) 08:40 Facts about BTXA you didn’t know
08:40 Subtypes, staging and prognosis of sarcomas
Taiki Isei (Japan) 08:55 Q&A
09:00 Paraneoplastic diseases
Hisashi Uhara (Japan) 09:00 BTXA induced complications: how to avoid
and treat
Fotini Bageorgou (Greece)
09:15 Q&A
Fotini Bageorgou (Greece)
127
SY (SY21A) PHOTODERMATOLOGY -
SY ( SY04A) HIV AND AIDS: UPDATE - HIV AND
INTRODUCTION AIDS PART I
CHAIR: CHAIR:
Giovanni Leone (Italy) Christopher Bunker (UK)
Ljubomir Novakovic (UK) Tatsuyoshi Kawamura (Japan)
Bernardita Ortiz-Policarpio (Philippines) Kieron Leslie (USA)
08:00 Sun’s emitted radiation, amount and nature of 08:00 Epidemiology

each waveband reaching earth Christopher Bunker (UK)
Marco Morelli (UK)
08:20 Infection immunity
08:20 Interactions of solar radiation with skin Tatsuyoshi Kawamura (Japan)
Angeli Eloise Torres (Philippines)
08:40 Clinical Manifestations around the Globe
08:40 Acute effects of sunlight on skin Jorge Navarrete (Chile)
Ljubomir Novakovic (UK)
09:00 Monkey Pox and Emerging Infections in HIV
09:00 Chronic effects of sunlight on skin Kieron Leslie (USA)
Bernardita Ortiz-Policarpio (Philippines)

SUNTEC | LEVEL 3 | ROOM 328+329 | 08:00-09:20 RS ( RS07) MELANOMA AND NAEVI/ONCOLOGY
SY ( SY19A) MIXED CONNECTIVE TISSUE AND TRANSPLANT DERMATOLOGY
DISEASES - MIXED CONNECTIVE TISSUE (INCLUDING CADR TO NOVEL CHEMO AND
DISEASES I IMMUNE-THERAPIES)
CHAIR: CHAIR:
Qianjin Lu (China) Choon Chiat Oh (Singapore)
CO-CHAIRS: Sarah Arron (USA)
Jan Dutz (USA)
Victoria Werth (USA) 08:00 Has the 4th Edition of WHO Classification of
Skin Tumours (2018) unified our management
08:00 Immunopathogenesis of lupus of dysplastic nevi? Results from a 2022
Claudia Guenther (Germany) regional survey in Spain and review of the
literature
08:20 T
reatment of cutaneous lupus: risk factors of Gloria Baeza-Hernández (Spain)
progression to SLE
Qianjin Lu (China) 08:15 Epidemiology and prognosis of primary
cutaneous head and neck melanoma: A
08:40 S
ystemic LE: clinical manifestations and retrospective single center study of 100 cases
treatment Jinkyeong Kim (Republic of Korea)
Jan Dutz (USA)
08:30 B cell IGHE expression is higher in melanoma
09:00 New approaches to treatment of CLE patients who develop immune-related
Victoria Werth (USA) arthritis post combination checkpoint
immunotherapy
Weiyu Ye (UK)
08:45 Clinical Factors Associated with Skin

Neoplasms in Individuals with Lynch
Syndrome
Connie Zhong (USA)
09:00 The Tumour Microenvironment in Keratinocyte

Cancers from Organ Transplant Recipients
Catherine Zilberg (Australia)
09:15 Discussion
128
SUNTEC | LEVEL 3 | ROOM 332 | 08:00-09:20 SUNTEC| LEVEL 6 | HALL 603+604 | 09:30-10:50
EF (EF07) DERMATOLOGY EDUCATION WORLD CAFÉ HT
(HT02) HOT TOPIC AND ILDS SESSIONS
CHAIR: CHAIR:
Mini Singh (UK) Brigitte Dréno (France)
Sze Hon Chua (Singapore) Ncoza Dlova (South Africa)
Ncoza Dlova (South Africa) Omar Lupi Da Rosa Santos (Brazil)
08:00 Welcome and Orientation 09:30 S
kin microbiome as a new bacteriotherapy for
inflammatory skin diseases
08:05 Top tips for teaching with impact - When
Masayuki Amagai (Japan)
time is short
Tamara Griffiths (UK)
09:50 Monkeypox: the 40 years old outbreak
08:15 Top tips for teaching with impact - Small vs Omar Lupi Da Rosa Santos (Brazil)
large groups
Ncoza Dlova (South Africa) 10:10 Generative Artificial Intelligence in
Dermatology: Friend or Foe?
08:25 Top tips for teaching with impact - Inclusive Dirk Elston (USA)
Learning
Sidra Khan (UK) 10:30 Diversity, Equity and Inclusion
Bianca Tod (South Africa)
08:35 Developing the next generation of
dermatology education leaders 10:40 Diversity, Equity and Inclusion
Sze Hon Chua (Singapore) Ncoza Dlova (South Africa)
08:55 Priorities for Global Dermatology
Marie-Aleth Richard (France)
09:05 Priorities for Global Dermatology SY (SY23B) PSORIASIS - PSORIASIS II
Myrto Georgia Trakatelli (Greece)
CHAIR:
09:15 Summary and Closing remarks
Siew Eng Choon (Malaysia)
Mini Singh (UK)
CO-CHAIRS:
Claudia de la Cruz (Chile)
Joel Gelfand (USA)
SY (SY44A) FUNGAL DISEASES: CUTANEOUS
09:30 R
acial/Ethnic disparities in the prevalence of
AND SUBCUTANEOUS - DIFFERENTIAL psoriasis
DIAGNOSIS AND DIAGNOSTIC PROCEDURES Ricardo Romiti (Brazil)
CHAIR: 09:50 Current and emerging treatments for

Pietro Nenoff (Germany) generalized pustular psoriasis
CO-CHAIRS: Siew Eng Choon (Malaysia)
Boni Elizabeth Elewski (USA)
Mohammad Rafiqul Mowla (Bangladesh) 10:10 he importance of early detection and
T
management in PsA
08:00 Tinea capitis: Clinics and differential diagnosis Claudia de la Cruz (Chile)
Pietro Nenoff (Germany)
10:30 Challenges in managing psoriasis in tropical areas
08:16 Tinea pedis and tinea manuum: differential Hazel Oon (Singapore)
diagnosis and insights
Carlton Ralph Daniel (USA)
08:32 Tinea incognita

Mohammad Rafiqul Mowla (Bangladesh)
08:48 O
nychomycosis management and antifungal
stewardship
Boni Elizabeth Elewski (USA)
09:04 C
linical manifestations of terbinafine resistant
tinea - a close look
Shyam Verma (India)
129
SUNTEC | LEVEL 3 | NICOLL 1 | 09:30-10:50 10:20 Distinguishing progressive immunotherapy-
SY ( SY52B) SKIN ULCERS AND KELOIDS - related mucocutaneous eruption vs traditional
CHRONIC LEG ULCERS Stevens-Johnson syndrome: an international
case-control study
CHAIR: Steven Chen (USA)
Robert Kirsner (USA)
CO-CHAIRS: 10:30 Safety, tolerability and pharmacokinetics of
Jose Contreras Ruiz (Mexico) TPM203, a first-in-man T cell-tolerizing Topas
Fatimata Ly (Senegal) particle mixture in pemphigus vulgaris (PV):
preliminary results from a phase 1 study
09:30 Introduction (TPV11)
Robert Kirsner (USA) Dario Didona (Germany)
09:35 U
lcers of the lower leg: Differential diagnosis 10:40 Moderate DRESS: RCT comparing topical and
and pathophysiology oral corticosteroids (DRESSCODE study)
Fatimata Ly (Senegal) Saskia Oro (France)
09:50 Malignancy and chronic leg ulcers
Jose Contreras Ruiz (Mexico)
10:05 Compressing bandages in leg ulcers
Marco Romanelli (Italy)
SY ( SY37A) PAEDIATRIC DERMATOLOGY -
EMERGING TREATMENTS IN SPECIAL TOPICS
10:20 Surgical therapy and skin grafting in chronic
CHAIR:
leg ulcers
Robert Kirsner (USA) Lawrence Eichenfield (USA)
CO-CHAIRS:
10:35 Discussion Marissa Joseph (Canada)
Dong Youn Lee (Republic of Korea)
09:30 N
ew treatment options and biologics in
SUNTEC | LEVEL 3 | NICOLL 2 | 09:30-10:50 children
LB (LB02) LATE-BREAKER SESSION Mette Deleuran (Denmark)
CO-CHAIRS: 09:50 Emergencies including allergies in childhood

Rachel Watson (UK) Michele Ramien (Canada)
Pascal Joly (France)
10:10 Urticaria and Mastocytosis
09:30 Dupilumab effectively and rapidly treats Cathryn Sibbald (Canada)
bullous pemphigoid by inhibiting the
activities of multiple cell types 10:30 C
linical features and the natural course of
Tianmeng Yan (China) longitudinal melanonychia in children
Si-Hyung Lee (Republic of Korea)
09:40 Immunohistochemical expression of
inflammatory cytokines in lesional
skin of Sweet syndrome in adult-onset
immunodeficiency due to anti-IFN-γ
autoantibody
Panjit Chieosilapatham (Thailand)
09:50 Targeting of Th17-related cytokines in patients

with Darier Disease
Wolfram Hoetzenecker (Austria)
10:00 APOA4 as a novel predictor of prognosis in

Stevens-Johnson syndrome/toxic epidermal
ecrolysis: a proteomics analysis from two
prospective cohorts
Chao Ji (China)
10:10 A multi-omic single-cell atlas defines the

tissue-relevant immunopathogeneses of
severe cutaneous adverse drug reactions
Andrew Gibson (Australia)
130
SY ( SY48B) DERMATOPATHOLOGY FOR THE SY (SY47B) TOPICAL THERAPIES - TOPICAL

CLINICIAN - CLINICAL PATHOLOGICAL THERAPIES II
CORRELATIONS
CHAIR:
CHAIR: Heitor De Sá Gonçalves (Brazil)
Yu-Hung Wu (Chinese Taipei) CO-CHAIRS:
CO-CHAIRS: Margaret Lartey (Ghana)
Christina Mitteldorf (Germany) Yuping Ran (China)
Nopadon Noppakun (Thailand)
09:30 Topical antiseptic therapies
09:30 Common clinical diagnosis, complicated Francisca Regina Oliveira Carneiro (Brazil)
histopathology
Yu-Hung Wu (Chinese Taipei) 09:50 Topical antifungals
Margaret Lartey (Ghana)
09:43 Lessons learnt from misdiagnosis of cases due
to the lack of clinical pathological correlation 10:10 opical treatment of psoriasis in difficult to
T
Christina Mitteldorf (Germany) treat areas: face, genital, folds, palmoplantar
Ricardo Romiti (Brazil)
09:56 G
lobalization of the old disease opens a new
frontier of histologic investigation 10:30 Treating psoriasis and eczema of the scalp
Nopadon Noppakun (Thailand) Yuping Ran (China)
10:09 T
he intersection of dermatology and
pathology: pitfalls and pearls from
challenging cases SUNTEC - LEVEL 3 | ROOM 310+311 | 09:30-10:50
Christine Ahn (USA) CN ( CN02) ATOPIC DERMATITIS - EARLY
SYSTEMIC TREATMENT CHANGES THE
10:22
The importance of clinical-pathological NATURAL HISTORY OF ATOPIC DERMATITIS
correlation
Werner Kempf (Switzerland) CHAIR:
Stephen Shumack (Australia)
10:35 When the diagnosis is uncertain, DISCUSSANT AGAINST:
clinicopathologic correlation is essential Roberto Takaoka (Brazil)
David Elder (USA) DISCUSSANT FOR:
Chang Ook Park (Republic of Korea)
09:30 Introduction
SUNTEC | LEVEL 3 | SUMMIT 2 | 09:30-10:50 Stephen Shumack (Australia)
SY ( SY10B) HAIR DISEASES - ANDROGENETIC
AND CICATRICIAL ALOPECIA 09:40 Motion “For”
CHAIR:
Matthew Harries (UK) 09:50 Motion “Against”
CO-CHAIRS: Roberto Takaoka (Brazil)
Sonia Ocampo Garza (Mexico) 10:00 Intra-Panel Discussion
09:30 Androgenetic alopecia in men: diagnosis and 10:20 Q&A

treatment
Sonia Ocampo Garza (Mexico) 10:30 Closing Remarks “For”
09:50 Cicatricial alopecia: differential diagnosis
Maria Fernanda Gavazzoni (Brazil) 10:35 Closing Remarks “Against”
Roberto Takaoka (Brazil)
10:10 rontal fibrosing alopecia and lichen
F
planopilaris 10:40 Results
Matthew Harries (UK)
10:30 Androgenetic alopecia in women: diagnosis

and treatment
Ulrike Blume-Peytavi (Germany)
131
SY ( SY14B) DERMATO-ONCOLOGY - MERKEL SY ( SY41B) MEDICAL AESTHETICS II - PRACTICE
CELL CARCINOMAS MANAGEMENT INCLUDING PSYCHOLOGY,
LEGAL ISSUES, QUALIFICATIONS,
CHAIR: COMPLIANCES
Mahtab Samimi (France)
CO-CHAIRS: CHAIR:
Andrzej A. Dlugosz (USA) Nada Soueidan (Lebanon)
Sook Jung Yun (Republic of Korea) CO-CHAIRS:
Daniela Guzmán Sánchez (Mexico)
09:30 Merkel cell carcinoma (MCC): epidemiology, Peter Velthuis (Netherlands)
MCC-polyomavirus, prevalence and
tumorigenic potential 09:30 Legal aspects of filler treatments: a worldwide
Andrzej A. Dlugosz (USA) survey
Peter Velthuis (Netherlands)
09:50 Diagnosis, prognosis and AJCC staging of MCC
Jee Woong Choi (Republic of Korea) 09:42 Avoiding complications using approved
products and medical devices - Scientific and
10:10 Classical therapies: surgery, microscopic legal issues
control surgery and radiotherapies Daniela Guzmán Sánchez (Mexico)
Kelly Harms (USA)
09:54 Psychology of the aesthetic patient at
10:30 Immune therapies for MCC: possibilities, different ages
challenges and combination therapies Hassan Galadari (UAE)
Mahtab Samimi (France)
10:09 H
ow to handle difficult topics in the
workplace
Samar Khalil (UAE)
SY ( SY07B) PARASITIC INFECTIONS - 10:24 Dysmorphophobia
CUTANEOUS LEISHMANIASIS Nada Soueidan (Lebanon)
CHAIR: 10:39 Q&A

Alaa Moubasher (Egypt)
CO-CHAIRS:
Vahide Lajevardi (Iran)
V. Ramesh (India) SUNTEC | LEVEL 3 | ROOM 327 | 09:30 - 10:50
SY (SY21B) PHOTODERMATOLOGY -

09:30 Introduction to Cutaneous Leishmaniasis PHOTODERMATOSES
Alaa Moubasher (Egypt)
CHAIR:
09:35 Novel Diagnostic Methods for Cutaneous Akimichi Morita (Japan)
Leishmaniasis CO-CHAIRS:
Ali Khamesipour (Iran) Juan Carlos Diez de Medina (Bolivia)
Narumol Silpa-Archa (Thailand)
09:55 Clinical Presentations and Treatment of Old
World Cutaneous Leishmaniasis 09:30 Polymorphic light eruption and actinic prurigo
Vahide Lajevardi (Iran) Juan Carlos Diez de Medina (Bolivia)
10:15 Cutaneous Leishmaniasis in India: current 09:50 Hydroa vacciniforme, chronic actinic
Status and Confronting Challanges dermatitis, solar urticaria
V. Ramesh (India) Narumol Silpa-Archa (Thailand)
10:35 Q&A 10:10 Genetic photodermatoses: Xeroderma

pigmentosum, Bloom syndrome, Cockayne
syndrome
Shinchi Moriwaki (Japan)
10:30 Chemical photosensitization: Exogenous,

drugs and chemicals including BRAF inhibitors
Maria Ivonne Arellano Mendoza (Mexico)
132
SUNTEC | LEVEL 3 | ROOM 328+329 | 09:30-10:50 SUNTEC | LEVEL 3 | ROOM 331 | 09:30 - 10:50
SY ( SY19B) MIXED CONNECTIVE TISSUE RS (RS08) SKIN INFECTIONS/PSORIASIS
DISEASES - MIXED CONNECTIVE TISSUE
DISEASES II CO-CHAIRS:
Yulianto Listiawan (Indonesia)
CHAIR: Lee Chin Chan (Malaysia)
Claudia Guenther (Germany)
CO-CHAIRS: 09:30 Polymorphism of cytokine gene promoter
Cate Orteu (UK) region may be associated with clinical non-
Deepika Pandhi (India) response of Hansen’s disease- a cross-sectional
institution-based study from Eastern India
09:30 Drug development for LE Sk Shahriar Ahmed (India)
Claudia Guenther (Germany)
09:45 Differential requirement of oral
09:50 Eosinophilic fasciitis and Wells syndrome corticosteroids in upgrading and
Mette Mogensen (Denmark) downgrading Type1 Leprosy reactions: a
prospective clinico-therapeutic study
10:10 Pathophysiology of sclerosis Savitha Bathula (India)
Cate Orteu (UK)
10:00 Retrospective evaluation of clinical and
10:30 M
ixed connected tissue disease. Overlap or laboratory findings of erythroderma patients
separate entity? Tugba Ilter (Turkey)
Deepika Pandhi (India)
10:15
Necrotizing fasciitis in 5 years at tertiary
hospital, Bali, Indonesia: a retrospective case
series
SUNTEC | LEVEL 3 | ROOM 330 | 09:30 - 10:50 Pande Agung Mahariski (Idonesia)
SY ( SY04B) HIV AND AIDS: UPDATE - HIV AND
AIDS PART II 10:30 Effectiveness of brodalumab in “difficult-to-
treat areas” of psoriasis
CHAIR: Luca Mastorino (Italy)
Anja Potthoff (Germany)
Eugenia Ofondu (Nigeria)
Sinesio Talhari (Brazil)
09:30 HIV and AIDS in Africa

Eugenia Ofondu (Nigeria)
09:50 Early symptoms and diagnosis

Carolina Talhari (Brazil)
10:10 HIV treatment standards 2023

Anja Potthoff (Germany)
10:30 Immune Reconstitution Inflammatory

Syndrome (IRIS)
Chen Seong Wong (Singapore)
133
SUNTEC | LEVEL 3 | ROOM 332 | 09:30 - 10:50 SUNTEC | LEVEL 6 | HALL 603+604 | 11:00-12:30
EF (EF06) HISTORY OF DERMATOLOGY PL (PL03) PLENARY SESSION 3
CHAIR: CHAIRS:
Michael Geiges (Switzerland) Sabine Eming (Germany)
CO-CHAIRS: Henry W. Lim (USA)
Xinghua Gao (China) Daudi Mavura (Tanzania)
Christoph Loeser (Germany) Suat Hoon Tan (Singapore)
09:30 Chinese medicine in Han Dynasty (202 BC – 11:00 hy are Diversity, Equity, and Inclusion
W
220 AD): human body recognition from skin to important in Medicine
organs and systems Jabbar Bennett (USA)
Xinghua Gao (China)
11:30 eratinocyte cancers: how to win the battle of
K
09:43 Keep an eye on the dye - early progress in the clones
Dermatopathology Kiarash Khosrotehrani (Australia)
Christoph Loeser (Germany)
11:50 ew and Emerging Therapeutics for Pruritus
N
09:56 T
he importance of images in the evolution of Brian Kim (USA)
scientific knowledge of leprosy over time
Patricia Duarte Deps (Brazil) 12:10 Variations in Genetics, Biology, and Phenotype
of Cutaneous Disorders in Skin of Colour
10:09 T
he early use of wax models in anatomy marking Susan Taylor (USA)
the beginning of scientific medicine in Italy
Aldo Di Carlo (Italy)
10:22 M
oulages of skin diseases and its SUNTEC | LEVEL 6 | HALL 606 | 14:30-15:50
modernization in China SY (SY23C) PSORIASIS - PSORIASIS III
Xinghua Gao (China)
CHAIR:
10:36
The chisel of nature - dermatological wax April Armstrong (USA)
moulages as proof in scientific research CO-CHAIRS:
Michael Geiges (Switzerland) Nawaf Almutairi (Kuwait)
Andrew Blauvelt (USA)
SUNTEC | LEVEL 3 | ROOM 334+335+336 | 09:30-10:50 14:30 Cardiovascular Disease and Psoriasis: Can We
SY ( SY44B) FUNGAL DISEASES: CUTANEOUS Make a Difference with Our Treatments?
AND SUBCUTANEOUS - INFLAMMATORY Andrew Blauvelt (USA)
MYCOSES - THE GROWING IMPORTANCE OF
NEGLECTED FUNGAL TROPICAL DISEASES 14:46
Topical Therapies for Psoriasis: What, When,
(NTDS) OF THE SKIN and How?
Nawaf Almutairi (Kuwait)
CHAIR:
Alice Amani Uwajeni (Rwanda) 15:02 Phototherapy for Psoriasis: Still a Viable
CO-CHAIRS: Option?
James Roderick Hay (UK) Mark Berneburg (Germany)
Rataporn Ungpakorn (Thailand)
15:18 ral Therapies for Psoriasis: Methotrexate,
O
09:30 The changing face of Mycetoma Apremilast, or Deucravacitinib?
Maria de Guadalupe Chavez-Lopez (Mexico) April Armstrong (USA)
09:50 New findings in Chromoblastomycosis 15:34 New findings of clinical trials of phototherapy
Liyan Xi (China) for psoriasis
Joel Gelfand (USA)
10:10 Sporotrichosis - the new clinical and
epidemiological features
Regina Casz Schechtman (Brazil)
10:30 F
ungal skin infections and NTDs in Community
Settings
Guadalupe Estrada-Chavez (Mexico)
134
SUNTEC | LEVEL 3 | NICOLL 1 | 14:30-15:50 15:40 A
retrospective cohort study of monthly
SY ( SY52C) SKIN ULCERS AND KELOIDS - rifampicin, ofloxacin and minocycline in the
PATHOLOGICAL WOUND HEALING AND management of leprosy in the United Kingdom
KELOIDS Priyanka Sivakumaran (UK)
CHAIR:
David Ozog (USA)
CO-CHAIRS: SUNTEC | LEVEL 3 | NICOLL 3 | 14:30-15:50
Maria Cristina Puyat (Philippines) SY (SY37C) PAEDIATRIC DERMATOLOGY -

Eftychia Zouridaki (Greece) INFECTIOUS DISEASES OF CHILDHOOD
14:30 Pathogenesis’ biomarkers, and the future of keloids CHAIR:

Lamont Jones (USA) Deepak Parikh (India)
CO-CHAIRS:
14:50 Multimodal Approach for Keloid Scars Maria Eugenia Abad (Argentina)
Maria Cristina Puyat (Philippines) Eduardo David Poletti (Mexico)
15:10 sing fillers and neuromodulators for scars

U 14:30 Introduction of topic
David Ozog (USA)
14:32 Severe non-targetoid infantile exanthem
15:30 Atypical wounds mimicking ulcers of common causes Eduardo David Poletti (Mexico)
Eftychia Zouridaki (Greece)
14:44 Q&A
Eduardo David Poletti (Mexico)
SUNTEC | LEVEL 3 | NICOLL 2 | 14:30-15:50 14:47 Toxin-mediated exanthems

FC ( FC25) SKIN INFECTIONS, TROPICAL Maria Eugenia Abad (Argentina)
DERMATOLOGY, SKIN DISEASES AFFECTING
MIGRANTS AND REFUGEES 1 14:59 Q&A
Maria Eugenia Abad (Argentina)
CO-CHAIRS:
Jose Antonio Ruiz Postigo (Switzerland) 15:02 C
hanging trend of Dermatophyte Infection in
Yu Ping Ran (China) Children
Jayakar Thomas (India)
14:30 D
ermatitis cruris pustulosa et atrophicans
(DCPA) in Nigeria - seventy years later! 15:14 Q&A
Ayesha Omolara Akinkugbe (Nigeria) Jayakar Thomas (India)
14:40 Investigating the Effect of Wearing Hijab on 15:17 Skin manifestations of COVID-19 infection in
Variation Pattern of Malassezia Species on children
the Scalp
Bruno Ferrari (Argentina)
Yogi Faldian (Indonesia)
14:50 E
fficacy of topical 40% TCA (trichloroacetic 15:29 Q&A
acid) with needling versus needling alone Bruno Ferrari (Argentina)
in the management of plantar warts: A
Randomized Controlled Trial 15:32 Chikungunya - Clinical spectrum in neonatal
Rohit Kothari (India) age group
Sahana Srinivas (India)
15:00
Acute infectious purpura fulminans secondary
to Rickettsial infection: A case series 15:44 Q&A
Anupama Manohar Prasad (India) Sahana Srinivas (India)
15:10
Lucio’s phenomenon in a pregnant woman 15:47 Conclusion
with lucio’s leprosy: a case report
Adniana Nareswari (Indonesia)
15:20 The Impact of Climate Change on Neglected

Tropical Diseases of the Skin
Eva Rawlings Parker (USA)
15:30
Interleukin-17 Gene Polymorphism In Recurrent
Disseminated Pityriasis Versicolor
Alia H. Ramadan (Egypt)
135
SY (SY48C) DERMATOPATHOLOGY FOR THE
SY (SY47C) TOPICAL THERAPIES - TOPICAL

CLINICIAN - COMMUNICATION BETWEEN THERAPIES III
CLINICIANS AND DERMATOPATHOLOGISTS
CHAIR:
CHAIR: Brett King (USA)
Suat Hoon Tan (Singapore) CO-CHAIRS:
CO-CHAIRS: Brian Kim (USA)
Omar Sangueza (USA) Farzan Solimani (Germany )
Yemi Sokumbi (USA)
14:30 W
hat’s new in topical therapy of psoriasis
14:30 Is the histopathological diagnosis always the Mark G. Lebwohl (USA)
final diagnosis?
Christian Sander (Germany) 14:50 J AK inhibitors for alopecia areata and vitiligo
Brett King (USA)
14:45 Q&A
Christian Sander (Germany) 15:10 JAK inhibitors for eczema
Brian Kim (USA)
14:50 When should I request the pathologist to do
more for suspected Malignancy? 15:30 JAK inhibitors for lichen planus and other
Omar Sangueza (USA) dermatological disorders
Farzan Solimani (Germany)
15:05 Q&A
Omar Sangueza (USA)
15:10 hen should I request the pathologist to do

W SUNTEC | LEVEL 3 | ROOM 310+311 | 14:30-15:50
more for inflammatory diseases? FC (FC27) HAIR DISORDERS 1
Yemi Sokumbi (USA)
CO-CHAIRS:
15:25 Q&A Ohsang Kwon (Republic of Korea)
Yemi Sokumbi (USA) Chris Tan (Singapore)
15:30 W
hat should I do when the histopathology 14:30
Adipose Stem Cell Exosome (ASCE): Next
report returns as non-specific changes? Generation Regenerative Aesthetics &
Christine Ahn (USA) Therapeutics for Scalp & Hair
15:45 Q&A
Christine Ahn (USA) 14:40 S
uccessful treatment of female pattern hair
loss with injection of autologous adipose
derived adult stem cells: a randomized
SUNTEC | LEVEL 3 | SUMMIT 2 | 14:30-15:50 controlled clinical, trichoscopic and
SY (SY10C) HAIR DISEASES - BASIC
immunohistochemical trial
APPROACHES TO HAIR DISEASES Mahy El-Bassiouny El-Sayed (Egypt)
CHAIR: 14:50 C
omparison of scalp microbiome according to
Leopoldo Duailibe Santos (Brazil) the severity of androgenic alopecia and gender
CO-CHAIRS: Hye-Young Yoo (Republic of Korea)
Amos Gilhar (Israel)
Etienne Wang (Singapore ) 15:00 C
OVID-19 infection and vaccination preceding
alopecia areata
14:30 Hair cycle and its relation to hair diseases Betty Nguyen (USA)
Etienne Wang (Singapore)
15:10
Alopecia content on TikTok: A cross-sectional
14:50 T
he impact of immune cells in regulating the analysis
hair cycle Betty Nguyen (USA)
Amos Gilhar (Israel)
15:20 P
atient Reported Outcomes for Scalp,
15:10 Differential diagnosis of hair disorders Eyebrow and Eyelash Involvement in Patients
Leopoldo Duailibe Santos (Brazil) with Severe Alopecia Areata Treated with
Baricitinib: 52-Week Results from Two Phase 3
15:30 Dermoscopy of the scalp Clinical Trials
Daniel Fernandes Melo (Brazil) Justin Ko (USA)
136
15:30 B
reast cancer screening in patients with SUNTEC | LEVEL 3 | ROOM 324+325+326 | 14:30-15:50
Frontal Fibrosing Alopecia SY ( SY41C) MEDICAL AESTHETICS II - TREATING
Mehdi Shiri (Iran) CLASSIC MEDICAL DERMATOLOGY
INDICATIONS EXCLUDING SCARS WITH LASERS
15:40 L
ong-term safety and efficacy of ritlecitinib in
patients with alopecia areata: interim results CHAIR:
from the ALLEGRO-LT phase 3, open-label study Keyvan Nouri (USA)
Rodney Sinclair (Australia) CO-CHAIRS:
Maurice Adatto (Switzerland)
Richard Rox Anderson (USA)
Kui Young Park (Republic of Korea)
SY (SY14C) DERMATO-ONCOLOGY - SARCOMAS 14:30 Pulsed dye lasers in rare and new indication
Firas Al-Niaimi (UK)
CHAIR:
Toby Maurer (USA) 14:46 aser and EBD treatment of acne and rosacea
L
CO-CHAIRS: Keyvan Nouri (USA)
Lucia Achell-Nava (Mexico)
Satoshi Fukushima (Japan) 15:02
Laser treatment of pigmentary medical
disorders and congenital nevi
14:30 Dermatofibrosarcoma (DFSP): Diagnosis Kui Young Park (Republic of Korea)
Soichiro Sawamura (Japan)
15:18 Laser treatment for medical complications of
14:50 DFSP clinical behaviour and surgical treatment tattoos
Alejandro González Silva (Mexico) Maurice Adatto (Switzerland)
15:30 Pleomorphic sarcomas and rare mesenchymal 15:34 What’s new in lasers
tumors: diagnosis and treatment Richard Rox Anderson (USA)
Takamichi Ito (Japan)

SUNTEC | LEVEL 3 | ROOM 323 | 14:30-15:50 SY (SY21C) PHOTODERMATOLOGY -

SY (SY07C) PARASITIC INFECTIONS - SCABIES PHOTOTHERAPIES
CHAIR: CHAIR:
Daniel Engelman (Australia) Sunil Kalia (Canada)
Charlotte Bernigaud (France) Stefan Beissert (Germany)
Olivier Chosidow (France) Giovanni Leone (Italy)
14:30 C
linical manifestations of common scabies 14:30 UVB and UVB311 nm therapies
and scabies variants Giovanni Leone (Italy)
Charlotte Bernigaud (France)
14:50 Phototherapy for itch
14:50 S
cabies diagnosis and global epidemiology Tashmeeta Ahad (Canada)
Daniel Engelman (Australia)
15:10 Phototherapy and skin cancer
15:10 cabies treatments, resistance and new
S Sunil Kalia (Canada)
treatment options
Olivier Chosidow (France) 15:30 PUVA: Oral and bath PUVA
Cheng-Che Eric Lan (Chinese Taipei)
15:30 Community control of scabies
Susanna Lake (Australia)
137
SUNTEC | LEVEL 3 | ROOM 328+329 | 14:30-15:50 SUNTEC | LEVEL 3 | ROOM 331 | 14:30 - 15:50
SY ( SY19C) MIXED CONNECTIVE TISSUE FC ( FC29) PAEDIATRIC DERMATOLOGY,
DISEASES - MIXED CONNECTIVE TISSUE GENETICS AND GENODERMATOSES 1
DISEASES III
CO-CHAIRS:
CHAIR: Regina Foelster-Holst (Germany)
Sabine Eming (Germany) Marissa Joseph (Canada)
CO-CHAIRS:
Heidi Jacobe (USA) 14:30 M
odelling Darier disease using human
Cristián Vera-Kellet (Chile) epidermal organoids
14:30 Classification and molecular landscape of
fibrosis skin diseases 14:40 R
evisiting paediatric leprosy in the Indian
Sabine Eming (Germany) post-elimination era
Ankita Choudhary (India)
14:50 Novel insights into Systemic Sclerosis
Johann E. Gudjonsson (USA) 14:50 G
enotype phenotype correlation of
Epidermolysis Bullosa in thirteen Indian
15:10 Therapeutic Decision Making in Morphea patients
Heidi Jacobe (USA) Shibhani Sudheer Hegde (India)
15:00 Itch in recessive dystrophic epidermolysis

15:30 U
pdate on new and emerging treatments for
bullosa: findings from the Prospective
Systemic Sclerosis
Epidermolysis Bullosa Longitudinal Evaluation
Cristián Vera-Kellet (Chile) Study (PEBLES)
Jemima Mellerio (UK)
15:10 linical heterogeneity in epidermolysis bullosa

C
SUNTEC | LEVEL 3 | ROOM 330 | 14:30 - 15:50 simplex with plectin (PLEC) mutations - A
SY ( SY04C) HIV AND AIDS: UPDATE - HIV AND study of six unrelated families from India
AIDS PART III Manoj Srinivasa (India)
CHAIR: 15:20 W
hole Exome Sequencing Improves Mutation
Kayitesi Kayitenkore (Rwanda) Detection in Hailey-Hailey Disease
CO-CHAIRS: Zhe Wang (China)
Benson Yeo (Singapore)
Michel Janier (France) 15:30 A
n intensive study regarding a new potential
diagnostic criterion (Halo-like phenomenon) in
14:30 Pregnancy neurofibromatosis type 1
Armin Rieger (Austria) Jia Zhang (China)
14:50 Pre- and post-exposure prophylaxis 15:40
Genetic and phenotypic diversity of epidermal
Benson Yeo (Singapore) nevus syndromes
Jia Zhang (China)
15:10 Immune reconstitution syndrome
15:30 Side effects of treatment

Kayitesi Kayitenkore (Rwanda)
138
SUNTEC | LEVEL 3 | ROOM 332 | 14:30 - 15:50 SUNTEC | LEVEL 6 | HALL 606 | 16:00 - 17:20
EF ( EF09) COVID-19, POST COVID-19 SY (SY23D) PSORIASIS - PSORIASIS IV
SYNDROMES AND VACCINE REACTIONS
CHAIR:
CHAIR: Bruce Strober (USA)
Esther E. Freeman (USA) CO-CHAIRS:
CO-CHAIRS: Melinda Gooderham (Canada)
Marius-Anton Ionescu (France) Lars Iversen (Denmark)
Pascal Joly (France)
Dagmar Whitaker (South Africa)
16:00 Introduction
14:30 Introduction Bruce Strober (USA)
Esther E. Freeman (USA)
16:03 TNF antagonists with and without
14:35
Lupus signature from interferonopathies type methotrexate: indications, risks and
1 to COVID-19 acrosyndromes limitations
Marius-Anton Ionescu (France) Lars Iversen (Denmark)
14:40 The relationships between Covid, vaccination, 16:18 Discussion

and B cell depletion therapy in autoimmune Lars Iversen (Denmark)
bullous skin diseases
Pascal Joly (France) 16:22 IL-17 and IL-23 antagonists
Kenneth Gordon (USA)
14:45 The journey of Omicron: an African story
Dagmar Whitaker (South Africa) 16:37 Discussion
14:50 COVID in Latin America Kenneth Gordon (USA)
Omar Lupi Da Rosa Santos (Brazil)
16:41 JAK inhibitors
14:55 Registries in the context of COVID Melinda Gooderham (Canada)
Rodney Sinclair (Australia)
16:56 Discussion
15:00
Managing an international organization Melinda Gooderham (Canada)
through COVID/multi-specialty collaborations
George Hruza (USA) 17:00 New drugs in the pipeline
Bruce Strober (USA)
15:05 Re-imagining COVID in the future
Cristina Galvan Casas (Spain) 17:15 Discussion
Bruce Strober (USA)
15:10 Panel discussion
SUNTEC | LEVEL 3 | ROOM 334+335+336 | 14:30-15:50 SUNTEC | LEVEL 3 | NICOLL 1 | 16:00 - 17:20
SY (SY44C) FUNGAL DISEASES: CUTANEOUS
SY ( SY52D) SKIN ULCERS AND KELOIDS -
AND SUBCUTANEOUS - SUPERFICIAL TREATMENT OPTIONS FOR KELOIDS AND
FUNGAL INFECTIONS: WHEN TREATMENT HYPERTROPHIC SCARS
RESPONSE IS CHALLENGING
CHAIR:
CHAIR: Donald Glass (USA)
Ditte Marie Saunte (Denmark) CO-CHAIRS:
CO-CHAIRS: Siqi Fu (China)
Dimitris Rigopoulos (Greece) Ahmed Sadek (Egypt)
Shyam Verma (India)
16:00 Treatment with injectable steroids and
14:30 Overview: Types of fungal infections, cytotoxic agents
antifungal treatment and susceptibility testing Xiaomei Cui (China)
Ditte Marie Saunte (Denmark)
14:50 The challenge of terbinafine resistant 16:20 T

reatment with lasers and energy based
dermatophytosis devices
Shyam Verma (India) Ahmed Sadek (Egypt)
15:10 Tinea Unguium: why treatment fails and what to do 16:40 Cryotherapy
Dimitris Rigopoulos (Greece) Eva Kerby (USA)
15:30 Challenges of treating Recurrent Vulvo-vaginal 17:00 Combination therapies

Candidiasis Peter Peng (Chinese Taipei)
Gayle Fischer (Australia)
139
SUNTEC | LEVEL 3 | NICOLL 2 | 16:00 - 17:20 SUNTEC | LEVEL 3 | NICOLL 3 | 16:00 - 17:20
FC ( FC26) SKIN INFECTIONS, TROPICAL SY ( SY37D) PAEDIATRIC DERMATOLOGY -
DERMATOLOGY, SKIN DISEASES AFFECTING INFLAMMATORY DISEASES OF CHILDHOOD
CHAIR:
CO-CHAIRS: Christian Vestergaard (Denmark)
Andris Rubins (Latvia) CO-CHAIRS:
Aisha Sethi (USA) Leslie Castelo-Soccio (USA)
Regina Foelster-Holst (Germany)
16:00
Desert dermatosis: current pattern of non
infectious dermatosis in Thar desert 16:00 Paediatric dermatoses: a quiz
Vishal Chugh (India) Regina Foelster-Holst (Germany)
16:10
Scabies prevalence in a remote Indigenous 16:20 Auto Immune Diseaes
community in northern Australia prior to mass Leslie Castelo-Soccio (USA)
drug administration of ivermectin
Victoria Cox (Australia) 16:40 Cutaneous signs of systemic diseases
Christian Vestergaard (Denmark)
16:20 T
reatment of cutaneous Leishmaniasis in the
elderly with Liposomal Amphotericin B: a 17:00 Diagnoses of bullous diseases in children
randomized clinical trial Enno Schmidt (Germany)
Paulo Roberto Lima Machado (Brazil)
16:30
The immune-suppressive landscape in
lepromatous leprosy revealed by single-cell SUNTEC | LEVEL 3 | SUMMIT 1 | 16:00 - 17:20
RNA sequencing SY ( SY48D) DERMATOPATHOLOGY FOR
Zihao Mi (China) THE CLINICIAN - INTRODUCTION TO
DERMATOPATHOLOGY
16:40
Clinical and molecular characterization
of cutaneous leishmaniasis in Nepal: a CHAIR:
collaborative effort Dieter Metze (Germany)
Niraj Parajuli (Nepal) CO-CHAIRS:
16:50
Intralesional Immunotherapy of Cutaneous Dirk Elston (USA)
Warts using Tuberculin Purified Protein
Derivative and Vitamin D3 - A Randomized 16:00 Types of biopsies, common pitfalls:
Comparative study Inflammatory diseases
Harris Ishtiyaq Shaafie (India) Carly Elston (USA)
17:00
Trends in Hospitalization: a Review of 16:20 T
ypes of biopsies, common pitfalls: neoplastic
Monkeypox Cases Across 10 Countries from an diseases including nail biopsies
International Registry Francisco G. Bravo Puccio (Peru)
Alexis Strahan (USA)
16:40
Types of biopsies, common pitfalls: naevi,
17:10
Paracoccidioidomycosis: an atypical facial pigmented macules and melanomas
presentation Dirk Elston (USA)
Beatriz Zimermano Coimbra (Brazil)
17:00 What to do when the dermatopathology
report does not fit with my diagnosis?
Dieter Metze (Germany)
140
SUNTEC | LEVEL 3 | SUMMIT 2 | 16:00 - 17:20 SUNTEC | LEVEL 3 | ROOM 310+311 | 16:00-17:20
SY ( SY10D) HAIR DISEASES - GENETIC FC (FC28) HAIR DISORDERS 2
DISORDERS II AND SPECIAL ASPECTS
CO-CHAIRS:
CHAIR: Ncoza Dlova (Malaysia)
Rodney Sinclair (Australia) Ruban Nathan (Malaysia)
CO-CHAIRS:
George Cotsarelis (USA) 16:00
Health related quality of life and clinical
Mayumi Ito (USA) outcomes tools in patients with Alopecia
Jerry Shapiro (USA)
Areata: a Systematic Literature Review
16:00 Hirsutism, androgenetic alopecia and Slatina Christov (Germany)
treatment related hair loss
Rodney Sinclair (Australia) 16:10
Apremilast: an effective alternative in the
treatment of alopecia areata, oophiasis,
16:15 Q&A totalis, universalis
Rodney Sinclair (Australia) Sunil Ghate (India)
16:20 Management of Folliculitis decalvans 16:20

Oral minoxidil in Female Pattern Hair Loss: a
Michela Starace (Italy) tale of both serendipity and effective therapy
Monisha Madhumita (India)
16:35 Q&A
Michela Starace (Italy) 16:30 T
richoscopy findings of normal hair in
Black African traders in Lagos, Nigeria: a
16:40 L
ichen Planopilaris and Frontal Fibrosing community survey
Alopecia Erere Otrofanowei (Nigeria)
Jerry Shapiro (USA)
16:40
Oral JAK Inhibitor Baricitinib for Alopecia
16:55 Q&A
Jerry Shapiro (USA) Areata: a Real-World Study
Yuping Ran (China)
17:00 H
air follicle neogenesis. Making something
from nothing 16:50
The Global Registry of Alopecia Areata
George Cotsarelis (USA) Disease Severity and Treatment Safety
(GRASS) International: Results from the pilot
17:15 Q&A Huw Rees (Australia)
George Cotsarelis (USA)
17:00
Low dose oral minoxidil in non scarring
alopecia: a retrospective study of 128 patients
Anchal Shah (India)
SY (SY47D) TOPICAL THERAPIES - TOPICAL
17:10
Duration of current episode of alopecia areata
THERAPIES IV (AA) influences prognosis during treatment
with baricitinib in patients with severe AA
CHAIR: Brett King (USA)
Mark Pittelkow (USA)
CO-CHAIRS:
Jose Luis Lopez-Estebaranz (Spain)
16:00 Ivermectin
16:12 Topical antibiotics

Andreas Wollenberg (Germany)
16:24 Topical JAK inhibitors for psoriasis

16:36 Topical JAK inhibitors for lichenoid and

granulomatous diseases
Aaron Mangold (USA)
16:48 Topical alpha-mimetics

Mark Pittelkow (USA)
17:00 Discussion
141
SY (SY14D) DERMATO-ONCOLOGY - VASCULAR
SY ( SY41D) MEDICAL AESTHETICS II - WHAT’S
SARCOMAS NEW IN TREATMENTS FOR REJUVENATION
AND SIGNS OF AGEING
CHAIR:
Toby Maurer (USA) CHAIR:
CO-CHAIRS: Klaus Fritz (Germany)
Nicolas Dupin (France) CO-CHAIRS:
Satoshi Fukushima (Japan) Nancy Garcia-Tan (Philippines)
Peter Peng (Chinese Taipei)
16:00 Kaposis sarcoma - Diagnosis and Treatment in
East Africa 16:00
Macro vs. micro focused high intensity
Samson Kiprono (Kenya) ultrasound in fat melting and body contouring
Klaus Fritz (Germany)
16:16 Innovations in Diagnosis and Treatment in
Kaposis sarcoma 16:20 M
uscle stimulation and shaping in
Esther E. Freeman (USA) bodycontouring
Peter Peng (Chinese Taipei)
16:32 Barriers to Care and Innovations in Linkage to
Care for Kaposis sarcoma 16:40 A
ppropriate peeling for prevention and
treatment of ageing
16:48 Telemedicine, Artificial Intelligence - Can Marina Landau (Israel)
these modalities lead to early diagnosis of
Kaposis sarcoma? 17:00 Complications with peels
Sarah Coates (USA) Nancy Garcia-Tan (Philippines)
17:04 Reciprocal Innovation - Lessons to bring back

to the West for diagnosis and treatment of
Kaposis sarcoma SUNTEC | LEVEL 3 | ROOM 327 | 16:00-17:20
Toby Maurer (USA) SY ( SY21D) PHOTODERMATOLOGY - UV IN
HEALTH AND DISEASE
CHAIR:
SUNTEC | LEVEL 3 | ROOM 323 | 16:00-17:20 Peter Wolf (Austria)
SY ( SY07D) PARASITIC INFECTIONS - CO-CHAIRS:
SUPERFICIAL INFECTIONS AND INJURIES Elizabeth A. Buzney (USA)
Wei Liu (China)
CHAIR:
Yulianto Listiawan (Indonesia) 16:00 UV and skin microbiome
CO-CHAIRS: Peter Wolf (Austria)
Vidal Haddad Junior (Brazil)
Karen Manuelyan (Bulgaria) 16:20 Photoprovocation for PLE and lupus
erythematosus
16:00 Hair lice, crab and body lice Elizabeth A. Buzney (USA)
Sandra Widaty (Indonesia)
16:40 UV protection: what type? How and how
16:20 Cutaneous larva migraines and myasis much? And what about vitamin D?
Stefano Veraldi (Italy) Tasneem Mohammad (USA)
16:40 Bed bug bites 17:00 Sun exposure and associated risks in 17
Karen Manuelyan (Bulgaria) countries
Wei Liu (China)
17:00 Marine injuries
142
SY ( SY19D) MIXED CONNECTIVE TISSUE FC ( FC30) PAEDIATRIC DERMATOLOGY,
DISEASES - MIXED CONNECTIVE TISSUE GENETICS AND GENODERMATOSES 2
DISEASES: IV
CO-CHAIRS:
CHAIR: Jeffery Sugarman (USA)
Benjamin Chong (USA) John Su (Australia)
CO-CHAIRS:
Petra De Haes (Belgium) 16:00 R
eal world efficacy and safety of oral
Naoko Okiyama (Japan) Cyclosporine in the treatment of Alopecia
Totalis: A multicentric retrospective study
16:00 Clinical presentations in dermatomyositis over 10 years
Petra De Haes (Belgium) Samujjala Deb (India)
16:20 Dermatomyositis and rational diagnostics 16:10

Proposal of a new algorithm for topical
Naoko Okiyama (Japan) mTOR inhibitors in the treatment of facial
angiofibromas in Tuberous Sclerosis Complex
16:40 Dermatomyositis and organ involvement Giulia Rech (Italy)
Benjamin Chong (USA)
16:20
Xeroderma Pigmentosum: Our Experience
17:00 Treatment of dermatomyositis from Zanzibar
Victoria Werth (USA) Hafidh Hassan (Tanzania)
16:30 N
ovel mutations in BART’s syndrome
Amrita Hongal (India)
SY ( SY04D) HIV AND AIDS: UPDATE - HIV AND 16:40
Secukinumab controls inflammation but not
AIDS PART IV scaling in Autosomal Recessive Congenital
Ichthyosis: A case series
CHAIR: Shrishti Singh (India)
Stephen Tyring (USA)
CO-CHAIRS: 16:50
Evaluating behavioural problems in children
Ishwar Gilada (India) with atopic dermatitis in an Asian cohort: a
Mihael Skerlev (Croatia) pilot study in Singapore
Faith Ai Ping Zeng (Australia)
16:00 HPV in HIV infected patients
Mihael Skerlev (Croatia) 17:00
Biologics for psoriasis patients under 18 years
of age: Real-world evidence from the Chinese
16:20 Changing Pattern and Treatment of STIs in Psoriasis Real World Evidence Research Group
HIV-Infected Patients Yuxin Zheng (China)
Angela Yen Moore (USA)
17:10 fficacy of Human Urine-Derived Stem Cells
E
16:40 Tuberculosis and leprosy in HIV patients in a Mouse Model of Recessive Dystrophic
Ishwar Gilada (India) Epidermolysis Bullosa
Xingli Zhou (China)
17:00 Discussion
143
EF (EF10) PYODERMA GANGRENOSUM SY ( SY44D) FUNGAL DISEASES: CUTANEOUS
AND SUBCUTANEOUS - TREATMENT
CHAIR: OPTIONS
CO-CHAIRS: CHAIR:
Angelo Valerio Marzano (Italy) Adebola Ogunbiyi (Nigeria)
Alex G. Ortega-Loayza (USA) CO-CHAIRS:
Ricardo Galimberti (Argentina)
16:00 Introduction & Pathophysiology Lulyrithra Kini (Tanzania)
Angelo Valerio Marzano (Italy)
16:00 Treatment of tinea unguium
16:05 Introduction & Pathophysiology Ricardo Galimberti (Argentina)
16:20 Treatment of tinea capitis
16:10 Introduction & Pathophysiology James Roderick Hay (UK)
Toshiyuki Yamamoto (Japan)
16:40 Diagnosis and treatment under financial
16:15 Discussion restrictions
Adebola Ogunbiyi (Nigeria)
16:30 Diagnostic Challenges, Work Up and
Mimickers 17:00 Treatment of Dermatophytosis caused by
Mark Davis (USA) Trichophyton indotineae - a rapidly emerging
concern on the Indian subcontinent
16:35
Diagnostic Challenges, Work Up and Shyam Verma (India)
Mimickers
Eran Shavit (Israel)
16:40 Q&A
16:55 Pg Management and Wound Care

Alex G. Ortega-Loayza (USA)


Valentina Dini (Italy)
17:05 Q&A
144
SCIENTIFIC PROGRAMME | THURSDAY 6th JULY 2023 | PAN PACIFIC
PAN PACIFIC | PACIFIC 1 | 08:00-09:20 15:00 Mohs Micrographic Surgery and Melanoma:
CO (CO FD01) ADVANCED DERMATOLOGICAL
where are we and where are we going?
SURGERY Natália Guimarães Ribeiro (Brazil)
CHAIR: 15:15 ail unit melanoma: how to biopsy and how

N
Gabriel Gontijo (Brazil) to treat?
CO-CHAIRS: Elizabeth Billingsley (USA)
Allison Vidimos (USA)
Angeline Yong (Singapore) 15:30 How to prevent and manage surgical scars?
Elimar Gomes (Brazil)
08:00 Dermatological surgery: what is new?
Reinaldo Tovo (Brazil) 15:45 Discussion
Angeline Yong (Singapore)
08:15 Preventing disasters in dermatological surgery
Allison Vidimos (USA) 15:50 Break
08:30 Mohs Micrographic Surgery: challenges and 16:00 Advanced and innovative suture techniques:
how to manage be updated
Mariana Meireles (Brazil) Leandra d’Orsi Metsavaht (Brazil)
08:45 Nail surgery tips 16:15 ultidisciplinary approach in advanced skin

M
Elizabeth Billingsley (USA) tumours
Selma Schuartz Cernea (Brazil)
09:00 My favourite flaps
Luiz Roberto Terzian (Brazil) 16:30 Combining treatments for best outcomes on
scars after Mohs Micrographic Surgery
09:15 Discussion Angeline Yong (Singapore)
Gabriel Gontijo (Brazil)
16:45 Flaps and grafts: when and why?
09:20 Break Christine Poblete-Lopez (USA)
09:30 Advanced Basal Cell Carcinoma: how to 17:00 H

idradenitis suppurativa/Acne inversa: case-
manage it? based clinical and surgical pearls
Gabriel Gontijo (Brazil) Rachel De Avila Coelho (Brazil)
09:45 Advanced Squamous Cell Carcinoma: how to 17:15 Discussion and Closure
manage it?
Roberto Tarle (Brazil)
10:00 Mohs Micrographic Surgery for Penile PAN PACIFIC | PACIFIC 2 | 08:00-09:20
Carcinoma CO (CO FD24) UPDATE IN DERMATOPATHOLOGY

Anthony Rossi (USA)
CHAIR:
10:15 Techniques for scalp surgery Victor Prieto (USA)
Angeline Yong (Singapore) CO-CHAIRS:
Tammie Ferringer (USA)
10:30 Hypertrophic scar and keloid: how to Joyce Lee (Singapore)
manage?
Gisele Viana de Oliveira (Brazil) 08:00 Update in Immunohistochemistry
Tammie Ferringer (USA)
10:45 Discussion
Allison Vidimos (USA) 08:27
Update in Molecular Pathology applied to
Dermatopathology
10:50 Break Aleodor Andea (USA)
14:30 Five tips to achieve better results and reduce 08:53 Dermoscopy and pathological correlation
complications in dermatological surgery Katrin Kerl (Germany)
Miguel Sánchez Viera (Spain)
09:20 Break
14:45 Rare non melanoma skin cancers: diagnosis,
management and treatment 09:30 Reactions to targeted therapies
Allison Vidimos (USA) Jonathan Curry (USA)
145
09:56 Update in Infectious Disease 08:52 Lichen planopilaris and frontal fibrosing alopecia
Francisco G. Bravo Puccio (Peru) Daniel Fernandes Melo (Brazil)
10:22 Update in Alopecia 09:02 Q&A

Joyce Lee (Singapore) Daniel Fernandes Melo (Brazil)
10:48 Break 09:05 Trichotillomania and traction alopecia

Daniel Asz-Sigall (Mexico)
14:30 Update in Mucosal Pathology
Angelica Selim (USA) 09:15 Q&A
Daniel Asz-Sigall (Mexico)
14:57 Update in Melanocytic lesions
Victor Prieto (USA) 09:18 Break
15:23 Update in Adnexal tumours 09:30 Discoid lupus erythematosus and central
Doina Ivan (USA) centrifugal cicatricial alopecia
Amy McMichael (USA)
15:50 Break
09:40 Q&A
16:00 Update in Hematolymphoid Malignancies Amy McMichael (USA)
Christina Mitteldorf (Germany)
09:43 D
issecting cellulitis and folliculitis decalvans
16:27 Update in Soft Tissue Tumours Sergio Vano Galvan (Spain)
Jaime Eduardo Calonje (UK)
09:53 Q&A
16:53 Update in Epithelial Tumours Sergio Vano Galvan (Spain)
Richard Carr (UK)
09:56 Inflammatory scalp disorders
Michela Starace (Italy)
PAN PACIFIC | PACIFIC 3 | 08:00-10:50 10:06 Q&A

CO (CO HD23) TRICHOSCOPY Michela Starace (Italy)
CHAIR: 10:09 Hair shaft abnormalities

Anna Waskiel-Burnat (Poland) Adriana Rakowska (Poland)
CO-CHAIRS:
Michela Starace (Italy) 10:19 Q&A
Daniel Fernandes Melo (Brazil) Adriana Rakowska (Poland)
08:00 Basic trichoscopy structures 10:22 T
richoscopy in systemic diseases and general
Matilde Iorizzo (Switzerland) medicine
Lidia Rudnicka (Poland)
08:10 Q&A
Matilde Iorizzo (Switzerland) 10:32 Q&A
08:13 Androgenetic alopecia
Bianca Maria Piraccini (Italy) 10:36 Let’s go practice – Trichoscopy cases
Asmahane Souissi (Tunisia)
08:23 Q&A
Bianca Maria Piraccini (Italy) 10:46 Q&A
Asmahane Souissi (Tunisia)
08:26 Alopecia areata
Anna Waskiel-Burnat (Poland)
08:36 Q&A
Anna Waskiel-Burnat (Poland)
08:39 Trichoscopy of tinea capitis and other

infectious diseases of the scalp
Hoda Moneib (Egypt)
08:49 Q&A
Hoda Moneib (Egypt)
146
CO (CO HD12) EVALUATION OF AND TESTING

FOR DRUG ALLERGY/HYPERSENSITIVITY
CHAIR:
Michael Ardern-Jones (UK)
CO-CHAIRS:
Annick Barbaud (France)
Min Moon Tang (Malaysia)
14:30 Welcome and introduction

14:35 he overview of drug hypersensitivity

T
evaluation
Yen Loo Lim (Singapore)
14:50 In vivo allergy work up in drug

hypersensitivity
15:15 In vitro tests in the evaluation of drug

hypersensitivity
15:40 Q&A
15:55 Break
16:05 P
enicillin delabeling by ‘direct challenge’ - a
global perspective
Philip Li (Hong Kong)
16:25 The work-up of different phenotypes of

NSAIDs hypersensitivity
Bernard Thong Yu Hor (Singapore)
16:45 Genetic background in drug hypersensitivity

Min Moon Tang (Malaysia)
17:05 Q&A
147
148
SCIENTIFIC SESSIONS
FRIDAY 7th JULY 2023
149
DAY AT A GLANCE | FRIDAY 7th JULY 2023
7:00-7:45 DL01E PSORIASIS IN SOUTH-EAST ASIA SUNTEC - 320
7:00-7:45 DL02C IMMUNODERMATOLOGY IN SOUTH-EAST ASIA SUNTEC - 323
7:00-7:45 DL03B COSMECEUTICALS AND DERMATOSURGERY SUNTEC - 327
7:00-7:45 DL04A HIGHLIGHTS OF INDONESIAN DERMATOLOGY (PERDOSKI) SUNTEC - 330
7:00-7:45 DL05C PATIENT SUPPORT GROUPS/ADVOCACY - ECZEMA SUPPORT GROUP SUNTEC - 331
7:00-7:45 DL06B IMAGING IN DERMATOLOGY SUNTEC - 332
ACNE, ROSACEA AND HIDRADENITIS SUPPURATIVA: NEW DEVELOPMENTS -

8:00-9:20 SY11A SUNTEC - HALL 606
ACNE I: PATHOPHYSIOLOGY AND CLINICAL MANIFESTATIONS
8:00-9:20 SY15A LYMPHOMAS - CUTANEOUS LYMPHOMAS I SUNTEC - SUMMIT 1
8:00-9:20 SY25A DERMOSCOPY II - DERMOSCOPY: FUTURE DEVELOPMENTS SUNTEC - SUMMIT 2
MUCOSAL AND CUTANEOUS REACTIONS TO DRUGS AND INFECTIONS -

8:00-9:20 SY32A SUNTEC - NICOLL 1
DRUG REACTIONS: INTERFERENCE WITH SIGNALING PATHWAYS
PRURITUS AND DYSAESTHESIAS - CLASSICAL AND NEW TREATMENTS FOR

PRURITUS
SKIN DISEASE IN GENERAL MEDICINE AND SKIN SIGNS OF INTERNAL

DISEASE - ENDOCRINE DISORDERS
AUTOINFLAMMATION, SAPHO, PAPA AND NEUTROPHILIC DERMATOSES -

8:00-9:20 SY22A SUNTEC - 308+309
COMPLEX AUTOINFLAMMATORY DISEASES
8:00-9:20 CN05 PIGMENTATION MELASMA IS PREVENTABLE SUNTEC - 310+311
COVID-RELATED DERMATOSES/VACCINE REACTIONS AND MUCOSAL

8:00-9:20 FC31 SUNTEC - 320
DISEASES/SKIN MANIFESTATIONS OF INTERNAL DISEASES
8:00-9:20 FC34 NAIL DISORDERS SUNTEC - 323
8:00-9:20 SY34A SURGICAL THERAPY II - ADVANCED RECONSTRUCTION I SUNTEC - 324+325+326
8:00-9:20 FC38 AUTOIMMUNE BLISTERING DISEASES SUNTEC - 327
8:00-9:20 SY08A VIRAL INFECTIONS - COMMON VIRUSES SUNTEC - 328+329
8:00-9:20 FC41 SEXUALLY TRANSMITTED INFECTIONS AND HIV SUNTEC - 330
8:00-9:20 RS09 DERMATOLOGICAL SURGERY/WOUND AND SKIN HEALING SUNTEC - 331
8:00-9:20 EF11 HIDRADENITIS SUPPURATIVA SUNTEC - 332
8:00-9:20 SY49A ALLERGOLOGY - DRUG ALLERGIES I SUNTEC - 334+335+336
150
8:00-9:20 COHD08 CONTACT DERMATITIS PAN PACIFIC - PACIFIC 1
8:00-9:20 COHD19 PAEDIATRIC DERMATOLOGY: GENODERMATOSES PAN PACIFIC - PACIFIC 2
8:00-9:20 COHD14 LASER I: PIGMENT AND ASSISTED HAIR REMOVAL LASERS PAN PACIFIC - PACIFIC 3

9:30-10:50 SY11B SUNTEC - HALL 606
ACNE II: CLINICAL MANIFESTATIONS II AND THERAPIES
9:30-10:50 SY15B LYMPHOMAS - CUTANEOUS LYMPHOMAS II SUNTEC - SUMMIT 1
9:30-10:50 SY25B DERMOSCOPY II - DERMOSCOPY: INFLAMMATORY DISEASES SUNTEC - SUMMIT 2

MUCOCUTANEOUS REACTIONS TO DRUGS AND INFECTIONS I
9:30-10:50 SY43B PRURITUS AND DYSAESTHESIAS - MECHANISMS OF PRURITUS SUNTEC - NICOLL 2

DISEASE - IMMUNE MEDIATED INFLAMMATORY DISEASES

9:30-10:50 SY22B SUNTEC - 308+309
HIDRADENITIS SUPPURATIVA
9:30-10:50 CN06 PSORIASIS: PHOTOTHERAPY IS OBSOLETE FOR THE TREATMENT OF PSORIASIS SUNTEC - 310+311
9:30-10:50 FC35 NOVEL MEDICAL THERAPIES SUNTEC - 323
9:30-10:50 SY34B SURGICAL THERAPY II - ADVANCED RECONSTRUCTION II SUNTEC - 324+325+326
9:30-10:50 SY08B VIRAL INFECTIONS - HERPES VIRUSES SUNTEC - 328+329
9:30-10:50 FC42 MELANOMA AND NAEVI SUNTEC - 330
9:30-10:50 RS10 SKIN CANCERS AND LYMPHOMA SUNTEC - 331
PATIENT ENGAGEMENT: HOW TO ESTABLISH AN EFFECTIVE PATIENT

9:30-10:50 EF12 SUNTEC - 332
SUPPORT GROUP
9:30-10:50 SY49B ALLERGOLOGY - DRUG ALLERGIES II SUNTEC - 334+335+336
9:30-10:50 COHD08 CONTACT DERMATITIS PAN PACIFIC - PACIFIC 1
9:30-10:50 COHD19 PAEDIATRIC DERMATOLOGY: GENODERMATOSES PAN PACIFIC - PACIFIC 2
9:30-10:50 COHD14 LASER I: PIGMENT AND ASSISTED HAIR REMOVAL LASERS PAN PACIFIC - PACIFIC 3
151

14:30-15:50 SY11C SUNTEC - HALL 606
DIFFERENTIAL DIAGNOSIS AND THERAPIES
14:30-15:50 SY15C LYMPHOMAS - CUTANEOUS LYMPHOMAS III SUNTEC - SUMMIT 1
14:30-15:50 SY25C DERMOSCOPY II - DERMOSCOPY: NON-PIGMENTED SKIN LESIONS SUNTEC - SUMMIT 2

MUCOCUTANEOUS REACTIONS TO DRUGS AND INFECTIONS II
14:30-15:50 SY43C PRURITUS AND DYSAESTHESIAS - PRURITUS IN DIFFERENT SKIN TYPES SUNTEC - NICOLL 2

DISEASE - METABOLIC DISORDERS

14:30-15:50 SY22C SUNTEC - 308+309
NEUTROPHILIC DERMATOSES
NEW DRUGS, NEW INDICATIONS, NEW SIDE EFFECTS - NEW THERAPIES IN

14:30-15:50 SY27A SUNTEC - 310+311
DERMATOLOGY ONCOLOGY I
DERMATOLOGY IN ELDERLY PATIENTS, PHLEBOLOGY AND VASCULAR

14:30-15:50 FC32 SUNTEC - 320
DISORDERS AND SKIN OF COLOUR
ONCOLOGY AND TRANSPLANT DERMATOLOGY (INCLUDING CADR TO

14:30-15:50 FC36 SUNTEC - 323
NOVEL CHEMO AND IMMUNE-THERAPIES)
14:30-15:50 SY34C SURGICAL THERAPY II - DERMATOSURGERY FOR SKIN TUMOURS I SUNTEC - 324+325+326
14:30-15:50 FC39 PRURITUS AND DYSAESTHESIAS SUNTEC - 327
14:30-15:50 SY08C VIRAL INFECTIONS - HPV SUNTEC - 328+329
14:30-15:50 FC43 PIGMENTARY DISORDERS 1 SUNTEC - 330
PHLEBOLOGY AND VASCULAR DISEASES - HAEMANGIOMAS AND VASCULAR

14:30-15:50 SY31A SUNTEC - 331
MALFORMATIONS
14:30-15:50 EF16 TELEDERMATOLOGY SUNTEC - 332
14:30-15:50 SY49C ALLERGOLOGY - SYSTEMIC SENSITIZATION SUNTEC - 334+335+336
14:30-15:50 COHD11 EPIDEMIOLOGICAL METHODS IN DERMATOLOGY RESEARCH PAN PACIFIC - PACIFIC 1
PAEDIATRIC DERMATOLOGY: VASCULAR ANOMALIES AND PRACTICAL

THERAPIES
14:30-15:50 COHD15 LASER II: SKIN REJUVENATION AND SCARS PAN PACIFIC - PACIFIC 3

16:00-17:20 SY11D SUNTEC - HALL 606
ROSACEA: PATHOPHYSIOLOGY AND MANIFESTATIONS
16:00-17:20 SY15D LYMPHOMAS - MYCOSIS FUNGOIDES AND SÉZARY SYNDROME SUNTEC - SUMMIT 1
152
16:00-17:20 SY25D DERMOSCOPY II - DERMOSCOPY: SPECIAL INDICATIONS SUNTEC - SUMMIT 2

STEVENS JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS
16:00-17:20 SY43D PRURITUS AND DYSAESTHESIAS - SPECIAL MANIFESTATIONS OF PRURITUS SUNTEC - NICOLL 2

DISEASE - PARANEOPLASTIC DISORDERS

16:00-17:20 SY22D SUNTEC - 308+309
PATHOPHYSIOLOGY AND CLINICAL SYNDROMES
NEW DRUGS, NEW INDICATIONS, NEW SIDE EFFECTS - NEW THERAPIES IN

16:00-17:20 SY27B SUNTEC - 310+311
DERMATOLOGY ONCOLOGY II
16:00-17:20 FC33 DERMATOLOGY IN WOMEN AND DURING PREGNANCY SUNTEC - 320
16:00-17:20 FC37 PHOTOBIOLOGY AND PHOTOTHERAPY SUNTEC - 323
16:00-17:20 SY34D SURGICAL THERAPY II - DERMATOSURGERY FOR SKIN TUMOURS II SUNTEC - 324+325+326
16:00-17:20 FC40 VASCULITIS AND VASCULOPATHIES SUNTEC - 327
16:00-17:20 SY08D VIRAL INFECTIONS - SPECIAL ASPECTS SUNTEC - 328+329
16:00-17:20 FC44 PIGMENTARY DISORDERS 2 SUNTEC - 330
16:00-17:20 SY31B PHLEBOLOGY AND VASCULAR DISEASES - PHLEBOLOGY SUNTEC - 331
16:00-17:20 EF14 CHALLENGING INFECTIOUS DISEASES IN DERMATOLOGY SUNTEC - 332
16:00-17:20 SY49D ALLERGOLOGY - TYPE I AND TYPE IV ALLERGIES SUNTEC - 334+335+336
16:00-17:20 COHD11 EPIDEMIOLOGICAL METHODS IN DERMATOLOGY RESEARCH PAN PACIFIC - PACIFIC 1
PAEDIATRIC DERMATOLOGY: VASCULAR ANOMALIES AND PRACTICAL

THERAPIES
16:00-17:20 COHD15 LASER II: SKIN REJUVENATION AND SCARS PAN PACIFIC - PACIFIC 3
153
SCIENTIFIC PROGRAMME | FRIDAY 7th JULY 2023 | SUNTEC
DL (DL01E) PSORIASIS IN SOUTH-EAST ASIA DL
(DL03B) COSMECEUTICALS AND
DERMATOSURGERY
CHAIRS:
Siew Eng Choon (Malaysia) CHAIRS:
Hazel Oon (Singapore) Por Ang (Singapore)
Maurice van Steensel (Singapore)
07:00 Psoriasis: Pearls from the Philippines
Bryan Edgar K. Guevara (Philippines) 07:00 Cosmaceuticals for Skin of Colour
Jeanine Downie (USA)
07:13 soriasis in Singapore: perspectives from the
P
07:15 Microbiome and Aging
little red dot Maurice van Steensel (Singapore)
Hazel Oon (Singapore)
07:30 Rejuvenating the Asian Face: Pearls and
07:26 W
hat’s in the pipelines for psoriasis in Pitfalls
Southeast Asia? Angeline Yong (Singapore)
07:39 Q&A
DL (DL04A) HIGHLIGHTS OF INDONESIAN

DERMATOLOGY (PERDOSKI)
DL (DL02C) IMMUNODERMATOLOGY IN SOUTH-
CHAIRS:
EAST ASIA Yulianto Listiawan (Indonesia)
Diah Puspitosari (Indonesia)
CHAIRS:
Agnes Heng (Malaysia) 07:00 Teledermatology in Indonesia: dermatologists
perception and future use after Covid-19
Jasmin Jamora (Philippines)
Srie Prihianti Gondokaryono (Indonesia)
07:00 Introduction 07:13 STI and HIV in Indonesia
Hanny Nilasari (Indonesia)
07:02 Case of Psoriasis and Autoimmune blistering
disease overlap 07:26 Neglected Tropical Diseases in Indonesia
Jyh Jong Tang (Malaysia) Prasetyadi Mawardi (Indonesia)
07:12 Introduction 07:39 Q&A
07:13 Epidermolysis Bullosa Acquisita: Challenges in

Diagnosis and Management in SEA context
Bryan Edgar K. Guevara (Philippines) DL (DL05C) PATIENT SUPPORT GROUPS/

ADVOCACY - ECZEMA SUPPORT GROUP
07:23 Introduction
CHAIRS:
07:24 Cutaneous vasculitis after COVID-19 vaccine Madeline Ho (Singapore)
Pawinee Rerknimitr (Thailand) Justinian Liew (Singapore)
07:34 Introduction 07:00 Atopic Dermatitis in Singapore: Unmet needs
Madeline Ho (Singapore)
07:35 COVID vaccination induced/aggravated
autoimmune blistering disease 07:05 Psychosocial support for patients and
Vanessa Lim Ziying (Singapore) caregivers - NSC experience in eczema
support group
Sophia Xu (Singapore)
07:20 Q&A
Sophia Xu (Singapore)
07:25 Living with atopic dermatitis - a patient’s

journey
Justinian Liew (Singapore)
07:40 Q&A
Justinian Liew (Singapore)
154
DL (DL06B) IMAGING IN DERMATOLOGY SY (SY32A) MUCOSAL AND CUTANEOUS

REACTIONS TO DRUGS AND INFECTIONS
CHAIRS: - DRUG REACTIONS: INTERFERENCE WITH
Sai Yee Chuah (Singapore) SIGNALING PATHWAYS
Hong Liang Tey (Singapore)
CHAIR:
07:00 Advances in skin cancer management using Emily Chu (USA)
non-invasive imaging CO-CHAIRS:
Sai Yee Chuah (Singapore) Saeko Nakajima (Japan)
David Rutkowski (UK)
07:25 Non-invasive imaging in idiopathic
hypohidrosis - uncovering pathogenesis and 08:00 EGFR inhibitors: Pathophysiology
curative treatments David Rutkowski (UK)
08:20 EGFR inhibitors: Clinical presentation and
treatment
Cuong Nguyen (USA)
SY (SY11A) ACNE, ROSACEA AND HIDRADENITIS
08:40 Cutaneous adverse reactions associated with
SUPPURATIVA: NEW DEVELOPMENTS - oncological therapies
ACNE I: PATHOPHYSIOLOGY AND CLINICAL Emily Chu (USA)
MANIFESTATIONS
09:00 Cutaneous adverse reactions caused by new
CHAIR: non-oncological drugs
Jenny Kim (USA) Saeko Nakajima (Japan)
CO-CHAIRS:
Ehiaghe Anaba (Nigeria)
Jerry Tan (Canada)
08:00 Pilosebaceous unit in health and in acne SY (SY43A) PRURITUS AND DYSAESTHESIAS

Sewon Kang (USA) - CLASSICAL AND NEW TREATMENTS FOR
PRURITUS
08:20 Acne and inflammation
Maurice van Steensel (Singapore) CHAIR:
Thomas Bieber (Germany)
08:40 Acne and microbiome CO-CHAIRS:
Brigitte Dréno (France) Hong Liang Tey (Singapore)
Manjunath Shenoy (India)
09:00 Age distribution and clinical manifestations
and subtypes in skin types I – III and ethnicity 08:00 Pruritus and psychodermatology
Jerry Tan (Canada) Manjunath Shenoy (India)
08:20 Anti-IL-31 in pruritus

Kenji Kabashima (Japan)
08:40 JAK inhibitors

09:00 Innovations in Improving Itch Management

155
SUNTEC | LEVEL 3 | NICOLL 3 | 08:00-09:20 SUNTEC | LEVEL 3 | SUMMIT 1 | 08:00 - 09:20
SY (SY54A) SKIN DISEASE IN GENERAL
SY (SY15A) LYMPHOMAS - CUTANEOUS

MEDICINE AND SKIN SIGNS OF INTERNAL LYMPHOMAS I
DISEASE - ENDOCRINE DISORDERS
CHAIR:
CHAIR: Youn Kim (USA)
Leonardo Marini (Italy) CO-CHAIRS:
CO-CHAIRS: Antonio Cozzio (Switzerland)
Akolawole Abayomi (Nigeria) Maarten Vermeer (Netherlands)
Karim Cherti (Morocco)
08:00 New concepts in the pathogenesis of
08:00 Introduction cutaneous lymphomas
Leonardo Marini (Italy) Maarten Vermeer (Netherlands)
08:05 Cutaneous manifestations of arterial and 08:15 Q&A

venous thrombosis and diabetes Maarten Vermeer (Netherlands)
08:20 Cutaneous CD30+ lymphoproliferative
08:20 Skin and Thyroid disorders (LPDs)
Amal Said (Morocco) Antonio Cozzio (Switzerland)
08:35 Abdominal fat - Food intolerances - Intestinal 08:35 Q&A

microbiota - Insulin resistance: Their complex Antonio Cozzio (Switzerland)
influence on skin function and disease
Leonardo Marini (Italy) 08:40 C
utaneous CD8+ acral T-cell and CD4+ small/
medium T-LPDs, evolution of entities
08:50 Skin signs of adrenal disorders Maxime Battistella (France)
08:55 Q&A
09:00 Premenopausal alterations of the skin and Maxime Battistella (France)
mucosae: a role for personalized hormone
replacement therapy? 09:00 Management of aggressive T-cell lymphomas
Ulrike Blume-Peytavi (Germany) Youn Kim (USA)
09:15 Q&A 09:15 Q&A

Youn Kim (USA)
SUNTEC | LEVEL 3 | SUMMIT 2 |08:00 - 09:20

SY (SY25A) DERMOSCOPY II - DERMOSCOPY:

FUTURE DEVELOPMENTS
CHAIR:
Giuseppe Argenziano (Italy)
CO-CHAIRS:
Alex Chamberlain (Australia)
Cliff Rosendahl (Australia)
08:00 Dermoscopy: past, present, future

Giuseppe Argenziano (Italy)
08:20 What is new on AI algorithms on skin cancer

diagnosis
Harald Kittler (Austria)
08:40 AI Systems: Replacing or supporting clinicians

Claire Felmingham (Australia)
09:00 What does AI-related research tell us about

swarm intelligence?
Cliff Rosendahl (Australia)
156
SUNTEC | LEVEL 3 | ROOM 308+309 | 08:00-09:20 SUNTEC - LEVEL 3 - ROOM 320 | 08:00-09:20
SY
(SY22A) AUTOINFLAMMATION, SAPHO, FC (FC31) COVID-RELATED DERMATOSES/

PAPA AND NEUTROPHILIC DERMATOSES - VACCINE REACTIONS AND MUCOSAL
COMPLEX AUTOINFLAMMATORY DISEASES DISEASES/SKIN MANIFESTATIONS OF
INTERNAL DISEASES
CHAIR:
Alexander A. Navarini (Switzerland) CO-CHAIRS:
CO-CHAIRS: Marius-Anton Ionescu (France)
Johann E. Gudjonsson (USA) Mark Kaufmann (USA)
08:00
Chronic graft vs. host disease aggravated by
08:00 Autoinflammatory diseases with skin and COVID-19 vaccination: a case series
bone involvement Mary Joyce Chiong (Philippines)
08:10 A
nalysis of antiviral and inflammatory
08:20 Autoinflammatory keratinization diseases components in the skin from autopsies of
Alexander A. Navarini (Switzerland) patients with COVID-19 infection
Tatiana Mina Yendo (Brazil)
08:40 The interferonopathies
Johann E. Gudjonsson (USA) 08:20 C
ombined grass pollen and ozone exposure
impairs skin physiology and mucosal
09:00 C
linical characteristics of Granulomatous functions: A prospective case-control study
Diseases and Blau Syndrome in patients with grass pollen allergy in an
Julie Schaffer (USA) exposure chamber

A cross-sectional study on cutaneous
CN (CN05) PIGMENTATION - MELASMA IS
reactivity to an inactivated SARS-CoV-2
PREVENTABLE vaccine (CoronaVac) and viral vector SARS-
CoV-2 vaccine (AZD1222) in adults: A single
CHAIR: institute experience
Margarita Larralde (Argentina) Patricia Rochelle Gan (Philippines)
DISCUSSANT AGAINST:
Rashmi Sarkar (India) 08:40
American Academy of Dermatology/
DISCUSSANT FOR: International League of Dermatologic
Tania Cestari (Brazil) Societies COVID-19 registry: Two and a Half
Years in Review
08:00 Introduction Alexis Strahan (USA)
Margarita Larralde (Argentina)
08:50
Skin manifestations in kidney transplant
08:10 Motion “For” patients
Tania Cestari (Brazil) Yasmine Mahdar (Morocco)
08:20 Motion “Against” 09:00

Covid-19 vaccination leading to leprosy
Rashmi Sarkar (India) reactions – a cross sectional study from a
tertiary care centre in Eastern India
08:30 Intra-Panel Discussion Samujjala Deb (India)
08:50 Q&A 09:10 Discussion

Tania Cestari (Brazil)

Rashmi Sarkar (India)
09:10 Results
157
SUNTEC | LEVEL 3 | ROOM 323 | 08:00 - 09:20 08:40 Advanced reconstruction periorbital defects
FC (FC34) NAIL DISORDERS Terrence Cronin (USA)
CO-CHAIRS: 09:00 Advanced reconstruction auricular defects

Fatih Goktay (Turkey) Gilberto Moreno (Australia)
Adam Rubin (USA)
08:00
Clinical and demographic characteristics of
retronychia: a description of 55 cases SUNTEC | LEVEL 3 | ROOM 327 | 08:00 - 09:20
Asli Bilgic Temel (Turkey) FC (FC38) AUTOIMMUNE BLISTERING DISEASES
08:10
Prospective single-arm study on the effect, CO-CHAIRS:
safety and tolerability of topical 0.1% Frédéric Caux (France)
tazarotene gel in onychomycosis treatment Jane Setterfield (UK)
Elena Campione (Italy)
08:00
The effect of systemic treatment on mortality
08:20
Clinical, onychoscopic and ultrasonographic in Bullous Pemphigoid: A Swedish Population
characteristics of glomus tumour of nail unit: a Cohort Study
cross sectional study Zeyad Albadri (Sweden)
Charvi Chanana (India)
08:10
Pemphigus scoring systems and their
08:30
Oral minoxidil on nail strength, growth, and validation studies – are they sufficient for
appearance: A cross-sectional analysis assessing new treatments?
Betty Nguyen (USA) Darby Boucher (Australia)
08:40
CO2 laser-assisted avulsion of the proximal 08:20
The optimum time to vaccinate rituximab
nail plate as a new treatment strategy in users: a lesson learnt from a retrospective
patients affected by retronychia cohort study of coronavirus disease 2019
Andrea Sechi (Italy) vaccine immunogenicity in immune-mediated
dermatologic disease patients
08:50
A new conservative treatment for Pincer Nail Sonphet Chirasuthat (Thailand)
from Japan
Chihiro Shiiya (Japan) 08:30
Quantifying Glucocorticoid Toxicity in
an International Cohort of Patients with
09:00
Molecular characterization of Autoimmune Blistering Diseases
onychomatricoma: spatial profiling reveals the Joslin Johal (Australia)
role of onychofibroblasts in onychomatricoma
pathogenesis 08:40
Direct immunofluorescence IgG autoantibody
Joonho Shim (Republic of Korea) subclass analysis as a tool to differentiate
between bullous systemic lupus erythematosus
09:10
Crisaborole for treatment of mild and and epidermolysis bullosa acquisita
moderate trachyonychia in children: A Touraj Khosravi-Hafshejani (Canada)
retrospective cohort study
Xue Wang (China) 08:50
Characterization of circulating autoantibodies
in autoimmune blistering diseases by
immunoblotting: A fifteen-year prospective
cohort study from Singapore
SUNTEC | LEVEL 3 | ROOM 324+325+326 | 08:00-09:20 Shi Yu Derek Lim (Singapore)
SY (SY34A) SURGICAL THERAPY II - ADVANCED

RECONSTRUCTION I 09:00
The risk of adverse events in US bullous
pemphigoid patients treated with oral
CHAIR: corticosteroids
Terrence Cronin (USA) Aaron Mangold (USA)
CO-CHAIRS:
Gilberto Moreno (Australia) 09:10
Dupilumab therapy in patients with bullous
Curt Treu (Brazil) pemphigoid: A real-world retrospective
monocentric study
08:00 Facial defects: how would you reconstruct Bin Peng (China)
and how did I reconstruct?
Megan Cronin (USA)
08:20 Advanced reconstruction nasal defects

George Hruza (USA)
158
SUNTEC | LEVEL 3 | ROOM 328+329 | 08:00-09:20 09:10 A
review of the literature on Efficacy and
SY (SY08A) VIRAL INFECTIONS - COMMON
Safety Profile of Tuberculin Protein Purified
VIRUSES Derivate Injection as Immunotherapy for the
Treatment of Cutaneous and Anogenital Warts
CHAIR: Yuni Yunitasari (Indonesia)
Julie Schaffer (USA)
CO-CHAIRS:
Michele Ramien (Canada)
Nilendu Sarma (India) SUNTEC | LEVEL 3 | ROOM 331 | 08:00-09:20
RS (RS09) DERMATOLOGICAL SURGERY/WOUND

08:00 Measles AND SKIN HEALING
Michele Ramien (Canada)
CO-CHAIRS:
08:20 Enteroviruses: hand, foot and mouth disease Melissa Tan Wee Ping (Singapore)
Nilendu Sarma (India) Kar Seng Lim (Singapore)
08:40 Rubella 08:00
Sézary syndrome: different erythroderma
Julie Schaffer (USA)
morphological features with proposal for a
clinical score system
09:00 Pox viruses
Gabriele Roccuzzo (Italy)
Jerome Coulombe (Canada)
08:15
A prospective study evaluating the efficacy
of intralesional sodium tetradecyl sulfate in
SUNTEC | LEVEL 3 | ROOM 330 | 08:00-09:20 pyogenic granuloma
FC (FC41) SEXUALLY TRANSMITTED INFECTIONS
Sinu Rose Mathachan (India)
AND HIV
08:30
Efficacy 10% of mangosteen pericarp extract
CO-CHAIRS: (MPE) cream in the treatment of uvb-induced
Vladimir Vasku (Czech Republic) erythema
Yeo Benson (Singapore) Ghea Anisah (Indonesia)
08:00
Geographic and demographic distribution 08:45
Polyamine metabolism is a critical regulator
of monkeypox cases across 10 countries: the of cell migration during cutaneous wound
AAD/ILDS monkeypox registry healing
Janet Lubov (USA) Meng Shi (Singapore)
08:10
Vitamin D levels in adults with HIV/AIDS 09:00
A comparative study on the efficacy of
Ludmila Nathaly Ribeiro Porfírio (Brazil) intralesional radiofrequency ablation
combined with triamcenalone versus
08:20
Bacterial load of C. trachomatis and features intralesional triamcenalone alone in treatment
of the clinical course of urogenital chlamydia of keloid
Ekaterina Negasheva (Russia) Sahil Kakkar (India)
08:30
Prevalence of alpha, beta and gamma Human 09:15 Discussion
Papillomaviruses in genital Lichen Sclerosus
Aldo Morrone (Italy)
08:40 M
onkeypox outbreak: differential clinical and
epidemiological findings in those patients
with STI coinfection in a prospective cross-
sectional study in Spain
Josep Riera-Monroig (Spain)
08:50
Out of pocket and catastrophic health
expenditure amongst patients of sexually
transmitted infections at a tertiary care
centre: A cross-sectional study
Swastika Suvirya (India)
09:00
First case series of monkeypox outbreak 2022
in Singapore: Disease features and differential
diagnosis
Mingjuan Tan (Singapore)
159
SUNTEC | LEVEL 3 | ROOM 332 | 08:00-09:20 SUNTEC | LEVEL 6 | HALL 606 | 09:30-10:50
EF (EF11) HIDRADENITIS SUPPURATIVA SY (SY11B) ACNE, ROSACEA AND HIDRADENITIS

SUPPURATIVA: NEW DEVELOPMENTS -
CHAIR: ACNE II: CLINICAL MANIFESTATIONS II AND
Gregor Jemec (Denmark) THERAPIES
CO-CHAIRS:
Perpetua Uchechi Ibekwe (Nigeria) CHAIR:
María Cecilia Rivitti Machado (Brazil) Linda Stein Gold (USA)
CO-CHAIRS:
08:00 How to build your confidence to treat HS Fahad Al Ajmi (Saudi Arabia)
Afsaneh Alavi (USA) Chong Chor Chang (Malaysia)
08:13 T
he Handicap of Hidradenitis, the Patient 09:30 Age distribution and clinical manifestations
Journey and subtypes in skin types IV – VI and
Gregor Jemec (Denmark) ethnicity
Ehiaghe Anaba (Nigeria)
08:27 Progress in procedures Surgery/procedures
Imaging 09:50 Topical therapies
Klemens Rappersberger (Austria) Linda Stein Gold (USA)
08:40 Mass Cytometry uncovers dysregulated 10:10 System therapies and isotretinoin
immune cells in the blood and skin of patients Chong Chor Chang (Malaysia)
with hidradenitis suppurativa
Qing-Sheng Mi (USA) 10:30 Acne fulminans: Diagnosis and treatment
Brigitte Dréno (France)
08:53 Global prevalence - the GHiSA study
Comorbidities
Dorra Bouazzi (Denmark)
09:06 Syndromic and overlaps HS (Dissecting SY (SY32B) MUCOSAL AND CUTANEOUS

folliculitis) REACTIONS TO DRUGS AND INFECTIONS -
María Cecilia Rivitti Machado (Brazil) MUCOCUTANEOUS REACTIONS TO DRUGS
AND INFECTIONS: I
CHAIR:
SUNTEC | LEVEL 3 | ROOM 334+335+336 | 08:00-09:20 Riichiro Abe (Japan)
SY (SY49A) ALLERGOLOGY - DRUG ALLERGIES I CO-CHAIRS:
Jean Kanitakis (France)
CHAIR: Robert Micheletti (USA)
CO-CHAIRS: 09:30 C
linical spectrum, classification,
Michael Ardern-Jones (UK) histopathology
Chun-Bing Chen (Chinese Taipei) Natsumi Hama (Japan)
08:00 What is new in drug allergy 09:50 Pathophysiology and skin resident T cells
Margarida Goncalo (Portugal) Youichi Ogawa (Japan)
08:20 M
echanisms of drug hypersensitivity: allergy 10:10 Genetic aspects of drug reactions
versus tolerance Haur Yueh Lee (Singapore)
10:30 Lichenoid reactions
08:40 Classification of cutaneous drug Jean Kanitakis (France)
manifestations
Chun-Bing Chen (Chinese Taipei)
09:00 Diagnostic work-up of drug hypersensitivity

160
SY (SY43B) PRURITUS AND DYSAESTHESIAS -
SY (SY15B) LYMPHOMAS - CUTANEOUS

MECHANISMS OF PRURITUS LYMPHOMAS II
CHAIR: CHAIR:
Gil Yosipovitch (USA) Joan Guitart (USA)
TBA Marie Beylot-Barry (France)
Martin Metz (Germany) Shang Ian Tee (Singapore)
09:30 Introduction 09:30 Pseudolymphomas and differential diagnosis

of CTCL
09:35 Dysaesthesias Shang Ian Tee (Singapore)
Martin Metz (Germany)
09:50 The value of clonality, morphology and
10:00 Itch as Type 2 inflammation phenotype in the diagnosis of CTCL
Gil Yosipovitch (USA) Joan Guitart (USA)
10:25 Microbiome and itch 10:10 New systemic therapies in cutaneous T-cell
Hazel Kim (Republic of Korea) lymphomas
Marie Beylot-Barry (France)
10:30
Impact and progress of patient advocacy in
SUNTEC | LEVEL 3 | NICOLL 3 | 09:30-10:50 cutaneous lymphomas
SY (SY54B) SKIN DISEASE IN GENERAL
Susan Thornton (USA)
MEDICINE AND SKIN SIGNS OF
INTERNAL DISEASE - IMMUNE MEDIATED
INFLAMMATORY DISEASES
CHAIR: SY (SY25B) DERMOSCOPY II - DERMOSCOPY:

Matthias Goebeler (Germany) INFLAMMATORY DISEASES
CO-CHAIRS:
Javier Consigli (Argentina) CHAIR:
Hua Liang Joel Lim (Singapore) Aimilios Lallas (Greece)
CO-CHAIRS:
09:30 Skin manifestations associated with Manas Chatterjee (India)
rheumatoid arthritis Masaru Tanaka (Japan)
Matthias Goebeler (Germany)
09:30 Dermoscopy of inflammatory and infectious
09:50 Granulomatous Types of Vasculitis diseases of the nail
Mar Llamas-Velasco (Spain) Michela Starace (Italy)
10:10 Skin diseases in inflammatory bowel disease 09:50 V

ariation of dermatoscopic features of
Hua Liang Joel Lim (Singapore) common inflammatory diseases according to
the skin colour
10:30 Skin diseases from immunosuppression Manas Chatterjee (India)
Javier Consigli (Argentina)
10:10 Dermoscopy for monitoring the treatment
response in common inflammatory
dermatoses
Yaei Togawa (Japan)
10:30 Connective tissue disorders: The value of

dermoscopy in diagnosis and management
Aimilios Lallas (Greece)
161
SY
(SY22B) AUTOINFLAMMATION, SAPHO, LB (LB04) LATE-BREAKER SESSION
PAPA AND NEUTROPHILIC DERMATOSES -
HIDRADENITIS SUPPURATIVA CO-CHAIRS:
Victoria Mar (Australia)
CHAIR: Alexander A. Navarini (Switzerland)
John Ingram (UK)
CO-CHAIRS: 09:30 R
isk of melanoma recurrence 7-years after
Illtefat Hamzavi (USA) diagnosis of a high-risk primary tumour
Christos C. Zouboulis (Germany) Lena von Schuckmann (Australia)
09:30 Hidradenitis suppurativa: The clinical spectrum 09:40 Personalized decision making in cutaneous
Kelsey van Straalen (Netherlands) squamous cell carcinoma: development and
validation of a clinico-pathological model to
09:50 Hidradenitis suppurativa: Pathophysiology predict absolute metastatic risk
Christos C. Zouboulis (Germany) Marlies Wakkee (Netherlands)
10:10 idradenitis suppurativa: Non-surgical

H 09:50 Statin use inhibits cutaneous T-cell lymphoma
therapies growth via inducing KLF2 upregulation
John Ingram (UK) FengJie Liu (China)
10:30 Hidradenitis suppurativa: Surgery 10:00 Chondroitin Sulfate Proteoglycan 4 as

Illtefat Hamzavi (USA) a Marker for Aggressive Squamous Cell
Carcinoma – an update
Kathryn Chen (Australia)
SUNTEC | LEVEL 3 | ROOM 310+311 | 09:30-10:50 10:10 The use of chatbots with artificial intelligence
CN (CN06) PSORIASIS - PHOTOTHERAPY
as an element of training doctors for
IS OBSOLETE FOR THE TREATMENT OF the diagnostics of tumors based on
PSORIASIS dermatoscopic images
Svetlana Bobko (Russia)
CHAIR:
Maria Ivonne Arellano Mendoza (Mexico) 10:20 Selectivity Profile of OR-101, a Next
DISCUSSANT AGAINST: Generation JAK3 Inhibitor, and Its
Elizabeth A. Buzney (USA) Effectiveness in Murine Models of Skin
DISCUSSANT FOR: Disorders
Pravit Asawanonda (Thailand) Seemal Desai (USA)
09:30 Introduction 10:30 A comparative Study of Therapeutic Efficacy

Maria Ivonne Arellano Mendoza (Mexico) between Microneedling with 5-Fluorouracil Vs
Topical Tacrolimus in localised stable Vitiligo
09:40 Motion “For” Monica Das (India)
10:50 Validation of a deep learning pipeline for
09:50 Motion “Against” intraoperative tumour detection for Mohs
Elizabeth A. Buzney (USA) micrographic surgery
David Lim (New Zealand)
10:20 Q&A


Elizabeth A. Buzney (USA)
10:40 Results
162
FC (FC35) NOVEL MEDICAL THERAPIES SY (SY34B) SURGICAL THERAPY II - ADVANCED

RECONSTRUCTION II
CO-CHAIRS:
Li He (China) CHAIR:
Thomas Luger (Germany) Divya Srivastava (USA)
CO-CHAIRS:
09:30 C
omparative study of intralesional BCG, Yasuhiro Nakamura (Japan)
intralesional MMR and intralesional Vitamin Almudena Nuño Gonzalez (Spain)
D in the management of multiple cutaneous
non-genital warts 09:30 Advanced reconstruction perioral defects
Gnaneshwar Angoori (India) Divya Srivastava (USA)
09:40
A double-blind randomized controlled study 09:50 Combination repairs
for comparing the efficacy and safety of Ricardo Vieira (Portugal)
topical Bacillus Calmette-Guerin vaccine
in management of verruca in paediatric 10:10 taged flaps and Reconstructions using
S
population cartilage
Rozy Badyal (India) Ian Maher (USA)
09:50
Mesenchymal Stem Cell and Its Derivates as 10:30 Scalp Reconstruction
Treatments for Atrophic Acne Scars, Is It the Yasuhiro Nakamura (Japan)
Answer? A Systematic Review
Levina Ameline Moelyono (Indonesia)
10:00 T
he Effect of Oral Supplementation SUNTEC | LEVEL 3 | ROOM 327 | 09:30-10:50
of Lactoferrin as an adjunct to Topical LB (LB05) LATE-BREAKER SESSION
Medications in the Severity of Psoriasis
Vulgaris: A Randomized, Double-Blind, CO-CHAIRS:
Placebo-Controlled Trial Thomas Bieber (Germany)
Kyla Janika Nerva (Philippines) Mark G. Lebwohl (USA)
10:10
African Leaf Extract (Vernonia amygdalina 09:30 Efficacy and adverse effects of oral JAK
Del.): Against The Instruction Zone of The inhibitors in the treatment of atopic
Bacteria Cutibacterium acnes dermatitis: An initial real-world experience in
Febrina Dewi Pratiwi (Indonesia) an Asian clinical cohort
Yik Weng Yew (Singapore)
10:20
Clinical Observation on 108 Cases of Multiple
Palmoplantar Warts in Paediatric patients 09:40 Ivarmacitinib, a highly selective JAK1 inhibitor
Treated with Xiancao Xiaoyou decoction for Moderate-to-Severe Atopic Dermatitis
Warm-hot Soaking (AD): 16-week results in China subpopulation
Qiufang Qian (China) from a Phase 3 pivotal study
Jianzhong Zhang (China)
10:30 Clinical-dermoscopic-histopathological
features in perforating calcific elastosis 09:50 R
ocatinlimab improves SCORAD and DLQI
and role of oral bisphosphonate as a novel in adults with moderate–severe atopic
therapeutic modality: a case series dermatitis and these effects were maintained
Abheek Sil (India) in the 20-week off-treatment period in a
double-blind randomized Phase 2b study
10:40 Discussion Emma Guttman-Yassky (USA)
10:00 Clinically relevant differences in the chemical

and structural mechanism of action of cAMP
hosphodiesterase-IV inhibitors used in
dermatologic therapy
Christopher Bunick (USA)
10:10 High Induction Dosing of Risankizumab in

Patients With Moderate-to-Severe Plaque
Psoriasis: Interim Results From the Phase 2
KNOCKOUT Study
Andrew Blauvelt (USA)
163
10:20 Maintenance of efficacy and safety with SUNTEC | LEVEL 3 | ROOM 330 | 09:30-10:50
lebrikizumab up to one year of treatment FC (FC42) MELANOMA AND NAEVI
in patients with moderate-to-severe
atopic dermatitis with or without topical CO-CHAIRS:
corticosteroids Aideen McInerney-Leo (Australia)
Emma Guttman-Yassky (USA) Alexander Roesch (Germany)
10:30 Long-term safety and efficacy of Oleogel-S10 in 09:30

Melanoma Risk Associated with BRCA1/BRCA2
dystrophic epidermolysis bullosa: Sub-analysis Mutations: A Meta-analysis
from the 24-month open-label EASE study John Durkin (USA)
Dedee Murrell (Australia)
09:40
The Role of NETs in coagulation and
10:40 An open label single arm study to assess metastasis for Malignant melanoma patients
the efficacy and safety of secukinumab in treated with immune-checkpoint inhibition
congenital ichthyosis Julian Koett (Germany)
Sanjeev Handa (India)
09:50 Looking beyond the Hutchinson’s sign:
a retrospective study of clinical factors
indicating the presence and invasiveness
SUNTEC | LEVEL 3 | ROOM 328+329 | 09:30-10:50 of nail unit melanoma in patients with
SY (SY08B) VIRAL INFECTIONS - HERPES
longitudinal melanonychia
VIRUSES Sang Gyun Lee (Republic of Korea)
CHAIR: 10:00 Immunotherapy for melanoma in Singapore:

Georg Stary (Austria) Experience from a tertiary academic medical
CO-CHAIRS: centre
Arjen Fokko Nikkels (Belgium) Agnes Lim (Singapore)
Daisuke Watanabe (Japan)
10:10
3D total body imaging reveals hereditary
09:30 Herpes zoster: Clinical manifestations and melanoma genes cause high naevus count:
treatment in immunecompromised patients CDKN2A, POT1, POLE and BAP1
Arjen Fokko Nikkels (Belgium) Ellie Maas (Australia)
09:50 H
erpes zoster: Risks in immune compromised 10:20 C
omparing fitness and essential genes in BRAF
patients mutant and wild type melanoma cell lines
Georg Stary (Austria) Anthony Mak (Canada)
10:10 Herpes zoster: Vaccines when and why 10:30 T

he mutational status is a useful indicator of
Daisuke Watanabe (Japan) cutaneous melanoma progression.
César Martins (Portugal)
10:30 G
enital herpes: Differential diagnosis and
treatment 10:40 E
xploration of primary and metastatic
Olivier Chosidow (France) melanoma tumor microenvironments
Manon Motte (France)
164
SUNTEC | LEVEL 3 | ROOM 331 | 09:30 - 10:50 10:07 How to fundraise for a support group
RS (RS10) SKIN CANCERS AND LYMPHOMA Gaylord Inena Wa Inena
(Democratic Republic of Congo)
CO-CHAIRS:
Kirsten Yeo (Singapore) 10:12
Common pitfalls of sustaining a support
Larisa Paramitha Wibawa (Indonesia) group/role of culture and religion in
facilitating patient groups
09:30
Primary cutaneous T cell lymphoma: findings Rachel Ogola (Kenya)
from a 10-year national retrospective study
Abirami Pararajasingam (UK) 10:17 Mentoring patient organisations globally
Josef de Guzman (Philippines)
09:45 A
case series of Squamous cell carcinoma in
situ presenting as monodactylous longitudinal 10:24 Q&A
melanonychia
Ahmed Hawas (USA)
10:00
Follow-up of Cutaneous Squamous SUNTEC | LEVEL 3 | ROOM 334+335+336 | 09:30-10:50
Cell Carcinoma (FOCS): A Multicentre SY (SY49B) ALLERGOLOGY - DRUG ALLERGIES II
Retrospective Cohort Study
Jorge Georgakopoulos (Canada) CHAIR:
Wen-Hung Chung (Chinese Taipei)
CO-CHAIRS:
10:15
Melanocytic features and pigmentation Rannakoe Joseph Lehloenya (South Africa)
markers expression in basal cell carcinoma Elizabeth Phillips (USA)
KI Martinez-Rosales (Mexico)
09:30 Medications and new causes of anticancer
10:30 Ex Vivo Confocal Microscopy Features immunotherapies related to severe cutaneous
of Common Benign Lesions That Mimics adverse reactions
Keratinocyte Skin Cancers Maja Mockenhaupt (Germany)
Banu Farabi (USA)
09:50 Diagnosis and new imaging assessment for
10:45 Discussion severe cutaneous adverse reactions
10:10 Immune mechanism and management of severe

cutaneous adverse reactions: what is new?
Wen-Hung Chung (Chinese Taipei)
EF (EF12) PATIENT ENGAGEMENT: HOW TO ESTABLISH

AN EFFECTIVE PATIENT SUPPORT GROUP 10:30 N
ew advances in the pharmacogenomics and
prevention for severe cutaneous adverse reactions
CHAIR: Elizabeth Phillips (USA)
Ritu Jain (Singapore)
CO-CHAIRS:
Richard Huggins (USA)
Rachel Ogola (Kenya) SUNTEC | LEVEL 6 | HALL 603+604 | 11:00-12:30
PL (PL04) PLENARY SESSION 4
09:30 Opening
Ritu Jain (Singapore) CHAIRS:
Jennifer Austin (Canada)
09:33 Introduction Lars French (Germany)
Richard Huggins (USA) Ricardo Romiti (Brazil)
09:35 Starting a support group – considerations and 11:00 urturing Curiosity and Breakthrough Thinking
N
best practices David Lane (UK)
Marc Yale (USA)
11:30 hat do common and rare have in common?
W
09:50 Role of Industry as partners in establishing Eli Sprecher (Israel)
Ken O’Reilly (UK)
11:50 Global Cooperation to elevate medical
09:55 Physician perspectives on starting and running a dermatology and grown care and treatments
support group/patients as partners in research capacity
Richard Huggins (USA) Marc Yale (USA)
10:02 H
ow to perform effective advocacy through a 12:10 Systemic Drug Therapy in Melanoma: An
support group: A Case Study Overview and the Increasing Role of the
Dermatologist
Ritu Jain (Singapore) Georgina Long (Australia)
165
SY (SY43C) PRURITUS AND DYSAESTHESIAS -

SUNTEC | LEVEL 6 | HALL 606 | 14:30-15:50 PRURITUS IN DIFFERENT SKIN TYPES
SY (SY11C) ACNE, ROSACEA AND HIDRADENITIS

SUPPURATIVA: NEW DEVELOPMENTS - CHAIR:
DIFFERENTIAL DIAGNOSIS AND THERAPIES Hong Liang Tey (Singapore)
CO-CHAIRS:
CHAIR: Yozo Ishiuji (Japan)
Martin Schaller (Germany) Francoise Anne Poot (France)
CO-CHAIRS:
Luiz Mauricio Costa Almeida (Brazil) 14:30 Pruritus and Quality of life in European
Andrea L. Zaenglein (USA) countries
Francoise Anne Poot (France)
14:30 Hormonal treatments for acne
Andrea L. Zaenglein (USA) 14:50 Pruritus in Asian skin
Yozo Ishiuji (Japan)
14:50 Differential diagnosis of rosacea
Luiz Mauricio Costa Almeida (Brazil) 15:10 Pruritus in the Tropics
15:10 Recommendations for rosacea management
Martin Schaller (Germany) 15:30 Pruritus in the Elderly
Thomas Luger (Germany)
15:30 Treatment development for acne and rosacea
Richard Gallo (USA)
SY (SY54C) SKIN DISEASE IN GENERAL

SY (SY32C) MUCOSAL AND CUTANEOUS MEDICINE AND SKIN SIGNS OF INTERNAL
DISEASE - METABOLIC DISORDERS
REACTIONS TO DRUGS AND INFECTIONS -
MUCOCUTANEOUS REACTIONS TO DRUGS CHAIR:
AND INFECTIONS II Jeffrey Callen (USA)
CO-CHAIRS:
CHAIR: Alejandro Barrera Godinez (Mexico)
Hideaki Watanabe (Japan) Nikolay Tsankov (Bulgaria)
CO-CHAIRS:
Wolfram Hoetzenecker (Austria) 14:30 Introduction
Kiran Motaparthi (USA) Jeffrey Callen (USA)
14:30 DRESS: Clinical presentation, causative 14:32 Obesity
agents, diagnosis, and treatment Gil Yosipovitch (USA)
Yoshiko Mizukawa (Japan)
14:47 Q&A
14:50 AGEP: Clinical presentation, causative agents, Gil Yosipovitch (USA)
diagnosis, and treatment
Kiran Motaparthi (USA) 14:51 Mucinoses
Franco Rongioletti (Italy)
15:10 Drugs as causes of mucocutaneous reactions
Akito Hasegawa (Japan) 15:06 Q&A
Franco Rongioletti (Italy)
15:30 Infection causes: Diagnosis, frequency and
treatment 15:10 Porphyrias
Wolfram Hoetzenecker (Austria) Robert Dawe (UK)
15:25 Q&A
Robert Dawe (UK)
15:29 Lipid disorders

Jeffrey Callen (USA)
15:44 Q&A
15:48 Summary
166
SY (SY15C) LYMPHOMAS - CUTANEOUS
SY
(SY22C) AUTOINFLAMMATION, SAPHO,
LYMPHOMAS III PAPA AND NEUTROPHILIC DERMATOSES -
NEUTROPHILIC DERMATOSES
CHAIR:
TBA CHAIR:
CO-CHAIRS: Angelo Valerio Marzano (Italy)
Evangelia Papadavid (Greece) CO-CHAIRS:
Jose Antonio Sanches Jr (Brazil) Alexander A. Navarini (Switzerland)
Yayoi Tada (Japan)
14:30 Cutaneous B-cell lymphomas: Clinical features
and diagnosis 14:30 Inborn Errors of Immunity Contribute to
TBA the Pathogenesis and Population Burden of
Hidradenitis Suppurativa
14:50 Cutaneous B-cell lymphomas: Therapy Lynn Petukhova (USA)
Jose Antonio Sanches Jr (Brazil)
14:45 The spectrum of neutrophilic dermatoses
15:10 BV-positive cutaneous lymphoproliferations:
E Angelo Valerio Marzano (Italy)
An emerging spectrum
Ulrike Wehkamp (Germany) 15:00 Discussion
15:30 Treatments under development 15:10 ystemic treatment of neutrophilic

S
Evangelia Papadavid (Greece) dermatoses: traditional and emerging options
Yayoi Tada (Japan)
15:20 Topical treatment and wound care in

SUNTEC | LEVEL 3 | SUMMIT 2 | 14:30-15:50 neutrophilic dermatoses
SY (SY25C) DERMOSCOPY II - DERMOSCOPY:
Afsaneh Alavi (USA)
NON-PIGMENTED SKIN LESIONS
15:30 Neutrophilic dermatoses: challenging cases
CHAIR: Alex G. Ortega-Loayza (USA)
Iris Zalaudek (Austria)
Moon Bum Kim (Republic of Korea)
Caterina Longo (Italy)
14:30 Actinic keratoses and squamous cell SUNTEC | LEVEL 3 | ROOM 310+311 | 14:30-15:50
carcinoma SY (SY27A) NEW DRUGS, NEW INDICATIONS,

Iris Zalaudek (Austria) NEW SIDE EFFECTS - NEW THERAPIES IN
DERMATOLOGY ONCOLOGY I
14:50 Basal cell carcinoma
Caterina Longo (Italy) CHAIR:
Ellen Kim (USA)
15:10 Skin tumours in skin of colour CO-CHAIRS:
Moon Bum Kim (Republic of Korea) Alexander Enk (Germany)
15:30 Dermoscopy on mucosa
Zoe Apalla (Greece) 14:30 Imatinib
Ellen Kim (USA)
14:50 Anti PD-1/PDL1

15:10 BRAF/MEK
Emily Chu (USA)
15:30 AntiCTLA4
Clara-Curiel Lewandrowski (USA)
167
FC (FC32) DERMATOLOGY IN ELDERLY
FC (FC36) ONCOLOGY AND TRANSPLANT

PATIENTS, PHLEBOLOGY AND VASCULAR DERMATOLOGY (INCLUDING CADR TO
DISORDERS AND SKIN OF COLOUR NOVEL CHEMO AND IMMUNE THERAPIES)
Ayesha Omolara Akinkugbe (Nigeria) Jean Lynn Bolognia (USA)
Elke Sattler (Germany) Stephan Grabbe (Germany)
14:30 Vascular Origins of Reticular Eruptions 14:30

Skin Diseases in the HIV Kidney Transplant
Kang Mina (Australia) Cohort compared to a Matched non-HIV
Kidney Transplant Cohort
14:40
Somatic mutation spectrum of a Chinese Fatima Ali (UK)
cohort of paediatrics with vascular
malformations 14:40
Spectrum and chronology of cutaneous
Bin Zhang (China) metastases in patients with internal
Malignancy: a prospective study
14:50
Melanoma in a large Hispanic cohort: the dire Pooja Arora (India)
consequences of health disparities
Jacqueline McKesey (USA) 14:50
In a multicenter study, the 40-gene expression
profile (40-GEP) test accurately stratifies
15:00 Choosing the red little pill in skin aging: a metastatic risk in an immunosuppressed
randomized, double-blind, placebo-controlled patient population with high-risk cutaneous
trial of coenzyme q10 in elderly women squamous cell carcinoma
Marcelle Nogueira (Brazil) Sarah Arron (USA)
15:10
Varied Clinical Morphologies seen in a patient 15:00 D
ermatologic immune related adverse event
of Angioimmunoblastic T Cell Lymphoma disease definitions: a multi-institutional Delphi
Sweta Rambhia (India) consensus project presented on behalf of the
oncodermatology working group
15:20 The importance of cultural humility and Steven Chen (USA)
cultural safety in dermatology
Neda So (Australia) 15:10
Follicular immune-related adverse events
caused by immune checkpoint inhibitors: clinical
15:30 D
ermatological presentations in paediatric characterization and treatment outcomes
patients with skin of colour Azael Freites-Martinez (Spain)
Michelle Rodrigues (Australia)
15:20
Treatment outcomes for advanced melanoma
15:40 Analyses of clinical characteristics, of unknown primary compared to melanoma
treatment effect and pathogenic mutations with known primary
in Chinese children with phakomatosis Oana-Diana Persa (Germany)
pigmentovascularis
Bin Zhang (China) 15:30
Response to treatment of cutaneous immune-
related adverse events following immune
checkpoint inhibitor therapy
Steven Chen (USA)
15:40 B
intrafusp alpha (a bifunctional fusion protein
targeting TGF-β and PD-L1) induced self-
resolving keratoacanthoma and squamous cell
carcinoma like cutaneous proliferations
Sweta Subhadarshani (USA)
168
SUNTEC | LEVEL 3 | ROOM 324+325+326 | 14:30-15:50 15:30
How to treat different severity stages of
SY (SY34C) SURGICAL THERAPY II -
chronic nodular prurigo in 2023: what are the
DERMATOSURGERY FOR SKIN TUMORS I guidelines recommending and what is new?
Sonja Ständer (Germany)
CHAIR:
Po-Han Patrick Huang (Chinese Taipei) 15:40
Serum Level of Protein-Bound Uraemic Toxins
CO-CHAIRS: in Patients with Chronic Kidney Disease-
Lukas Kofler (Germany) Associated Pruritus: Myths and Facts
Jorge Ocampo Candiani (Mexico) Karolina Świerczyńska-Mróz (Poland)
14:30 Treatment of BCC

Lukas Kofler (Germany)
14:50 Treatment of SCC SY (SY08C) VIRAL INFECTIONS - HPV
Shigeto Matsushita (Japan)
CHAIR:
15:10 Surgery for Lentigo Maligna and Melanoma Mario Poljak (Slovenia)
Jorge Ocampo Candiani (Mexico) CO-CHAIRS:
15:30 Surgery for acral melanoma Norazirah Nor (Malaysia)
Kee Yang Chung (Republic of Korea)
14:30 Treating extensive or complicated hand and
foot warts
Norazirah Nor (Malaysia)
SUNTEC | LEVEL 3 | ROOM 327 | 14:30 - 15:50
FC (FC39) PRURITUS AND DYSAESTHESIAS 14:45 Q&A
Norazirah Nor (Malaysia)
CO-CHAIRS:
Martin Metz (Germany) 14:50 HPV infection of the mucosa
Hazel Kim (Republic of Korea) Wan Syazween (Malaysia)
Comparison between Cowhage-induced Itch

14:30 15:05 Q&A
Scores and the Current Perception Threshold Wan Syazween (Malaysia)
(CPT): use as Diagnostic Tools for Sensitive
Skin Syndrome 15:10 Recent advances in management of genital
Wei Hua (China) warts
14:40 T
he Burden of Disease for Prurigo Nodularis
in a Commercially and Medicare-insured U.S. 15:25 Q&A
Population: A Retrospective, Case-control Study Niti Khunger (India)
Shawn Kwatra (USA)
15:30 R
ole of HPV vaccination in prevention of HPV-
14:50 P
ruritus and clinical severity measures among related benign and Malignant tumours
patients with prurigo nodularis Mario Poljak (Slovenia)
Shawn Kwatra (USA)
15:45 Q&A
15:00 In vivo imaging of patients with chronic pruritus Mario Poljak (Slovenia)
of unknown origin reveals partial sweat duct
obstruction with partial itch resolution upon
retinoid treatment
Shi Yu Derek Lim (Singapore)
15:10 Greater Reductions in Pruriginous Lesions With

Oral Nalbuphine Extended-Release Versus
Placebo in Patients With Prurigo Nodularis:
Results From a Phase 2b/3, Double-Blind,
Placebo-Controlled Study
15:20
Prurigo Activity and Severity Score:
Development of a tool to assess chronic prurigo
objectively in clinical trials and clinical practice
169
FC (FC43) PIGMENTARY DISORDERS 1 SY (SY31A) PHLEBOLOGY AND VASCULAR

DISEASES - HAEMANGIOMAS AND VASCULAR
CO-CHAIR: MALFORMATIONS
Van Thuong Nguyen (Vietnam)
Shital Poojary (India) CHAIR:
Lisa Weibel (Switzerland)
14:30 Role of Erythroid differentiation regulator 1 CO-CHAIRS:
(Erdr1) cytokine in vitiligo: a case-control study Martin Theiler-Pang (Switzerland)
Maha Fathy Elmasry (Egypt) Margarita Larralde (Argentina)
14:40 Noble function of Pantoea wallisii Lumiteria as 14:30 Infantile hemangiomas: challenges today and
an effective skin microbiome to regulate skin current therapy
pigmentation Martin Theiler-Pang (Switzerland)
Hyeyoun Kim (Republic of Korea)
14:45 Q&A
14:50 Is AHR at the centerstage of systemic Martin Theiler-Pang (Switzerland)
and topical responses of skin to pollution
exposure, leading to pigmentary disorder? 14:50 C
apillary malformations: when to worry and
Namita Misra (France) how to investigate
15:00 T
argeting the Elevated IFN-γ in Vitiligo Patients
15:05 Q&A
by Human Anti- IFN-γ Monoclonal Antibody
Hampers Direct Cytototoxicity in Melanocyte
Chau Yee Ng (Chinese Taipei)
15:10 ascular anomalies with overgrowth: a
V
dermatologist’s perspective and new
15:10 itiligo onset and exacerbation in patients
V
targeted therapies
receiving biologic therapy
Jensen Yeung (Canada)
15:25 Q&A
15:20 P
olyamines: novel regulators of human
epidermal pigmentation
Leah Vardy (Singapore)
15:30 L
ymphatic malformations clinical aspects and
how to manage
15:30 Investigating the role of resident memory T
TBA
cells in normal appearing skin of vitiligo
15:45 Q&A
15:40 P
ooled Analysis of Total Vitiligo Area Scoring TBA
Index Response Stability or Shifts Among
Adolescents With Vitiligo During 52 Weeks
of Ruxolitinib Cream Treatment in the TRuE-V
Phase 3 Studies
170
SUNTEC | LEVEL 3 | ROOM 332 | 14:30-15:50 15:30 Is eosinophilic esophagitis a variant of
EF (EF16) TELEDERMATOLOGY intestinal atopic dermatitis? Type 2 gene
overexpression and endotypes
CHAIR: Roberta Fachini Jardim Criado (Brazil)
Trilokraj Tejasvi (USA)
CO-CHAIRS:
Christophe Hsu (Switzerland)
Amanda Oakley (New Zealand) SUNTEC | LEVEL 6 | HALL 606 | 16:00-17:20
Alain Taieb (France) SY (SY11D) ACNE, ROSACEA AND HIDRADENITIS

SUPPURATIVA: NEW DEVELOPMENTS
14:30 Managing referrals by non-contact first - ROSACEA: PATHOPHYSIOLOGY AND
specialist assessment -- teledermatology in MANIFESTATIONS
the Waikato
Amanda Oakley (New Zealand) CHAIR:
Dae Hun Suh (Republic of Korea)
14:41 essons from SAF teledermatology projects in
L CO-CHAIRS:
Western Europe and Subsaharan Africa Giuseppe Micali (Italy)
Alain Taieb (France) Martin Steinhoff (Qatar)
14:52 3D total-body photography research

A 16:00 Rosacea: Pathophysiology and microbiome
network: the Australian experiment Martin Steinhoff (Qatar)
16:20 R
osacea: Clinical manifestations in skin types
15:03 Driving High-Value Digital Dermatology Care I – III
through AI-augmented and Data-driven Giuseppe Micali (Italy)
Approaches
Justin Ko (USA) 16:40 R
osacea: Clinical manifestations in skin types
IV – VI
15:14 Innovative Models of Care and Technology Michelle Rodrigues (Australia)
with Teledermatology
George Han (USA) 17:00 Rosacea: Atypical variants and
ophthalmorosacea
15:26 rioritizing Equity in the Development of AI for
P Martin Schaller (Germany)
Dermatology
Jenna Lester (USA)
15:38 Teledermatology at the first level of attention: SUNTEC | LEVEL 3 | NICOLL 1 | 16:00-17:20
a Holistic view SY (SY32D) MUCOSAL AND CUTANEOUS

Guadalupe Estrada-Chavez (Mexico) REACTIONS TO DRUGS AND INFECTIONS -
STEVENS JOHNSON SYNDROME AND TOXIC
EPIDERMAL NECROLYSIS
SUNTEC | LEVEL 3 | ROOM 334+335+336 | 14:30-15:50 CHAIR:
SY
(SY49C) ALLERGOLOGY - SYSTEMIC Sarah Walsh (UK)
SENSITIZATION CO-CHAIRS:
Maja Mockenhaupt (Germany)
CHAIR: Daniel Creamer (UK)
Paulo Criado (Brazil)
CO-CHAIRS: 16:00 EM to SJS/TEN: the clinical spectrum
Yuko Chinuki (Japan) Maja Mockenhaupt (Germany)
TBA
16:20 Developing Guidelines for SJS/TEN: where are
14:30 Percutaneous sensitization in atopic we now
dermatitis Daniel Creamer (UK)
TBA
16:40 Long-term complications of SJS/TEN:
14:50 Percutaneous sensitization in red meat anticipation and challenges
allergy: The alpha Gal syndrome Haur Yueh Lee (Singapore)
Tilo Biedermann (Germany)
17:00 S
ystemic therapy plus supportive care versus
15:10 ercutaneous sensitization in wheat allergy:
P supportive care alone: both sides of the
The new concept of wheat dependent argument
exercise induced anaphylaxis (WDEIA) Michael Ardern-Jones (UK)
Yuko Chinuki (Japan)
171
SY (SY43D) PRURITUS AND DYSAESTHESIAS -
SY (SY15D) LYMPHOMAS - MYCOSIS FUNGOIDES

SPECIAL MANIFESTATIONS OF PRURITUS AND SÉZARY SYNDROME
CHAIR: CHAIR:
Sonja Ständer (Germany) Jose Antonio Sanches Jr (Brazil)
Jesper Elberling (Denmark) Emmanuella Guenova (Switzerland)
Raj Chovatiya (USA) Maarten Vermeer (Netherlands)
16:00 Chronic pruritus of unknown origin 16:00 Mycosis fungoides: Clinical and histological
TBA spectrum (without: folliculotropic Mycosis
fungoides)
16:20 Itch and alloknesis – understanding and Maarten Vermeer (Netherlands)
diagnosis
Jesper Elberling (Denmark) 16:20
Folliculotropic Mycosis fungoides: new subsets
with prognostic and therapeutic impact
16:40 Chronic kidney disease-associated pruritus Adele De Masson (France)
Raj Chovatiya (USA)
16:40 Mycosis fungoides: Phototherapies and
17:00 What is new in pruritus & prurigo? topical therapies
Sonja Ständer (Germany) Jose Antonio Sanches Jr (Brazil)
17:00 S
ézary syndrome: Update on diagnostic
criteria and novel treatment modalities
SUNTEC | LEVEL 3 | NICOLL 3 | 16:00-17:20 Emanuella Guenova (Switzerland)
SY (SY54D) SKIN DISEASE IN GENERAL

MEDICINE AND SKIN SIGNS OF INTERNAL
DISEASE - PARANEOPLASTIC DISORDERS
CHAIR: SY (SY25D) DERMOSCOPY II - DERMOSCOPY:

Norbert Miklos Wikonkal (Hungary) SPECIAL INDICATIONS
CO-CHAIRS:
Mark Kirchhof (Canada) CHAIR:
Drew Kuraitis (USA)
CO-CHAIRS:
16:00 Amyloidosis
Bengu Nisa Akay (Turkey)
Eduardo David Poletti (Mexico)
Gabriel Salerni (Argentina)
16:20 Purpura
Mark Kirchhof (Canada) 16:00 Trichoscopy in mimickers of androgenetic
alopecia
16:40 Hypereosinophilic syndromes and the heart Lidia Rudnicka (Poland)
Drew Kuraitis (USA)
16:10 Difficult to diagnose melanomas
17:00 L
ongterm use of glucocorticosteroids and the Gabriel Salerni (Argentina)
immune suppressive drugs including hydroxy urea
Norbert Miklos Wikonkal (Hungary) 16:20 Adnexal tumours
Bengu Nisa Akay (Turkey)
16:30 Collision tumours

Raimonds Karls (Latvia)
16:40 Dermoscopy of scalp blood vessels

Martyna Slawinska (Poland)
16:48 Dermoscopy in hypopigmentation disorders

in dark skin phototypes
Nkechi Anne Enechukwu (Nigeria)
16:56 Q&A
172
SY
(SY22D) AUTOINFLAMMATION, SAPHO, FC (FC33) DERMATOLOGY IN WOMEN AND

PAPA AND NEUTROPHILIC DERMATOSES DURING PREGNANCY
- PATHOPHYSIOLOGY AND CLINICAL
SYNDROMES CO-CHAIRS:
Jo Lydie Lambert (Belgium)
CHAIR: Jenny Murase (USA)
Edward W. Cowen (USA)
CO-CHAIRS: 16:00 C
onfluent and reticulated papillomatosis as
Karoline Krause (Germany) a cutaneous marker of polycystic ovarian
Toshiyuki Yamamoto (Japan) syndrome - a case report
Thelma Bassey (Nigeria)
16:00 Autoinflammatory diseases: Pathogenesis
and classification (Mechanism of Disease, Not 16:10
Treatment outcomes in Extra-Mammary Vulval
Clinical Features) Paget’s Disease
Lars French (Germany) Jenny G Chung (UK)
16:20 Clinical spectrum of autoinflammatory 16:20

Successful Treatment of Impetigo
diseases with skin involvement (Overview of Herpetiformis with Low Dose Narrowband
Phenotypes) UVB and Medium Potency Topical
Toshiyuki Yamamoto (Japan) Corticosteroid
Puti Rineska Meilinda (Indonesia)
16:40 Neutrophilic autoinflammatory diseases
Edward W. Cowen (USA) 16:30 N
eed for extensive evaluation in patients with
excessive facial hair: a prospective, cross-
17:00 VEXAS syndrome sectional, observational study
Lauren Michelle Madigan (USA) Akash Mustari (India)
16:40
Clinical features of squamous cell carcinoma
in women with vulvar lichen sclerosus
SUNTEC | LEVEL 3 | ROOM 310+311 | 16:00-17:20 Olga Parygina (Russia)
SY (SY27B) NEW DRUGS, NEW INDICATIONS,

NEW SIDE EFFECTS - NEW THERAPIES IN 16:50
Management of triggering factors effect in
DERMATOLOGY ONCOLOGY II sensitive skin with a specific dermo-cosmetic
product
CHAIR: Helena Polena (France)
Martine Bagot (France)
CO-CHAIRS: 17:00
Disease burden and patient needs in
Bernhard Homey (Germany) women of childbearing age with psoriasis: a
Marius Rademaker (New Zealand) comparative study with same-age men and
older women using data from the German
16:00 Hedgehog signaling pathway inhibitors PsoBest registries
Markus Heppt (Germany) Rachel Sommer (Germany)
16:20 Antiangiogenic drugs 17:10

Treatment of pustular psoriasis with infliximab
Marius Rademaker (New Zealand) during pregnancy: case report and review of
the literature
16:40 EGF receptor inhibitors Yang Sun (Singapore)
Bernhard Homey (Germany)
17:00 S
mall molecules and antibodies for cutaneous
T cell lymphomas
Martine Bagot (France)
173
FC
(FC37) PHOTOBIOLOGY AND SY (SY34D) SURGICAL THERAPY II -

PHOTOTHERAPY DERMATOSURGERY FOR SKIN TUMORS II
CO-CHAIRS: CHAIR:
Giovanni Leone (Italy) Daniela Hartmann (Germany)
Harvey Lui (Canada) CO-CHAIRS:
Seong Jin Jo (Republic of Korea)
16:00
The Efficacy of Off-label Use of Omalizumab Ally-Khan Somani (USA)
for Solar Urticaria: a Systematic Review
Tashmeeta Ahad (Canada) 16:00 W
hen can imaging technologies help in
Dermatological Surgery?
16:10
The therapeutic and preventive effects Daniela Hartmann (Germany)
of light-emitting diodes (LED) irradiation
for post-inflammatory erythema and 16:13 Discussion
hyperpigmentation: a clinical observation Daniela Hartmann (Germany)
Yanjun Dan (China)
16:16 When can imaging technologies help before
16:20
Estimation of Tissue Level of Human Beta- and after dermatological surgery?
Defensin 1 (HBD-1) In Vitiligo Before and After Julia Welzel (Germany)
Narrowband Ultraviolet B Phototherapy
Maha Fathy Elmasry (Egypt) 16:29 Discussion
Julia Welzel (Germany)
16:30 U
rolithin A (UroA) protects human dermal
fibroblasts from UVA-induced photoaging 16:32 Controversies in Mohs Micrographic Surgery –
through NRF2 activation and mitophagy European view
Min Jiang (China) Severin Laeuchli (Switzerland)
16:40
Biological Responses of Skin Fibroblasts and 16:45 Discussion
Keratinocytes to Infrared Irradiation Severin Laeuchli (Switzerland)
Su Ji Kim (Republic of Korea)
16:48 Controversies in Mohs Micrographic Surgery –
16:50
Photodermatoses in Indian skin type: An US view
analysis of the cross-sectional study of Ravi S. Krishnan (USA)
disease spectrum; its association with Minimal
Erythema Dose for NBUVB and UVA 17:01 Discussion
Bijaylaxmi Sahoo (India) Ravi S. Krishnan (USA)
17:00 R
ecently-reported Worldwide Series of Chronic 17:04 M
ohs Micrographic Surgery: experiences from
Actinic Dermatitis : Various Postulations different continents (panel discussion)
concerning its Pathogeneses including Contact Ally-Khan SOmani (USA)
and Photocontact Allergies, Immunoregulatory
Events, and Climatic and Environmental Changes 17:17 Discussion
Ki-Ho Kim (Republic of Korea) Ally-Khan Somani (USA)
17:10
Characterization of skin microbiome in
patients with chronic actinic dermatitis
through 16S rRNA sequencing
Yunhua Tu (China)
174
SUNTEC | LEVEL 3 | ROOM 327 | 16:00-17:20 16:35 Q&A
FC (FC40) VASCULITIS AND VASCULOPATHIES Marimar Saez de Ocariz (Mexico)
CO-CHAIRS: 16:40 The climate crisis impact on the rise

Robert Micheletti (USA) of infectious skin diseases – what do
Erkan Alpsoy (Turkey) dermatologists need to know?
Sarah Coates (USA)
16:00
Polyarteritis nodosa reveals cerebral
toxoplasmosis in an immunocompromised 16:55 Q&A
patient Sarah Coates (USA)
Glenn Geidel (Germany)
17:00 COVID-19 & Skin
16:10
Ultrasound-guided biopsy improves the Roni Dodiuk-Gad (Israel)
diagnostic accuracy of cutaneous vasculitic
and vasculopathic conditions 17:15 Q&A
Mina Kang (Australia) Roni Dodiuk-Gad (Israel)
16:20
Clinico-pathological and Immunofluorescence
study of cutaneous small vasculitis: a hospital
based cross-sectional study SUNTEC | LEVEL 3 | ROOM 330 | 16:00-17:20
Ayushi Khandelwal (India) FC (FC44) PIGMENTARY DISORDERS 2
16:30 L
ivedo rash in Trousseau’s syndrome CO-CHAIRS:
secondary to non-Hodgkin’s lymphoma: a Cheng-Che Eric Lan (Chinese Taipei)
case report Prasad Kumarasinghe (Australia)
Wei Jian Russell Lim (Australia)
16:00 Impact of Postinflammatory
16:40 G
rowing Nodule in Patient with Sneddon Hyperpigmentation on Quality of Life in
Syndrome patients of Skin of Color
Vinod Nambudiri (USA) Ipshita Bhattacharya (India)
16:50
Intralesional sodium thiosulfate as adjuvant 16:10
Pigmentary disorders, prevalence, impact on
therapy in severe calciphylaxis quality of life, social stigmatization: results of
Denys Penaloza (Argentina) the first large international survey
17:00
Case series of Challenging Ulcerative lesions
Swagata Tambe (India) 16:20
Topical Tranexamic Acid with Microneedling In
Melasma: a Split Face Crossover Study
17:10
Extensive mucocutaneous lesions in Behçet Amrit Kaur (India)
disease associated with Aplastic Anemia and
other Autoimmune diseases 16:30 O
xidative stress in melasma: a case control study
Nohemi Trejo Chaviro (Mexico) Madhu Kuthial (India)
16:40
The role of ISG15-USP18 axis in oxidative
stress-induced vitiligo
SUNTEC | LEVEL 3 | ROOM 328+329 | 16:00-17:20 Il Joo Kwon (Republic of Korea)
SY (SY08D) VIRAL INFECTIONS - SPECIAL

ASPECTS 16:50 E
xosomes containing miRNAs from
keratinocytes under oxidative stress
CHAIR: contributes to melanocyte loss in vitiligo
Roni Dodiuk-Gad (Israel) Jingjing Ma (China)
CO-CHAIRS:
Marimar Saez de Ocariz (Mexico) 17:00
Thyroid dysfunction in paediatric vitiligo – is
Martin Theiler-Pang (Switzerland) there a need for new recommendations on
screening?
16:00 Gianotti-Crosti disease Shreya Poddar (India)
Martin Theiler-Pang (Switzerland)
17:10
CCN1: a potential clinical marker for melasma
16:15 Q&A or Riehl’s melanosis and may be decreased by
Martin Theiler-Pang (Switzerland) the administration of tranexamic acid
Zhongyi Xu (China)
16:20 A
utoimmune cutaneous disorders triggered
by virus
Marimar Saez de Ocariz (Mexico)
175
SUNTEC | LEVEL 3 | ROOM 331 | 16:00-17:20 17:02 Overcoming Antiviral and Antiparasitic
SY (SY31B) PHLEBOLOGY AND VASCULAR
Resistance and Pandemics
DISEASES - PHLEBOLOGY Stephen Tyring (USA)
CHAIR: 17:12 vercoming Antibiotic and Antifungal

O
Teresita Ferrariz (Philippines) Resistance and Conclusion
CO-CHAIRS: Angela Yen Moore (USA)
Mitchel P. Goldman (USA)
Elke Sattler (Germany)
16:00 Lipedema- Diagnosis, Therapy and Differential SUNTEC | LEVEL 3 | ROOM 334+335+336 | 16:00-17:20
Diagnosis SY (SY49D) ALLERGOLOGY - TYPE I AND TYPE IV

Martin Barsch (Austria)
ALLERGIES
16:15 Diagnosis of Venous Insufficiency
Teresita Ferrariz (Philippines) CHAIR:
Claudia Traidl-Hoffmann (Germany)
16:30 Improving Outcome on the Treatment of CO-CHAIRS:
Reticular and Leg Telangiectasia Carmen Cantisani (Italy)
Robert Weiss (USA) Kalman Watsky (USA)
16:45 Closure of the Great Saphenous Vein as a 16:00 Clinical manifestation of Type IV allergies
Treatment for Venous Reflux Kalman Watsky (USA)
Mitchel P. Goldman (USA)
16:20 Type I allergies - pathomechanisms driven by
17:00 Q&A intrinsic and extrinsic factors
Claudia Traidl-Hoffmann (Germany)
16:40 Mechanisms of type IV sensitization

SUNTEC | LEVEL 3 | ROOM 332 | 16:00-17:20 Gyohei Egawa (Japan)
EF (EF14) CHALLENGING INFECTIOUS DISEASES

IN DERMATOLOGY 17:00 Type I allergy diagnostics – from molecular
diagnostic to prediction of disease
CHAIR:
Manfred Kneilling (Germany)
CO-CHAIRS:
Resham Punit Bhojani (India)
16:00 Introduction on Challenging Infectious

Diseases in Dermatology
16:02 Leprosy before and after the pandemic: The

Sri Lankan Perspective
16:12 Challenging cases of Atypical Mycobacterial

infections
Abir Saraswat (India)
16:22 New World Leishmaniasis

Sinesio Talhari (Brazil)
16:32 Recalcitrant Dermatophytosis – An Indian

perspective
Resham Punit Bohjani (India)
16:42 Mycetoma, Chromoblastomycosis, and New

World Dermatophytes
Roberto Arenas (Mexico)
16:52 New World Dermatology Infections in Times

of Disturbance
Omar Lupi Da Rosa Santos (Brazil)
176
SCIENTIFIC PROGRAMME | FRIDAY 7th JULY 2023 | PAN PACIFIC
PAN PACIFIC | PACIFIC 1 | 08:00-10:50 10:10 Inflammatory disorders
CO (CO HD08) CONTACT DERMATITIS Maurice van Steensel (Singapore)
CHAIR: 10:30 New targeted therapies

Rosemary Nixon (Australia) Amy Paller (USA)
CO-CHAIR:
Shan Xian Lee (Singapore)
08:00 Patch test technique PAN PACIFIC | PACIFIC 3 | 08:00-10:50

Suzana Ljubojević (Croatia) CO (CO HD14) LASER I: PIGMENT AND ASSISTED

HAIR REMOVAL LASERS
08:40 Microhistory and microexamination
Lee Xian Shan (Singapore) CHAIR:
Leihong Flora Xiang (China)
09:00 Update on occupational contact dermatitis CO-CHAIRS:
Rosemary Nixon (Australia) Joyce Lim (Singapore)
Douglas Wu (USA)
09:20 Break
08:00 Treating pigmentary lesions with lasers
09:30 New/emerging contact allergens Joyce Lim (Singapore)
Pailin Puangpet (Thailand)
08:20 S
trategy for complex pigmentations
09:50 Implant allergy treatment in Asian patients
Suzanne Cheng (Singapore) Peter Peng (Chinese Taipei)
10:10 Role of patch testing in drug hypersensitivity 08:40 Photobiomodulation for pigmentary skin
Ying Xin Teo (UK) disorders
10:30 Instructive cases from Singapore
Chee Leok Goh (Singapore) 09:00 PicoToning: A Breakthrough Application of
Laser Dermatology
PAN PACIFIC | PACIFIC 2 | 08:00-10:50 09:20 Break

CO (CO HD19) PAEDIATRIC DERMATOLOGY:

GENODERMATOSES 09:30 The application of picosecond lasers for the
treatment of benign pigmentation in all skin
CHAIR: types
John McGrath (UK) Douglas Wu (USA)
CO-CHAIRS:
John Su (Australia) 09:50 Melasma: to laser or not to laser
Maurice van Steensel (Singapore) Alexandra Zhang (USA)
08:00 Skin development 10:10 Laser hair removal: what’s new and paradigm shift
Muzlifah Haniffa (UK) Po-Han Patrick Huang (Chinese Taipei)
08:20 Ectodermal dysplasias 10:30 Combining Wavelengths for Laser Hair

John McGrath (UK) Removal – Where Are We Now
Michael Gold (USA)
08:40 Mosaic skin disorders
09:00 Epidermolysis bullosa

Liat Samuelov (Israel)
09:20 Break
09:30 Skin tumour syndromes

Neil Rajan (UK)
09:50 Photosensitivity disorders

John Su (Australia)
177
PAN PACIFIC | PACIFIC 1 | 14:30-17:20 PAN PACIFIC | PACIFIC 2 | 14:30-17:20
CO (CO HD11) EPIDEMIOLOGICAL METHODS IN
CO (CO HD20) PAEDIATRIC DERMATOLOGY:

DERMATOLOGY RESEARCH VASCULAR ANOMALIES AND PRACTICAL
THERAPIES
CHAIR:
Laurence Le Cleach (France) CHAIR:
CO-CHAIRS: Christine Leaute-Labreze (France)
Christian Apfelbacher (Germany) CO-CHAIRS:
Yik Weng Yew (Singapore) Mark Koh (Singapore)
Julie Powell (Canada)
14:30 Introduction
14:30 ISSVA classification and updates on the
14:35 Study designs in Dermatology genetics of vascular anomalies
Yik Weng Yew (Singapore) Mark Koh (Singapore)
15:00 Q&A 14:50 V

ascular tumours of infancy
Yik Weng Yew (Singapore) Christine Leaute-labreze (France)
15:05 Measuring outcomes in Dermatology 15:10 anagement of complex infantile

M
Christian Apfelbacher (Germany) hemangiomas
Julie Powell (Canada)
15:30 Q&A
Christian Apfelbacher (Germany) 15:30 Update on the genetics of vascular anomalies
and vascular syndromes
15:35 Systematic reviews and meta-analyses in Pierre Vabres (France)
Dermatology
Laurence Le Cleach (France) 15:50 Break
16:00 Q&A 16:00 C

apillary malformations – diagnosis and
Laurence Le Cleach (France) management
16:05 Break
16:20 V
enous and lymphatic malformations – multi-
16:15 se of Health-insurance databases in
U disciplinary diagnosis and management
Dermatology research Olivia Boccara (France)
Emilie Sbidian (France)
16:40 Conclusion & Q&A
16:40 Q&A Christine Leaute-Labreze (France)
Emilie Sbidian (France)
16:45 Use of Registries in Dermatology research Julie Powell (Canada)
Zenas Yiu (UK)
17:10 Q&A Mark Koh (Singapore)
Zenas Yiu (UK)
17:15 Conclusion
178
CO (CO HD15) LASER II: SKIN REJUVENATION

AND SCARS
CHAIR:
Jill Waibel (USA)
CO-CHAIRS:
Michael Gold (USA)
TBA
14:30 Scar Overview

14:45 Treatment of Acne Scars

Greg Goodman (Australia)
15:00 Treatment of Surgical Scars

Ofir Artzi (Israel)
15:15 Burn Scars from Italy

Matteo Tretti Clementoni (Italy)
15:45 Break
15:30 Scar Adjunctive Therapies

Michael Gold (USA)
15:55 Treatment of Scars in Skin of Colour

Henry Hin Lee Chan (China)
16:10 Laser Assisted Drug Delivery for Scars

Jill Waibel (USA)
16:25 Future Scars Innovations

David Ozog (USA)
16:40 Chemical Peels for acne and scars

Peter Rullan (USA)
16:55 Q&A
179
180
SCIENTIFIC SESSIONS
SATURDAY 8th JULY 2023
181
DAY AT A GLANCE | SATURDAY 8th JULY 2023
7:00-7:45 DL01A ATOPIC ECZEMA IN SOUTH-EAST ASIA SUNTEC - 320
7:00-7:45 DL02A SEXUALLY TRANSMITTED INFECTIONS IN SOUTH-EAST ASIA SUNTEC - 323
7:00-7:45 DL03D IMMUNODERMATOLOGY IN SINGAPORE SUNTEC - 327
7:00-7:45 DL04E HIGHLIGHTS OF VIETNAM DERMATOLOGY SUNTEC - 330
PATIENT SUPPORT GROUPS/ADVOCACY - SINGAPORE RARE SKIN

7:00-7:45 DL05E SUNTEC - 331
CONDITION SOCIETY
7:00-7:45 DL06A GAMIFICATION IN DERMATOLOGY SUNTEC - 332
8:00-9:20 SY26A SKIN OPTICS - ARTIFICAL INTELLIGENCE DIAGNOSIS SUNTEC - SUMMIT 1
8:00-9:20 SY20A VASCULITIS AND VASCULOPATHIES - VASCULITIS SUNTEC - SUMMIT 2
ANTIBODIES AND SMALL MOLECULES (E.G. JAK INHIBITORS, IFN ANTAGONISTS)

- TARGETING CYTOKINES WITH SMALL MOLECULES AND ANTIBODIES
PHYSICAL THERAPIES: PDT, CRYOTHERAPY, PEELING, IONTOPHORESIS -

PHYSICAL THERAPIES I
8:00-9:20 SY56A MUCOSAL DISEASES - MUCOSAL DISEASES I SUNTEC - NICOLL 3
8:00-9:20 SY38A GERIATRIC DERMATOLOGY - DERMATOLOGY IN THE ELDERY I SUNTEC - 308+309
8:00-9:20 SY45A FUNGAL DISEASES: SYSTEMIC MYCOSES - DEEP FUNGAL INFECTIONS I SUNTEC - 310+311
8:00-9:20 FC45 CUTANEOUS ADVERSE DRUG REACTIONS SUNTEC - 320
8:00-9:20 FC47 EDUCATION IN DERMATOLOGY SUNTEC - 323
DERMATOLOGY IN WOMEN AND DURING PREGNANCY - AUTOIMMUNE

8:00-9:20 SY17A SUNTEC - 324+325+326
DISEASES AND NAIL DISORDERS
8:00-9:20 EF18 SOCIOECONOMIC CONSIDERATIONS IN DELIVERY OF DERMATOLOGICAL CARE SUNTEC - 327
DERMATOLOGICAL EMERGENCIES: DIAGNOSIS AND TREATMENT -

8:00-9:20 SY58A SUNTEC - 328+329
DERMATOLOGICAL EMERGENCIES I
8:00-9:20 FC50 PSYCHODERMATOLOGY SUNTEC - 330
8:00-9:20 RS11 HAIR AND PIGMENTARY DISORDERS/MISCELLANEOUS SUNTEC - 331
8:00-9:20 EF15 CURRENT UNMET NEEDS IN PAEDIATRIC DERMATOLOGY SUNTEC - 332
8:00-9:20 SY59A NEGLECTED TROPICAL DISEASES - IMPORTANT CAUSES OF NTD SUNTEC - 334+335+336
8:00-9:20 COHD16 LASER III: VASCULAR LESIONS PAN PACIFIC - PACIFIC 1
182
DAY AT A GLANCE | SATURDAY 8th JULY 2023
8:00-9:20 COHD17 MOTIVATIONAL INTERVIEWING IN SUPPORTIVE PATIENT CARE PAN PACIFIC - PACIFIC 2
CUTANEOUS T, B AND NK CELL LYMPHOMAS: DIAGNOSIS AND

DIFFERENTIAL DIAGNOSIS
9:30-10:50 SY26B SKIN OPTICS - SKIN IMAGING SUNTEC - SUMMIT 1
9:30-10:50 SY20B VASCULITIS AND VASCULOPATHIES - VASCULOPATHIES SUNTEC - SUMMIT 2
ANTIBODIES AND SMALL MOLECULES (E.G. JAK INHIBITORS, IFN

ANTAGONISTS) - TARGETING KEY MESSENGERS OF INFLAMMATION
PHYSICAL THERAPIES: PDT, CRYOTHERAPY, PEELING, IONTOPHORESIS -

PHYSICAL THERAPIES II
9:30-10:50 SY56B MUCOSAL DISEASES - MUCOSAL DISEASES II SUNTEC - NICOLL 3
9:30-10:50 SY38B GERIATRIC DERMATOLOGY - DERMATOLOGY IN THE ELDERY II SUNTEC - 308+309
9:30-10:50 SY45B FUNGAL DISEASES: SYSTEMIC MYCOSES - DEEP FUNGAL INFECTIONS II SUNTEC - 310+311
9:30-10:50 FC46 CUTANEOUS LYMPHOMAS SUNTEC - 320
9:30-10:50 FC48 ETHICS, QUALITY OF CARE, QUALITY OF LIFE AND COSTS IN DERMATOLOGY SUNTEC - 323
9:30-10:50 SY17B DERMATOLOGY IN WOMEN AND DURING PREGNANCY - PREGNANCY SUNTEC - 324+325+326
9:30-10:50 FC49 RHEUMATOLOGIC DERMATOLOGY SUNTEC - 327
DERMATOLOGICAL EMERGENCIES: DIAGNOSIS AND TREATMENT -

9:30-10:50 SY58B SUNTEC - 328+329
DERMATOLOGICAL EMERGENCIES II
9:30-10:50 FC51 DERMATOPATHOLOGY SUNTEC - 330
9:30-10:50 RS12 SEXUALLY TRANSMITTED INFECTIONS AND HIV SUNTEC - 331
9:30-10:50 EF17 VITILIGO SUNTEC - 332
NEGLECTED TROPICAL DISEASES - SPECTRUM OF NEGLECTED TROPICAL

9:30-10:50 SY59B SUNTEC - 334+335+336
DISEASES
9:30-10:50 COHD16 LASER III: VASCULAR LESIONS PAN PACIFIC - PACIFIC 1
9:30-10:50 COHD17 MOTIVATIONAL INTERVIEWING IN SUPPORTIVE PATIENT CARE PAN PACIFIC - PACIFIC 2
CUTANEOUS T, B AND NK CELL LYMPHOMAS: DIAGNOSIS AND DIFFERENTIAL PAN PACIFIC - PACIFIC 3
9:30-10:50 COHD10 DIAGNOSIS
11:00-12:30 PL05 PLENARY SESSION SUNTEC - SUMMIT 1
12:45-13:45 CLOSING CEREMONY SUNTEC - SUMMIT 1
183
SCIENTIFIC PROGRAMME | SATURDAY 8th JULY 2023 | SUNTEC
SUNTEC | LEVEL 3 | ROOM 320 | 07:00-07:45 07:28 Q&A
DL (DL01A) ATOPIC ECZEMA IN SOUTH-EAST ASIA
CHAIRS: 07:30 Comparing RA dose regime with low

Srie Prihianti Gondokaryono (Indonesia) dose regime of rituximab in treatment of
Mark Tang (Singapore) pemphigus - Singapore’s experience
07:00 The Asian Endotype and Phenotype in Atopic
Dermatitis - Does it Really Matter? 07:43 Q&A
Yik Weng Yew (Singapore) Yen Loo Lim (Singapore)
07:15 Primary Prevention and Long-Term Outcome

Modification in Atopic Dermatitis - Dream or
Reality? SUNTEC | LEVEL 3 | ROOM 330 | 07:00-07:45
Kin Fon Leong (Malaysia) DL (DL04E) HIGHLIGHTS OF VIETNAM

DERMATOLOGY
07:30 C
hallenges in Managing Atopic Dermatitis in
Asia - Off label and Off Guidelines Options CHAIRS:
Maria Victoria Dizon (Philippines) Tran Hau Khang (Vietnam)
Huu Sau Nguyen (Vietnam)
07:00 S
erum platelet-activating factor (PAF) levers in
SUNTEC | LEVEL 3 | ROOM 323 | 07:00 - 07:45 chronic inducible urticarial and its association
DL (DL02A) SEXUALLY TRANSMITTED with clinical severity and antihistamine
INFECTIONS IN SOUTH-EAST ASIA treatment responses
Thi Hong Hanh Ngo (Vietnam)
CHAIR:
Martin Chio (Singapore) 07:15 The additive effect of excimer lam on non-
Ariyatash Tungsanga (Thailand) cultured epidermal cell suspension for
treatment of vitiligo: A clinical trial in a
07:00 Current controversies in the management of Vietnamese patient
STIs Van Tam Hoang (Vietnam)
Iskander Azwa (Malaysia)
07:30 Correlation between total serum IGE levels
07:15 Optimising the use of social media in outreach and some characteristics in Vietamese
for STI messaging pemphygoid patients
Ariyatash Tungsanga (Thailand) Pham Ngan Giang (Vietnam)
07:30 Qualitative research to enhance STI clinical

services – worth the effort?
Rayner Tan (Singapore) SUNTEC | LEVEL 3 | ROOM 331 | 07:00-07:45
DL ( DL05E) PATIENT SUPPORT GROUPS/
ADVOCACY - SINGAPORE RARE SKIN
CONDITION SOCIETY
DL (DL03D) IMMUNODERMATOLOGY IN
CHAIRS:
SINGAPORE Mark Koh (Singapore)
Wendy Liong (Singapore)
CHAIRS:
Chia Chun Ang (Singapore) 07:00 Clinical landscape of rare skin conditions in
Baptiste Janela (Singapore) Singapore
Emily Gan Yiping (Singapore)
07:00 Understanding the immune mechanisms of
B cell for the development of better therapies 07:10 R
are Skin Conditions Society (RSCS)
in pemphigus Singapore – Who we are and what we do?
Baptiste Janela (Singapore) Shi Yun Chia (Singapore)
07:13 Q&A 07:20 C

aregiver sharing - Children with rare skin
Baptiste Janela (Singapore) conditions
Wendy Liong (Singapore)
07:15 Acquired hemophilia in association with
bullous pemphigoid- the Singapore experience 07:33 Caregiver sharing - Children with rare skin
Benjamin Ho (Singapore) conditions
Elaine Ng (Singapore)
184
DL (DL06A) GAMIFICATION IN DERMATOLOGY SY ( SY46A) PHYSICAL THERAPIES: PDT,
CRYOTHERAPY, PEELING, IONTOPHORESIS -
CHAIRS: PHYSICAL THERAPIES I
Chee Hian Tan (Singapore)
Chan Vicheth (Cambodia) CHAIR:
Paola Pasquali (Spain)
07:00 Introduction CO-CHAIRS:
Piergiacomo Calzavara Pinton (Italy)
07:05 G
amification and Game-based strategies for Nellie Konnikov (USA)
Dermatology Education
Daniel Strock (USA) 08:00 PDT treatment regimes
Piergiacomo Calzavara Pinton (Italy)
07:20 Gamification for Diagnosis of Pigmented Skin
Lesions 08:20 What should you know about electrosurgery
Harald Kittler (Austria) Nellie Konnikov (USA)
07:35 Q&A 08:40 Most common peelings in dermatology

Lucia Achell-Nava (Mexico)
09:00 The when and how of cryosurgery

SUNTEC | LEVEL 3 | NICOLL 1 | 08:00-09:20 Paola Pasquali (Spain)
SY (SY28A) ANTIBODIES AND SMALL

MOLECULES (E.G. JAK INHIBITORS, IFN
ANTAGONISTS) - TARGETING CYTOKINES
WITH SMALL MOLECULES AND ANTIBODIES SUNTEC | LEVEL 3 | NICOLL 3 | 08:00-09:20
SY (SY56A) MUCOSAL DISEASES - MUCOSAL

CHAIR: DISEASES I
Richard Langley (Canada)
CO-CHAIRS: CHAIR:
Maria Hordinsky (USA) Jane Setterfield (UK)
Manfred Kneilling (Germany) CO-CHAIRS:
Ginat Mirowski (USA)
08:00 Journey to JAKs and Tyk2 inhibitors Malgorzata Olszewska (Poland)
Maria Hordinsky (USA)
08:00 Aphthous ulceration
08:25 IL23 and IL17 antagonists: Modes of action and Catherine Hong Hsu Ling (Singapore)
possible implications for disease control and
remission 08:20 Recurrent erythema multiforme
Richard Langley (Canada) Malgorzata Olszewska (Poland)
08:50 Inhibiting tumour necrosis factor 08:40 Mucosal manifestations of autoimmune

Manfred Kneilling (Germany) blistering diseases
Jane Setterfield (UK)
09:15 Q&A
09:00 Xerostomia: What the Dermatologist Needs to
Know
Ginat Mirowski (USA)
185
SY ( SY26A) SKIN OPTICS - ARTIFICAL SY ( SY38A) GERIATRIC DERMATOLOGY -
INTELLIGENCE DIAGNOSIS DERMATOLOGY IN THE ELDERY I
CHAIR: CHAIR:
Elke Sattler (Germany) Mark Berneburg (Germany)
Jung Im Na (Republic of Korea)
Alexander Zink (Germany) Ulrike Blume-Peytavi (Germany)
Luciana Laura Tirelli (Argentina)
08:00 AI for general dermatological condition
Jung Im Na (Republic of Korea) 08:00 Mechanims of progeroid syndromes
Kevin Koschitzki (Germany)
08:20 AI for Skin Cancer
Veronica Rotemberg (USA) 08:20 Hair and nail disorders in mature patients
Ulrike Blume-Peytavi (Germany)
08:40 A
I to improve image acquisition and quality
Alexander Zink (Germany) 08:40 Pruritus in the eldery
Luciana Laura Tirelli (Argentina)
09:00 Incorporation of AI into dermatology practice
Harald Kittler (Austria) 09:00 Emergencies in the eldery
Mark Berneburg (Germany)

SY ( SY20A) VASCULITIS AND VASCULOPATHIES -
VASCULITIS SUNTEC | LEVEL 3 | ROOM 310+311 | 08:00 - 09:20
SY ( SY45A) FUNGAL DISEASES: SYSTEMIC
CHAIR: MYCOSES - DEEP FUNGAL INFECTIONS I
Cord Sunderkötter (Germany)
CO-CHAIRS: CHAIR:
Katrin Kofler (Germany) Roberto Arenas (Mexico)
David A. Wetter (USA) CO-CHAIRS:
Jayadev Betkerur (India)
08:00 Overview and nomenclature
Eder R. Juárez-Durán (Mexico)
Cord Sunderkötter (Germany)
08:12 Q&A 08:00 Tinea capitis in elderly

Cord Sunderkötter (Germany) Eder R. Juárez-Durán (Mexico)
08:15 Immune complex vasculitides: special 08:16 Deep Mycoses and HIV
reference to henoch schonlein vasculitis Jayadev Betkerur (India)
Katrin Kofler (Germany)
08:32 Cutaneous candidiasis
08:27 Q&A Roberto Arenas (Mexico)
Katrin Kofler (Germany)
08:48 Clinical analysis of deep mycoses - Pakistan
08:30 Small vessel vasculitides not caused by experience
immune-complexes
Robert Micheletti (USA) Wajeeha Saeed (Pakistan)
08:42 Q&A 09:04 Subcutaneous Mycoses - Diagnosis and

Robert Micheletti (USA) Treatment
Janaka Akarawita (Sri Lanka)
08:45 H
elpful Morphological Principles (with
Illustrative Examples) in the Differential
Diagnosis of Vasculitis
David A. Wetter (USA)
08:57 Q&A
David A. Wetter (USA)
09:00 Medium and large vessel vasculitis in

dermatology
Tamihiro Kawakami (Japan)
09:15 Q&A
Tamihiro Kawakami (Japan)
186
FC (FC45) CUTANEOUS ADVERSE DRUG
FC (FC47) EDUCATION IN DERMATOLOGY
REACTIONS
CO-CHAIRS:
CO-CHAIRS: Christopher Griffiths (UK)
Andrew Gibson (Australia) Brad Glick (USA)
Margarida Goncalo (Portugal)
08:00
Scoping Review of Medical Students’
08:00 In vivo and ex vivo have long-term durability Perceptions of the Field of Dermatology &
in antibiotic-associated drug reaction with Medical Student Dermatology Programming
eosinophilia and systemic symptoms Efficacy
Awad Andrew (Australia) Rewan Abdelwahab (USA)
08:10 U
ltraviolet Recall Phenomenon in a Patient 08:10 E
ducational video as a more effective
with Metastatic Rectal Cancer teaching method for dermatology patients
Toy Jeffrey (Canada) relative to traditional methods: a systematic
review and meta-analysis
Chinechelum Anyanechi (Nigeria)
08:20 Subcutaneous Glatiramer Acetate-Induced
Nicolau Syndrome – A Case Report 08:20 A
Comparison Between the United States and
Haroon Abdullah (Canada) Foreign Countries’ Dermatology Teaching
Methods: A Scoping Review and Proposal
08:30 Incidence of Severe Cutaneous Adverse Drug Claudia Hernandez (USA)
Reactions (SCAR) in Johor Bahru, Malaysia: a
population-based Study 08:30 D
ermatology Education in Medical Schools: a
Jin Huang Lim (Malaysia) Systematic Review
Patrick Ireland (Australia)
08:40 P
rogressive Bronchiolitis Obliterans in Toxic
Epidermal Necrolysis in an adult patient 08:40
Evaluating medical undergraduates’ and
associated with Mycoplasma pneumoniae dermatology faculty members’ perceptions
infection: a case report of the use of three-dimensional (3D) images
Ivan Arni Preclaro (Philippines) in the learning of dermatology in a time of
COVID-19 – a mixed methods study
08:50 D-penicillamine induced cutis laxa and Delwyn Zhi Jie Lim (Singapore)
review of acquired cutis laxa secondary to
medications 08:50
Moving Beyond the ABCDE’s: a Randomized
Daniel Cordas (Australia) Educational Intervention Study to Improve
Patient Recognition of Atypical Nevi
09:00 T
AP2 drives HLA-B*13:01-linked dapsone John Zic (USA)
hypersensitivity syndrome tolerance and
reactivity 09:00 D
ermaverse: traversing a new reality of
Lele Sun (China) dermatological education in metaverse
Anjali Ancy (India)
09:10 Discussion
09:10 E
xpanding the horizons for youth: results
from two community-based dermatology
education and mentorship programs
Jennifer Huang (USA)
187
SY ( SY17A) DERMATOLOGY IN WOMEN AND SY ( SY58A) DERMATOLOGICAL EMERGENCIES:
DURING PREGNANCY - AUTOIMMUNE DIAGNOSIS AND TREATMENT -
DISEASES AND NAIL DISORDERS DERMATOLOGICAL EMERGENCIES I
CHAIR: CHAIR:
Branka Marinovic (Croatia) Ken Tomecki (USA)
Dedee Murrell (Australia) Jose Dario Martinez (Mexico)
Smitha Prabhu (India) Veronika Slonkova (Czech Republic)
08:00 Nail health in women in skin of colour 08:00 Paediatric Derm Emergencies
Smitha Prabhu (India) Esteban Fernandez Faith (USA)
08:20 Nail involvement in AIBD 08:20 Travelers Maladies: Fever and Rash
Dedee Murrell (Australia) Jose Dario Martinez (Mexico)
08:40 Nail conditions as a sign of systemic disease 08:40 Climate Change: an Existential Threat
Branka Marinovic (Croatia) Mark Davis (USA)
09:00 Nail surgery in women 09:00 Exfoliative Dermatitis
Asli Bilgic Temel (Turkey) Brad Glick (USA)
EF ( EF18) SOCIOECONOMIC CONSIDERATIONS FC (FC50) PSYCHODERMATOLOGY
IN DELIVERY OF DERMATOLOGICAL CARE
CO-CHAIRS:
CHAIRS: Mohammad Jafferany (USA)
Matthias Augustin (Germany) Wei Liang Koh (Singapore)
Meera Al Adawi (UAE)
Mark Kaufmann (USA) 08:00
British Association of Dermatologists guidelines
Jose Luis Lopez-Estebaranz (Spain) for the management of adults with delusional
Rashmi Sarkar (India) infestation 2022 - Translating recommendations
Hosea Wilfred Waweru (Kenya) into everyday practice
Jianzhong Zhang (China) Alia Ahmed (UK)
08:00 Introduction 08:10
Experience of Setting up a
Psychodermatology Virtual Multidisciplinary
08:10 Socioeconomic considerations in delivery of Team Meeting
dermatological care in Europe Alia Ahmed (UK)
08:20
Using Motivational Interviewing to help
08:15 S
ocioeconomic considerations in delivery of people change health risk behavior
dermatological care in North Africa/Middle Rachael Hewitt (UK)
East
Meera Al Adawi (UAE) 08:30
Depression and Psoriasis: Pearls for diagnosis
and management
08:20 Socioeconomic considerations in delivery of Mohammad Jafferany (USA)
dermatological care in North America
Mark Kaufmann (USA)
08:40
Management of Psychocutaneous disorders: A
08:25 S
ocioeconomic considerations in delivery of practical approach for dermatologists
dermatological care in Latin America Mohammad Jafferany (USA)
08:50
Anxiety and depression in vitiligo patients
08:30 Socioeconomic considerations in delivery of Sumeet Pethe (India)
dermatological care in India
Rashmi Sarkar (India) 09:00 P
hase 1 of DEVISE Intervention: A Systematic
Review Identifying Predictors and Correlates
08:35 Socioeconomic considerations in delivery of Associated with Self-stigma in People with
dermatological care in Africa Visible Chronic Skin Diseases
Hosea Wilfred Waweru (Kenya) Rachel Sommer (Germany)
08:40 Socioeconomic considerations in delivery of 09:10 ackling self-stigmatisation in people with visible
T
dermatological care in China chronic skin diseases - a systematic review and
Jianzhong Zhang (China) development of an online intervention
Rachel Sommer (Germany)
08:45 Panel discussion
188
SUNTEC | LEVEL 3 | ROOM 331 | 08:00-09:20 08:34 Chronic GVHD in children in the era of HSCT
RS ( RS11) HAIR AND PIGMENTARY DISORDERS/ Arti Nanda (Kuwait)
MISCELLANEOUS
08:43 Late effects of the skin in childhood cancer
CO-CHAIRS: survivors
Etienne Wang (Singapore) Jennifer Huang (USA)
Koushik Lahiri (India)
08:52 Panel Discussion - New understanding of skin
08:00
Dermatologists and burnout: Myth or reality? disease after childhood cancer treatment &
Yasmine Mahdar (Morocco) immunosuppression
08:15
Dendritic cells as predictive markers of 08:57 Atopic dermatitis in Sub-Saharan Africa: many
responsiveness to hydroxychloroquine more challenges remain
treatment in primary cicatricial alopecia Kouadio Celestin Ahogo (Côte d’Ivoire)
patients
Agata Klosowicz (Poland) 09:06 New developments in the pathogenesis of acne
Andrea L. Zaenglein (USA)
08:30
Diagnosis and treatment strategies in Fibro-
adipose vascular anomaly 09:15 Panel Discussion - What’s new in inflammatory
Rui He (China) skin disease
08:45
Efficacy of low-dose oral minoxidil in the
management of anticancer therapy-induced
alopecia in patients with breast cancer: A SUNTEC | LEVEL 3 | ROOM 334+335+336 | 08:00-09:20
retrospective cohort study SY ( SY59A) NEGLECTED TROPICAL DISEASES -
Jeewoo Kang (South Korea) IMPORTANT CAUSES OF NTD
09:00
Comparison of the efficacy of intralesional CHAIR:
Tranexamic Acid versus placebo in the Andrew Steer (Australia)
treatment of hyperpigmented and CO-CHAIRS:
erythematous postoperative scars Romain Blaizot (Guyana)
Meriem Cherif (Tunisia) Rie Yotsu (Japan)
08:00 Perspectives and strategies in eliminating

Scabies
SUNTEC | LEVEL 3 | ROOM 332 | 08:00-09:20 Andrew Steer (Australia)
EF ( EF15) CURRENT UNMET NEEDS IN
PAEDIATRIC DERMATOLOGY 08:20 Onchocerciasis - Opportunities and
Challenges
Michele Murdoch (UK)
CHAIR:
Jeffrey Sugarman (USA)
08:40 Wound-causing Skin NTDs
CO-CHAIRS:
Rie Yotsu (Japan)
Kouadio Celestin Ahogo (Côte d’Ivoire)
Arti Nanda (Kuwait) 09:00 Leprosy in children
Romain Blaizot (Guyana)
08:00 Welcome and Introduction
08:02 Advances in the treatment of epidermal nevus

syndrome
Jeffrey Sugarman (USA)
08:11 Drug repurposing and genetic skin diseases: a

novel paradigm
Eli Sprecher (Israel)
08:20 Genomics Directed Management of Vascular

Lesions
08:29 Panel Discussion - Cutting edge

developments in using molecular medicine to
treat pediatric skin disease
189
SUNTEC | LEVEL 3 | NICOLL 1 | 09:30-10:50 SUNTEC | LEVEL 3 | NICOLL 3 | 09:30-10:50
SY ( SY28B) ANTIBODIES AND SMALL SY ( SY56B) MUCOSAL DISEASES - MUCOSAL
MOLECULES (E.G. JAK INHIBITORS, DISEASES II
IFN ANTAGONISTS) - TARGETING KEY
MESSENGERS OF INFLAMMATION CHAIR:
Paula Boggio (Argentina)
CHAIR: CO-CHAIRS:
Hervè Bachelez (France) Samia Djoudi (Algeria)
CO-CHAIRS: Bethanee Schlosser (USA)
Brett King (USA)
Thomas Kundig (Switzerland) 09:30 Mucosal lichen planus
Paula Boggio (Argentina)
09:30 IL-1
Thomas Kundig (Switzerland) 09:50 Mucosal lichen sclerosus
Aruna Venkatesan (USA)
09:46 IL-36
Hervè Bachelez (France) 10:10 Mucosal HPV
Bethanee Schlosser (USA)
10:02 IL-4 and IL-13
Tilo Biedermann (Germany) 10:30 Therapeutic Advances in Oral Leukoplakia/SCC
Katherine Bodiford (USA)
10:18 IL-17 and IL-23
10:34 Interferons SUNTEC | LEVEL 3 | SUMMIT 1 | 09:30-10:50

Brett King (USA) SY (SY26B) SKIN OPTICS - SKIN IMAGING
CHAIR:
Allan Halpern (USA)
SUNTEC | LEVEL 3 | NICOLL 2 | 09:30-10:50 CO-CHAIRS:
SY ( SY46B) PHYSICAL THERAPIES: PDT, Joachim Fluhr (Germany)
CRYOTHERAPY, PEELING, IONTOPHORESIS - Indermeet Kohli (USA)
PHYSICAL THERAPIES II
09:30 Innovative imaging techniques in clinical
CHAIR: dermatology: Basics and possibilities
Rolf-Markus Szeimies (Germany) Joachim Fluhr (Germany)
CO-CHAIRS:
Thomas Dirschka (Germany) 09:50 F
rom bench to bedside: RCM and OCT in
Yolanda Gilaberte (Spain) clinical trials
Indermeet Kohli (USA)
Rolf-Markus Szeimies (Germany) 10:10 dvances in total body imaging and artificial
A
intelligence
09:35 Oral preparations in primary prevention of Allan Halpern (USA)
skin cancer
10:30 Imaging Standards and resources for
09:50 Dermabrasion advancing skin imaging research
Thomas Dirschka (Germany) Veronica Rotemberg (USA)
10:05 Iontopheresis & Shave excision

Rolf-Markus Szeimies (Germany)
10:20 Laser-assisted drug delivery

Emily Cathrine Wenande (Denmark)
10:35 Discussion and Summary
190
SY ( SY20B) VASCULITIS AND VASCULOPATHIES - SY ( SY45B) FUNGAL DISEASES: SYSTEMIC
VASCULOPATHIES MYCOSES - DEEP FUNGAL INFECTIONS II
CHAIR: CHAIR:
Ko-Ron Chen (Japan) Regina Casz Schechtman (Brazil)
Erkan Alpsoy (Turkey) May El-Samahy (Egypt)
Soyun Cho (Republic of Korea) Fabio Francesconi (Brazil)
09:30 Morbus Behçet and Cogan Syndrome 09:30 Mycetoma: pathogenesis, clinical
Toshiyuki Yamamoto (Japan) manifestations and therapy
Stefano Veraldi (Italy)
09:50 Sarcoid vasculitis: a rare but important
vasculitis syndrome 09:50 Chromoblastomycosis and mucormycosis, an
Ko-Ron Chen (Japan) emerging disease
May El-Samahy (Egypt)
10:10 Cutaneous vasculitis: an algorithmic approach
to diagnosis 10:10 yperendemic sporotrichosis, zoonotic
H
Erkan Alpsoy (Turkey) transmission, typical and atypical
presentations, hypersensitivity reactions and
10:30 Livedoid vasculopathy: Diagnosis and increasing severity
management Regina Casz Schechtman (Brazil)
Soyun Cho (Republic of Korea)
10:30 Histoplasmosis. Evidence-based approaches
to epidemiology, diagnosis and management
Fabio Francesconi (Brazil)
SY ( SY38B) GERIATRIC DERMATOLOGY -
DERMATOLOGY IN THE ELDERY II
CHAIR:
Daisuke Tsuruta (Japan)
CO-CHAIRS:
Eleni Linos (USA)
09:30 Chronic itching in the elderly

TBA
09:50 W
hat Matters, Medication, Mentation, and
Mobility
Justin Endo (USA)
10:10 Pemphigus vulgaris as a disease in the elderly

10:30 Bullous pemphigoid as a disease in the elderly

Sho Hiroyasu (Japan)
191
Assessing patient-relevant benefits in the
FC (FC46) CUTANEOUS LYMPHOMAS topical treament of psoriasis – Development
of a new Patient Benefit Index questionnaire
CO-CHAIRS: (PBI-TOP)
Pietro Quaglino (Italy) Frenz Ohm (Germany)
Rudolf Stadler (UK)
10:11 evelopment and validation of the Patient-
D
09:30
Senescent dendritic cells drive ROS-induced Reported Impact of Dermatological Diseases
DNA damage in CTCL (PRIDD) measure
Agata Klosowicz (USA) Nirohshah Trialonis-Suthakharan (Germany)
09:40
Real-world study of the use of pegylated 10:20
Quality Of Life In Nepalese Patients With
interferon alfa-2a for treatment of primary Alopecia: A Cross-Sectional Observational
cutaneous T-cell lymphomas: an EORTC CLTF Study At A Tertiary Center
study Prajwal Pudasaini (Nepal)
Keila Mitsunaga (Spain)
10:30 T
he Medicolegal Risks of Skin Cancer: An
09:50 M
ycosis fungoides and Sézary syndrome: a Analysis of Canadian Closed Medicolegal Data
cohort of 727 cases in Brazil between 2016 and 2020
Denis Miyashiro (Brazil) Jeffrey Toy (Canada)
10:00
Folliculotropic Mycosis Fungoides: Current
10:40
Factor structure and Rasch measurement
Guidance and Experience from Clinical
theory analyses of the Patient-Reported Impact
Practice
of Dermatological Diseases (PRIDD) measure
Gabriele Roccuzzo (Italy)
Rachael Pattinson (UK)
10:10
The impact of pregnancy on the clinical course
of mycosis fungoides and Sézary syndrome
Betina Nogueira da Silva (Brazil)
10:20 D
iagnostic and Prognostic Value of Bone SY ( SY17B) DERMATOLOGY IN WOMEN AND
Marrow Biopsies in Cutaneous T-Cell Lymphoma DURING PREGNANCY - PREGNANCY
Sima Rozati (USA)
CHAIR:
10:30 TBA Jenny Murase (USA)
TBA CO-CHAIRS:
Tetsuya Honda (Japan)
10:40 Illness perception in patients with cutaneous Jo Lydie Lambert (Belgium)
T-cell lymphoma: A prospective 6-month study
Munjal Ananya (USA) 09:30 Physiologic features of the female skin during
pregnancy, including the management
of dysplastic nevi and melanoma in the
pregnant patient
SUNTEC | LEVEL 3 | ROOM 323 | 09:30-10:50 Linda Martin (Australia)
FC (FC48) ETHICS, QUALITY OF CARE, QUALITY

OF LIFE AND COSTS IN DERMATOLOGY 09:45 Management of psoriasis treatment during
pregnancy
CO-CHAIRS: Tetsuya Honda (Japan)
Tay Yong Kwang (Singapore)
Isabel Casas (Argentina) 10:00 Q&A
09:30
Assessing patient-relevant benefits with the 10:10 Management of atopic dermatitis treatment
new 10-item version of the Patient Benefit during pregnancy
Index (PBI-S-10) Jo Lydie Lambert (Belgium)
10:25 T
he safety and ethics of performing aesthetic
09:40
Psychosocial and Financial impacts of procedures in pregnancy
chemotherapy-induced alopecia on patients Jenny Murase (USA)
with cancer undergoing chemotherapy
Ahmed Jribi (Tunisia) 10:40 Q&A
09:50
Treatment improves sleep in patients with
inflammatory skin diseases
Caroline Mann (Germany)
192
SUNTEC | LEVEL 3 | ROOM 327 | 09:30-10:50 SUNTEC | LEVEL 3 | ROOM 328+329 | 09:30-10:50
FC (FC49) RHEUMATOLOGIC DERMATOLOGY SY ( SY58B) DERMATOLOGICAL EMERGENCIES:
DIAGNOSIS AND TREATMENT -
CO-CHAIRS: DERMATOLOGICAL EMERGENCIES II
Jorge Ocampo Candiani (Mexico)
Victoria Werth (USA) CHAIR:
Jean Bolognia (USA)
09:30
Characteristics of patients with psoriatic arthritis CO-CHAIRS:
in dermatologic and rheumatologic care: analysis Chia-Yu Chu (Chinese Taipei)
of two nationwide disease registries Lauren Michelle Madigan (USA)
Nesrine Ben-Anaya (Germany)
09:30 Toxic epidermal necrolysis and its mimickers
09:40 D
eciphering deeper than skin: a study of Chia-Yu Chu (Chinese Taipei)
cutaneous and systemic manifestations of
autoimmune connective tissue diseases in 09:50 Acute retiform purpura
skin of colour Caroline Nelson (USA)
Sahana P Raju (India)
10:10 Herpetic infections in immunocompromised
09:50
Circulating Neutrophil Extracellular Traps in hosts
Cutaneous Lupus Erythematosus Lauren Michelle Madigan (USA)
Martina Burlando (Italy)
10:30 Periorbital infections
10:00
Rnasel as a novel marker of immune-
Kin Fon Leong (Malaysia)
inflammatory mechanisms of skin thickness
in scleroderma and its relation to TGF-β1 and
pro/antioxidative balance
Hristina Kocic (Serbia)
10:10 Does alopecia have diagnostic weight in
FC (FC51) DERMATOPATHOLOGY
systemic lupus erythematosus?
Lauren Knight (South Africa) CO-CHAIRS:
Christian Sander (Germany)
10:20 R
eactive arthritis and skin revisited: A Anjela Galan (USA)
retrospective cross-sectional hospital-based
study from Eastern India 09:30
Assessment of the utility of Tzanck smear
Rashid Shahid (India) cytology in the diagnosis of acantholytic
dermatoses and viral infections.
10:30
Bimekizumab improves outcomes in disease Prachi Bodkhe (India)
core domains in patients with active psoriatic
arthritis and psoriasis: Pooled 16-week results 09:40
Dermoscopic-Histopathologic Correlation
from two phase 3 randomised, placebo- Between Pigmentation of Basal Cell Carcinoma
controlled studies and Tumor Aggressiveness in Asian Patients
Barbara Ink (USA) Jong Heon Park (Republic of Korea)
10:40 T
he risk of liver injury in Chinese patients 09:50
The availability of clinical images and
with psoriasis and rheumatoid arthritis is dermoscopy report may influence the
associated with metabolic risk factors rather histopathology diagnosis of melanocytic skin
than methotrexate and leflunomide lesions amongst expert dermatopathologists
Christina Sze Man Wong (Hong Kong) Belinda Lai (Australia)
10:00
Cutaneous melanocytic tumor with CRTC1-
TRIM11 Translocation: A Potential Pitfall
Rosalynn Nazarian (USA)
10:10 lear cell acanthoma arising in a patient with

C
epidermolytic ichthyosis
Yuying Qin (Japan)
10:20
Clinical, histopathologic,
immunohistochemical and electron
microscopic findings in monkeypox
Francisco José Rodríguez-Cuadrado (Spain)
193
10:30
Porocarcinoma, a clinicopathological study SUNTEC | LEVEL 3 | ROOM 332 | 09:30-10:50
emphasizing pitfall of histopathological EF (EF17) VITILIGO
diagnosis
Panitta Sitthinamsuwan (Thailand) CHAIR:
10:40
Development of inflammatory dermatosis CO-CHAIRS:
models using ex vivo human skin Prasad Kumarasinghe (Australia)
Ying Chen (USA) Michelle Rodrigues (Australia)
09:30 Introduction and Current understanding of

the pathogenesis of vitiligo
SUNTEC | LEVEL 3 | ROOM 331 | 09:30-10:50 Mauro Picardo (Italy)
RS (RS12) SEXUALLY TRANSMITTED INFECTIONS

AND HIV 09:42 News on immune pathogenesis
CO-CHAIRS:
Yogesh Marfatia (India) 09:49 C
ellular stress in vitiligo - causes and
Enbiale Yeshanehe Wendemagegn (Ethiopia) potential therapeutic intervention
Davinder Parsad (India)
09:30 Evaluation of the knowledge of general
practitioners in the region of Fez regarding 09:56 2 Mimickers of vitiligo that should not be missed
the management of sexually transmitted Michelle Rodrigues (Australia)
infections
Kautar Mejjati (Morocco) 10:03 V
alue of patient support groups in vitiligo
Prasad Kumarasinghe (Australia)
09:45 Evaluation of needling-induced
autoinoculation in the management of genital 10:10 Phototherapies in Vitiligo
warts Marwa Abdallah (Egypt)
N. G. Mohamed (Egypt)
10:17 Advances in NCECG/practice tips for
10:00 Clinico-microbiological profile of vulvovaginal maximizing success with NCEG
candidiasis and drug sensitivity pattern in Boon Kee Goh (Singapore)
women attending STD clinic in a tertiary care
centre in North India 10:24 The Algorithm for Vitiligo management: New
Aastha Choudhary (India) International Guidelines 2023
Nanja Van Geel (Belgium)
10:15 Trends of Neisseria gonorrhoeae Infections
and Molecular Epidemiology of Multidrug- 10:31 Current targeted and pipeline therapeutics
Resistance Isolates in Singapore for vitiligo
Woo Chiao Tay (Singapore) Amit G. Pandya (USA)
10:30 Clinico-etiological study and diagnosis of 10:38 Discussion

urethral discharge syndrome in men attending
sexually transmitted infections clinic in India
Sonal Nagia (India)
10:45 Discussion
194
SY ( SY59B) NEGLECTED TROPICAL DISEASES
- SPECTRUM OF NEGLECTED TROPICAL
DISEASES
CHAIR:
Paulo Cunha (Brazil)
CO-CHAIRS:
Jose Antonio Ruiz Postigo (Switzerland)
Vijay Zawar (India)
09:30 T
he Spectrum of Neglected Tropical Diseases
09:42 Scabies as a neglected tropical disease:

Global scenario and newer insights
Vijay Zawar (India)
09:54 Tools for capacity building: implementing the

WHO strategic framework on skin-related
neglected tropical diseases
Jose Antonio Ruiz Postigo (Switzerland)
10:06 When to Think of Leprosy

Paulo Cunha (Brazil)
10:18 Health and Migration

Aldo Morrone (Italy)
10:34 Discussion

PL (PL05) PLENARY SESSION 5
CHAIRS:
Martin Röcken (Germany)
Sabeera Begum (Malaysia)
Qianjin Lu (China)
11:00 hould we accept climate change and adapt

S
our lives to global warming?
Harald Lesch (Germany)
11:30 New Insights in Cutaneous T Cell Lymphoma:

Molecular subtyping and Beyond
Yang Wang (China)
11:50 An atlas of the developing human skin

Muzlifah Haniffa (UK)
12:10 Nail diseases: Are we doing enough?

Chander Grover (India)
SUNTEC | LEVEL 3 | SUMMIT 1 | 12:45 - 13:45

CC (CC) CLOSING CEREMONY
195
SCIENTIFIC PROGRAMME | SATURDAY 8th JULY 2023 | PAN PACIFIC
PAN PACIFIC | PACIFIC 1 | 08:00-10:50 08:54 How patient organisations/charities can
CO (CO HD16) LASER III: VASCULAR LESIONS contribute to patient care
Ritu Jain (Singapore)
CHAIR:
David Ozog (USA) 09:18 Break
CO-CHAIRS:
Madhuri Agarwal (India) 09:28 Using Motivational Interviewing to help
Philip Bekhor (Australia) people change health risk behaviour
Rachael Hewitt (UK)
08:00 Introduction and just a bit of science
David Ozog (USA) 09:52 Using Motivational Interviewing to help
shared decision making in the dermatology
08:21 V
enous malformations and beyond: Mastering consultation
the NdYAG Sandy McBride (UK)
Philip Bekhor (Australia)
10:16 Motivational Interviewing as part of
08:42 Vascular laser treatment in Asians: Port Wine managing people with complex co-morbid
stains, scars and beyond psychological/psychiatric problems
Henry Hin Lee Chan (China) Padma Mohamdas (UK)
09:03 S
trategies and settings for skin of colour 10:40 Conclusion/summary
success
09:24 Break PAN PACIFIC | PACIFIC 3 | 08:00-10:50

CO (CO HD10) CUTANEOUS T, B AND NK CELL

09:34 Paediatric pifalls: from port wine stains to LYMPHOMAS: DIAGNOSIS AND DIFFERENTIAL
hemangiomas DIAGNOSIS
Richard Rox Anderson (USA)
CHAIR:
09:35 Intradermal radiofrequency and other novel Maarten Vermeer (Netherlands)
treatments CO-CHAIRS:
Madhuri Agarwal (India)
Dong Youn Lee (Republic of Korea)
Suat Hoon Tan (Singapore)
10:16 Vascular scars: more than just erythema
Jill Waibel (USA)
08:00 Introduction to CL
Maarten Vermeer (Netherlands)
10:37 Q&A
08:15 Mycosis fungoides
Suat Hoon Tan (Singapore)
CO (CO HD17) MOTIVATIONAL INTERVIEWING IN
08:40 Erythroderma and SS
SUPPORTIVE PATIENT CARE Youn Kim (USA)
CHAIR: 08:55 CD30+ lymphoproliferations

Christine Bundy (UK) Antonio Cozzio (Switzerland)
CO-CHAIRS:
Jennifer Austin (Canada) 09:20 Break
Anthony Bewley (UK)
09:30 ATLL
08:00 Introduction Keiji Iwatsuki (Japan)
Jennifer Austin (Canada)
09:50 Cutaneous NK/T cell lymphoma
08:10 Introduction Woo Jin Lee (Republic of Korea)
Anthony Bewley (UK)
10:15 CBCL
08:20 Introduction Nicola Pimpinelli (Italy)
Christine Bundy (UK)
10:40 Q&A
08:30 Using Motivational Interviewing to help
patient self-management
Rachael Pattinson (UK)
196
WCD2023 POSTER ROUND SESSIONS
197
WCD2023 POSTER ROUND SESSIONS
MEDICAL DERMATOLOGY
4th July 2023 | SUNTEC | Level 6 | Hall 602 | 14:30:00-15:30:00
NEOPLASTIC DERMATOLOGY
DERMATOLOGICAL SURGERY & COSMETOLOGY

SMORGASBORD
These sessions aim to showcase the top posters selected from over 4,300 submissions for their outstanding scientific
and educational value. A total of 25 “featured” ePosters for the 4 sessions (8 feature platinum, 17 feature posters per
session) will be on display in the ePosters Area during the slated hour from 4th July to 7th July.
Each Platinum posters presenter will have eight-minute window during this hour to present the first two minutes
the findings/results of his work and leave the remaining six minutes for questions from the invited moderators and
attending delegates.
ALL posters will be available for viewing within the ePosters Area during operating hours throughout the entire
conference. When the posters are not on special display as a “Feature Platinum posters and Feature Posters”, they
will still be available for viewing at the kiosk workstations.
198
SPONSORED SESSIONS
4th - 7th JULY 2023
199
12:45 - 14:15 | LS01 | SUNTEC HALL 606

Small Molecules: A New Frontier of Modern Dermatology.
12:45 - 14:15 | LS02 | SUNTEC SUMMIT 2

Small Molecules at the Forefront of Modern Dermatology
12:45 - 14:15 | LS03 | SUNTEC NICOLL 3

Improving our knowledge on hormones impact on skin and Scalp Health: New insights from an
epidemiological worldwide study
12:45 - 14:15 | LS04 | SUNTEC 324+325+326

New perspectives on personalized management of acne and acne sequelae
12:45 - 14:15 | LS05 | SUNTEC 334+335+336

Ecobiology: Dialogue between skin barrier and its ecosystem
17:30 - 18:45 | SS01 | SUNTEC NICOLL 1

Practical Perspective on PsO Patient Plights
17:30 - 18:45 | SS02 | SUNTEC NICOLL 2

Tips and tricks on managing Chronic Urticaria
17:30 - 18:45 | SS03 | SUNTEC NICOLL 3

Patients as partners in dermatology: How to drive better patient engagement through a holistic
approach. Artificial intelligency and R&D innovation as key success factors
17:30 - 18:45 | SS04 | SUNTEC 308+309

Advances in Skin Health
17:30 - 18:45 | SS05 | SUNTEC 310+311

THIAMIDOL: Innovation in hyperpigmentation/therapeutic benefits
17:30 - 18:45 | SS06 | SUNTEC 324+325+326

Pond’s skin rebalance new technology and Insight sharing
17:30 - 18:45 | SS07 | SUNTEC 328+329

Pso/PsA – Through the leukin glass: IL-23 inhibition in psoriatic disease
17:30 - 18:30 | ME02 | SUNTEC 330

MEET THE EXPERT: The Dr.Ci:Labo Clinic Method: From Collagen Health to The Art of
Omotenashi Care
17:30 - 18:45 | SS08 | SUNTEC 334+335+336

New Insights in Skin Biology Across Multiple Ethnicities
200
12:45 - 14:15 | LS06 | SUNTEC HALL 606

The Great Debate: Is it Time to swITCH Your Approach in AD?
12:45 - 14:15 | LS07 | SUNTEC SUMMIT 2

The Biologic Revolution in Atopic Dermatitis: recent advances and future potential
12:45 - 14:15 | LS08 | SUNTEC NICOLL 1

Long-Term Disease Control in Moderate to Severe Atopic Dermatitis: Exploring the Potential
of Biologic Therapies Supported by an educational
grant provided by Lilly and Almirall
12:45 - 14:15 | LS09 | SUNTEC NICOLL 3

Pigmentary Disorders: not a fatality! From prevention to corrective innovative solutions to
improve patients’ quality of life
12:45 - 14:15 | LS10 | SUNTEC 324+325+326

Diversity and inclusion in dermatology: a worldwide profiling of sensitive skin Utilizzati 2 Colori Pantone:
P. 424 C P. 296 C
17:30 - 18:45 | SS09 | SUNTEC SUMMIT 2
Derm update! New insights in the management of inflammatory skin diseases
17:30 - 18:45 | SS10 | SUNTEC NICOLL 2

Patient Centricity in Skin Treatments – Global meeting of Experts in Dermatology
17:30 - 18:45 | SS11 | SUNTEC NICOLL 3

Scratching the surface of TYK2 in psoriasis: From TYK2 inhibition to long-term clinical outcomes
17:30 - 18:45 | SS12 | SUNTEC 308+309

Navigating the management of GPP
17:30 - 18:45 | SS13 | SUNTEC 310+311

Maximising dermal outcomes with energy based technologies
17:30 - 18:30 | ME03 | SUNTEC 320

MEET THE EXPERT: Preventative Scalp Care: A New Paradigm for Healthy Hair and a Truly
Healthy Scalp
17:30 - 18:30 | ME01 | SUNTEC 323

MEET THE EXPERT: A game-changing discovery for skin longevity
17:30 - 18:45 | SS18 | SUNTEC 324+325+326

Hybrid Cooperative Complexes (HCCs): the latest frontier of hyaluronic acid-based
treatment for face and body skin restoration
17:30 - 18:30 | ME04 | SUNTEC 327

MEET THE EXPERT: New non-laser technology for the treatment of pigmented and vascular lesions
17:30 - 18:45 | SS15 | SUNTEC 328+329

Target the change: minimal disease activity in atopic dermatitis
17:30 - 18:30 | ME05 | SUNTEC 330

MEET THE EXPERT: Can Emollient Prescription Stop Atopic Dermatitis Before It Starts?
17:30 - 18:45 | SS19 | SUNTEC 331

The future of home-use beauty device
17:30 - 18:45 | SS16 | SUNTEC 334+335+336

A fundamental discovery on aging: beyond the genome the proteome
201
12:45 - 14:15 | LS11 | SUNTEC HALL 606

A Multidisciplinary Approach to Alopecia Areata: Optimizing the Patient Experience
12:45 - 14:15 | LS12 |SUNTEC SUMMIT 2

IL-4 AND IL-3: Shared unique roles in atopic dermatitis and prurigo nodularis
12:45 - 14:15 | LS13 | SUNTEC NICOLL 1

Prevention, early detection and management of skin cancer: new weapons for tomorrow’s
battles
12:45 - 14:15 | LS14 | SUNTEC NICOLL 3

Skin Barrier and Atopic Dermatitis: Ethnic Variations and Cultural Considerations During
Treatment
12:45 - 14:15 | LS15 | SUNTEC 324+325+326

Thinking differently about atopic dermatitis: Is it time to evolve our paradigms?
Utilizzati 2 Colori Pantone:
17:30 - 18:45 | LS17 | SUNTEC SUMMIT 2 P. 424 C P. 296 C

Charting a new course in Prurigo Nodularis: Changing the treatment paradigm with biologic
therapy
17:30 - 18:45 | LS18 | SUNTEC NICOLL 2

Breaking news in Aesthetic Medicine! Remodeling time with conscious innovation
17:30 - 18:45 | SS22 | SUNTEC 310+311

Targeting long-term control in atopic dermatitis – a question of balance
17:30 - 18:30 | ME06 | SUNTEC 320

MEET THE EXPERT: Bimekizumab from clinical trials to clinical practice - hear from those who
know!
17:30 - 18:30 | ME07 | SUNTEC 323

MEET THE EXPERT: From RCTs to real world clinical practice: How are IL-23p19 inhibitors
living up to their expectations?
17:30 - 18:30 | ME08 | SUNTEC 327

MEET THE EXPERT: Benev Expert Session
17:30 - 18:45 | SS21 | SUNTEC 328+329

Sirtuins and Longevity
17:30 - 18:30 SUNTEC 330

MEET THE EXPERT: A Novel Multi-Targeting Approach to Hair Thinning Using a Standardized
Nutraceutical
17:30 - 18:45 | SS22 | SUNTEC 334+335+336

Early Onset Skin Aging and Solutions: New Research Findings
202
12:45 - 14:15 | LS16 | SUNTEC HALL 606

Beyond EASI: Meeting Individual Needs of Patients with AD
12:45 - 14:15 | LS17 | SUNTEC NICOLL 1

Transforming Scientific Findings into Clinically Relevant Patient Management in Atopic
Dermatitis
12:45 - 14:15 | LS18 | SUNTEC NICOLL 3

New Scientific Advances in Skin Aging: From Metals in Pollution to Integrated Skincare Approaches
12:45 - 14:15 | LS19 | SUNTEC 324+325+326

What’s on the horizon for prurigo nodularis? Navigating new data
12:45 - 14:15 | LS20 | SUNTEC 334+335+336 P. 424 C P. 296 C
Sun-induced damages on the skin: what’s new to protect our patients?
17:30 - 18:45 | SS23 | SUNTEC NICOLL 2

Atopic Dermatitis
17:30 - 18:30 | ME09 | SUNTEC 320

MEET THE EXPERT: Intimate hair removal: Evolving needs and latest innovations in a growing
category
203
204
SPONSORED SESSIONS
4th - 7th JULY 2023
205
SPONSORED SESSIONS | TUESDAY 4th JULY 2023
LS LS
( LS01) PFIZER - SMALL MOLECULES AT THE

(LS03) IMPROVING OUR KNOWLEDGE
FOREFRONT OF MODERN DERMATOLOGY ON HORMONES IMPACT ON SKIN AND
SCALP HEALTH: NEW INSIGHTS FROM AN
12:45 Welcome and Introductions EPIDEMIOLOGICAL WORLDWIDE STUDY
Ahmed Kazmi (UK)
CHAIR:
12:50 Modern Dermatology Experience with Small Christos C. Zouboulis (Germany)
Molecules in AD: Lessons from the Past
Linda Stein Gold (USA) 12:45 Introduction
Stephanie LECLERC-MERCIER (France)
13:20 Next Stop AA: Unlocking the Potential of Small
Molecules
12:47 An epidemiological study evaluating
Manabu Ohyama (Japan)
hormonal impact on skin and scalp in women
at every lifestage
13:40 Charting a New Frontier with Small Molecules
in Vitiligo Christos C. Zouboulis (Germany)
Iltefat Hamzavi (USA)
13:02 How are hormones impacting acne flare ups?
13:50 Panel Discussion/Q&A Edileia Bagatin (Brazil)
13:17
Melasma: latest advances on pathophysiology,
what is the impact in clinical practice?
SUNTEC | LEVEL 3 | SUMMIT 2 | 12:45-14:15 Thierry Passeron (France)
LS
13:32 ow hormones impact scalp and hair health
H
Angeline Yong (Singapore)
13:47 dermocosmetic range improving Peri-

A

(LS02) ATOPIC DERMATITIS IN CHILDREN: Menopause and Menopause skin impact and
EARLY INTERVENTION CAN REDUCE LONG- Quality of Life
TERM DISEASE IMPACT Frederic Flament (France)
CHAIR: 13:57 How dermocosmetics can improve skin

Amy Paller (USA) disorders induced by hormonal changes at
every lifestage
12:45 Welcome/Introductory Discussion Stephanie Leclerc-Mercier (France)
Amy Paller (USA)
14:06 Q&A
12:55 Challenges That Dermatologists Face When Christos C. Zouboulis (Germany)
Managing Atopic Dermatitis in Children
Mark Koh (Singapore)
13:10 ew Perspectives in Understanding

N
Pathophysiology of Atopic Dermatitis in
Children
Stephan Weidinger (Germany)
13:20 Emerging Clinical Data in Children with Atopic

Dermatitis
Elaine Siegfried (USA)
13:40
Clinical Implications for the Management of
Children with Moderate-to-Severe Atopic
Dermatitis in Everyday Practice
Amy Paller (USA)
14:00 Discussion/Q&A closure

All Faculty
206
SUNTEC | LEVEL 3 | ROOM 324+325+326 | 12:45-14:15 SUNTEC | LEVEL 3 | NICOLL 1 | 17:30-18:45
LS SS
( LS04) NEW PERSPECTIVES ON ( SS01) PRACTICAL PERSPECTIVES ON PSO

PERSONALIZED MANAGEMENT OF ACNE AND PATIENT PLIGHTS
ACNE SEQUELAE
CHAIR:
CHAIR: April Amstrong (USA)
Jerry Tan (Canada)
12:45 Welcome and introduction April Armstrong (USA)
Jerry Tan (Canada) Andreas Pinter
Brian Kirby
12:50 PACE: Addressing unmet needs in acne
management
Jerry Tan (Canada) 17:35 Disproportion impact of psoriasis in patients
with involvement of challenging body areas:
13:05 What’s new in topical acne treatment? Panel discussion and Q&A
Joann See (Australia) April Armstrong (USA)
Andreas Pinter
13:25 ecent topical approaches to the
R Brian Kirby
management of acne-induced sequelae
Seemal Desal (USA) 17:43 isproportion impact of psoriasis in patients
D
with involvement of challenging body areas:
13:55 Conclusions Panel discussion and Q&A
Jerry Tan (Canada) April Armstrong (USA)
Andreas Pinter
14:05 Live Panel Q&A Brian Kirby
All faculty
17:51 Role of the dermatologist in the recognition
and management of psoriatic arthritis: Panel
discussion and Q&A
SUNTEC | LEVEL 3 | ROOM 334+335+336 | 12:45 – 14:15 April Armstrong (USA)
LS Andreas Pinter
Brian Kirby
18:06 Prevention and delay of PsA with biologic

( LS05) ECOBIOLOGY: DIALOGUE BETWEEN treatment: Panel discussion and Q&A
SKIN BARRIER AND ITS ECOSYSTEM April Armstrong (USA)
Andreas Pinter
CHAIR: Brian Kirby
18:21 Role of real-world evidence in clinical decision
12:45 Introduction making: Panel discussion and Q&A
Brigitte Dréno (France) April Armstrong (USA)
Andreas Pinter
12:50 Skin barrier, an organ still in adaptation Brian Kirby
Enzo Berardesca (USA)
18:36 Additional Q&A and Closing
13:05 Environmental triggers and the skin barrier April Armstrong (USA)
Kenji Kabashima (Japan) Andreas Pinter
Brian Kirby
13:20 S
kin Microbiome: a new actor in cutaneous
neurogenic inflammation
13:35 topy: an ecobiological approach for a

A
targeted skin care formula
Stéphane Fauverghe (France)
13:50 Q&A
207
SUNTEC | LEVEL 3 | ROOM NICOLL 2 | 17:30-18:45 flares (PO-SCORAD apps) for patients and POP
SS training (Patient Optimisation Pathway) for
health care professionals
Andreas Wollenberg (Germany)
18:30 Q&A and closing remarks

(SS02) TIPS AND TRICKS ON MANAGING Eggert Stockfleth (Germany)
CHRONIC URTICARIA
CHAIR:
Marcus Maurer (Germany) SUNTEC | LEVEL 3 | ROOM 308+309 | 17:30-18:45
SS
17:30 Introduction
Marcus Maurer (Germany)
17:35 Optimizing antihistamine treatments in CSU

Emek Kocatürk Göncü (Turkey) (SS04) ADVANCES IN SKIN HEALTH
17:55 New insights on Chronic Inducible Urticaria CHAIR:

Jason Fok (Australia) Joyce Lim (Singapore)
18:15 New development in Urticariology 17:30 Advances in Skin Health

Marcus Maurer (Germany) Zein Obagi (USA)
18:35 Q&A 18:30 Q&A
SUNTEC | LEVEL 3 | NICOLL 3 | 17:30-18:45 SUNTEC | LEVEL 3 | ROOM 310+311 | 17:30-18:45

SS SS
( SS03) PATIENTS AS PARTNERS IN ( SS05) THIAMIDOL: INNOVATION IN

DERMATOLOGY: HOW TO DRIVE BETTER HYPERPIGMENTATION/THERAPEUTIC
PATIENT ENGAGEMENT THROUGH BENEFITS
A HOLISTIC APPROACH. ARTIFICIAL
INTELLIGENCY AND R&D INNOVATION AS CHAIR:
KEY SUCCESS FACTORS. Desai Seemal (USA)
CHAIR: 17:30 Challenges in Hyperpigmentation

Eggert Stockfleth (Germany) Desai Seemal (USA)
17:30
Comprehensive approach in photoprotection: 17:40
Discovery of Thiamidol: cosmetic innovation
how to be SAFE (Sunscreen Assessment Ludger Kolbe (Germany)
Family Experience)
Henry Lim (USA) 17:55 Post-inflammatory Hyperpigmentation:
therapeutic experience in European patients
17:45
What’s new about occupational diseases Firas Al-Niaimi (UK)
in Germany? Photoprotection: time to
protect our children in kindergardens. 18:10 Thiamidol as an Adjunctive with Triluma for
Focus on Triasorb new sunscreen filter for melasma treatment in Asian
intergenerational worldwide population Ratchathorn Panchaprateep (Thailand)
Eggert Stockfleth (Germany)
18:20 Prevention of Laser-induced PIH with
18:00 Chronic dermatoses and their handicap for Thiamidol: the Asian experience
patients: results from VDS (Visible Diseases of Vasanop Vachiramon (Thailand)
Skin) study
Richard Marie-Aleth (France) 18:30 Q&A
Desai Seemal (USA)
18:15 olistic approach for atopic dermatitis
H
patients: artificial intelligency to predict the
208
SS SS
( SS06) POND’S SKIN REBALANCE NEW ( SS07) - THROUGH THE LEUKIN GLASS: IL-23
TECHNOLOGY AND INSIGHT SHARING INHIBITION IN PSORIATIC DISEASE
CHAIRS: CHAIR:
Erica Liang (XXX); Sunny Du (XXX) Richard Warren (UK)
17:30 Opening Address 17:30 Welcome and introductions

Jason Harcup (UK) Richard Warren (UK)
17:40 N
iasorcinol™, a new skin brightening & even 17:35 Leukin at the need for optimal treatment
tone cosmetic agent strategies in psoriasis
Anita Damodaran (India) Richard Warren (UK)
17:50 A Novel Brightening Technology-Niasorcinol™ 17:45 eukin at the benefit/risk profile of IL-23
L
for Spot Reduction in Ascian Population inhibition in psoriasis
Vasanop Vachiramon (Thailand) Melinda Gooderham (Canada)
18:00 L
eukin at the benefit/risk profile of IL-23
18:00 N
ew Methodology: deep spot analysis and
inhibition in psoriatic arthritis
application to Niasorcinol™ study
Andrew Östör (Australia)
Tan Yimei (China)
18:10 eukin at patient profiles with a high clinical
L
18:10 Novel combination of cosmetic ingredients burden associated with uncontrolled disease
retinyl propionate, 4-hexyl resorcinol, and Richard Warren (UK)
Niacinamide reverses features of photoaging Melinda Gooderham (Canada)
Nirmala Nair (India) Andrew Östör (Australia)
18:20 A Novel Anti-aging technology- Hexyl-Retinol ™ 18:25 Summary and Q&A
for Superior Improving Facial Photodamage in a Richard Warren (UK)
Asian Population
Nadia Shannaz Yusharyahya (Indonesia)
18:30 H
exyl-Retinol™ a cosmetic technology which SUNTEC | LEVEL 3 | ROOM 330 | 17:30-18:30
provides comparable anti-ageing effect at ME
prescription treatment
Purita (Peachy) Paz-Lao (Philippines)
( ME02) THE DR.CI:LABO CLINIC METHOD:

FROM COLLAGEN HEALTH TO THE ART OF
OMOTENASHI CARE
CHAIR:
Siti Shahera Anwar (Singapore)
17:30
Dr.Ci:Labo’s philosophy of collagen health &
retinol technologies
Cecilia Li (China)
17:55
Omotenashi - Providing holistic aesthetic
clinic experience to drive patient compliance
Hiromitsu Aizawa (Japan)
209

SS
( SS08) - NEW INSIGHTS IN SKIN BIOLOGY

ACROSS MULTIPLE ETHNICITIES
CHAIRS:
Alexa B. Kimball (USA)
Paul Matts (UK)
17:30 Intro: Fundamental Skin Understanding across

Multidecade and Multiethnicities
17:40 M
ultiethnic Skin Treatment: Impact of low pH
Niacinamide and Peptides
Paul Matts (UK)
18:00 P
reempt and reverse skin aging with
Galactomyces Ferment Filtrate (PITERATM)
containing products
Kukizo Miyamoto (Japan)
18:15 Insights from Chinese Decade Longitude

Skin study
Danny Deng (Singapore)
18:35 Closing: Practical Applications of Insights to

Dermatology
210
SPONSORED SESSIONS | WEDNESDAY 5th JULY 2023
SUNTEC | LEVEL 6 | HALL 606 | 12:45-14:15 14:00 P

anel discussion and Q&A: Exploring the full
LS potential of targeting key cytokines in type 2
inflammation
Faculty pan discussion
14:15 Summary and close

(LS06) THE GREAT DEBATE: IS IT TIME TO Diamant Thaci (Germany)
SWITCH YOUR APPROACH IN AD?
12:45 Welcome and Introductions

Johannes Ring (Germany) SUNTEC | LEVEL 3 | NICOLL 1 | 12:45-14:15
LS
12:55 hat Factors Should Be Monitored to
W
Supported by an educational
Determine if an Advanced Systemic Therapy Is grant provided by Lilly and Almirall
Working?
Johannes Ring (Germany)
Sonja Ständer (Germany) ( LS08) LONG-TERM DISEASE CONTROL IN
Zuotao Zhao (China) MODERATE TO SEVERE ATOPIC DERMATITIS:
EXPLORING THE POTENTIAL OF BIOLOGIC
13:25 How Fast Can Itch Be Controlled? THERAPIES
CHAIR:
13:50 How Long Do You Wait for a Response? Emma Guttman-Yassky (USA)
Zuotao Zhao (China)
12:45 U
nderstanding moderate to severe atopic
14:00 How to Keep Winning With Systemic JAK dermatitis
Inhibitors? Emma Guttman-Yassky (USA)
Zuotao Zhao (China)
13:07 nmet needs for patients with moderate to
U
14:10 Closing Remarks and Questions severe atopic dermatitis
Johannes Ring (Germany)
13:21 Immunopathogenesis of atopic dermatitis
Zuotao Zhao (China)
Melinda Gooderham (Canada)
13:36 Expert Quick Fire: Differential MOA & key

clinical data on current & emerging biologics
SUNTEC | LEVEL 3 | SUMMIT 2 | 12:45-14:15 All faculty
LS
13:51 Relating the data to clinical practice
All faculty
14:05 Interactive Q&A and Conclusions

( LS07) - THE BIOLOGIC REVOLUTION IN All faculty
ATOPIC DERMATITIS: RECENT ADVANCES
AND FUTURE POTENTIAL

Diamant Thaci (Germany)
12:50 Great expectations: Evolving the standard of

care in AD
Mark Tang (Singapore)
13:15 dvanced systemic treatments: An

A
opportunity to achieve lasting control
Diamant Thaci (Germany)
13:40 Transforming AD treatment: Achieving more

for our youngest patients
211
SUNTEC | LEVEL 3| NICOLL 3 | 12:45-14:15 SUNTEC | LEVEL 3 | ROOM 324+325+326 | 12:45-14:15

LS LS

( LS09) PIGMENTARY DISORDERS: NOT ( LS10) DIVERSITY AND INCLUSION IN

A FATALITY! FROM PREVENTION TO DERMATOLOGY: A WORLDWIDE PROFILING
CORRECTIVE INNOVATIVE SOLUTIONS TO OF SENSITIVE SKIN
IMPROVE PATIENTS QUALITY OF LIFE
CHAIR:
CHAIRS: Adam Friedman (USA)
Delphine Kerob (France) 12:45 Introduction
Adam Friedman (USA)
12:45 P
IGMENTARY DISORDERS: What is their
12:50 A worldwide profiling of sensitive skin
worldwide prevalence and impact on QOL?
research: overview on the results
What are the gaps in terms of education? Adam Friedman (USA)
Chee Leok Goh (Singapore) 13:05 Panel discussion
12:55 Role of the most insidious UV rays: the Xiang Leihong (China)
UVAS! From skin cancer to photoaging Flavia Alvim Sant’Anna Addor (Brazil)
and pigmentary disorders: understanding Anurag Tiwari (India)
the magnitude of their effect according to
phototypes. 13:25 Q&A and conclusion
Latest innovation with mexoryl 400 Adam Friedman (USA)
Henry W. Lim (USA)
Françoise Bernerd (France)
13:10 All - Panel Discussion (Q&A) SUNTEC | LEVEL 3 | SUMMIT 2 | 17:30-18:45

Henry W. Lim (USA) SS
13:15 What is PIH? How frequent is it and which
populations are most concerned?
Andrew Alexis (USA)
( SS09) DERM UPDATE! NEW INSIGHTS IN
13:25 cne and PIH: Let’s listen to patients’
A THE MANAGEMENT OF INFLAMMATORY SKIN
experience DISEASES
CHAIRS:
13:35 Role of dermocosmetics in acne management Siew Eng Choon (Malaysia)
Clinical results from randomised controlled Colin Theng (Singapore)
trials to visualisations of the clinical benefits
Delphine Kerob (France) 17:30 Psoriasis Today & Tomorrow: new advances in
Jerry Tan (Canada) the management of psoriatic disease
Yayoi Tada (Japan)
13:45 atest patented innovation with a new mode
L
of action 17:40 Psoriasis Today & Tomorrow: can we change
Peggy Sextius (France) the course early in psoriasis?
13:55 ow to leverage social media to improve
H
17:55 Panel Discussion and Q&A
patient education? Interactive experience
Thierry Passeron (France) 18:05 T
he Derm Newsroom! Emerging Trends for
Daniel Sugai (USA) Inflammatory Skin Diseases
April Armstrong (USA)
14:10 Panel Discussion (Q&A) Melinda Gooderham (Canada)
Thierry Passeron (France) Dedee Murrell (Australia)
212
P. 424 C P. 296 C
SUNTEC | LEVEL 3 | NICOLL 2 | 17:30-18:45 SUNTEC – LEVEL 3 – ROOM 308+309 - 17:30 – 18:45
SS SS

(SS12) NAVIGATING THE MANAGEMENT OF GPP
( SS10) PATIENT CENTRICITY IN SKIN
TREATMENTS – GLOBAL MEETING OF CHAIR:
EXPERTS IN DERMATOLOGY Jonathan Barker (UK)
CHAIR: 17:30 Welcome and introduction
Maria Purita (Peachy) Paz-Lao (Philippines) Jonathan Barker (UK)
17:30 Opening remarks 17:35 Mapping the course: the evolving

Maria Purita (Peachy) Paz-Lao (Philippines) understanding of generalized pustular
psoriasis
17:35 ocus lecture on the skin journey over time:
F Jonathan Barker (UK)
changes in the functional integrity of ageing
skin and dermatological needs 17:45 Setting sail! Results of IL-36 inhibitors in
patients with GPP
Giuseppe Micali (Italy) Thaci Diamant (Germany)
17:50 New Hyperpigmentation management 18:00 Arriving in port: Management of GPP in the
program clinical results in combination with United States
Aesthetic Medicine Techniques Gelfand Joel (USA)
Maria Purita (Peachy)
Paz-Lao (Philippines) 18:15
What’s next on the horizon: Long-term
management of chronic GPP
18:05 C
linical trial on subjects with dermatitis with a Morita Akimichi (Japan)
non-steroidal medical device
Giovanni Pellacani (Italy) 18:30 Q&A
18:20 Acne Multifactor targeting approach:

favouring patient compliance
Giuseppe Micali (Italy) SS
18:35 Q&A and closing remarks
( SS13) MAXIMISING DERMAL OUTCOMES

SUNTEC | LEVEL 3 | NICOLL 3 | 17:30-18:45 WITH ENERGY-BASED TECHNOLOGIES
SS
CHAIR:
Davin Lim (Australia)
17:30 Opening address

( SS11) SCRATCHING THE SURFACE OF TYK2 Cynosure LLC
IN PSORIASIS: FROM TYK2 INHIBITION TO 17:35 new approach for total skin revitalization
A
LONG-TERM CLINICAL OUTCOMES Kentaro Oku (Japan)
CHAIR: 17:50 reatment and management of pigmentation
T
Conrad Curdin (Switzerland) in Asian skin
Niwat Polnikorn (Thailand)
17:30 Unmet needs and disease burden of psoriasis:
a global perspective 18:05
International Experts Panel discussion: The
Linda Stein Gold (USA) efficacy of energy-based treatments on anti
ageing and rejuvenation
17:45 TYK2-mediated pathways in psoriasis and Robert Weiss (USA)
their crucial involvement in inflammation Niwat Polnikorn (Thailand)
James Krueger (USA) Henry Chan (Hong Kong)
Lin Tong (PRC)
18:00 A new class is in session: results from the Peter Peng (Chinese Taipei)
long-term extension of the first approved
TYK2 inhibitor in psoriasis. 18:35 Closing & Thank You
Lynda Spelman (Australia) Bebe Teo (Singapore)
213
ME
SS
( ME03) PREVENTATIVE SCALP CARE: A NEW ( SS14) HYBRID COOPERATIVE COMPLEXES

PARADIGM FOR HEALTHY HAIR AND A TRULY (HCCS): THE LATEST FRONTIER OF
HEALTHY SCALP HYALURONIC ACID-BASED TREATMENT FOR
FACE AND BODY SKIN RESTORATION
CHAIRS:
Jeni Thomas (USA) 17:30 IBSA patented technology as a novel frontier
Melissa Piliang (USA) for cellular re-activation
Cara Mcdonald (Australia)
17:30 Why Scalp Care Matters: New Psychosocial
links between Dandruff and Quality of Life 17:45 Q&A
Christian S Chan (Honk Kong) Cara Mcdonald (Australia)
17:45 eyond Symptom Free: The Route to (and

B 17:50 fficacy and tolerance of HCCs in skin laxity
E
Root of) Better hair and a TRULY Healthy Scalp treatment of Asian patients – preliminary data
James R Schwarts (USA) and insights from a pilot study
Suzanne Cheng Wei Na (Singapore)
18:10 reventative Scalp Care: Considerations in
P
Clinical Practice 18:05 Q&A
Melissa Piliang (USA) Suzanne Cheng Wei Na (Singapore)
18:10 Treatment of aesthetic skin conditions related

to dermatological diseases & disorders
SUNTEC | LEVEL 3 | ROOM 323 | 17:30-18:30 Ofir Artzi (Israel)
ME
18:25 Q&A
Ofir Artzi (Israel)
18:30 Conclusions & final Q&A

(ME01) A GAME-CHANGING DISCOVERY FOR
SKIN LONGEVITY
CHAIR: SUNTEC | LEVEL 3 | ROOM 327 | 17:30-18:30

Julie Faitg (UK) ME
17:30 A game-changing discovery for skin longevity
Vincenzo Sorrentino (Italy)
Julie Faitg (Switzerland) ( ME04) NEW NON-LASER TECHNOLOGY
FOR THE TREATMENT OF PIGMENTED AND
VASCULAR LESIONS
CHAIR:
Klaus Fritz (Germany)
17:30 Restoration of basement membrane to better

manage melasma in chronically uv-exposed
skin types
Tin Song Ling (Malaysia)
18:00 A new paradigm for microneedling RF therapy

Michael Gold (USA)
214
SS SS
( SS15) TARGETING MINIMAL DISEASE

(SS19) THE FUTURE OF HOME-USE BEAUTY DEVICE
ACTIVITY IN ATOPIC DERMATITIS: THE TIME
IS NOW CHAIR:
Lai Wei (China)
CHAIR: Leihong Flora Xiang (China)
Mark Kirchhof (Canada)
17:30 ome-use beauty device: a new challenge or
H
17:30 Welcome and introductions opportunity for Chinese dermatologists
Mark Kirchhof (Canada) Yan Wu (China)
17:50 AMAN: how 45-year innovation and insight

Y
17:35 ifelong impact of uncontrolled AD
L
in beauty technology give birth to next
Amy Foulkes (UK) generation home-use device?
Maeda Kazunori (Japan)
17:45
Do we need to go further than current
treatment goals? 18:05
Latest progress in 585 nm light-emitting
Chih-ho Hong (Canada) diode and its potential application as a home-
use device
17:55 A novel minimal disease activity concept in Chengfeng Zhang (China)
AD management
Mark Kirchhof (Canada) 18:25
Revolution of Precision Skincare: a Novel
Intelligentized Multifunctional Skincare System
18:05 MDA: the path to optimizing patient care Boyang Jiang (China)
Panel (Mark Kirchhof, Chih-ho Hong, Amy Foulkes)
18:35 Discussion
18:25 Summary and close
Mark Kirchhof (Canada)

SS
ME
( SS16) A FUNDAMENTAL DISCOVERY

ON AGING: BEYOND THE GENOME THE
(ME05) CAN EARLY INTERVENTIONS PROTEOME
PREVENT ATOPIC DERMATITIS?
CHAIRS:
CHAIR Giovanni Pellacani (Italy)
Menas Kizoulis (USA) Marco Rocha (Brazil)
17:30 Emollient use in the management of atopic 17:30 pdate on combined cosmetic &
U
dermatitis dermatological strategies in comprehensive
Chao Yuan (China) skin aging management
17:45 Early initiation of short-term emollient use for
the prevention of atopic dermatitis in high- 17:45 Proteome alteration as the root cause of skin aging
risk infants Elodie Valin (France)
Jonathan Hourihane (Ireland)
18:00 Specificities of Asian skin in aging
18:15 Implications for clinical practice & Hee Young Kang (Republic of Korea)
recommendation of emollients to patients
Menas Kizoulis (USA) 18:15 roteome protection: a new therapeutic way
P
for healthy aging
Marco Rocha (Brazil)
18:30 Q&A
215
SPONSORED SESSIONS | THURSDAY 6th JULY 2023
SUNTEC | LEVEL 6 | HALL 606 | 12:45 - 14:15 SUNTEC | LEVEL 3 | NICOLL 1 | 12:45-14:15
LS LS

(LS11) A HOLISTIC APPROACH TO ALOPECIA ( LS13) PREVENTION, EARLY DETECTION
AREATA: OPTIMIZING THE PATIENT AND MANAGEMENT OF SKIN CANCER: NEW
EXPERIENCE WEAPONS FOR TOMORROW’S BATTLES
12:45 Welcome and Introductions CHAIR:

Rodney D. Sinclair (Australia) Alex Hauschild (Germany)
12:55 Perspectives on Burden of AA 12:45 S

un, aging and carcinogenesis: what’s new
All/Rodney D. Sinclair (Australia) from non-invasives technologies
13:25 Perspectives on Pathophysiology of AA
All/Brett King (USA) 13:00 Field cancerization in actinic keratosis:
from concept to reality and therapeutic
13:45 Perspectives on Disease Severity Assessment implications
All/Rodney D. Sinclair (Australia) Eggert Stockfleth (Germany)
14:00 Q&A 13:15 High-risk melanoma primaries: what to do?

All Axel Hauschild (Germany)
14:10 Summary and Conclusion 13:30 What’s new in imagery (with clinical cases)?
Rodney D. Sinclair (Australia) Aimilios Lallas (Greece)
13:50 Photoprotection & self-skin examination to

improve Malignant melanoma survival
SUNTEC | LEVEL 3 | SUMMIT 2 | 12:45-14:15 Enric Barba (Spain)
LS
14:05 Q&A closing remarks
(LS12) IL-4 AND IL-3: SHARED UNIQUE ROLES SUNTEC | LEVEL 3 | NICOLL 3 | 12:45-14:15
LS
CHAIR:
12:45 Welcome/Introductory Discussion

(LS14) SKIN BARRIER AND ATOPIC
DERMATITIS: ETHNIC VARIATIONS AND
12:55 Atopic Dermatitis (AD) and Prurigo Nodularis CULTURAL CONSIDERATIONS DURING
(PN): Commonalities and Differences – A Case TREATMENT
Study
Mark Tang (Singapore) CHAIR:
Andrew F. Alexis (USA)
13:05 Type 2 inflammation alters the structure and
function of the skin in AD 12:45 R
acial/Ethnic variations in skin barrier and
Lisa Beck (USA) the relationship of skin barrier disruption with
xerosis and atopy
13:20 Type 2 Inflammation Modulates the Andrew F. Alexis (USA)
Neuroimmune Axis in PN
Gil Yosipovitch (USA) 13:05 Ethnic variations and cultural considerations
when treating atopic dermatitis in Latin
14:35 Discussion: sharing insights & exploring the American patients
characteristics of AD and PN Valeria Aoki (Brazil)
All Faculty
13:25 Ethnic variations and cultural considerations
14:05 Discussion / Q&A Closure when treating atopic dermatitis in African
All Faculty patients
Dlova Ncoza (South Africa)
216
13:45 thnic variations and cultural considerations
E SUNTEC | LEVEL 3 | SUMMIT 2 | 17:30-18:45
when treating atopic dermatitis in Asian SS
patients
Therdpong Tempark (Thailand)
14:05 Q&A
( SS17) CHARTING A NEW COURSE IN
PRURIGO NODULARIS: CHANGING THE
TREATMENT PARADIGM WITH BIOLOGIC
SUNTEC | LEVEL 3 | ROOM 324+325+326 | 12:45-14:15 THERAPY
LS CHAIR:
Shawn Kwatra (USA)
17:30 Welcome and introduction

Shawn Kwatra (USA)
( LS15) THINKING DIFFERENTLY ABOUT
ATOPIC DERMATITIS: IS IT TIME TO EVOLVE 17:35 Practical management of Prurigo Nodularis:
OUR PARADIGMS? understanding the clinical presentation of this
complex disease
CHAIRS: Jennifer Soung (USA)
Jonathan Silverberg (USA)
Melinda Gooderham (Canada) 17:50 rom bench to bedside: understanding the
F
role of IL-4 and IL-13 in Prurigo Nodularis
12:45 Welcome and Introduction Sonja Stander (Germany)
Diamant Thaçi (Germany)
18:05 It’s PRIME time: efficacy and safety of biologic
12:50 B
eyond the visible: alleviating the disease therapy in Prurigo Nodularis
burden for patients with atopic dermatitis Shawn Kwatra (USA)
18:20 E
xperience of biologic therapy in the
13:10 IL-31 - A mastermind of itch, inflammation and treatment of Prurigo Nodularis
skin barrier dysfunction
18:30 Q&A
Martin Steinhoff (Germany)
18:40 Close
13:25 IL-31 Signalling inhibition - a global clinical Shawn Kwatra (USA)
perspective
13:45 Exploring the full potential of IL-31 inhibition

in the long term
Kenji Kabashima (Japan)
13:57 Conclusions
14:02 Live Q&A with all speakers

217
P. 424 C SPONSORED SESSIONS | THURSDAY 6th JULY 2023

P. 296 C
SUNTEC | LEVEL 3 | NICOLL 2 | 17:30-18:45 SUNTEC | LEVEL 3 | ROOM 310+311 | 17:30-18:45

SS SS
( SS18) BREAKING NEWS IN AESTHETIC ( SS20) THE INTERNATIONAL TALK SHOW:

MEDICINE! REMODELLING TIME WITH TARGETING LONG-TERM CONTROL IN ATOPIC
CONSCIOUS INNOVATION DERMATITIS – A QUESTION OF BALANCE
CHAIR: CHAIR:
Maria Purita (Peachy) Paz-Lao (Philippines) Chih-ho Hong (Canada)
17:30 Welcoming and program presentation 17:30 Atopic Dermatitis: When skin loses its balance
Maria Purita (Peachy) Paz-Lao (Philippines) Yayoi Tada (Japan)
17:35 ifferent ageing processes between

D 17:45 Targeted treatment: a balance of choice
Caucasians and Asians: Definisse Fillers XTR Linda Stein Gold (USA)
technology as a valuable option
Jaime Anthony Arzadon (Philippines) 18:00 Balancing what patients want from their AD
treatment
17:45 Improving the zygomatic area: final Clinical Chang-Ook Park (Republic of Korea)
trial result with Definisse Core “Pegasus
technique” 18:15 Balancing long-term efficacy and safety
Giovanni Salti (Italy) Andreas Wollenberg (Germany)
17:55 eshaping the malar area and jawline: FREE

R 18:30 Establishing an equilibrium in the real world
Clinical study results with Definisse Threads Anwar Al Hammadi (UAE)
Piero Salvatore Fundarò (Italy)
18:10 PULL OUT TEST with Definisse Threads

Piero Salvatore Fundarò (Italy) SUNTEC | LEVEL 3 | ROOM 320 | 17:30-18:30
ME
18:20 D
efinisse Threads case report with Definisse
Double Needle and Free Floating Threads
Praditsuwan Danai (Thailand)
18:30 KP1 Collagen Modulator: clinically proven ( ME06) BIMEKIZUMAB FROM CLINICAL
effective first in class bio-active peptide TRIALS TO CLINICAL PRACTICE - HEAR FROM
Adele Sparavigna (Italy) THOSE WHO KNOW!
18:40 Q&A closing remarks CHAIR:

Richard Warren (UK)
17:30 Bimekizumab from clinical trials to clinical

practice – hear from those who know!
Richard Warren (UK)
218
ME ME
( ME07): FROM RCTS TO REAL WORLD ( ME11) UNILEVER - A NOVEL MULTI-

CLINICAL PRACTICE: HOW ARE IL- TARGETING APPROACH TO HAIR THINNING
23P19 INHIBITORS LIVING UP TO THEIR USING A STANDARDIZED NUTRACEUTICAL
EXPECTATIONS?
CHAIR:
17:30
Welcome and Introduction Doris Day (USA)
17:30 Novel Multi-Targeting Approach to Hair
A
17:35 Results review of IL23p19 inhibitors from RCT Thinning Using a Standardized Nutraceutical
and clinical practice Doris Day (USA)
Peter Foley (Australia)
17:50
Tips and tricks for clinical practice and future SUNTEC | LEVEL 3 | ROOM 334+335+336 | 17:30-18:45
perpective SS
Peter Foley (Australia)
18:25 Q&A
( SS22) EARLY ONSET SKIN AGEING AND
SOLUTIONS: NEW RESEARCH FINDINGS
SUNTEC | LEVEL 3 | ROOM 327 | 17:30-18:30 CHAIRS:

ME Paul Matts (UK)
Rolanda Wilkerson (USA)
17:30 Early Onset of Senescence: Inflammaging in

Human Photo Exposed Skin
(ME08) BENEV EXPERT SESSION Alexa Kimball (USA)
17:30 ExoSCRT Exsomes: the future of aesthetic 17:45 Cellular Senescence: DNA damage response
regeneration is now with Niacinamide
Michael Gold (USA) Sophie Bellanger (Singapore)
18:00 V
iviscalPro: a clinically proven dietary 18:10 he Role of Galactomyces Ferment Filtrate in
T
supplement for thinking hair and hair growth Inflammaging
Todd Schlesinger (USA) Gaku Tsuji (Japan)

SS

(SS21) SIRTUINS AND LONGEVITY
CHAIR:
17:30 Sirtuins and youthful active skin

Nadine Pernodet (USA)
17:55 Sirtuins in aging and aging related disease

Danica Chen (USA)
219
SPONSORED SESSIONS | FRIDAY 7th JULY 2023
LS LS

(LS16) BEYOND EASI: MEETING INDIVIDUAL ( LS18) NEW SCIENTIFIC ADVANCES IN SKIN
NEEDS OF PATIENTS WITH AD AGING: FROM METALS IN POLLUTION TO
INTEGRATED SKINCARE APPROACHES
12:45 Welcome and Introductions
Martin Steinhoff (Germany) 12:45 Benefits of a Topical Antioxidant
Ted Lain (USA)
12:50 Spectrum of AD: How Differences Impact
Management 13:05 Anti-Pollution Benefits of a Topical Antioxidant
Martin Steinhoff (Germany) Against New Environmental Stressors
Giuseppe Valacchi (USA)
13:10 Global Case Studies and Panel Discussion
Martin Steinhoff (Germany) 13:30 C E Ferulic Impact on Global Warming
Mahreen Ameen (UK) Induced Skin Aging
Chih-ho Hong (Canada) Jean Krutmann (Germany)
Susanne Grether-Beck (Germany)
14:00 Questions and Answers
13:50 Updated Approaches to Integrated Skincare
Mahreen Ameen (UK)
Ted Lain (USA)
Chih-ho Hong (Canada)
14:10 Closing Remarks

LS
SUNTEC – LEVEL 3 – NICOLL 1 - 12:45 – 14:15
LS

( LS19) WHAT’S ON THE HORIZON FOR
PRURIGO NODULARIS? NAVIGATING NEW
DATA
( LS17) TRANSFORMING SCIENTIFIC FINDINGS
INTO CLINICALLY RELEVANT PATIENT CHAIR:
MANAGEMENT IN ATOPIC DERMATITIS Sonja Ständer (Germany)
CHAIR: 12:45 Welcome and introduction

Andreas Wollenburg (Germany) Sonja Ständer (Germany)
12:45 Welcome and introduction 12:52 Lost in the wilderness: the unique burden of
Andreas Wollenburg (Germany) prurigo nodularis
Shawn Kwatra (USA)
12:55 hat is the clinical relevance of JAK
W
Selectivity? Preclinical versus Clinical 13:07 Finding true north: recent discoveries and the
Outcomes driving forces of neuroimmune dysfunction in
Kenji Kabashina (Japan) prurigo nodularis
Takashi Hashimoto (Japan)
13:15 ow well do clinical trials in AD translate into
H
what patients want in real life? 13:22 Mapping new territories: new and emerging
Augustin Matthias (Germany) treatments for prurigo nodularis
13:35 atient management in Atopic Dermatitis:
P
how to use JAKis in your Therapeutic Toolbox 13:42 Expert panel discussion and Q&A
Christine Bangert (Austria) Sonja Ständer (Germany)
13:55
Key takeaways for using these data to inform 14:00 Closure
clinical practice Sonja Ständer (Germany)
Andreas Wollenburg (Germany)
14:05 Q&A/Panel Discussion
220
SPONSORED SESSIONS | FRIDAY 7th JULY 2023
SUNTEC | LEVEL 3 | ROOM 334+335+336 | 12:45-14:15 SUNTEC | LEVEL 3 | ROOM 320 | 17:30-18:30
LS ME

( LS20) SUN-INDUCED DAMAGES ON THE ( ME09) INTIMATE HAIR REMOVAL: EVOLVING

SKIN: WHAT’S NEW TO PROTECT OUR NEEDS AND LATEST INNOVATIONS IN A
PATIENTS? GROWING CATEGORY
CHAIR: CHAIRS:
Brigitte Dréno (France) Frauke Neuser (UK)
Christine Dierickx (Luxembourg)
12:45 Introduction
Brigitte Dréno (France) 17:30 volving consumer needs across genders &
E
regions - implications for shaving products
12:50 Hyperpigmentation: new benefits from the Miriam Rietzler (Germany)
research for the patient
Thierry Passeron (France) 17:50 At-home use of light-based hair removal (IPL)
- a practicing dermatologist’s perspective
13:05 Long-term effects of UV on the skin Christine Dierickx (Luxembourg)
Sergio Schalka (Brazil)
18:10 New applications for light-based hair removal
13:20 The emerging role of secondary - safety & tolerability of female intimate area
photoprotection treatments
Giovanni Leone (Italy) J Frank Nash (USA)
13:35 cobiological approach of sun protection: to

E
reinforce the natural mechanisms of the skin
Stephane Fauverghe (France)
13:50 Q&A
P. 424 C P. 296 C

SS
(SS23) ATOPIC DERMATITIS
CHAIR:
Lisa Braganza (Singapore)
17:30 The rising of atopic dermatitis- focus on

exposome as a cause and milestones in
management of patients
Maria Lourdes Palmero (Philippines)
17:40 Dermatological study in Asian patients with

atopic dermatitis: treatment, results and
consensus across Asian countries
Kwun Cheung Hau (Hong Kong)
17:50 Integrated care in paediatric eczematous

dermatitis and dry sensitive skin
Wai Kwong Cheong (Singapore)
18:00
A novel treatment of intertrigo in athletes and
overweight subjects
Giuseppe Micali (Italy)
221
222
SPONSOR PROFILES
223
DIAMOND
SPONSOR PROFILES
Breakthroughs That Change Patients’ Lives Sanofi, a global healthcare leader, discovers, de-
At Pfizer, we apply science and our global resourc- velops, and distributes therapeutic solutions fo-
es to bring therapies to people that extend and cused on patients’ needs. Regeneron, a leading
significantly improve their lives. We strive to set biopharmaceutical company, discovers, develops,
the standard for quality, safety and value in the dis- manufactures, and commercializes biologic med-
covery, development and manufacture of health icines for serious medical conditions. Since 2007,
care products, including innovative medicines and Sanofi and Regeneron have collaborated to devel-
vaccines. Every day, Pfizer colleagues work across op and commercialize fully human monoclonal an-
developed and emerging markets to advance tibodies utilizing proprietary technologies.
wellness, prevention, treatments and cures that
challenge the most feared diseases of our time.
Consistent with our responsibility as one of the

world’s premier innovative biopharmaceutical
companies, we collaborate with health care pro-
viders, governments and local communities to
support and expand access to reliable, affordable
health care around the world. For more than 170
years, we have worked to make a difference for all
who rely on us.
We routinely post information that may be impor-

tant to investors on our website at www.Pfizer.com.
In addition, to learn more, please visit us on

www.Pfizer.com and follow us on Twitter at @
Pfizer and @Pfizer News, LinkedIn, YouTube and
like us on Facebook at Facebook.com/Pfizer.
224
PLATINUM
SPONSOR PROFILES
Galderma is the pure-play dermatology category L’Oréal Dermatological beauty, the world leader in
leader, present in approximately 90 countries. We medical beauty, is the dermatological division of
deliver an innovative, science-based portfolio of the L’Oréal Group.
premium flagship brands and services that span Its mission is to pioneer health and beauty to offer
the full spectrum of the fast-growing dermatology sustainable and life-changing dermatological solu-
market though Injectable Aesthetics, Dermatolog- tions for all.
ical Skincare and Therapeutic Dermatology. Since The division relies on unique complementary brands
our foundation in 1981, we have dedicated our fo- that are recommended by healthcare professionals
cus and passion to the human body’s largest organ worldwide – La Roche-Posay, CeraVe, Vichy, Skin-
– the skin – meeting individual consumer and pa- Ceuticals and Skinbetter science. Its products are
tient needs with superior outcomes in partnership available in over 100 countries and cover all skincare
with healthcare professionals. Because we under- and haircare categories. They address both skin
stand that the skin we are in shapes our lives, we pathologies and aesthetic needs.
are advancing dermatology for every skin story. The Division accompanies healthcare profession-
For more information: www.galderma.com. als to change people’s lives and increase access to
skin health, to everyone, everywhere. The division
is proud to work alongside the ILDS to improve skin
health access and reward responsible actions from
dermatologists. Furthermore, the Division’s brands
are committed to society and are involved in impor-
tant causes: Fighting against cancer and improving
patients’ lives (La Roche-Posay), increasing access
to skin health through education (Cerave), promot-
ing age and skin inclusivity (Vichy, SkinCeuticals).
On the education front, the Division is committed to
empowering healthcare professionals thanks to its
own scientific forum Skin Alliance, organized every
2 years, and a dedicated platform L’Oréal Dermato-
logical Beauty Pro, tailormade for healthcare pro-
fessionals, offering access to scientific content, in
the form of webcasts, studies summary, congress
reports, webinars and accredited courses.
225
PLATINUM
SPONSOR PROFILES
Taking care, living Better

Pierre Fabre is the 2nd largest dermo-cosmetics
laboratory in the world, the 2nd largest private
French pharmaceutical group and the market lead-
er in France for over-the-counter products sold in
pharmacies.
With nearly 10,000 employees worldwide, Pierre
FABRE designs and develops innovative solutions
that contribute to the well-being of all, from health
to beauty combining the best of medical and natu-
ralness. We achieve this by cooperating with health
care professionals, our long-standing trusted part-
ners, by drawing relentless inspiration from nature;
and by placing pharmaceutical ethics at the very
heart of our operations. We focus our research
and manufacturing activities in South-West France
where our roots lie.
We are proud to belong to a public-interest organ-
ization, the Pierre Fabre Foundation, which is ded-
icated to improving access to high-quality health
care and medication in the poorest countries.
Our CSR commitment led to the creation of the

Green Impact Index. A transparent score that uses
20 different criteria to assess the impact of its prod-
ucts. A method validated and approved by AFNOR
Certification. It is the 1st tool that measures, im-
proves and communicates on the environmental
and societal impacts of cosmetics and family health
care products.
Pierre FABRE portfolio includes several medi-
cal franchises and international brands including
Pierre Fabre Oncology, Pierre Fabre Medical Der-
matology, Eau Thermale Avène, Klorane, Ducray,
René Furterer, A-Derma, Naturactive, Pierre Fabre
Oral Care, Darrow and Glytone.
226
GOLD
SPONSOR PROFILES
AbbVie’s mission is to discover and deliver inno- Bristol Myers Squibb is a leading global biophar-
vative medicines that solve serious health issues ma company focused on discovering, developing
today and address the medical challenges of to- and delivering innovative medicines for patients
morrow. We strive to have a remarkable impact on with serious diseases in areas including oncology,
people’s lives across several key therapeutic areas: hematology, immunology, cardiovascular, fibrosis
immunology, oncology, neuroscience, eye care, vi- and neuroscience. Our employees work every day
rology, women’s health and gastroenterology, in to transform patients’ lives through science.
addition to products and services across its Aller- For more information: bms.com
gan Aesthetics portfolio.
For more information about AbbVie, please visit us

at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram,

YouTube and LinkedIn. Lilly is a global healthcare leader that unites car-
ing with discovery to create medicines that make
life better for people around the world. We were
founded more than a century ago by a man com-
mitted to creating high-quality medicines that
meet real needs, and today we remain true to that
mission in all our work. Across the globe, Lilly em-
ployees work to discover and bring life-changing
medicines to those who need them, improve the
understanding and management of disease, and
give back to communities through philanthropy
and volunteerism.
To learn more about Lilly, please visit us at www.

lilly.com and newsroom.lilly.com/social-channels
227
GOLD P. 424 C
P. 296 C
SPONSOR PROFILES
Procter & Gamble is one of the world’s largest con- Conscious innovation approach to well-being
sumer goods companies. Our brands are used and RELIFE is a new Dermatology and Aesthetic Medi-
trusted in millions of bathrooms and households cine global company that finds its roots in the ME-
around the world by over 5 billion people every NARINI GROUP (founded in 1886, with more than
day. They know they can trust P&G’s brands to de- 17,000 employees in 136 countries in the world).
liver superior performance for superior value. This new Italian company inherits MENARINI’s sci-
ence-based and patient-centred approach to pro-
At P&G we are committed to leadership, citizenship vide high-quality standards from development and
and innovation. For over 180 years we have been manufacturing to Medical Education.
creating products that make a difference to peo-
ples’ lives in small but meaningful ways. Our aim is With healthcare professionals, to healthcare
to transform the everyday, so it’s always more than professionals.
ordinary – by making daily tasks a little easier, the We work with Healthcare Professionals and Scien-
experience of using products more enjoyable and tific Communities to provide the results of our con-
creating proven solutions that deliver every time. scious innovation to all.
We seek to create irresistible product solutions Relife. My skin says how I feel
through our commitment to science - bringing to- RELIFE considers skin as the mirror of well-being.
gether What’s Needed and reimagining What’s Therefore, it focuses on helping people achieve
Possible through the application of science and the their complete well-being, starting with their skin.
expertise of our scientists. P&G dedicates over $1.9 In Dermatology, we will treat each specific skin
Billion to scientific research annually, through our condition by providing men, women, and children
network of Global Innovation Centres (in the Amer- with effective and highly innovative complete pre-
ica’s, Europe and Asia) and our partnerships with mium product ranges.
thought leading Universities, Research Institutes, In Aesthetic Medicine, we will offer healthcare pro-
scientists and medical researchers and practitioners. fessionals a holistic approach thanks to a combina-
tion of unique techniques to provide patients with
P&G products can be found in a diverse range of cat- natural-looking results.
egories familiar to all of us: Beauty and Grooming;
Feminine and Baby Care; Fabric and Home Care; Fam-
ily and Health Care; with trusted, quality, leadership
brands, including: Olay®, SK-II®, Head & Shoulders®,
Pantene®, Gillette®, Gillette Venus® and Braun®.
To learn more about P&G, our commitments, scientif-

ic approaches and brands please visit www.pg.com
228
SILVER
SPONSOR PROFILES
Amgen is committed to unlocking the potential of At Johnson & Johnson, we believe good health is
biology for patients suffering from serious illness- the foundation of vibrant lives, thriving communities
es by discovering, developing, manufacturing and and forward progress. That’s why for more than 135
delivering innovative human therapeutics. This ap- years, we have aimed to keep people well at every
proach begins by using tools like advanced human age and every stage of life. Today, as the world’s
genetics to unravel the complexities of disease and largest and most broadly based healthcare com-
understand the fundamentals of human biology. pany, we are committed to using our reach and
Amgen focuses on areas of high unmet medi- size for good. We strive to improve access and af-
cal need and leverages its expertise to strive for fordability, create healthier communities, and put a
solutions that improve health outcomes and dra- healthy mind, body and environment within reach
matically improve people’s lives. A biotechnology of everyone, everywhere. We are blending our
pioneer since 1980, Amgen has grown to be one heart, science and ingenuity to profoundly change
of the world’s leading independent biotechnol- the trajectory of health for humanity.
ogy companies, has reached millions of patients
around the world and is developing a pipeline of Learn more at www.jnj.com
medicines with breakaway potential. Follow us at @JNJNews
For more information, visit www.amgen.com and

follow us on www.twitter.com/amgen
229
BRONZE
SPONSOR PROFILES
Boehringer Ingelheim is working on breakthrough NAOS is the company behind BIODERMA, Institut Es-
therapies that transform lives, today and for gen- thederm and Etat Pur. When he created the first BIO-
erations to come. As a leading research-driven bi- DERMA and Institut Esthederm products in 1977, Jean-
opharmaceutical company, the company creates Noël Thorel, a pharmacist-biologist, paved the way
value through innovation in areas of high unmet for active cosmetics by integrating biology into cos-
medical need. Founded in 1885 and family-owned metics. Our brands are designed with a unique sci-
ever since, Boehringer Ingelheim takes a long-term entific approach: ecobiology. Combining skin ecolo-
perspective. More than 52,000 employees serve gy and skin biology, this approach is inspired by the
over 130 markets in the three business areas, Hu- skin itself; it considers the skin as an ecosystem that
man Pharma, Animal Health, and Biopharmaceuti- must be preserved and acts with its natural mecha-
cal Contract Manufacturing. nisms to strengthen them. Ecobiology is a positive
boehringer-ingelheim.com and respectful approach that promotes lasting ef-
fectiveness and balance for the whole person. NAOS
is owned by an endowment fund whose purpose is
to contribute to the realization of human potential.
This very innovative business model offers a better
sharing of the value we create, which guarantees the
LEO Pharma is a global company dedicated to ad- sustainability of the company and makes it possible
vancing the standard of care for the benefit of peo- to use the dividends for generous purposes.
ple with skin conditions, their families and society. www.naos.com
Founded in 1908 and majority owned by the LEO
Foundation, LEO Pharma has devoted decades of
research and development to advance the science
of dermatology, and today, the company offers a
wide range of therapies for all disease severities.
LEO Pharma is headquartered in Denmark with a
global team of 5,800 people, serving millions of pa-
tients across the world. In2021, the company gener-
ated net sales of EUR 1,339 million.
leo-pharma.it
230
BRONZE
SPONSOR PROFILES
At Novartis we are reimaging medicine. As a leading Unilever is one of the world’s leading suppliers of
global medicines company, we use innovative sci- Beauty & Wellbeing, Personal Care, Home Care, Nu-
ence and digital technologies to deliver high-value trition and Ice Cream products, with sales in over
medicines for challenging and often-ignored condi- 190 countries and products used by 3.4 billion peo-
tions. We are continuing to bring unimagined possi- ple every day. Our vision is to be the global leader
bilities to life through our relentless determination. in sustainable business and to demonstrate how
With human compassion, commitment, and unwa- our purpose-led, future-fit business model drives
vering scientific curiosity, we develop and drive ac- superior performance. We have a long tradition of
cess to medicines for those who need them most. being a progressive, responsible business.
We are now building on our deep therapy area ex- Our team of 5,000 scientists and PHDs, work at
pertise in dermatology, prioritizing conditions like the cutting edge of science to deliver superior
hidradenitis suppurativa and chronic spontaneous product benefits. They are part of an exceptional
urticaria, to better serve those with few, or inade- ecosystem that covers a broad range of academ-
quate, treatment options. ic institutions, government partnerships and other
scientific partnerships. In short, we translate our
scientific discoveries into everyday products that
care for the planet and improve people’s health,
confidence, and wellbeing.
UCB is a global biopharmaceutical company, inspired

by the needs of people living with severe diseases. At
UCB, we are consistently delivering on our commit-
ment to improve the lives of people living with severe
neurological and immunological conditions. UCB is
headquartered in Belgium with approximately 8,600
colleagues across nearly 40 countries worldwide. Our
people have lived our purpose each day since 1928,
making critical investments in biopharmaceutical re-
search and leading innovations that strive to achieve
a meaningful impact on the lives of those we serve.
www.ucb.com
231
EXHIBITION HALL
FLOOR PLAN
232
EXHIBITION HALL FLOOR PLAN
Aakaar Medical Technologies K52 Fotofinder B11 Noreva C52
Abbvie H06 Fotona J62 Novoxel K07
Advantest A16 Galderma F04 Opatra D50
Aerolase B41 Glenmark Pharma B30 P&G C04
Alma Laser J35 Glisodin F50 Pfizer D16
Alta Care Laboratoires J31 GMV Srl K09 Pharma Cosmetics D52
Amazentis K51 GSD Aesthetic L08 Pierre Fabre E28
Amgen B28 H&O Equipments J30 Promoitalia E51a
Apex Pharma F49 Healux H74 Quanta System Spa G55
APS Device G65 Hyphens Pharma Pte Ltd J21 Quantificare H61
AQ Skin Solutions E20 Hyundae Meditech B31 Regenera A03
Asclepion A18 Ibsa Farmaceutici Italia Srl F28 Relife J45
Aslan Pharmaceuticals K06 IDS K50 Revivo Biosystems B06
Asterasys B59 Illuco E52 Sanofi Regeneron G05
B48 InMode J65 Scientis Pharma A01
Benev A04 Innovaderm Research Inc. K01 Sciton L01
BioSkin E51 Isis Pharma F43 SiHealth B05
Boehringer L12 JBP Korea E50 Simfle Stick K03
Bomtech K17 Johnson&Johnson F24 SkinTech Pharma Group D49
Bristol Meyers Squibb B21 K1med K13 Sofwave K18
Canfield Scientific B51 Kernel Medical Equipment K33 Suno Hada B04
Crystal Tomato D10 L'Oreal Village G25 Suu Balm C44
Cutera B40 L’Oréal Dermatological K53 Termosalud J62a
Cynosure L04 L’Oréal Paris B60a Theraderm K10
Daavlin International B43 LeafLife Tech K26 Unilever D40
Deka J53 Leo Pharma J05 Uriage L09
Dermaceutic H64 LSI Silderma B54 Viol B10
DermLite C20 Lutronic K41 Vivascope B49
Eli Lilly H30 Md Ceuticals J55 Vydence Medical F52
EndyMed Medical Ltd. G63 MediPro by Aromase B60 Wellchem Pharmaceuticals A14
Ennogen H70 MediThinQ H78 Wingderm A02
Eucerin E44 Mesoestetic C50 Winona D04
Eufoton S.r.l. J25 Naos C28 Yatsen Global G64
Eunsung K25 NeoStrata H77 Zhuhai Yasha Medical B47
Exocobio A06 Niks Professional B02 Zo Skin Health H54
LEVEL 4 | SUNTEC SINGAPORE CONVENTION & EXHIBITION CENTRE
K53 K52 K51 K50 J65 J62a J62 H78 H77 H74 G65 G64 G63 F52 F50 F49 E52 E51 E51a E50 D52 D50 D49 C52 C50 B60 B60A B59
A18
H70 B54 B48

K41 J55 J53 H61 G55 F43 E44 C44 B51
H64 B49 B47 A16
D40
L12
A14
B43
K33 J45 H54 B41 B40
F28 E28 C28

B28
L09 K26 K25 J35 J31 G25 B31 B30
H30
D16
L08
J30
K18 K17 J21 F25 E20 C20 B23 B21
J25
A06
L04 K13
K10 B11 B10 A04
K09
J05 H06 G05 F04 C04 A03

K07 K06 D10 D04 B06 B05 A02
L01 K01 B04
K03 B02 A01
233
NOTES
234
235
www.wcd2023Singapore.org
236

Congress Programme 31 Final

Uploaded by

Copyright:

Available Formats

Congress Programme 31 Final

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Congress Programme 31 Final

Uploaded by

Copyright:

Available Formats

CONGRESS PROGRAMME

3rd to 8th JULY 2023

ILDS MEMBER SOCIETY & SISTER SOCIETIES MEETINGS 50

WCD2023 POSTER ROUND SESSIONS 198

SPONSORED SESSIONS 200

Sponsor Profiles 224

Printed in June 2023

Dear friends and colleagues,

Lights, Camera, and Action!

With best wishes

Prof. Roy CHAN A/Prof. Yen Loo LIM

With my best personal regards,

Wishing you a fruitful time at the WCD 2023!

A/Prof. Haur Yueh Lee

DERMATOLOGICAL SOCIETY OF SINGAPORE

ILDS BOARD MEMBERS

María Ivonne Arellano Mendoza, Mexico

ILDS EXECUTIVE DIRECTOR

Ramesha Bhat, India Christopher Griffiths, UK

NATIONAL ORGANISING COMMITTEE

Chia Chun Ang, Changi General Hospital

Scientific Programme Scholarships Social Programme

Pan Pacific Singapore

Host: DSS - Dermatological Society of Singapore

PROFESSIONAL CONGRESS ORGANISER

TGI Singapore Pte Ltd

Registration Desk Hours:

Congress Delegate Registration Fees include:

Scientific Programme sessions are open to registered delegates only.

Accompanying Persons Registration Fees include:

Advanced Dermoscopy Half Day 5th July 2023 PM 100 SGD

Basic Dermoscopy Half Day 5th July 2023 AM 100 SGD

Chemical Peels Half Day 4 July 2023 AM

Contact Dermatitis Half Day 7th July 2023 AM 100 SGD

Motivational Interviewing in Supportive Patient Care Half Day 8 July 2023 AM

Nail surgery Half Day 5th July 2023 PM 100 SGD

Paediatric Immunodermatology Half Day 5th July 2023 PM 100 SGD

Phototherapy & Photoprotection Half Day 4 July 2023 PM

Trichoscopy Half Day 6th July 2023 AM 100 SGD

Update in Dermatopathology Full Day 6th July 2023 200 SGD

PATIENT ORGANISATIONS & DERMATOLOGY COMMUNITY VILLAGE

Registration Desk Hours:

WCD2023 Media Centre opening hours are:

PRESS CREDENTIAL ACCESS

There is an SGD 80.00 fee to issue a replacement for a lost badge.

Press is prohibited from attending:

PHOTOGRAPHY, VIDEO AND AUDIO RECORDING

Registered media are prohibited from:

WCD2023 MEDIA CENTRE USE

The Interview Room is located in Room 305 Suntec Congress Venue.

INTERPRETATION & APPLICATION OF MEDIA & PRESS GUIDELINES

SOCIAL MEDIA CHANNELS FOR WCD2023

and use the official Congress hashtag & tag: #WCD2023Singapore

WCD2023 ePOSTER AREA

POSTER ROUND SESSION

SPEAKERS’ PREVIEW ROOMS

Hall 602 will be open as follows:

Hall 605 will be open as follows:

LOST AND FOUND

MEETING ROOM CAPACITIES